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Abstract	  	  	  	  	   Cohesin	   has	   a	   well-­‐established	   role	   in	   sister	   chromatid	   cohesion	   and	  postreplicative	  DNA	  repair.	  In	  addition,	  previous	  work	  in	  our	  laboratory	  suggested	  a	  positive	  correlation	  between	  cohesin	  binding	  and	  gene	  expression	  (Parelho	  et	  al.	  2008).	  We	  decided	  to	  establish	  the	  ChIP-­‐seq	  technique	  to	  address	  the	  relationship	  between	  cohesin	  binding	  and	  gene	  expression	  at	  the	  genome-­‐wide	  level.	  However,	  in	   the	   meantime,	   several	   other	   groups	   reported	   genome-­‐wide	   binding	   maps	   of	  cohesin	   in	   embryonic	   stem	   (ES)	   cells,	   demonstrating	   cell-­‐type-­‐specific	   cohesin	  binding	  and	  its	  correlation	  with	  gene	  expression	  (Schmidt	  et	  al.	  2010;	  Kagey	  et	  al.	  2010;	  Nitzsche	  et	  al.	  2011).	  Kagey	  and	  colleagues	  argue	  that	  cohesin	  is	  required	  for	  the	  expression	  of	  pluripotency-­‐associated	  genes,	  based	  on	  cohesin	  downregulation	  for	   an	   extended	   time	   period.	   We	   believe	   this	   method	   generates	   indirect	   effects	  such	   as	   cell	   stress,	   death	   and	   enrichment	   for	   slowly	   cycling	   differentiating	   cells,	  biasing	   the	   results	   towards	   differentiated	   cells.	   We	   have	   generated	   ES	   cells	  homozygous	   for	   conditional	  Rad21	  alleles	  and	  have	   found	   that,	  unlike	   the	  Kagey	  approach,	  rapid	  24-­‐hour	  cohesin	  depletion	  does	  not	   induce	  cell	  stress	  responses.	  We	   detect	   a	   stronger	   correlation	   between	   cohesin-­‐bound	   genes	   and	   gene	  expression	   changes,	   suggesting	   our	   approach	   is	  more	   accurate	   in	   understanding	  the	  role	  of	  cohesin	  in	  gene	  expression.	  We	  have	  expanded	  our	  analysis	  of	  cohesin	  binding	   by	   generating	   ES	   cells	   expressing	   epitope-­‐tagged	   BORIS,	   a	   paralogue	   of	  CTCF.	   We	   have	   mapped	   BORIS	   binding	   sites	   in	   ES	   cells	   and	   data	   suggest	   that	  BORIS,	  unlike	  CTCF,	  does	  not	  recruit	  cohesin.	  To	  study	  the	  specific	  involvement	  of	  cohesin	  in	  gene	  expression,	  two	  developmentally	  regulated	  models,	  T	  cell	  receptor	  
α	   (Tcrα)	   rearrangement	   and	   X	   chromosome	   inactivation	   (XCI),	   have	   been	   used.	  Cohesin	   loss	   in	   non-­‐cycling	   developing	   thymocytes	   leads	   to	   impaired	   Tcrα	  rearrangement.	  Finally,	  we	  present	  evidence	   that	   cohesin	  contributes	   to	   creating	  chromatin	   boundaries	   that	   segregate	   facultative	   heterochromatin	   from	   active	  chromatin	  on	  the	  inactive	  X	  chromosome	  in	  differentiating	  female	  ES	  cells.	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  109	  Figure	   3.19	   Genomic	   region	   with	   different	   combinations	   of	   cohesin,	   CTCF	   and	  	   BORIS	  peaks.	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  Figure	   3.20	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   consensus	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   BORIS	   non-­‐CTCF	   peaks	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   half	  of	  the	  CTCF	  consensus	  sequence.	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  Figure	  3.21	  CTCF	  and	  cohesin	  binding	  does	  not	  substantially	  change	  upon	  ectopic	  	   BORIS	  expression.	   	   	   	   	   	   	   	   	  	  	  	  	  113	  Figure	   3.22	   BORIS	   binding	   does	   not	   preclude	   cohesin	   binding	   to	   non-­‐	   developmentally	  regulated	  CTCF	  sites	  at	  the	  Xic	  in	  ES	  cells.	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  Figure	  3.23	  DNA	  methylation	  statuses	  of	   the	  H19	   and	  GTL2	  DMRs	  and	   the	  BORIS	  	   promoter.	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  Figure	  3.24	  BORIS,	  expressed	  at	  endogenous	  levels,	  is	  not	  able	  to	  recruit	  cohesin	  in	  	   CTCF-­‐deficient	  ES	  cells.	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  Figure	  3.25	  Cohesin	  recruitment	  is	  impaired	  in	  CTCF-­‐deficient	  	  	   FLAG-­‐BORIS	  ES	  cells.	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  Figure	  3.26	   Increased	  binding	  of	  BORIS	  does	  not	   increase	   the	  binding	  of	   cohesin	  	   without	  changes	  in	  CTCF	  binding	  at	  cohesin	  and	  BORIS	  non-­‐CTCF	  sites.	  	  123	  Figure	  4.1	  Distribution	  of	  the	  different	  cohesin	  peak	  types	  within	  or	  	  	   close	  to	  genes.	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  133-­135	  Figure	  4.2	  Genes	  with	  shared	  cohesin	  and	  CTCF	  peaks	  tend	  to	  be	  developmentally	  	   regulated.	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  Figure	  4.3	  Genes	  with	   cell-­‐type-­‐specific	   cohesin	  and	  CTCF	  peaks	  or	   cohesin	  non-­‐	   CTCF	  peaks	  are	  cell-­‐type-­‐specifically	  expressed.	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  Figure	   4.4	   Fast	   depletion	   of	   Rad21	   after	   24h	   treatment	   of	   Rad21lox/lox	   ERt2-­‐Cre	  	   with	  4’OHT.	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Figure	  4.5	  Log2	  Fold	  Change	  distribution	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  Figure	   4.6	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   microarray	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   correlates	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   microarray	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  and	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  Figure	   4.7	   No	   correlation	   between	   genes	   with	   cohesin	   and	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  Figure	   4.8	   The	   Kagey	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   is	   enriched	   for	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   repair	  and	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   dependent.	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  Figure	  4.9.	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  Figure	   4.11	  CTCF	   and	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   and	  Tsix	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  154	  Figure	   4.12	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Figure	  4.22	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  of	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  ES-­‐derived	  neurons	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Chapter	  1:	  Introduction	  	  	  
1.1	  The	  cohesin	  complex	  	  	   Two	  major	   events	  during	   the	   cell	   cycle	   are	   at	   the	  base	  of	   cell	   growth	  and	  proliferation	  of	  all	  living	  organisms,	  DNA	  replication	  and	  mitosis.	  DNA	  replication	  is	   essential	   for	   the	   even	   passage	   of	   genetic	   information	   to	   daughter	   cells.	  Replication	   during	   the	   S	   phase	   of	   the	   cell	   cycle	   generates	   two	   identical	   sister	  chromatids	   from	   the	   parental	   chromosome.	   These	   two	   chromatids	   are	   held	  together	  and	  intertwined	  until	  mitosis.	  In	  mitosis,	  chromosomes	  are	  aligned	  at	  the	  metaphase	   plate	   so	   that	   each	   sister	   kinetochore	   is	   attached	   to	   one	  microtubule	  that	   extends	   to	   opposing	   spindle	   poles.	   Cohesive	   forces	   at	   kinetochores	   provide	  tension	   to	   microtubules	   so	   that,	   when	   these	   cohesive	   forces	   are	   broken	   down,	  chromatids	  are	  released	  and	  are	  pulled	  apart	  to	  separate	  spindle	  poles.	  This	  allows	  for	  correct	  segregation	  of	  chromatids,	  one	  to	  each	  daughter	  cell.	  	   The	   phenomenon	   by	   which	   sister	   chromatids	   are	   maintained	   together	  between	   replication	   and	   mitosis	   is	   known	   as	   sister	   chromatid	   cohesion.	   It	   is	  mediated	  by	  a	  multi-­‐subunit	  complex	  called	  cohesin	  (Losada	  et	  al.,	  1998;	  Michaelis	  et	   al.,	   1997).	   To	   investigate	   the	   molecular	   basis	   of	   sister	   chromatid	   cohesion,	  Michaelis	   and	   co-­‐workers	   screened	  Saccharomyces	   Cerevisiae	  mutants	   that	   could	  segregate	  sister	  chromatids	  in	  the	  absence	  of	  anaphase	  promoting	  complex	  (APC)	  activity;	   it	   was	   known	   by	   then	   that	   the	   loss	   of	   sister	   chromatid	   cohesion	   in	  anaphase	  was	  dependent	  on	  APC.	  In	  this	  way,	  three	  of	  the	  four	  core	  subunits	  were	  found,	  two	  belonging	  to	  the	  structural	  maintenance	  of	  chromosomes	  (Smc)	  family,	  Smc1	   and	   Smc3,	   and	   one	   named	   Scc1	   for	   sister	   chromatid	   cohesion,	   also	   called	  Rad21	   in	  mammalian	  cells	   (Michaelis	  et	  al.	  1997).	  Scc3,	   the	   fourth	  protein	  of	   the	  core	   cohesin	   complex	   was	   described	   in	   a	   later	   study	   using	   a	   similar	   technique	  (Toth	   et	   al.	   1999).	   Phenotypic	   characterisation	   of	   the	   Scc1	   and	   Scc3	   mutants	  showed	   that	   chromatids	   segregated	   prematurely,	   compared	   to	   wild	   type	   cells.	  Orthologues	   of	   the	   cohesin	   subunits	   were	   later	   reported	   in	   other	   eukaryotic	  organisms,	  such	  as	  Xenopus,	  Drosophila,	  chicken	  and	  mammals	  (Losada	  et	  al.	  1998;	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Sumara	  et	  al.	  2000;	  Sonoda	  et	  al.	  2001).	  Drosophila	  cells	  depleted	  of	  Rad21	  show	  normally	   condensed	   chromatin	   but	   prematurely	   segregated	   chromatids	   in	  metaphase.	   Injection	   of	   Rad21	   dsRNA	   into	   embryos	   copies	   the	   effects	   seen	   in	  cultured	  cells,	  although	  in	  some	  cases,	  the	  phenotypes	  are	  more	  severe,	  anaphase	  bridging,	  misalignment	  of	  chromosomes	  on	  the	  metaphase	  plate	  and	  in	  some	  cases,	  arrest	  of	  nuclear	  division	  and	  hypercondensation	  of	  chromatin	  (Vass	  et	  al.	  2003).	  Again,	  deletion	  of	  Rad21	  in	  chicken	  cells	  produces	  misalignment	  of	  chromosomes	  at	   the	  metaphase	   plate	   and	   premature	   segregation	   of	   chromatids	   (Sonoda	   et	   al.	  2001).	  Altogether,	  these	  results	  showed	  that	  in	  a	  highly	  conserved	  fashion	  across	  evolution,	   cohesin	   is	   required	   for	   sister	   chromatid	   cohesion	   and	   proper	  chromosome	  segregation	  in	  anaphase.	  	   The	   organisation	   and	   structure	   of	   the	   cohesin	   complex	   was	   firstly	  characterised	   in	   S.	   Cerevisiae	   (Haering	   et	   al.	   2002).	   The	   structure	   of	   the	   cohesin	  complex	  was	  determined	  in	  vitro	  by	  creating	  deletion	  mutants	  of	  yeast	  Smc1,	  Smc3	  and	   Scc1,	   and	   expressing	   them	   in	   insect	   cells.	   In	   combination	   with	   electron	  microscopy,	   it	  was	   deduced	   that	   Smc1	   and	   Smc3	   form	   long	   intra-­‐molecular	   and	  anti-­‐parallel	  coiled	  coils.	  They	  interact	  directly	  through	  the	  hinge	  domain,	  which	  is	  necessary	  and	  sufficient	  for	  their	  interaction,	  forming	  a	  V-­‐shaped	  structure.	  The	  N-­‐	  and	  C-­‐termini,	  at	   the	  other	  end,	   form	  a	  globular	  domain	   that	   interacts	  with	  Scc1.	  The	  N-­‐terminal	  fragment	  of	  Scc1	  interacts	  with	  the	  head	  domain	  of	  Smc3	  and	  the	  C-­‐terminal	   fragment	   with	   the	   head	   domain	   of	   Smc1.	   These	   interactions	   are	  independent	   of	   the	   Smc1/Smc3	   interactions	   at	   their	   hinge	   domains.	   As	   Scc1	   is	  unable	   to	   dimerise,	   it	   was	   proposed	   that	   Scc1	   and	   Smc3	   bridge	   at	   their	   head	  domains	  through	  one	  molecule	  of	  Scc1.	  In	  this	  sense,	  Smc1,	  Smc3	  and	  Scc1	  form	  a	  putative	   large	   ~35nm-­‐diameter	   proteinaceous	   ring	   (Figure	   1.1)(Haering	   et	   al.	  2002;	  Gruber	  et	  al.	  2003).	  In	  addition,	  Scc3	  only	  interacts	  with	  Scc1	  through	  Scc1’s	  C-­‐terminal	  domain,	  failing	  to	  immunoprecipitate	  with	  Smc1	  or	  Smc3	  in	  the	  absence	  of	  Scc1.	  Co-­‐immunoprecipitation	  of	  the	  subunits	  tagged	  with	  different	  epitopes	  did	  not	  occur,	  suggesting	  that	  the	  cohesin	  ring	  is	  composed	  of	  one	  molecule	  of	  each	  of	  the	  four	  core	  subunits	  (Haering	  et	  al.	  2002).	  In	  vitro	  studies	  of	  the	  cohesin	  subunit	  interactions	   were	   confirmed	   in	   vivo	   using	   S.	   cerevisiae	   (Gruber	   et	   al.	   2003).	  Moreover,	   the	  yeast	  Scc3	  subunit	  has	   two	  orthologues	   in	  vertebrate	  cells,	  SA1	  or	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SA2,	  which	   can	  be	   co-­‐expressed	   in	   the	   same	  cell	  but	  do	  not	   co-­‐exist	   in	   the	   same	  complex	  (A.	  Losada	  et	  al.	  2000;	  Sumara	  et	  al.	  2000).	  	  
	   	   	   	   	  
Figure	  1.1	  Ring-­like	  model	  of	  the	  cohesin	  structure.	  Smc1	   and	   Smc3	   form	   long	   anti-­‐parallel	   coiled	   coil	   structures	   that	   heterodimerise	   in	   the	   cohesin	  ring.	  They	  interact	  through	  their	  hinge	  domain	  and	  through	  Scc1	  at	  their	  other	  side.	  The	  N-­‐terminal	  domain	  of	  Scc1	  interacts	  with	  Smc3	  and	  the	  C-­‐terminal	  domain	  interacts	  with	  Smc1.	  This	  creates	  a	  closed-­‐ring	   structure.	   Scc3,	   in	   turn,	   interacts	  with	   the	   C-­‐terminal	   domain	   of	   Scc1,	   stabilising	   the	  whole	  structure.	  Adapted	  from	  Haering	  et	  al.	  2002.	  	  	   This	  model	  seemed	  very	  attractive	  to	  the	  understanding	  of	   the	  topological	  interaction	  of	  cohesin	  with	  chromatin	  and	  sister	  chromatid	  cohesion:	  entrapment	  of	  both	  sister	  chromatids	  within	  one	  ring	  would	  result	  in	  cohesion.	  Consequently,	  cohesion	  and	  subsequent	  chromosome	  segregation	  would	  be	  lost	  upon	  opening	  of	  the	   ring	  by	   separation	  of	   the	   subunits	   or	  by	  physiological	   cleavage	  of	   any	  of	   the	  cohesin	  subunits.	  	  	  
1.2.	  Functions	  of	  cohesin	  	  
	   1.2.1.	  Canonical	  roles	  
	   	   1.2.1.1.	  In	  chromosome	  cohesion	  and	  segregation	  
	  	   Loading	  of	  cohesin	  onto	  chromatin	  occurs	  in	  yeast	  at	  the	  end	  of	  G1	  while	  in	  higher	  organisms,	  it	  occurs	  at	  the	  end	  of	  telophase	  (Darwiche	  et	  al.	  1999;	  Sumara	  et	   al.	   2000;	   Gerlich	   et	   al.	   2006).	   Loading	   is	   achieved	   by	   the	   cohesin-­‐loading	  complex,	  which	  is	  formed	  of	  two	  highly	  conserved	  proteins	  called	  Scc2	  and	  Scc4	  in	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yeast,	  called	  Nipbl/Mau2	   in	  mouse	  and	  humans	  (Krantz	  et	  al.	  2004;	  Tonkin	  et	  al.	  2004;	  Seitan	  et	  al.	  2006).	  Several	  studies	   in	  S.	  cerevisiae,	  Xenopus,	  Drosophila	  and	  mammalian	  cells	  have	  shown	  that	  the	  formation	  of	  the	  soluble	  cohesin	  complex	  is	  not	   impaired	   in	   the	   absence	   of	   Scc2/Scc4	   (Arumugam	   et	   al.	   2003)	   whereas	   the	  association	   of	   cohesin	   with	   chromatin	   is	   (Ciosk	   et	   al.	   2000;	   Toth	   et	   al.	   1999;	  Takahashi	  et	  al.	  2004;	  Seitan	  et	  al.	  2006;	  Watrin	  et	  al.	  2006).	  As	  expected	  from	  a	  cohesin-­‐loading	  complex,	  temperature	  sensitive	  Scc2	  yeast	  mutants	  failed	  to	  stably	  associate	   cohesin	   with	   chromatin	   at	   the	   end	   of	   G1	   and	   showed	   premature	  chromatid	   segregation	   (Ciosk	   et	   al.	   2000).	   SiRNA-­‐mediated	   depletion	   of	   Scc4	   in	  human	   cells	   impeded	   proper	   loading	   of	   cohesin	   to	   chromatin,	   resulting	   in	   cells	  accumulating	   in	   prometaphase	   and	   precocious	   sister	   chromatin	   separation	  (Watrin	  et	  al.	  2006).	  How	  the	  Scc2/Scc4	  complex	  loads	  cohesin	  onto	  chromatin	  is	  poorly	  understood.	   It	  might	  do	   this	   through	  physically	  opening	   the	   cohesin	   ring,	  and	  permitting	  in	  this	  way	  entrapment	  of	  DNA.	  Indirectly,	  another	  way	  might	  be	  by	  modifying	  the	  chromatin	  fibre	  in	  some	  way	  that	  allows	  cohesin	  entrapment.	  Were	  the	  first	  scenario	  true,	  cohesin	  would	  physically	  interact	  with	  its	  loading	  complex.	  In	   yeast,	   several	   reports	   have	   shown	   that	   the	   Scc2/Scc4	   complex	   interacts	  with	  cohesin	   physically	   by	   Western	   Blotting	   (WB)	   of	   immunoprecipitates	   and	   mass	  spectrometry	   (Toth	   et	   al.	   1999;	   Arumugam	   et	   al.	   2003).	   In	   mouse,	   Nipbl	   co-­‐immunoprecipitates	  with	  Smc3	  (Kagey	  et	  al.	  2010).	  It	  has	  also	  been	  shown	  that	  the	  loading	  of	  cohesin	  also	  depends	  on	  the	  ATPase	  activity	  of	  the	  Smc1	  and	  Scm3	  head	  domains.	   Abolition	   of	   the	   Smc1	   ATP	   binding	   domain	   impedes	   binding	   to	   Scc1,	  demonstrating	  that	  ATP	  binding	  to	  Smc1	  is	  required	  to	  form	  the	  tripartite	  cohesin	  ring.	  Hydrolysis,	  on	  the	  other	  hand,	  is	  not	  required	  for	  the	  ring	  to	  form.	  Contrarily,	  abolition	  of	  the	  hydrolysis	  capacity,	  but	  not	  binding,	  of	  ATP	  of	  either	  the	  Smc1	  or	  Smc3	   heads	   completely	   blocked	   association	   of	   cohesin	   with	   chromosomes	  (Arumugam	   et	   al.	   2003;	   Weitzer	   et	   al.	   2003).	   It	   might	   thus	   be	   possible	   that	  Scc2/Scc4	   promotes	   loading	   of	   cohesin	   onto	   chromosomes	   by	   stimulating	   its	  ATPase	  activity	  and	  presumably	  opening	  the	  ring.	  	  	   Cohesion	  can	  only	  be	  established	  when	  DNA	  has	  been	  replicated.	  The	   fact	  that	   cohesin	   is	   loaded	   on	   chromosomes	   before	   replication	   of	   DNA,	   suggests	   two	  mechanisms	   for	   cohesion	   establishment:	   one	   is	   that	   cohesin	   is	   unloaded	   just	   in	  front	  of	   the	  replication	  machinery	  and	  then	  actively	  reloaded	  after	   its	  passage	  or	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even	  in	  G2,	  independently	  of	  replication,	  or	  that	  the	  replication	  machinery	  is	  able	  to	  pass	   through	   the	   cohesin	   ring,	   faithfully	   entrapping	   the	  newly	   replicated	  DNA	  strand	   with	   the	   template	   chromatid	   automatically	   behind	   the	   replication	   fork	  (Haering	   et	   al.	   2002).	   At	   present	   it	   is	   not	   known	   how	   exactly	   this	   is	   achieved.	  Several	   arguments	   favour	   the	   fact	   that	   cohesion	   cannot	   only	   be	   established	   by	  replication	  through	  cohesin	  rings.	  The	  idea	  that	  the	  replication	  machinery	  passes	  through	  the	  cohesin	  ring	  brings	  up	  a	  seemingly	  obvious	  counterargument,	  in	  that	  the	  machinery,	  with	   all	   its	   subunits,	  might	   simply	   be	   too	   voluminous.	   One	  well-­‐studied	  situation	  of	  replication-­‐independent	  cohesion	  takes	  place	  at	  double	  strand	  breaks	  (DSB)	  in	  G2,	  where	  DNA	  damage	  response	  pathways	  are	  activated,	  cohesin	  is	   recruited	   and	   de-­‐novo	   cohesion	   is	   established	   at	   the	   break	   point	   but	   also	  genome-­‐wide	  (see	  section	  1.2.1.2.).	  	  	   In	   addition,	   a	   great	   number	   of	   proteins	   have	   been	   involved	   in	   chromatid	  cohesion,	   but	   not	   cohesin	   loading.	   The	   discovery	   of	   the	   yeast	   acetyl	   transferase	  Eco1/Ctf7	   shed	   some	   light	   onto	   the	   actual	   cohesion	   mechanism.	   Eco1	   is	   not	  important	  for	  cohesin	  loading	  onto	  chromatin	  but	  is	  essential	  for	  sister	  chromatid	  cohesion	  (Toth	  et	  al.	  1999;	  Skibbens	  et	  al.	  1999).	  Interestingly,	  Eco1	  is	  dispensable	  for	   cohesion	   once	   it	   has	   been	   established,	   indicating	   it	   has	   a	   specific	   role	   in	  establishing	  cohesion.	  In	  accordance	  with	  this,	  depletion	  of	  ESCO1	  or	  ESCO2	  (two	  human	   orthologues	   of	   Eco1/Ctf7)	   by	   siRNA	   in	   human	   cells	   exhibits	   defective	  sister-­‐chromatid	   cohesion,	   although	   cohesin	   (Rad21)	   is	   still	   bound	   to	   chromatin	  (Hou	  et	  al.	  2005).	  Eco1/ESCO1	  is	  therefore	  called	  a	  “cohesion	  factor”,	  its	  depletion	  produces	   similar	   phenotypes	   as	   the	   cohesin	   subunit	   mutants,	   binds	   chromatin	  during	  interphase	  and	  is	  not	  required	  for	  cohesin	  binding	  to	  chromatin,	  although	  it	  is	   required	   for	   cohesion.	   Recently,	   it	  was	   shown	   that	   Eco1’s	  main	   function	   is	   to	  acetylate	   two	   lysine	   residues,	   K112	   and	   K113	   in	   yeast,	   that	   are	   located	   in	   the	  ATPase	   domain	   of	   Smc3	   (Ben-­‐Shahar	   et	   al.	   2008;	   Zhang	   et	   al.	   2008;	   Unal	   et	   al.	  2008).	  Similar	  results	  were	  reported	  in	  human	  cells	  with	  ESCO1	  and	  SMC3	  (Zhang	  et	   al.	   2008).	   	   How	   does	   the	   acetylation	   of	   Smc3	   effect	   chromatid	   cohesion?	  Discovery	   in	   S.	   pombe,	   that	   Pds5	   mutants	   can	   override	   Eco1’s	   orthologue	   Eso1	  deletion	  suggested	  that	  the	  effect	  of	  Eco1	  on	  Smc3	  was	  to	  counteract	  the	  activity	  of	  Pds5,	   that	   otherwise	   interferes	   with	   the	   establishment	   of	   sister	   chromatid	  cohesion	  during	  S	  phase	   (Tanaka	  et	  al.	  2001);	  absence	  of	   this	   “antiestablishment	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activity“	   renders	   the	   Eco1	  mutation	   redundant.	   In	   addition,	   lethality	   due	   to	   the	  absence	  of	  Eco1	  is	  suppressed	  by	  inactivation	  of	  the	  protein	  Rad61/Wpl1	  in	  yeast	  (Unal	   et	   al.	   2008)	   and	   ESCO2-­‐related	   precocious	   sister	   chromatid	   separation	  disappears	   in	   HeLa	   cells	   depleted	   for	   both	   ESCO2	   and	   WAPL,	   the	   vertebrate’s	  orthologue	  of	  yeast	  Wpl1	  (Gandhi	  et	  al.	  2006).	  Altogether,	  these	  results	  imply	  that	  sister	  chromatid	  cohesion	  can	  be	  established,	  albeit	  inefficiently,	  in	  the	  absence	  of	  Eco1,	   and	   all	   that	   Eco1	   does	   is,	   through	   acetylation	   of	   Smc3,	   hinder	  antiestablishment	   activities	   of	   Pds5	   and	   Rad61/Wapl.	   Whether	   the	   acetylated	  lysine	  residues	  on	  Smc3	  enable	  entrapment	  of	  sister	  chromatids	  or	  whether	  they	  stabilise	  entrapment	  after	  it	  has	  taken	  place	  is	  unknown.	  Recent	  work	  has	  shown	  that	   overexpression	   of	   Hos1,	   the	   Smc3	   deacetylase,	   in	   M	   phase	   cells	   produces	  rapid,	  although	  not	  complete,	  loss	  of	  acetyl	  marks	  on	  K112	  and	  K113	  (Beckouët	  et	  al.	  2010).	  This	  is	  also	  phenotypically	  followed	  by	  sister	  chromatid	  cohesion	  defects	  pointing	   then	   to	  entrapment	   stabilisation	  as	   a	   role	   for	  K112ac	  and	  K113ac.	  How	  entrapment	   is	   stabilised	   is	   not	   clear,	   possibly	   through	   the	   inhibition	   of	   ATP	  hydrolysis	  or	  by	  allowing	  binding	  of	  additional	  proteins	  that	  stabilise	  the	  cohesive	  cohesin	  complex.	  	   In	   addition,	   vertebrate	   cells	   express	   a	   protein	   called	   Sororin	   that	   is	   also	  important	   for	   chromatid	   cohesion	   (Rankin	   et	   al.	   2005;	   Schmitz	   et	   al.	   2007;	  Nishiyama	   et	   al.	   2010).	   Overexpression	   in	   Xenopus	   produces	   delayed	   chromatid	  segregation	   and	   increased	  metaphase-­‐bound	   cohesin.	   Concomitantly,	   in	   a	   recent	  report	   by	   Nishiyama	   and	   colleagues,	   depletion	   of	   Sororin	   in	   synchronised	   HeLa	  cells	   results	   in	   premature	   chromatid	   segregation	   in	   G2	   and	   even	   S	   phase	  (Nishiyama	  et	  al.	  2010).	  In	  addition,	  Sororin	  deposition	  on	  chromatin	  is	  dependent	  on	  Scc1,	  showing	   that	  Sororin	   interacts	  with	  cohesin.	  Smc3	  acetylation	  promotes	  Sororin	   recruitment	   to	   chromatin-­‐bound	   cohesin.	   The	   authors	   suggest	   that	  Sororin-­‐bound	   cohesin	   locks	   itself	   into	   a	   cohesive	   state	   during	   S	   and	  G2	  phases.	  Indeed,	  two	  distinct	  modes	  of	  cohesin	  binding	  have	  been	  described	  in	  interphase,	  one	  that	  takes	  place	  in	  G1	  when	  cohesin	  binds	  to	  chromatin	  in	  a	  dynamic	  fashion,	  the	  other	   takes	  place	   in	  G2	  where	  one	   third	   to	  half	   of	   the	   cohesin	  pool	   is	  bound	  very	  stably	  (Gerlich	  et	  al.	  2006).	  This	  suggests	  that	  stably	  bound	  cohesin	  might	  be	  cohesive	  cohesin,	  in	  that	  this	  might	  be	  Sororin-­‐bound	  cohesin	  too.	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   When	  cells	  are	  in	  mitosis,	  chromatids	  need	  to	  separate	  to	  different	  daughter	  cells,	   pulled	   away	   by	  microtubules	   attached	   to	   sister	   kinetochores	   and	   opposed	  spindle	   poles.	   Premature	   loss	   of	   cohesion	   at	   kinetochores	   (before	   microtubules	  have	  attached	  to	  them	  and	  to	  spindle	  poles)	  would	  result	  in	  lack	  of	  tension	  created	  by	   the	   opposing	   pulling	   and	   subsequent	   unequal	   segregation	   of	   chromatids,	  leading	  to	  aneuploidy	  and	  eventually	  cell	  death.	  The	  mechanisms	  by	  which	  cohesin	  dissociates	  from	  mitotic	  chromosomes	  must	  be	  tightly	  controlled.	  Cohesin	  removal	  from	   chromatin	   needs	   to	   be	   achieved	   by	   means	   of	   two	   mechanisms,	   either	   by	  dissociation	  of	  the	  complex	  in	  its	  basic	  subunits,	  or	  either	  by	  cleavage	  of	  one	  of	  the	  subunits	  and	  subsequent	  ring	  opening.	  Two	  main	  pathways	  of	  cohesin	  dissociation	  exist	   in	   eukaryotic	   cells.	   	   The	   first,	   called	   the	   prophase	   pathway,	   takes	   place	   in	  prophase	  and	  prometaphase	  of	  insect	  and	  vertebrate	  cells,	  when	  almost	  all	  cohesin	  complexes	  are	  lost	  from	  chromatid	  arms,	  but	  not	  at	  centromeres	  and	  is	  cleavage-­‐independent,	  at	  least	  of	  Scc1	  (Warren	  et	  al.	  2000;	  Waizenegger	  et	  al.	  2000;	  Gerlich	  et	  al.	  2006).	  It	  depends	  mainly	  on	  Plk1	  and	  Wapl	  (Ana	  Losada	  et	  al.	  2002;	  Sumara	  et	   al.	   2002;	   Gandhi	   et	   al.	   2006;	   Kueng	   et	   al.	   2006).	   The	   kinase	   activity	   of	   Plk1	  induces	   cohesin	   dissociation	   in	   mitosis.	   The	   mechanistic	   basis	   involves	   Scc1	  and/or	  SA1/2.	  Levels	  of	  phosphorylated	   forms	  of	  Scc1	  and	  SA1/2	  decrease	  upon	  depletion	  of	  Plk1	  in	  Xenopus	  mitotic	  extracts	  (Sumara	  et	  al.	  2002;	  Giménez-­‐Abián	  et	   al.	   2004).	   The	   effect	   of	   Wapl	   depletion	   is	   more	   dramatic	   than	   Plk1.	   Wapl	  depletion	  in	  HeLa	  cells	  translates	  in	  an	  accumulation	  of	  cells	  at	  the	  prometaphase	  stage	  with	  poorly	  resolved	  chromatids	  and	  high	  levels	  of	  cohesin	  on	  chromosomes	  whereas	  Wapl	  overexpression	  produces	  premature	  chromatid	  separation	  (Gandhi	  et	   al.	   2006).	   As	   stated	   before,	   Sororin	   depletion	   causes	   premature	   chromatid	  segregation	   and,	   on	   the	   contrary,	   Wapl	   depletion	   causes	   delayed	   chromatid	  segregation.	   A	   recent	   study	   shows	   that	   double	   depletion	   of	   Wapl	   and	   Sororin	  results	   in	   the	  same	  phenotype	  as	  sole	  depletion	  of	  Wapl,	   suggesting	   that	  Sororin	  antagonises	  Wapl	   (Nishiyama	  et	  al.	  2010).	  Sororin	  and	  Wapl	   share	  a	   similar	  FGF	  sequence	  motif	  that	  is	  able	  to	  bind	  Pds5.	  The	  authors	  propose	  the	  model	  whereby,	  within	  the	  cohesin	  complex,	  Sororin	  stabilises	  cohesin	  interaction	  with	  chromatin	  in	  S	  and	  G2	  phases	  by	  binding	  to	  Pds5	  and	  preventing	  Pds5’s	  binding	  with	  Wapl.	  Moreover,	   phosphorylation	   of	   Sororin	   upon	   entry	   into	  mitosis	   inactivates	   it	   and	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that	   enables	  Wapl-­‐mediated	   release	   of	   cohesin	   from	   chromatids	   in	   prophase.	   In	  fact,	  depletion	  of	  Wapl	   in	   interphase	  causes	  an	   increase	   in	   the	  residence	   time	  on	  chromosomes	   of	   the	   dynamically	   bound	   cohesin	   in	   G2	   (Kueng	   et	   al.	   2006).	  Altogether,	   this	   suggests	   that	   Wapl	   promotes	   cohesin	   dissociation	   in	   G2	   and	  prophase	   and	   that	   this	   antiestablishment	   capacity	   is	   antagonised	   by	   Sororin,	  protecting	  cohesin	  from	  removal	  until	  prophase.	  	   The	  second	  pathway	  takes	  place	   later	   in	  mitosis,	  at	   the	  onset	  of	  anaphase,	  when	   all	   remaining	   cohesin	   complexes	   are	   lost,	   mainly	   from	   centromeres,	   by	  cleavage	  of	  the	  Scc1	  subunit	  by	  separase	  (Uhlmann	  et	  al.	  1999;	  Waizenegger	  et	  al.	  2000).	  Work	  by	  Uhlmann	  and	  colleagues	  showed	  in	  budding	  yeast	  that	  expression	  of	  a	  non-­‐cleavable	  version	  of	  Scc1	  prevents	  its	  dissociation	  from	  chromosomes	  and	  sister	   chromatid	   separation,	   resulting	   in	  aneuploidic	   cells	   (Uhlmann	  et	   al.	  1999).	  Non-­‐cleavable	   Rad21	   in	   human	   cells	   results	   in	   a	   similar	   phenotype	   (Hauf	   et	   al.	  2001).	  The	  proper	  functioning	  of	  separase	  is	  controlled	  by	  securin	  by	  binding	  to	  it	  and	   keeping	   it	   inactive.	   Upon	   biorientation	   of	   chromosomes	   and	   attachment	   of	  microtubules	   to	   opposite	   sister	   kinetochores,	   the	   APC	   targets	   securin	   for	  degradation,	  releasing	  separase	  from	  its	  inhibition,	  allowing	  it	  to	  cleave	  Scc1	  along	  chromosome	  arms	  in	  yeast	  and	  at	  centromeres	  in	  vertebrate	  cells	  (Waizenegger	  et	  al.	  2000;	  Hauf	  et	  al.	  2001;	  Waizenegger	  et	  al.	  2002).	  Accordingly,	  levels	  of	  separase	  are	  low	  in	  interphase	  and	  gradually	  increase	  in	  mitosis	  until	  early	  anaphase,	  when	  cleavage	   products	   of	   Scc1	   are	   detected	   (Waizenegger	   et	   al.	   2000).	   	   Securin	  degradation	   also	   occurs	   at	   late	   metaphase-­‐early	   anaphase,	   when	   separase	   is	  activated.	   Further	   more,	   separase	   null	   mutations	   are	   embryonic	   lethal	   between	  E3.5	   and	  E8.5	   and	   result	   in	   cells	   not	   being	   able	   to	   separate	   sister	   chromatids	   at	  their	  centromeres,	  although	  intact	  separated	  chromosome	  arms	  in	  metaphase	  are	  seen,	  suggesting	  that	  separase	  is	  critical	  for	  Scc1	  cleavage	  at	  centromeres	  (Kumada	  et	  al.	  2006;	  Wirth	  et	  al.	  2006).	  No	  data	  up	   to	  date	   in	  vertebrate	  cells	  proves	   that	  Scc1	  cleavage	  by	  separase	   is	  sufficient	   for	  chromatid	  dissociation	  along	   the	  arms	  and	   at	   centromeres,	   although	  data	   suggests	   this	   is	   the	   case,	   since	   inactivation	  of	  the	  prophase	  pathway	  by	  Wapl	  depletion	   in	  mammalian	   cells	   results	   in	   the	   cells	  being	  able	  to	  proceed	  to	  anaphase	  with	  more	  cohesin	  bound	  to	  chromatids.	  At	  this	  point,	   cohesin	   complexes	   disappear	   from	   chromosomes	   and	   eventually	   Wapl-­‐depleted	   cells	   separate	   chromosomes,	   presumably,	   due	   to	   activation	   of	   separase	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(Kueng	   et	   al.	   2006).	   This	   suggests	   separase	   is	   able	   to	   cleave	   increased	   levels	   of	  chromatin-­‐bound	  cohesin	  if	  the	  prophase	  pathway	  is	  inactivated.	  In	  yeast,	  only	  the	  separase	   pathway	   is	   present	   and	   all	   cohesin	   complexes	   dissociate	   from	  chromosomes	  by	  cleavage	  of	  Scc1	  in	  the	  metaphase-­‐anaphase	  transition.	  	   One	   of	   the	   outcomes	   of	   removal	   of	   cohesin	   from	   chromosome	   arms	   in	  metazoans	   in	   a	   cleavage-­‐independent	   manner	   is	   that	   cohesin	   subunits	   remain	  intact	  during	  mitosis	  and	  enables	  cells	  to	  reload	  all	  that	  pool	  on	  chromosomes	  as	  early	   as	   telophase.	   This	   results	   in	   cohesin	   being	   already	   loaded	   on	   chromatin	  before	   G1	   or	   in	   early	   G1.	   Why	   would	   cohesin	   be	   loaded	   as	   early	   as	   G1	   onto	  chromatin	  when	  no	  cohesion	  exists?	  This	  question	  suggests	  that	  cohesin	  might	  be	  moonlighting	  during	  interphase.	  	  	  	   	   1.2.1.2.	  In	  DNA	  repair	  	  	   Rad21	   was	   firstly	   discovered	   in	   S.	   pombe	   in	   a	   screen	   for	   mutants	   that	  showed	   hypersensitivity	   to	   radiation-­‐induced	  DNA	  damage	   suggesting	   a	   role	   for	  cohesin	   in	  DNA	  damage	   repair	   (Birkenbihl	   et	   al.	   1992).	   In	   addition,	   temperature	  sensitive	  mutants	  of	  Scc1	  showed	  that	  sole	  expression	  of	  Scc1	  after	  S	  phase	  does	  not	   restore	   DNA	   repair	   ability	   and	   that	   cohesion	   is	   also	   required	   (Sjögren	   et	   al.	  2001).	  Work	  by	  two	  groups	  demonstrated	  that	  a	  single	  double	  strand	  break	  (DSB)	  created	  with	   the	  HO	   endonuclease	   at	   an	   artificially	   introduced	  HO	   endonuclease	  site	   in	   S.	   cerevisiae,	   actively	   recruits	   cohesin	   to	   a	   50-­‐100kb	  window	   around	   the	  DSB	  and	  that	  this	  process	  is	  Scc2/Scc4-­‐dependent	  suggesting	  that	  active	  loading	  of	  cohesin	   is	   needed	   for	   this	   recruitment	   (Ström	   et	   al.	   2004;	   Unal	   et	   al.	   2004).	  Furthermore,	   Ström	   and	   co-­‐workers	   demonstrated	   that	   DSBs	   draw	   cohesion	   of	  sister	  chromatids	  in	  G2	  and	  that	  cohesion	  is	  necessary	  for	  DSB	  repair.	  The	  fact	  that	  cohesin	   is	   actively	   recruited	   to	  DSBs	   and	   that	   cohesion	   is	   needed	  was	   critical	   to	  understand	   that	  de	  novo	  cohesion	  could	  occur	   in	  a	  DNA	  replication-­‐independent	  manner,	  outside	  of	  S	  phase.	  Later,	  it	  was	  clearly	  demonstrated	  that	  cohesin	  loaded	  onto	   G2	   chromatids	   is	   able	   to	   create	   cohesion	   at	   DSBs	   and,	   surprisingly,	   that	  cohesion	   is	  reinforced	  genome-­‐wide,	  something	   that	  also	  happens	   in	  mammalian	  cells	   (Ström	  et	  al.	  2007;	  Kim	  et	  al.	  2010).	  G2-­‐cells	  have	  no	  replication	  machinery	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assembled	   on	   unbroken	   chromosomes.	   This	   automatically	   suggested	   that	   the	  reinforcement	  of	  cohesion	  genome-­‐wide	  is	  replication-­‐independent.	  However,	  how	  does	  the	  DSB	  signal	  cohesin	  for	  recruitment	  and	  cohesion?	  Work	  by	  the	  Koshland	  group	  showed	  that	  cohesin	  recruitment	  to	  DSB	  is	  dependent	  on	  phosphorylation	  of	  H2AX	   (γ-­‐H2AX),	  which	   is	   in	   turn	   dependent	   on	   two	   critical	   kinases	   of	   the	   DNA-­‐damage	   checkpoint	   response,	   Mec1	   and	   Tel1	   (Unal	   et	   al.	   2004).	   A	   non-­‐phosphorylatable	   version	   of	   H2AX	   precludes	   DSB-­‐induced	   cohesin	   binding.	  Furthermore,	   Mec1	   activates	   Chk1	   that	   in	   turn	   phosphorylates	   Scc1	   in	   residue	  Serine	   83	   in	   vitro	   (Heidinger-­‐Pauli	   et	   al.	   2008).	   Indeed,	   inactivation	   of	   Chk1	  abolishes	  DSB-­‐induced	   cohesion	  but	  not	   cohesin	  binding	   and	  mutation	  of	   S83	   to	  S83A	  blocks	  cohesion	  generation.	  Mimicking	  phosphorylation	  by	  mutating	  S83	  to	  S83D	  bypasses	  the	  need	  of	  Chk1	  and	  even	  DSB.	  Moreover,	  Eco1	  mutants,	  which	  are	  able	   to	   load	  cohesin	  onto	  chromosomes	  but	   fail	   to	  establish	  cohesion,	  also	   fail	   to	  repair	  DSB	  suggesting	  that	  Eco1	  is	  necessary	  for	  the	  establishment	  of	  cohesion	  at	  DNA	  damage	  sites	   (Sjögren	  et	  al.	  2001).	   It	  was	   further	  demonstrated	   that	  Eco1’s	  acetyltransferase	   activity	   is	   required	   for	   DSB-­‐induced	   cohesion	   and	   that	   Eco1	  acetylates	   Scc1	   residues	   K84	   and	   K210	   upon	   phosphorylation	   of	   S83	   by	   Chk1	  (Unal	  et	  al.	  2007).	  Again,	  mutations	  to	  the	  non-­‐acetylatable	  residue	  arginine	  at	  K84	  and	  K210	  prevent	  cohesion.	  As	  already	  stated,	  Eco1	  activity	  on	  Smc3	  antagonises	  Wpl1	  in	  budding	  yeast.	  Heidinger-­‐Pauli	  and	  co-­‐workers	  showed	  that	  acetylation	  of	  K84	  and	  K210	  also	  hinders	  the	  antiestablishment	  activity	  of	  Wpl1	  suggesting	  that	  Eco1	  antagonises	  Wpl1	  through	  acetylation	  of	  Smc3	  at	  residues	  K112	  and	  K113	  for	  S-­‐phase	   cohesion	   and	   Scc1	   at	   residues	   K84	   and	  K210	   for	   DSB-­‐induced	   cohesion	  (Heidinger-­‐Pauli	  et	  al.	  2009).	  	   In	  human	  cells,	  acetylation	  or	  phosphorylation	  of	  Scc1	  (Rad21)	  has	  not	  been	  detected	   or	   is	   even	   inexistent	   (Kim	   et	   al.	   2010).	   On	   the	   other	   hand,	  posttranslational	  modifications	  of	  SMC1	  at	  S957	  and	  S966	  and	  SMC3	  at	  S1083	  have	  turned	   out	   to	   be	   critical	   for	   DSB	   repair.	   DSBs	   produce	   an	   increase	   of	  phosphorylation	   of	   SMC1	   and	   SCM3	   that	   is	   ATM	   dependent	   which	   results	   in	  increased	  cohesion	  of	  sister	  chromatids,	   in	  a	  similar	  manner	  as	  happens	   in	  yeast	  with	   Scc1’s	   phosphorylation	   and	   acetylation.	   How	   phosphorylation	   of	   SMC1	   and	  SMC3	   are	   mechanistically	   involved	   in	   DNA	   repair	   is	   currently	   unknown.	   Very	  speculative	   models	   propose	   that	   the	   SMC3S1083	   is	   in	   some	   way	   capable	   of	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modulating	   ATP	   hydrolysis	   due	   to	   the	   close	   proximity	   of	   S1083	   and	   the	   ATP	  hydrolysis	   pocket.	   Other	   models	   propose	   a	   similar	   mechanism	   as	   in	   yeast	   cells	  through	   PDS5-­‐WAPL,	   although	   no	   proof	   up	   to	   date	   has	   been	   brought	   up	   in	  vertebrate	  cells.	  	   On	   the	   whole,	   apart	   from	   its	   canonical	   role	   in	   chromatid	   cohesion	   and	  segregation,	  cohesin	  is	  essential	  for	  enhanced	  sister	  chromatid	  cohesion	  at	  sites	  of	  DSB	   where	   it	   is	   regulated	   by	   a	   complicated	   network	   of	   posttranslational	  modifications.	  	  	  	   1.2.2.	  Non-­canonical	  role	  in	  gene	  expression	  
	   	   1.2.2.1.	  In	  model	  organisms	  	  	   Indications	   of	   cohesin’s	   involvement	   in	   processes	   other	   than	   chromatid	  cohesion	  and	  DNA	  repair	  arose	  a	  decade	  ago	  in	  model	  organisms.	  In	  S.	  cerevisiae,	  the	  HMR	  mating-­‐type	  locus	  is	  transcriptionally	  silent	  thanks	  to	  the	  presence	  of	  two	  silencers	  that	  act	  as	  recruiting	  beacons	  for	  the	  Sir	  proteins.	  The	  normal	  functions	  of	  boundary	  elements	  that	  flank	  the	  hidden	  MAT	  right	  (HMR)	  locus	  to	  avoid	  spread	  of	   heterochromatin	   into	   neighbouring	   active	   areas	   were	   compromised	   by	  mutations	   in	   Smc1	   and	   Smc3	   (Donze	   et	   al.	   1999).	   Indeed,	   work	   in	   yeast	  demonstrated	   that	   cohesin	   deposition	   on	   chromosomes	   is	   not	   random.	   Cohesin	  strongly	  binds	  pericentromeric	  regions,	  concordant	  with	  the	  model	  of	  centromeric	  cohesion	  between	  sister	  chromatids	  before	  they	  are	  pulled	  apart	  by	  microtubules	  attached	  to	  opposing	  spindle	  poles.	  Nevertheless,	  most	  of	  the	  cohesin	  binding	  sites	  are	  found	  between	  convergently	  transcribed	  genes	  (Glynn	  et	  al.	  2004;	  Lengronne	  et	   al.	   2004).	   In	   this	   sense,	   cohesin	   binding	   seems	   incompatible	   with	   gene	  transcription	   in	   yeast	   (Lengronne	   et	   al.	   2004).	   Removal	   of	   the	   STE2	   promoter	  results	  in	  a	  loss	  of	  cohesin	  accumulation	  at	  its	  3’	  end.	  In	  addition,	  the	  HSP30	  gene	  is	  covered	   by	   cohesin	   at	   23ºC	  when	   the	   gene	   is	   inactive,	   upon	   transferral	   to	   37ºC,	  
HSP30	  is	  activated	  and	  cohesin	  binding	  is	  lost	  from	  the	  gene.	  Conversely,	  SRO9	  is	  expressed	   at	   23ºC	   and	   cohesin-­‐free	   but	   upon	   transfer	   to	   higher	   temperatures,	   it	  becomes	  repressed	  and	  binds	  cohesin.	  Using	  synchronised	  cells,	  it	  was	  shown	  that	  cohesin	  is	  loaded	  at	  Scc2/Scc4	  sites	  and	  subsequently,	  cohesin	  is	  relocated	  to	  new	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sites	   between	   transcriptionally	   convergent	   genes,	   “pushed”	   by	   the	   RNA	  transcription	   machinery	   (Lengronne	   et	   al.	   2004).	   In	   S.	   pombe,	   a	   similar	   picture	  occurs.	   In	   an	   elegant	   report,	   Gullerova	   and	   Proudfoot	   analysed	   the	   binding	   of	  cohesin	   at	   three	   convergent	   gene	   pairs	   (Gullerova	   et	   al.	   2008).	   Surprisingly,	  overlapping	   transcripts	   in	   between	   the	   paired	   genes	   and	   cohesin	   binding	   were	  observed.	  This	  was	  partly	  unexpected	  in	  light	  of	  the	  Lengronne	  study.	  The	  authors	  found	   that	   overlapping	   transcripts	   were	   abolished	   in	   G2	   if	   both	   genes	   were	  transcribed.	   Conversely,	   if	   one	   of	   the	   convergent	   genes	   is	   not	   transcribed,	   read-­‐through	   transcription	   of	   its	   partner	   gene	   overlaps	   with	   its	   open	   reading	   frame	  (ORF).	  Using	  a	  temperature-­‐sensitive	  Rad21	  mutant,	  the	  authors	  found	  that	  upon	  Rad21	  inactivation,	  readthrough	  transcription	  between	  convergently	  active	  genes	  also	   occurred	   in	  G2	   and	   concluded	   that	   cohesin	   acts	   as	   transcription	   terminator	  between	  transcriptionally	  active	  convergent	  genes.	  	  	   Intensive	   work	   in	  Drosophila	   has	   implicated	   the	   cohesin	   complex	   and	   its	  loading	   factor	   Nipped-­‐B	   (homologue	   of	   yeast	   Scc2)	   in	   the	   regulation	   of	  evolutionary	   conserved	   genes	   and	   developmental	   pathways.	   Screens	   for	   factors	  involved	  in	  long-­‐range	  enhancer-­‐promoter	  interactions	  found	  that	  Nipped-­‐B	  loss-­‐of-­‐function	  mutants	   diminished	   expression	   of	   the	   cut	   gene	   (Rollins	   et	   al.	   1999).	  The	  cut	  gene	   is	  activated	   in	  wing	  margin	  precursor	  cells	  and	   is	  controlled	  by	   the	  wing	   margin	   enhancer,	   wme,	   which	   is	   positioned	   80Kb	   upstream	   of	   the	   cut	  transcription	   start	   site	   (TSS).	   Control	   of	   cut	   by	   wme	   can	   be	   impeded	   by	   the	  insertion	  of	  an	  insulator	  sequence	  gypsy	  that	  binds	  the	  insulator	  protein	  Su(Hw).	  The	  phenotype	  arising	  from	  the	  insertion	  of	  a	  gypsy	  sequence	  is	  partially	  rescued	  with	  the	  presence	  of	  a	  weak	  Su(Hw).	  In	  this	  scenario,	  loss	  of	  function	  mutation	  of	  Nipped-­‐B	  magnifies	   the	   effect	   of	   the	  weak	   su(Hw),	   decreasing	   the	   expression	   of	  
cut.	  Moreover,	   heterozygous	  Nipped-­‐B	  mutations	   also	   result	   in	   a	  decrease	   in	  cut	  expression	   in	   the	   absence	   of	   the	   gypsy	   insulator.	   The	   authors	   hypothesised	   that	  Nipped-­‐B	   was	   important	   for	   long-­‐range	   enhancer-­‐promoter	   interactions.	  Moreover,	   Nipped-­‐B	   heterozygous	   mutants	   are	   viable	   and	   do	   not	   show	  chromosomal	  defects.	  Only	  homozygous	  mutants	  exhibit	  sister	  chromatid	  cohesion	  defects	   (Rollins	   et	   al.	   2004).	   In	   this	   sense,	   mRNA	   levels	   of	   Nipped-­‐B	   in	  heterozygous	  mutants	  are	  only	  reduced	  to	  80%	  of	  the	  wild-­‐type	  levels,	  suggesting	  that	  a	  reduction	  of	  20%	  is	  sufficient	  to	  misregulate	  the	  cut	  gene	  but	  is	  insufficient	  
 27	  
to	  affect	  sister	  chromatid	  cohesion.	  Being	  Nipped-­‐B	  implicated	  in	  sister	  chromatid	  cohesion,	  the	  question	  of	  whether	  cohesin	  is	  also	  involved	  in	  the	  regulation	  of	  the	  
cut	   gene	   was	   raised.	   Contrarily	   to	   Nipped-­‐B,	   reduction	   of	   Smc1,	   SA	   or	   Rad21	  resulted	  in	  an	  increase	  in	  cut	  expression	  (Rollins	  et	  al.	  2004).	  This	  suggested	  that	  cohesin	  was	   acting	   as	   an	   insulator	   between	   the	   enhancer	   and	   the	   cut	   promoter.	  The	  authors	  hypothesised	  that	  interaction	  with	  Nipped-­‐B	  would	  unload	  it	  from	  its	  binding	  site	  and	  thus	  result	  in	  gene	  activation.	  In	  this	  way,	  reduction	  of	  Nipped-­‐B	  would	   hinder	   removal	   of	   cohesin	   from	   chromatin	   and	   thus	   reduce	   gene	   activity.	  Nipped-­‐B	  would	   in	   this	  way	  be	  necessary	   for	  a	  dynamic	  equilibrium	  of	  unloaded	  versus	  loaded	  cohesin	  at	  the	  cut	  locus.	  Later,	  a	  role	  for	  cohesin	  in	  gene	  expression	  in	   a	   different	   system	   in	   Drosophila	   was	   described.	   Post-­‐mitotic	   Drosophila	  mushroom	  body	  g	  neurons	  express	  cohesin	  and	  are	  postmitotic,	  meaning	  they	  will	  not	   undergo	   DNA	   replication	   anymore	   and	   thus	  will	   not	   need	   cohesin	   for	   sister	  chromatid	   cohesion,	   pointing	   to	   an	   additional	   role	   of	   cohesin	   in	   these	   neurons	  (Schuldiner	  et	  al.	  2008).	  Indeed,	  mutations	  in	  SMC1	  and	  SA	  disrupts	  axon	  pruning	  and	  can	  be	  rescued	  by	  re-­‐expressing	  wild-­‐type	  SMC1.	  This	  suggests	  that	  cohesin	  is	  involved	   in	   axon	   pruning	   independently	   of	   cell	   proliferation.	   These	   results	  were	  also	  confirmed	  using	  an	  engineered	  Rad21	  protein	  containing	  a	  TEV	  protease	  site	  (Pauli	  et	  al.	  2008).	  Co-­‐expression	  of	  TEV	  and	  Rad21TEV	  in	  g	  neurons	  caused	  severe	  defects	   in	   pruning	   and	   also	   resulted	   in	   lethality.	  Mechanistically,	   it	   is	   likely	   that	  cohesin	   regulates	   the	   expression	   of	   the	   ecdysone	   receptor	   (EcR)	   gene	   as	   EcR	  protein	   levels	   were	   significantly	   reduced	   in	   Smc1	  mutant	   cells.	   EcR	   is	   a	   master	  gene	   that	   regulates	   axon	   pruning.	   Ectopic	   EcR	   expression	   in	   Smc1	   mutant	  postmitotic	  neurons	   rescued	   the	  Smc1	  mutant	  phenotype.	   Several	  other	   types	  of	  neurons	   in	   Drosophila	   were	   affected	   by	   deletion	   of	   one	   of	   the	   cohesin	   subunits	  (Schuldiner	  et	  al.	  2008;	  Pauli	  et	  al.	  2008).	  In	  addition,	  expression	  of	  TEV	  protease	  and	   Rad21TEV	   in	   terminally	   differentiated	   Drosophila	   salivary	   glands	   results,	  within	  a	  few	  hours,	  in	  misregulation	  of	  a	  set	  of	  genes,	  also	  ecdysone	  targets	  (Pauli	  et	  al.	  2010).	  Moreover,	  genome-­‐wide	  mapping	  of	  cohesin	  binding	  in	  three	  different	  
Drosophila	   cell	   lines	   showed	   that	   cohesin	   and	   Nipped-­‐B	   broadly	   overlap	   on	  chromosomes	   (Misulovin	   et	   al.	   2008).	   In	   sharp	   contrast	   to	   yeast,	   cohesin	  preferentially	  binds	  to	  actively	  transcribed	  gene	  units.	  Cohesin	  and	  Nipped-­‐B	  bind	  less	   to	   intergenic	   regions	   than	   to	   genes	   and	  within	   genes	   shows	   preference	   for	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introns	  and	  5’	  untranslated	  regions	  (UTRs).	  Binding	  of	  cohesin	  and	  Nipped-­‐B	  to	  the	  
Abd-­B	  gene	  occurred	  only	  in	  cells	  where	  Abd-­B	  is	  active.	  Moreover,	  the	  majority	  of	  the	   genes	   enriched	   for	   the	   Enhancer	   of	   zeste	   Polycomb	   group	   silencing	   protein	  which	   methylates	   H3K27	   and	   whose	   binding	   correlates	   with	   gene	   repression,	  showed	   little	   binding	   of	   cohesin	   and	   Nipped-­‐B	   (Misulovin	   et	   al.	   2008).	   A	  subsequent	   study	   correlated	   the	   binding	   of	   cohesin	   and	   Nipped-­‐B	   with	   gene	  expression	  microarrays	  resulting	   from	  cohesin	  or	  Nipped-­‐B	  RNAi	  depletions	   in	  a	  cell	  line	  derived	  from	  the	  central	  nervous	  system	  of	  Drosophila	  (Schaaf	  et	  al.	  2009).	  Out	  of	  the	  340	  genes	  that	  increase	  in	  expression,	  189	  (57%)	  are	  bound	  by	  cohesin,	  whereas	  out	  of	  the	  407	  genes	  that	  decrease,	  146	  (36%)	  are	  bound	  suggesting	  that	  cohesin	   has	   a	   more	   repressive	   effect	   than	   an	   activating	   effect.	   These	   studies	  demonstrated	   firstly	   that	   cohesin	   deposition	   in	   Drosophila	   is	   completely	  compatible	  with	  gene	  expression,	  conversely	   to	  yeast,	  and	  secondly,	   that	  cohesin	  deposition	  correlates	  with	  actively	  transcribed	  genes,	  again	  confirming	  the	  role	  of	  cohesin	  in	  gene	  expression.	  	   In	  zebrafish,	  a	  genetic	  screen	   identified	  Rad21	  as	  being	  essential	   for	  Runx	  expression.	  A	  non-­‐sense	  mutation	  in	  Rad21	  resulted	  in	  depletion	  of	  Runx1	  and	  loss	  of	  Runx3	  expression	  from	  the	  early	  hematopoietic	  cells	  (Horsfield	  et	  al.	  2007).	  This	  was	  not	  due	  to	  cell	  death	  as	  a	  consequence	  of	  Rad21	  absence	  since	  the	  cells	  were	  present	  and	  expressed	  the	  Runx1	  and	  Runx3	  binding	  partner	  Cbfb.	  Heterozygous	  Rad21	   mutants	   also	   showed	   a	   decrease	   in	   Runx1	   expression,	   suggesting,	   as	   in	  Drosophila,	  that	  regulation	  of	  gene	  expression	  by	  cohesin	  is	  dosage	  dependent.	  	  	   Work	   in	   PDS5B	   deficient	   mice	   has	   shown	   that	   the	   cohesin-­‐associated	  protein	  PDS5B	   is	   critical	   for	  development	   (Zhang	  et	  al.	  2007).	  Pds5b-­‐/-­‐	  mice	  died	  shortly	  after	  birth	  and	  showed	  a	  wide	  range	  of	  developmental	  disorders,	  such	  as	  growth	  retardation,	  cleft	  palate,	  heart	  defects,	  fusion	  of	  ribs,	  abnormal	  peripheral	  nervous	   system	   development,	   primordial	   germ	   cell	   deficiency,	   etc.	   Surprisingly,	  these	   disorders	   are	   not	   accompanied	   by	   sister	   chromatid	   cohesin	   defects.	   In	  addition,	   mice	   heterozygous	   for	   Nipbl	   also	   show	   widespread	   defects,	   such	   as	  abnormal	   heart	   and	   bone	   development,	   craniofacial	   abnormalities,	   reduced	  growth,	   reduced	   adiposity,	   impaired	   hearing,	   etc.	   Reminiscent	   of	   Drosophila,	  mRNA	   and	   protein	   levels	   were	   reduced	   by	   only	   25-­‐30%,	   and	   since,	   precocious	  sister	  chromatid	  separation	  was	  not	  detected,	   the	  authors	  postulate	   that	  Nipbl	   is	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involved	   in	   gene	   regulation	   (Kawauchi	   et	   al.	   2009).	   Indeed,	   gene	   expression	  analysis	   of	  Nipbl+/-­‐	   embryonic	   day	   13.5	   brains	   showed	   that	   978	   genes	   in	   brain	  were	  misregulated,	  although	  moderately	  (97.5%	  of	  the	  changing	  genes	  show	  less	  than	  a	  1.5-­‐fold	  change	  compared	  to	  wild	  type).	  Whether	  these	  targets	  are	  primary	  or	  are	  due	  to	  downstream	  effects	  of	  gene	  misregulation	  is	  unknown.	  	  	   Altogether,	   these	   results	   suggest	   that	   cohesin	   and	   cohesin-­‐associated	  proteins	   are	   important	   for	   gene	   expression	   and	   proper	   development	   of	   model	  organisms	  in	  a	  mitotic	  independent	  manner.	  	  	  	   	   1.2.2.2.	  In	  humans	  	  	   Cohesin	   and	   cohesin-­‐associated	   protein	   defects	   have	   also	   been	   linked	   to	  developmental	   disorders	   in	   humans.	   Cornelia	   de	   Lange	   syndrome	   (CdLS)	   has	   a	  wide	  spectrum	  of	  severity,	  ranging	  from	  mild	  as	  a	  result	  of	  mutations	  in	  SMC1	  and	  
SMC3	  and	  more	  severe	  in	  case	  of	  mutations	  in	  NIPBL	  (50%	  of	  the	  cases)(Krantz	  et	  al.	  2004;	  Tonkin	  et	  al.	  2004;	  Musio	  et	  al.	  2006;	  Deardorff	  et	  al.	  2007).	  CdLS	  patients	  exhibit	  abnormalities	  in	  their	  facial	  structure,	  gastroesophageal	  and	  genitourinary	  systems,	  bone	  structure,	  hearing	  impairment	  and	  mental	  and	  growth	  retardation.	  The	   incidence	   is	  one	  case	  per	  10,000-­‐50,000	  births	  and	  most	  cases	  are	  sporadic.	  Severe	  developmental	  abnormalities	  in	  CdLS	  patients	  were	  linked	  to	  mutations	  in	  
NIPBL,	   which	   predict	   a	   truncated	   protein,	   although	   this	   has	   not	   been	   proven	  (Krantz	  et	  al.	  2004).	  Heterozygous	  loss	  or	  altered	  function	  of	  NIPBL	  might	  be	  the	  cause	  of	  half	  of	   the	  severe	  CdLS	  phenotypes	  (Tonkin	  et	  al.	  2004).	  Moreover,	  a	  de	  
novo	   insertion-­‐deletion	  in	  exon	  1	  of	  NIPBL	  was	  found	  in	  a	  mildly	  affected	  patient	  and	  her	   father	   (Borck	   et	   al.	   2006).	  Analysis	   of	  mRNA	   levels	   of	  NIPBL	   in	   isolated	  lymphocytes	  from	  the	  patients	  showed	  that	  even	  a	  15%	  decrease	  in	  mRNA	  levels	  of	  NIPBL	  results	  in	  mild	  CdLS	  symptoms.	  This	  again	  is	  in	  agreement	  with	  results	  in	  
Drosophila	  and	  mouse,	  where	  phenotypes	  are	  noticeable	  with	  a	  30%	  reduction	  in	  mRNA	  and	  protein	  levels.	  The	  mutation	  is	  found	  in	  a	  highly	  conserved	  region	  of	  the	  5’-­‐UTR	  of	  NIPBL	  suggesting	  it	  disrupts	  a	  regulatory	  sequence.	  Missense	  mutations	  in	  SMC1	   cause	  mild	   cases	   in	  a	  CdLS-­‐affected	   family	   that	   lack	  mutations	   in	  NIPBL	  (Musio	   et	   al.	   2006).	   The	   protein	   framework	   is	   maintained	   and	   the	   protein	   is	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expressed	   at	   normal	   levels	   in	   peripheral	   blood	   lymphocytes.	   Another	   study	  described	   a	   large	   list	   of	   mildly	   affected	   CdLS	   individuals	   with	   several	   other	  mutations	   in	   SMC1	   or	   SMC3,	   all	   affecting	   evolutionarily	   conserved	   amino	   acids,	  some	  of	   them	  close	   to	   the	  hinge	  domain	  and	  others	   to	   the	  head	  domain	  of	  SMC1	  (Deardorff	  et	  al.	  2007).	  These	  mutations	  could	  modify	  the	  ATP	  binding	  or	  the	  DNA	  binding	   capacity	   of	   SMC1	   or	   SMC3.	   In	   addition,	   no	   truncating	   mutations	   were	  identified,	   possibly	   due	   to	   lethality	   in	   early	   stages	   in	   development	   associated	   to	  cohesion-­‐related	  defects,	  suggesting	  that	  mutated	  SMC1	  or	  SMC3	  in	  these	  patients	  are	  capable	  of	  exerting	  their	  normal	  role	  in	  sister	  chromatid	  cohesion.	  Indeed,	  no	  precocious	   sister	   chromatid	   cohesion	   defects	   are	   detected	   in	   cells	   expressing	  mutated	   CdLS-­‐related	   SMC1	   or	   SMC3	   (Revenkova	   et	   al.	   2009).	   It	   was	   also	  confirmed	  that	  some	  of	  these	  SMC1	  and	  SCM3	  mutations	  cause	  the	  hinge	  domain	  to	   interact	  better	  with	  DNA,	  disrupting	   the	  dynamic	   interactions	  of	   cohesin	  with	  DNA.	  There	  is	  thus	  a	  correlation	  between	  the	  appearance	  of	  missense	  mutations	  in	  
SMC1	  or	  SMC3	  with	  mild	  CdLS	  phenotypes	  and	  NIPBL	   truncating	  mutations	  with	  more	  severe	  phenotypes.	  	   The	   Roberts	   SC-­‐phocomelia	   syndrome	   is	   also	   caused	   by	   mutations	   to	  another	   protein	   of	   the	   cohesin	   network,	   ESCO2.	   As	   described	   earlier,	   ESCO2	  depletion	  in	  human	  cells	  causes	  defective	  sister	  chromatid	  cohesion.	  Patients	  with	  RS	  syndrome	  show	  severe	  birth	  defects,	  especially	  with	  the	  upper	  limbs.	  The	  bones	  in	   the	   arms	   and	   other	   appendages	   may	   be	   symmetrically	   shortened	   or	   absent.	  Microcephaly,	  cleft	  lip	  and	  palate	  and	  growth	  retardation	  are	  also	  seen,	  as	  with	  the	  CdLS	  syndrome	  (Schüle	  et	  al.	  2005;	  Vega	  et	  al.	  2005).	  Cultured	  cells	  from	  patients	  with	   Roberts	   syndrome	   display	   defects	   in	   sister	   chromatids	   cohesion	   at	  centromeric	   regions	   and	   aneuploidy.	   Cohesion	   is	   affected	   specifically	   at	  heterochromatic	   regions	   but	   not	   along	   chromosome	   arms.	   Different	   truncating	  mutations	  were	  described	  in	  unrelated	  probands	  (Schüle	  et	  al.	  2005).	  Later,	  it	  was	  discovered	   that	   other	   ESCO2	   mutations	   affect	   its	   acetyltransferase	   domain.	  Missense	  mutation	  W539G	  results	   in	   loss	  of	  acetyltransferase	  activity,	  equivalent	  to	  other	  phenotypes	  resulting	  from	  missense	  and	  frameshift	  mutations	  leading	  to	  loss	   of	   mRNA	   and	   protein	   (Gordillo	   et	   al.	   2008).	   It	   is	   thus	   clear	   that	   CdLS	   and	  Robert	   syndromes	   are	   related	   to	   the	   cohesin	   network.	   However,	   no	   clear	   link	  between	  CdLS	  and	  overt	  cohesion	  defects	  has	  been	  described.	  It	  is	  thus	  tempting	  to	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suggest	   that	   cohesin	  might	  be	   involved	   in	   the	   regulation	  of	   genes	   at	   the	  basis	   of	  these	   syndromes	   during	   development,	   but	   how	   cohesin	   and	   NIPBL	   could	   be	  mechanistically	  involved	  is	  unknown.	  	   A	  big	  breakthrough	  in	  the	  understanding	  of	  how	  cohesin	  could	  be	  involved	  in	  gene	  regulation	  in	  mammalian	  cells	  came	  with	  the	  mapping	  of	  cohesin	  binding	  sites	  to	  chromosomes.	  	  	  
1.3.	  Cohesin	  distribution	  along	  mammalian	  chromosomes	  	  	   Compared	   to	   lower	   organisms,	   mammalian	   cells	   show	   a	   very	   different	  picture	   in	   terms	   of	   cohesin	   binding.	   Previous	   work	   in	   our	   lab	   has	   shown	   that	  cohesin	  binds	   to	  a	  constitutive	  DNase	   I	  hypersensitive	  site	   (HSS)	  at	   the	  3’	  end	  of	  the	   Igll1	   gene	   (Parelho	   et	   al.	   2008).	   Binding	   of	   cohesin	   is	   independent	   of	  expression	  of	  Igll1,	  as	  thymocytes,	  where	  the	  gene	  is	  not	  transcribed,	  also	  exhibit	  binding	  at	  that	  HSS.	  Binding	  of	  cohesin	  to	  HSSs	  was	  shown	  at	  two	  other	  loci,	  Cd4	  and	  Cd8.	   Cohesin	   bound	   prominently	   to	   one	   HSS	   of	   Cluster	   I	   (regulatory	   region	  containing	   a	   cluster	   of	   HSS	   downstream	   of	   CD8a),	   both	   in	   CD8-­‐expressing	  thymocytes	   and	   CD8-­‐non-­‐expressing	   thymoma	   cells.	   In	   addition,	   binding	   of	  cohesin	   was	   confirmed	   at	   several	   HSS	   around	   the	   Cd4	   gene	   in	   CD4-­‐expressing	  thymocytes	  but	  also	  CD4-­‐non-­‐expressing	  pre-­‐B	  cells.	  At	   the	   Ifng	   locus,	  binding	  of	  cohesin	   to	   HSS3	  was	   perfectly	   compatible	  with	   induced	   expression	   of	   Ifng	   after	  activation	  of	  Th1	  cells.	  Insertion	  of	  a	  transgene	  array	  consisting	  of	  10-­‐12	  copies	  of	  
Vpreb1/Igll1	  resulted	  in	  increased	  recruitment	  of	  cohesin	  to	  HS1.	  Deletion	  of	  HS1	  abrogated	   cohesin	   binding.	   Moreover,	   the	   binding	   profile	   of	   cohesin	   (Rad21)	   in	  pre-­‐B	   cells	   and	   thymocytes	  was	   analysed	  using	  ChIP-­‐on-­‐chip.	  The	   genomic	   tiling	  array	  consisted	  of	  200Kb	  to	  2Mb	  surrounding	  120	  genes	  and	  a	  contiguous	  section	  of	   chromosome	   17,	   in	   total,	   representing	   3%	   of	   the	   mappable	   mouse	   genome.	  1,619	   binding	   sites	   were	   uncovered	   in	   pre-­‐B	   cells	   and	   1,	   217	   in	   thymocytes,	   of	  which	  889	  were	  present	  in	  pre-­‐B	  cells.	  In	  contrast	  to	  yeast,	  there	  is	  no	  correlation	  between	   intergenic	   regions	  between	  convergently	   transcribed	  genes	  and	  cohesin	  binding.	  On	   the	  other	  hand,	   similarly	   to	  yeast,	   the	  positioning	  of	   cohesin	  near	   to	  genes	  declines	  with	  distance.	  Binding	  of	   cohesin	   to	  HSS	   is	   also	   conserved	  across	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evolution.	  Many	  of	   the	  HSSs	  are	  conserved	  between	  human	  and	  mouse.	  Between	  30	   to	   50%	   of	   cohesin	   sites	   in	   pre-­‐B	   cells	   and	   thymocytes	   represent	   conserved	  noncoding	   sequences	   (CNS),	   whereas	   only	   2.5%	   of	   CNS	   are	   bound	   by	   cohesin,	  implying	   that	  cohesin	  binds	   to	  a	   small	   subset	  of	  CNS.	  Validation	  by	  ChIP	  RT-­‐PCR	  showed	  that	  binding	  to	  CNS	  is	  conserved	  between	  mouse	  and	  human.	  Analysis	  of	  the	  consensus	  binding	  sequence	  of	  cohesin	  demonstrated	  that	  the	  most	  significant	  and	  most	  robust	  sequence	  is	  highly	  similar	  to	  the	  consensus	  binding	  sequence	  of	  CTCF.	  CTCF	  ChIP	  confirmed	  the	  binding	  of	  CTCF	  at	  most	  of	  the	  cohesin	  sites.	  In	  this	  sense,	   CTCF	   ChIP-­‐on-­‐chip	   demonstrated	   that	   65%	   of	   cohesin	   sites	   are	   CTCF-­‐positive	   and	   that	   77%	   of	   CTCF	   sites	   are	   cohesin-­‐positive.	   Functional	   analysis	   of	  CTCF	   and	   cohesin	   co-­‐localisation	   further	   showed	   that	   CTCF	   removal	   by	   siRNA-­‐mediated	  knockdown	  severely	  disrupts	  cohesin	  localisation	  to	  its	  sites.	  Conversely,	  cohesin	   removal	  does	  not	   reduce	  CTCF	  binding	   to	  DNA.	  These	   results	   imply	   that	  cohesin	   is	   recruited	  by	  CTCF	   to	   specific	   sites	  on	   the	   chromosomes.	   Interestingly,	  cohesin	  is	  still	  associated	  with	  chromosomes	  upon	  CTCF	  depletion	  indicating	  that	  CTCF	  is	  necessary	  for	  cohesin	  recruitment	  to	  specific	  sites	  on	  chromatin	  but	  is	  not	  for	  cohesin	  association	  with	  chromosome	  arms.	  CTCF-­‐depleted	  cells	  do	  not	  exhibit	  clear	  sister	  chromatid	  cohesion	  defects,	  suggesting	  that	  cohesion	  is	  independent	  of	  CTCF-­‐mediated	   localisation	  of	   cohesin	   on	   chromosomes.	   In	   addition,	   the	   cohesin	  binding	   comparison	   between	   the	   two	   cell	   types	   demonstrated	   that	   cohesin	   and	  CTCF	   binding	   can	   be	   cell-­‐type	   specific.	   The	   capacity	   of	   CTCF	   to	   bind	   to	   DNA	   is	  dependent	   on	   the	   methylation	   status	   of	   its	   consensus	   binding	   sequence	   (see	  below).	   Methylation	   levels	   at	   CpG	   dinucleotides	   were	   assessed	   using	   bisulphite	  sequencing.	  At	  shared	  cohesin	  and	  CTCF	  sites,	  DNA	  methylation	   levels	  are	   low	  in	  both	   cell-­‐types.	   At	   sites	   with	   differential	   cohesin	   and	   CTCF	   binding,	   DNA	  methylation	  correlates	  inversely	  with	  cohesin	  and	  CTCF	  binding.	  This	  provided	  an	  epigenetic	  mechanism	  for	  differential	  cohesin	  localisation.	  	   Independent	   reports	   were	   published	   closely	   in	   time	   showing	   a	   similar	  picture	  of	  cohesin	  deposition	  of	  mammalian	  chromosome	  arms	  and	  its	  interaction	  with	  CTCF	  (Wendt	  et	  al.	  2008;	  Stedman	  et	  al.	  2008;	  Rubio	  et	  al.	  2008).	  Wendt	  and	  colleagues	   analysed	   the	   cohesin-­‐binding	   pattern	   in	   1%	   of	   the	   human	   genome	   in	  HeLa	  cells	  in	  the	  G1	  or	  G2	  phase	  of	  the	  cell	  cycle.	  Most	  of	  the	  cohesin-­‐enriched	  sites	  (82%)	  were	  present	  in	  both	  cell	  cycle	  phases	  implying	  that	  the	  binding	  of	  cohesin	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at	  specific	  sites	  is	  independent	  of	  cohesion.	  Many	  of	  the	  cohesin	  binding	  events	  are	  present	   in	   introns	  of	  actively	   transcribed	  genes	   in	  HeLa	  cells,	  again	  showing	  that	  cohesin	   binding	   in	  mammalian	   cells	   is	   compatible	  with	   transcription.	  Moreover,	  most	  of	  them	  (89%)	  are	  also	  bound	  by	  CTCF.	  Depletion	  of	  CTCF	  led	  to	  decreased	  binding	   of	   cohesin	   whereas	   down-­‐regulation	   of	   cohesin	   also	   led	   to	   a	   significant	  decrease	   in	  CTCF	  binding	  down	   to	  50%,	  unlike	   the	  Parelho	   study	   (Parelho	   et	   al.	  2008;	  Wendt	   et	   al.	   2008).	   Furthermore,	   cohesin	   loading	   on	   chromosomes	   is	   not	  altered	  upon	  CTCF	  depletion	  and	  consequently,	  no	  overt	  signs	  of	  cohesion	  defects	  are	   detected,	   similarly	   to	   the	   Parelho	   study.	   Stedman	   and	   colleagues,	   in	   an	  interesting	   study	   of	   the	   capacity	   of	   the	   Kaposi’s	   sarcoma-­‐associated	   herpesvirus	  (KSHV)	  to	  take	  advantage	  of	  a	  host	  cell,	  describe	  the	  binding	  profile	  of	  CTCF	  and	  cohesin	  on	  the	  KSHV	  genome	  (Stedman	  et	  al.	  2008).	  Deletion	  of	  the	  CTCF	  binding	  sites	   by	   site-­‐directed	   mutagenesis	   abrogated	   CTCF	   binding	   but	   also	   cohesin	  binding	   in	   vivo.	   Moreover,	   transfected	   293T	   cells	   were	   less	   abundant	   due	   to	  reduced	  growth	  as	  a	  result	  of	  the	  mutated	  CTCF	  and	  cohesin	  sites,	  concluding	  that	  mutation	   of	   these	   sites	   result	   in	   less	   stable	   transformation	   of	   293T	   cells.	   Co-­‐localisation	  of	  CTCF	  and	   cohesin	  was	  also	   confirmed	  at	   the	  host	  c-­myc	   promoter	  and	   the	   H19	   imprinting	   control	   region	   (ICR,	   see	   below)	   hinting	   at	   a	   more	  widespread	   co-­‐occurrence	   of	   these	   two	   proteins	   on	   the	   genome	   of	   mammalian	  cells.	  Genome	  wide	  analysis	  of	  cohesin	  and	  CTCF	  binding	  by	  Rubio	  and	  colleagues	  also	   confirmed	   their	   large	   co-­‐localisation	   in	   human	   Jurkat	   T	   cells	   (Rubio	   et	   al.	  2008).	   Functional	   analysis	   again	   demonstrated	   the	   requirement	   of	   CTCF	   for	  cohesin	   localisation.	   Mutation	   of	   the	   insulator	   element	   of	   the	   human	   myotonic	  dystrophy	  gene	  DM1	  abrogated	  CTCF	  binding	  and	  also	  cohesin	  binding.	  Together,	  it	   is	   thus	  clear	   that	  CTCF	  and	  cohesin	  bindings	  co-­‐occur	  on	  mammalian	  genomes	  and	  that	  CTCF	  is	  essential	  for	  cohesin	  recruitment	  to	  CTCF	  sites.	  	   Physical	   interaction	   of	   CTCF	   with	   cohesin	   has	   proven	   somewhat	   more	  confusing.	   Wendt	   and	   colleagues	   were	   not	   able	   to	   co-­‐IP	   the	   two	   proteins	   from	  HeLa	   extracts	   (Wendt	   et	   al.	   2008).	   On	   the	   other	   hand,	   Stedman	   and	   co-­‐workers	  were	   able	   to	   co-­‐IP	   CTCF	   with	   SMC1	   and	   Rad21	   but	   not	   robustly	   with	   SMC3,	  although	  SMC3	  could	  co-­‐IP	  with	  CTCF	  (Stedman	  et	  al.	  2008).	  Furthermore,	  using	  quantitative	  mass	   spectrometry,	  Rubio	   and	   colleagues	  were	   able	   to	   demonstrate	  interaction	   between	   SA1	   and	   CTCF	   (Rubio	   et	   al.	   2008).	  More	   recently,	   Xiao	   and	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colleagues	  were	  able	  to	  detect	  interactions	  between	  CTCF	  and	  the	  five	  members	  of	  the	  cohesin	  complex,	  Rad21,	  SMC1,	  SMC3,	  SA1	  and	  SA2	   (Xiao	  et	  al.	  2011).	  These	  interactions	   seem	   DNA	   independent.	   To	   distinguish	   between	   which	   cohesin	  subunits	   interact	  with	  CTCF,	   in	   vitro-­‐translated	   cohesin	   subunits	  were	   incubated	  with	  a	  GST-­‐tagged	  CTCF	  peptides	  (full	  length	  or	  truncated	  versions	  of	  CTCF).	  CTCF	  only	  interacted	  in	  vitro	  with	  SA1	  or	  SA2.	  SiRNA-­‐mediated	  knockdown	  of	  SA2	  leads	  to	  decreased	  interactions	  of	  CTCF	  with	  the	  other	  cohesin	  subunits	  except	  with	  SA1,	  again	  confirming	  the	  exclusivity	  of	  the	  Rad21,	  SMC1	  and	  SMC3	  trio	  to	  bind	  SA1	  or	  SA2	  within	   one	   complex	   (A.	   Losada	   et	   al.	   2000;	   Sumara	   et	   al.	   2000).	  Deletion	   of	  parts	  of	   the	  C-­‐terminal	  domain	  of	  CTCF	  results	   in	  reduced	   interactions	  with	  SA2.	  Indeed,	   a	   C-­‐terminally	   truncated	   form	   of	   CTCF	   is	   still	   able	   to	   bind	   to	   DNA	   but	  cohesin	   recruitment	   is	   impaired.	   Altogether,	   CTCF	   interactions	  with	   the	   cohesin	  complex	  seem	  to	  occur	  directly	  through	  SA1	  or	  SA2	  and	  the	  interactions	  detected	  between	  CTCF	  and	  Rad21,	  SMC1	  or	  SMC3	  are	  due	  to	  their	  association	  with	  SA1	  or	  SA2	  and	  thus	  indirect.	  	   The	   link	   between	   cohesin	   and	   CTCF	   shed	   light	   onto	   the	   potential	   role	   of	  cohesin	  in	  gene	  regulation	  because	  of	  the	  characteristic	  role	  of	  CTCF	  in	  mammalian	  cells.	  CTCF	  was	   initially	  discovered	  as	  a	  regulator	  of	  expression	  of	   the	  chicken	  c-­
Myc	  gene	  and	  was	  described	  has	  having	  a	  DNA	  binding	  domain	  composed	  of	  eleven	  Zinc	  (Zn)	  fingers,	  10	  of	  the	  C2H2	  class	  and	  1	  of	  the	  C2HC	  class	  (Lobanenkov	  et	  al.	  1990;	  Klenova	  et	  al.	  1993).	  CTCF	  is	  highly	  conserved	  between	  chicken,	  mouse	  and	  human,	  up	  to	  93%	  of	  identity	  (Filippova	  et	  al.	  1996).	  Sequence	  similarity	  between	  chicken	   and	   human	   at	   the	   Zn	   finger	   domain	   is	   100%.	   It	   was	   thus	   striking	   that	  seemingly	   divergent	   sites	   between	   chicken	   and	   human,	   such	   as	   the	   c-­Myc	  promoter,	  were	  able	  to	  bind	  CTCF.	  Using	  deletion	  constructs,	  in	  vitro	  experiments	  demonstrated	  that	  binding	  of	  CTCF	  to	  the	  chicken	  c-­Myc	  site	  V	  is	  dependent	  on	  a	  set	  of	  Zn	  fingers	  while	  binding	  to	  the	  human	  c-­Myc	  site	  A	  depends	  on	  another	  set	  of	  Zn	  fingers	  (Filippova	  et	  al.	  1996).	  This	  suggested	  that	  CTCF	  is	  able	  to	  bind	  to	  very	  different	   sites	   in	   the	   genome	   using	   different	   combinations	   of	   Zn	   fingers.	   It	   then	  became	  clear	  that	  CTCF	  could	  act	  as	  a	  repressor	  or	  an	  activator	  of	  gene	  expression.	  CTCF	  was	   required	   for	   repression	   of	   chicken	   and	   human	   c-­Myc	   and	   the	   chicken	  lysozyme	   gene	   but	   also	   for	   activation	   of	   the	   amyloid	   b–protein	   precursor	  (APP)(Filippova	  et	   al.	   1996;	  Vostrov	  et	   al.	   1997;	  Burcin	  et	   al.	   1997).	   It	  was	   later	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demonstrated	   that	  CTCF	  could	  regulate	  gene	  expression	  by	  being	  able	   to	  bind	   to	  insulator	   sequences.	   An	   insulator	   sequence	   is	   defined	   by	   being	   able	   to	   block	  enhancer-­‐promoter	   communications	   (enhancer-­‐blocking	   activity)	   and/or	   the	  advance	   of	   heterochromatin	   into	   active	   areas	   (chromatin-­‐barrier	   activity).	   One	  insulator	   in	   Drosophila	   is	   the	   sequence	   gypsy	   that	   binds	   the	   insulator	   protein	  Su(Hw),	  as	  described	  earlier	  (see	  section	  1.2.2.1).	  In	  mammals,	  only	  CTCF	  has	  been	  described	   to	   date	   as	   an	   insulator	   protein	   and	   being	   able	   to	   bind	   to	   insulator	  sequences.	  The	  clearest	  examples	  of	  the	  insulator	  function	  of	  CTCF	  are	  the	  chicken	  
b–globin	   and	   the	  H19/Igf2	   loci.	  Work	   by	   Bell	   and	   colleagues	   demonstrated	   that	  CTCF	   is	  necessary	   for	   insulation	  of	   the	  b–globin	   genes	   from	  upstream	  enhancers	  (Bell	  et	  al.	  1999).	  These	  experiments	  are	  based	  on	  transfection	  assays	  of	  plasmids	  bearing	   an	   insulator	   sequence	   between	   an	   SV40	   enhancer	   and	   a	   neomycin-­‐resistance	  gene	  reporter.	  The	  presence	  of	  the	  insulator	  prevents	  the	  access	  of	  the	  enhancer	   to	   the	   promoter.	   Counting	   how	  many	   colonies	   of	   transfected	   cells	   are	  resistant	   to	   G418	   treatment	   can	   thus	   evaluate	   the	   levels	   of	   insulation.	   Bell	   and	  colleagues	   showed	   that	   CTCF	   binds	   the	   HSS	   HS4	   upstream	   of	   the	   b–globin	  enhancer	  (Bell	  et	  al.	  1999).	  Mutation	  of	  HS4	  abrogates	  CTCF	  binding	  and	  enhancer-­‐blocking	  capacity	  of	   the	   insulator	   sequence.	   In	  addition,	  HS4	  acts	  as	  a	   chromatin	  barrier,	  preventing	  the	  access	  of	  upstream	  heterochromatin	  into	  the	  b–globin	  locus	  although	  this	  seems	  to	  be	  CTCF	  independent	  (Recillas-­‐Targa	  et	  al.	  2002).	  CTCF	  was	  subsequently	  described	  as	  being	  important	  for	  long-­‐range	  interactions	  within	  the	  locus	  using	  chromatin	  conformation	  capture	  (3C)(Splinter	  et	  al.	  2006).	  Depletion	  of	   CTCF	   in	   mouse	   erythroid	   cells	   results	   in	   fewer	   interactions	   between	   the	  upstream	  CTCF	  binding	  site	  HS5	  and	  the	  downstream	  3’HS1.	  Histone	  modifications	  also	  change	  at	  the	  CTCF	  binding	  sites	  upon	  CTCF	  depletion.	  Surprisingly,	  no	  change	  in	  b–globin	  gene	  expression	  was	  detected.	  	  	   Another	   very	   well	   documented	   case	   where	   CTCF	   acts	   as	   an	   enhancer-­‐blocking	   factor	   is	   the	  H19/Igf2	   locus.	   This	   locus	   is	   composed	   of	   the	   non-­‐coding-­‐RNA	  H19	   gene	  and	   the	   insulin	  growth	   factor	   Igf2	   gene	   (Figure	  1.2).	  This	   locus	   is	  imprinted	  such	  that	  H19	  is	  only	  expressed	  from	  the	  maternal	  allele	  whereas	  Igf2	  is	  expressed	  from	  the	  paternal	  allele	  (Bartolomei	  et	  al.	  1991;	  DeChiara	  et	  al.	  1991).	  Downstream	   enhancers	   regulate	   the	   expression	   of	   H19	   and	   access	   to	   these	  enhancers	  is	  regulated	  by	  CTCF.	  It	  was	  shown	  that	  a	  small	  region	  upstream	  of	  the	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H19	  promoter	  has	  enhancer-­‐blocking	  activity	   (Bell	  et	  al.	  2000).	  CpG	  dinucleotide	  methylation	   occurred	   in	   the	   paternal	   allele,	   whereas	   the	   maternal	   allele	   was	  unmethylated	  (Bartolomei	  et	  al.	  1993;	  Ferguson-­‐Smith	  et	  al.	  1993).	   Interestingly,	  the	  enhancer-­‐blocking	  activity	  was	  dependent	  on	  the	  levels	  of	  methylation.	  Indeed,	  using	  electrophoretic	  mobility	  shift	  assays	  (EMSA),	  in	  vitro	  methylation	  of	  the	  DNA	  fragment	   precluded	   CTCF	   binding	   and	   its	   associated	   enhancer-­‐blocking	   activity,	  whereas	  the	  unmethylated	  probe	  was	  able	  to	  bind	  CTCF	  (Bell	  et	  al.	  2000;	  Hark	  et	  al.	  2000;	  Kanduri	  et	  al.	  2000).	  This	  region	  was	  thus	  called	  the	   imprinting	  control	  region	   (ICR).	   CTCF	   binds	   to	   the	   ICR	  when	   it	   is	   not	  methylated	   on	   the	  maternal	  allele	  and	  exerts	  its	  enhancer-­‐blocking	  capacity	  of	  the	  H19-­‐downstream	  enhancers	  on	   Igf2	   so	   that	   Igf2	   is	   not	   expressed	   from	   the	   maternal	   allele	   whereas	   H19	   is	  (Figure	   1.2).	   On	   the	   other	   hand,	   the	   paternal	   allele	   is	  methylated,	   does	   not	   bind	  CTCF	   and	   the	   enhancers	   are	   able	   to	   reach	   the	   Igf2	   promoter	   promoting	   its	  expression.	   It	   was	   later	   demonstrated	   that	   CTCF	   is	   involved	   in	   long-­‐range	  chromosomal	  interactions	  within	  the	  H19/Igf2	  locus	  using	  3C	  (Murrell	  et	  al.	  2004;	  Kurukuti	   et	   al.	   2006).	  On	   the	  maternal	   allele,	   the	  CTCF-­‐bound	   ICR	   interacts	  with	  the	  differentially	  methylated	  region	  1	  (DMR1)	  located	  upstream	  of	  Igf2	  and	  with	  a	  matrix	  attachment	  region	  (MAR)	  located	  downstream	  of	  Igf2	  but	  upstream	  of	  the	  ICR,	   suggesting	   that	   the	   local	   architecture	   keeps	   Igf2	   within	   a	   repressive	   loop.	  Indeed,	   CTCF	   had	   been	   shown	   to	   interact	  with	   nucleophosmin	   at	   insulators	   and	  was	  necessary	  for	  the	  recruitment	  of	  insulators	  to	  the	  nucleolar	  surface,	  associated	  with	  repression	  (Yusufzai	  et	  al.	  2004).	  On	  the	  paternal	  allele,	  the	  ICR	  interacts	  with	  DMR2,	   another	   DMR	   close	   to	  MAR	   downstream	   of	   Igf2	   although	  which	   proteins	  mediate	   these	   interactions	   are	   not	   clear	   since	   CTCF	   does	   not	   bind	   to	   the	  methylated	  paternal	  ICR	  (Murrell	  et	  al.	  2004).	  CTCF-­‐dependent	  interactions	  within	  the	  locus	  create	  thus	  different	  loops	  depending	  on	  the	  parent-­‐of-­‐origin	  allele.	  One	  prediction	   of	   this	  model	   is	   that	   the	  H19	   enhancers	   are	   brought	   close	   to	   the	  H19	  promoter	   or	   the	   Igf2	   promoter	   by	   differential	   loop	   formation.	   Indeed,	   the	   H19	  enhancers	   are	   in	   close	   proximity	   of	   the	   Igf2	   promoter	   on	   the	   paternal	   allele,	  whereas	  on	  the	  maternal	  allele,	  where	  Igf2	   is	  inactive,	  they	  are	  not	  (Murrell	  et	  al.	  2004;	  Kurukuti	  et	  al.	  2006;	  Y.	  S.	  Yoon	  et	  al.	  2007).	  Vice	  versa,	   the	  H19	  enhancers	  interact	  with	  the	  H19	  promoter	  on	  the	  maternal	  allele,	  where	  it	  is	  active	  (Engel	  et	  al.	   2008).	   In	   addition,	   deletion	   of	   the	   ICR	   or	  mutation	   of	   the	   CTCF	   binding	   sites	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abrogate	  enhancer	  promoter	  interactions	  and	  lead	  to	  an	  up-­‐regulation	  of	  Igf2	  as	  a	  result	   of	   biallelic	   expression	   and	   a	   reduction	   in	   H19	   mRNA	   levels	   (Engel	   et	   al.	  2006;	  Yoon	  et	  al.	  2007;	  Engel	  et	  al.	  2008).	  Similarly,	  depletion	  of	  CTCF	  produces	  an	  up-­‐regulation	  of	  Igf2	  and	  a	  down-­‐regulation	  of	  H19	  in	  both	  human	  and	  mouse	  cells	  (Wendt	  et	  al.	  2008;	  Yao	  et	  al.	  2010).	  These	  results	  suggest	  that	  CTCF	  is	  involved	  in	  gene	   regulation	   and	   insulation	   activity	   through	   long-­‐range	   chromosomal	  interactions	  mediating	  at	  least	  local	  changes	  in	  chromatin	  architecture.	  	  
	  
Figure	  1.2	  Control	  of	  the	  H19/Igf2	  locus	  by	  CTCF.	  On	  the	  paternal	  allele,	   the	  ICR	  is	  methylated,	  and	  CTCF,	  being	  sensitive	  to	  DNA	  methylation,	  does	  not	  bind	  to	  it.	  This	  allows	  for	  the	  enhancers	  to	  reach	  to	  the	  Igf2	  promoter,	  which	  is	  expressed.	  H19	  on	   the	  other	  hand	   is	  not	  expressed.	  On	   the	  maternal	  allele,	  CTCF	   is	  bound	   to	   the	   ICR,	  as	   it	   is	  not	  methylated.	  CTCF	  acts	  as	  an	  enhancer	  blocker	  and	  thus	  impedes	  the	  access	  of	  the	  enhancers	  to	  the	  Igf2	   promoter.	   Igf2	   is	   not	   expressed	   from	   the	   maternal	   allele	   whereas	   H19	   is.	   Differential	  methylation	  and	  CTCF	  binding	  control	  the	  imprinting	  of	  the	  locus.	  	  	  	   Since	   cohesin	   is	   recruited	   by	   CTCF	   on	   mammalian	   chromosomes,	   the	  potential	   implications	   of	   cohesin	   in	   gene	   regulation	   were	   investigated	   at	   CTCF-­‐regulated	  loci,	  such	  as	  the	  chicken	  β-­‐globin	  HS4	  insulator	  and	  the	  H19	   ICR.	  Using	  the	   neomycin	   resistance	   insulator	   plasmids	   bearing	   the	   chicken	   β-­‐globin	   HS4	  insulator,	  siRNA-­‐mediated	  depletion	  of	  cohesin	  or	  CTCF	   in	  human	  cells	  results	   in	  an	   increase	   in	  Neo	  expression	   to	   similar	   levels	  as	   the	   control	  plasmid	  where	   the	  insulator	  sequence	  is	  not	  present	  (Parelho	  et	  al.	  2008).	  This	  suggests	  that	  cohesin	  contributes	  to	  the	  insulator	  function	  of	  CTCF	  at	  the	  chicken	  β-­‐globin	  HS4	  insulator.	  Similar	   results	  were	   reported	   for	   the	  H19/Igf2	   locus	  using	  a	   similar	   construct	  as	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the	   chicken	   β-­‐globin	   HS4	   insulator	   plasmid	   described	   previously.	   The	   insulator	  sequence	  of	  the	  H19/Igf2	  ICR	  is	  positioned	  between	  a	  luciferase	  reporter	  under	  the	  control	   of	   the	  mouse	  H19	  promoter	   and	   a	  downstream	  enhancer	   (Ishihara	   et	   al.	  2006;	  Wendt	  et	   al.	   2008).	  Depletion	  of	  CTCF	  or	   cohesin	   results	   in	  an	   increase	  of	  luciferase,	   suggesting	   a	   role	   for	   cohesin	   in	   enhancer-­‐blocking	   activity	   at	   the	  
H19/Igf2	  ICR	  at	  least	  in	  transient	  transfection	  assays.	  Experiments	  in	  human	  cells	  and	   mouse	   cells	   show	   that	   depletion	   of	   cohesin	   results	   in	   an	   increase	   in	   the	  endogenous	  Igf2	  expression,	  in	  consistence	  with	  the	  role	  of	  enhancer	  blocker,	  and	  in	  a	  debatable	  reduction	  in	  H19	  transcript	  levels	  (Wendt	  et	  al.	  2008;	  Nativio	  et	  al.	  2009;	  Xiao	  et	  al.	  2011;	  Lin	  et	  al.	  2011).	  	  	   Changes	   in	   the	  pattern	  of	   Igf2	   and	  h19	  expression	  have	  been	  observed	   in	  different	   human	   syndromes	   and	   cancers	   (Murrell	   et	   al.	   2008).	   CTCF	   has	   a	  paralogue	   called	   CTCF-­‐like	   (CTCFL)	   or	   Brother	   Of	   Regulator	   of	   Imprinted	   Sites	  (BORIS).	   BORIS	   shows	  high	   sequence	   similarity	  with	  CTCF	   at	   the	   level	   of	   the	  11	  Zinc-­‐finger	  domain	  although	  has	  different	  N-­‐	  and	  C-­‐terminal	  domains	  (Loukinov	  et	  al.,	   2002).	  The	  high	   similarity	  of	   the	  ZFs	  but	  dissimilar	   flanking	   regions	   suggests	  they	   might	   bind	   the	   same	   panel	   of	   sites	   although	   with	   different	   functional	  outcomes.	   Moreover,	   while	   CTCF	   is	   almost	   ubiquitously	   expressed,	   BORIS	   is	  expressed	   in	   testis,	   ES	   cells	   and	   abnormally	   expressed	   in	  many	   cancer	   cell	   lines	  and	   primary	   tumours	   (D'Arcy	   et	   al.,	   2008;	   Loukinov	   et	   al.,	   2002;	   Vatolin	   et	   al.,	  2005).	  Since	  BORIS	  is	  expressed	  in	  testis	  and	  cancer,	  it	  is	  considered	  a	  member	  of	  the	  cancer-­‐testis	  gene	  family,	  which	  is	  normally	  expressed	  in	  testis	  and	  aberrantly	  upregulated	  in	  cancers.	  CTCF	  binds	  to	  the	  promoters	  of	  many	  cancer-­‐testis	  genes	  which	  are	  silent	  in	  healthy	  somatic	  tissues	  (Hong	  et	  al.,	  2005;	  Vatolin	  et	  al.,	  2005).	  BORIS	   overexpression	   in	   normal	   cells	   evicts	   CTCF	   from	   the	   promoters	   of	   these	  genes	  and	  induces	  gene	  activation.	  Similarly,	  BORIS	  binding	  to	  the	  promoter	  of	  the	  anti-­‐apoptotic	   gene	   BAG-­‐1	   causes	   alterations	   in	   histone	   methylation	   and	   up-­‐regulation	  of	  BAG-­‐1	  expression	  (Sun	  et	  al.,	  2008).	  BORIS	  has	  been	  proposed	  to	  act	  as	  a	  scaffold	  for	  a	  protein	  recruitment	  factor,	  BAT3,	  and	  a	  H3K4	  methyltransferase,	  SET1A,	   at	   the	   promoter	   regions	   of	   Myc	   and	   BRCA1	   genes	   and	   at	   the	  H19	   DMR	  inducing	   H3K4	   dimethylation	   and	   gene	   expression	   (Nguyen	   et	   al.,	   2008).	   BORIS	  expression	  has	  thus	  been	  associated	  to	  tumourigenesis	  and	  cancer.	  However,	  if	  and	  how	   BORIS	   can	   mechanistically	   contribute	   to	   it	   is	   not	   well	   understood.	   Rivalry	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between	  BORIS	  and	  CTCF	  and	  thus	  cohesin	  for	  their	  common	  binding	  sites	  could	  be	  a	  mechanism;	  potential	  recruitment	  of	  cohesin	  by	  BORIS	  to	  novel	  sites	  could	  be	  another.	  Genome-­‐wide	  data	  of	  BORIS	  binding	  is	  not	  available	  up	  to	  date	  in	  ES	  cells,	  where	  CTCF	  and	  BORIS	  are	   co-­‐expressed.	   It	   is	   thus	  pressing	   to	  understand	  what	  the	  relationship	  of	  BORIS	  with	  cohesin	  and	  CTCF	  is	  in	  cells	  where	  BORIS	  and	  CTCF	  are	  co-­‐expressed,	  such	  as	  cancer	  cells	  or	  ES	  cells.	  	  	  
1.4.	  Cohesin	  forms	  developmentally	  regulated	  long-­range	  interactions	  	  	   Since	   cohesin	   mediates	   cohesion	   between	   sister	   chromatids	   by	   holding	  them	   together,	   a	   very	   attractive	   model	   for	   the	   regulation	   of	   cohesin	   of	   gene	  regulation	  would	  be	  the	  contribution	  of	  cohesin	  to	  the	  formation	  of	  DNA	  loops	  by	  bringing	  cis	  DNA	  sequences	  in	  close	  proximity.	  This	  would	  be	  in	  line	  with	  the	  fact	  that	   CTCF	   is	   required	   for	   enhancer-­‐promoter	   interactions	   and	   in	   more	   general	  terms,	  for	  local	  chromosomal	  architecture.	  This	  hypothesis	  was	  investigated	  in	  our	  laboratory	   at	   the	   IFNG	   locus.	   Previous	   work	   in	   our	   lab	   had	   demonstrated	   that	  cohesin	   and	   CTCF	   bind	   to	   regulatory	   regions	   around	   the	   Ifng	   gene	   and	   ChIP	  confirmed	   the	   binding	   in	   human	   CD4	   T	   cells	   at	   orthologous	   regions,	   mainly	   at	  63Kb	   upstream	   of	   the	   IFNG	   gene	   (-­‐63Kb)	   and	   1.5Kb	   and	   119Kb	   downstream	  (Parelho	  et	  al.	  2008).	  The	  IFNG	  locus	  becomes	  inducible	  when	  naïve	  non-­‐polarized	  CD4	   T	   cells	   differentiate	   into	   TH1,	   which	   express	   the	   chemokine	   receptor	   CCR5	  (Ansel	   et	   al.	   2003;	  Messi	   et	   al.	   2003).	  On	   the	   contrary,	   IFNG	   is	   repressed	   in	  TH2	  cells,	   which	   express	   the	   prostaglandin	   D2	   receptor	   CRTH2.	   CTCF	   and	   cohesin	  binding	   analysis	   around	   the	   IFNG	   gene	   showed	   that	   CTCF	   and	   cohesin	   bind	  similarly	  in	  naïve	  CD4	  T	  cells,	  CCR5+	  TH1	  cells,	  CRTH2+	  TH2	  cells	  and	  non-­‐lymphoid	  cells	   293T	   cells	   (Hadjur	   et	   al.	   2009).	   Interestingly,	   the	   enrichment	   of	   CTCF	   and	  cohesin	  at	  -­‐63Kb,	  +1.5Kb	  and	  +119Kb	  was	  higher	  in	  CCR5+	  TH1	  cells	  compared	  to	  the	  other	  three	  cell	  types.	  3C	  analysis	  using	  the	  +1.5Kb	  site	  as	  bait	   indicated	  that	  long-­‐range	  interactions	  with	  the	  -­‐63Kb	  and	  the	  +119Kb	  sites	  occur	  specifically	   in	  CCR5+	  TH1	  cells	  and	  not	  in	  non-­‐polarized	  CD4	  T	  cells	  or	  CRTH2+	  TH2	  cells.	  Since	  the	  dimension	  of	  CCR5+	  TH1	  and	  CRTH2+	  TH2	  cells	  is	  very	  similar	  and	  since	  G1-­‐sorted	  CCR5+	  TH1	  cells	  (that	  is,	  when	  sister	  chromatids	  have	  not	  been	  formed)	  exhibit	  the	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same	   interactions,	   the	   interactions	   between	   the	   bait	   and	   the	   other	   two	   sites	   are	  probably	  in	  cis,	  and	  not	  in	  trans.	  CTCF	  depletion	  resulted	  in	  reduced	  interactions,	  as	  with	  CTCF-­‐dependent	   long-­‐range	  interactions	  at	  the	  H19/Igf2	   locus	  and	  the	  β-­‐globin	  locus	  (Kurukuti	  et	  al.	  2006;	  Splinter	  et	  al.	  2006).	  Interestingly,	  depletion	  of	  cohesin	   also	   resulted	   in	   a	   decrease	   in	   interactions	   at	   the	   IFNG	   locus.	   This	  confirmed	  the	  hypothesis	  that	  cohesin	  can	  mediate	  long-­‐range	  intrachromosomal	  interactions.	  Rad21	  depletion	  did	  not	  reduce	  the	  levels	  of	  CTCF	  bound	  to	  the	  IFNG	  locus	  confirming	  that	  CTCF	  is	  not	  able	  to	  connect	  distant	  regions	  without	  cohesin.	  In	  addition,	  depletion	  of	  cohesin	  and	  consequent	  reduction	  of	  interactions	  resulted	  in	   lower	   levels	   of	   basal	   and	   induced	   IFNG	   expression.	   Altogether	   these	   data	  suggested	   that	   enhanced	   binding	   of	   CTCF	   and	   cohesin	   correlates	   with	   DNA	  interactions,	   within	   the	   local	   context	   at	   least,	   that	   are	   required	   for	   proper	  expression	   of	   the	   locus.	   In	   this	   sense,	   cohesin	   is	   capable	   of	   creating	  developmentally	   regulated	   long-­‐range	   intrachromosomal	   interactions.	   Similar	  results	   were	   published	   for	   several	   other	   loci	   such	   as	   the	   apolipoprotein	   (APO)	  gene	  region,	  the	  H19/Igf2	  and	  the	  β-­‐globin	  loci	  (Mishiro	  et	  al.	  2009;	  Nativio	  et	  al.	  2009;	   C.	   Hou	   et	   al.	   2010).	   The	   human	   APO	   gene	   cluster	   is	   formed	   by	   the	  
APOA1/C3/A4/A5	   genes,	   with	   a	   CTCF	   and	   cohesin	   binding	   site	   near	   the	   APOA5	  gene	   (site	   called	   AC2)	   and	   a	   cohesin	   binding	   site	   within	   APOC3	   (called	  AR1)(Mishiro	   et	   al.	   2009).	   Two	   more	   CTCF	   sites	   are	   present	   outside	   the	   APO	  cluster	   (AC1	   and	   AC3).	   These	   CTCF	   and	   cohesin	   sites	   were	   shown	   to	   have	  enhancer-­‐blocker	   activity.	   Indeed,	   depletion	   of	   CTCF	   or	   cohesin	   result	   in	   gene	  expression	   changes	   of	   the	   APO	   genes	   but	   also	   neighbouring	   genes	   in	   hepatic	  Hep3B	   cells.	   Importantly,	   interactions	   between	   the	   AC2,	   AR1	   and	   AC3	   sites	   are	  detected	   by	   3C	   and	   these	   are	   reduced	   upon	   depletion	   of	   CTCF	   or	   cohesin,	  reminiscent	   of	   the	   effects	   seen	   at	   the	   IFNG	   locus.	   Nativio	   and	   colleagues	   also	  identified	   specific	   high-­‐order	   chromatin	   conformation	   at	   the	   H19/Igf2	   locus	  between	  different	  regulatory	  regions	  (Nativio	  et	  al.	  2009).	  Cohesin	  depletion	  leads	  to	   decreased	   interactions	   between	   CTCF-­‐	   and	   cohesin-­‐bound	   regions	   along	   the	  locus	  and	  also	  increased	  biallelic	  expression	  of	  Igf2,	  detected	  by	  cDNA-­‐sequencing	  and	  RNA	  fluorescent	  in	  situ	  hybridisation	  (RNA-­‐FISH),	  proving	  the	  involvement	  of	  cohesin	   in	   insulation	   of	   the	   Igf2	   promoter	   on	   the	   maternal	   allele	   from	   the	  downstream	  enhancers.	  The	  authors	  propose	   the	  model	  by	  which	  cohesin	  brings	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together	   different	   regulatory	   regions	   of	   the	   H19/Igf2	   locus	   in	   a	   so-­‐called	  “chromatin	   hub”,	   simultaneously	   or	   in	   sequential	   order.	   The	   effect	   of	   cohesin	  depletion	   in	   H19/Igf2	   expression	   could	   not	   be	   confirmed	   in	   another	   study	   in	  mouse	   embryonic	   fibroblasts,	   where	   expression	   of	   Igf2,	   when	   increased	   upon	  cohesin	  subunit’s	  knockdown,	  came	  from	  the	  same	  active	  paternal	  allele,	  and	  not	  as	  a	  result	  of	  biallelic	  expression	  (Lin	  et	  al.,	  2011).	  In	  terms	  of	  the	  β-­globin	   locus,	  some	  reports	  defend	  the	  necessity	  of	  CTCF	  and	  cohesin	  for	  proper	  gene	  expression	  of	   the	   locus,	   while	   others	   show	   that	   CTCF	   or	   cohesin	   depletion	   or	   deletion	   of	  CTCF/cohesin	  binding	  sites	  does	  not	   result	   in	  gene	  expression	  changes.	  Hou	  and	  colleagues	   investigated	   the	   role	   of	   cohesin	   in	   creating	   long-­‐range	   interactions	   at	  the	  β-­‐globin	   locus	   (Hou	   et	   al.	   2010).	  Human	  erythroid	  K562	   cells	   express	   the	  β-­‐globin	   locus,	  whereas	   the	   fibroblast	   line	   293T	   does	   not.	   CTCF	   and	   cohesin	  were	  bound	  at	  many	  sites	  to	  chromatin	  across	  2Mb	  encompassing	  the	  locus	  in	  both	  cell	  types.	   The	   authors	   tested	   some	   interactions	   between	   these	   sites	   and	   confirmed	  cell-­‐specific	   interactions.	   Indeed,	   non-­‐expressing	   293T	   cells	   also	   showed	  interactions	   although	   they	   were	   more	   clustered	   suggesting	   a	   more	   condensed	  environment.	  Reduction	  by	  small	  hairpin	  RNA	  (shRNA)	  of	  CTCF	  levels	  or	  cohesin	  levels	  led	  to	  reduced	  interactions	  within	  the	  region.	  This	  also	  led	  to	  reduced	  RNA	  pol	  II	  recruitment	  across	  the	  locus	  and	  reduced	  expression	  of	  the	  γ-­‐	  and	  α-­‐globin	  genes	   in	   the	   case	   of	   CTCF	   depletion.	   Expression	   changes,	   if	   any,	   upon	   cohesin	  depletion	  were	  not	  shown.	  On	  the	  other	  hand,	  Bender	  and	  colleagues	  deleted	  two	  hypersensitive	  sites,	  HS62	  and	  3’HS1,	  where	  CTCF	  and	  cohesin	  bind,	  without	  any	  
β-­globin	  expression	  changes	  (Bender	  et	  al.	  2006).	  As	  described	  earlier,	  Splinter	  and	  colleagues	   showed	   that	   targeted	   deletion	   of	   the	   CTCF	   binding	   site	   at	   3’HS1	   did	  result	   in	   loss	   of	   interactions	   of	   that	   site	  with	   the	  HS62	   site	   but	   did	  not	   result	   in	  gene	  expression	  changes	  of	  the	  globin	  genes	  compared	  to	  wt	  cells	  suggesting	  that	  those	  interactions	  are	  not	  needed	  for	  expression	  of	  the	  locus	  (Splinter	  et	  al.	  2006).	  Additionally,	  the	  authors	  also	  showed	  that	  that	  site	  does	  not	  have	  insulator	  activity	  since	  its	  deletion	  did	  not	  change	  the	  expression	  levels	  of	  the	  downstream	  olfactory	  receptor	  genes,	  which	  are	  also	  controlled	  by	  the	  globin	  LCR.	  Very	  recently,	  Chien	  and	   co-­‐workers	   have	   shown	   that	   actually	   the	   CTCF	   and	   cohesin	   HS5	   and	   3’HS1	  sites	   and	   their	   interactions	   are	   not	   required	   for	   globin	   expression	   (Chien	   et	   al.	  2011).	  Instead,	  the	  CTCF-­‐independent	  Nipbl-­‐positive	  cohesin	  sites	  (see	  section	  1.5	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for	   further	   details	   about	   this	   type	   of	   sites)	   at	   HS2	   and	   the	  β-­major	   and	  β-­minor	  promoters	   are	   important	   for	   activation	   of	  β-­major	   and	  β-­minor	   genes	   in	  mouse:	  decreased	   Nipbl	   levels	   lead	   to	   decreased	   interactions	   between	   those	   sites,	  decreased	   RNA	   pol	   II	   recruitment	   and	   decreased	   β-­major	   and	   β-­minor	   gene	  expression.	  	   Proofs	   of	   a	   role	   for	   cohesin	   in	   chromatin	   barrier	   formation	   like	   CTCF	   are	  rare	  or	  even	  inexistent.	  The	  HoxA	  cluster	  is	  divided	  by	  a	  CTCF	  and	  cohesin	  binding	  site	   into	   two	   areas,	   one	   heterochromatic	   and	   one	   euchromatic,	   in	   human	  fibroblasts	  (Kim	  et	  al.,	  2011).	  Depletion	  of	  cohesin	  leads	  to	  increased	  expression	  of	  the	   HoxA	   genes	   found	   in	   the	   euchromatic	   areas,	   but	   the	   H3K27m3	  mark	   of	   the	  heterochromatin	  area	  does	  not	  spread,	  indicating	  that	  cohesin	  is	  not	  required	  for	  chromatin	   barrier	   formation,	   at	   least	   at	   the	   HoxA	   cluster	   (Kim	   et	   al.,	   2011).	  Instead,	   removal	   of	   CTCF	   does	   result	   in	   spread	   of	   H3K27me3.	   Since	   removal	   of	  cohesin	   does	   not	   result	   in	   reduction	   of	   CTCF	   binding,	   it	   is	   possible	   that	   the	  presence	  of	  CTCF	  is	  still	  sufficient	  for	  creating	  a	  chromatin	  barrier.	  	   Although	   the	   current	   model	   of	   cohesin’s	   involvement	   in	   gene	   expression	  through	   loop	   formation,	   insulation	  or	   chromatin	  barrier	   formation	   is	   based	  on	   a	  handful	   of	   loci	   and	   the	   evidences	   are	   not	   always	   concordant,	   there	   is	   increasing	  support	   for	  a	   role	  of	   cohesin	   in	  mediating	   long-­‐range	   interactions	  and	  creating	  a	  developmentally	   regulated	  scaffold	  upon	  which	  gene	  expression	   is	  dependent.	   In	  this	  way,	  cohesin	  could	  stabilise	  developmentally	  regulated	   loops	  by	  holding	  two	  different	   regions	   in	   cis	  within	   its	   ring	   as	   has	   been	   suggested	   to	   happen	   in	   sister	  chromatid	   cohesion.	   It	   is	   very	   probable	   the	   number	   of	   loci	   where	   cohesin	   is	  important	  for	  chromatin	  interactions	  and	  gene	  expression	  will	  expand	  with	  time.	  	  	  
1.5.	   CTCF-­independent	   cohesin	   binding	   sites	   promote	   enhancer-­promoter	  
	   interactions	   at	   active	   genes	   by	   means	   of	   basal	   transcriptional	  
	   machinery	  
	  	   Genome-­‐wide	   analysis	   of	   cohesin	   and	   CTCF	   binding	   to	   chromosomes	   in	  mammalian	  cells	  has	  uncovered	  a	  widespread	  overlap	  between	  these	  two	  proteins.	  Nevertheless,	  not	  all	  cohesin	  sites	  are	  CTCF-­‐positive.	  Using	  ChIP	  followed	  by	  high-­‐
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throughput	  sequencing	  (ChIP-­‐seq),	  Schmidt	  and	  colleagues	  mapped	  the	  binding	  of	  cohesin	   and	   CTCF	   in	   human	   breast	   cancer	   cells	   MCF-­‐7	   and	   hepatocellular	  carcinoma	  cells	  HepG2	  (Schmidt	  et	  al.	  2010).	  Cohesin	  is	  found	  at	  80%	  (39,444)	  of	  all	  CTCF	  binding	  events	  (49,243)	  in	  MCF-­‐7	  cells.	  16,523	  cohesin	  sites	  (30%)	  do	  not	  show	   enrichment	   for	   CTCF.	   Search	   for	   the	   binding	  motif	   under	   the	   cohesin	   and	  CTCF	  peaks	  rendered	  the	  CTCF	  motif,	  as	  had	  been	  described	  earlier.	  Interestingly,	  the	  cohesin	  non-­‐CTCF	  sites	  do	  not	  show	  enrichment	  for	  the	  CTCF	  motif	  and	  is	  close	  to	  background	  genome	   levels.	  A	  de	  novo	   search	  of	  motifs	   identified	   the	   estrogen	  response	   element	   (ERE),	   which	   is	   the	   consensus	   binding	  motif	   for	   the	   estrogen	  receptor	   alpha	   (ER).	   This	   suggested	   that	   cohesin	   and	   ER	   might	   co-­‐occupy	   non-­‐CTCF	   sites.	   Indeed,	   ChIP-­‐seq	   analysis	   of	   the	   ER	   binding	   pattern	   showed	   that	  cohesin	   and	   ER	   co-­‐bind	   6,573	   sites	   in	   the	   absence	   of	   CTCF.	   The	   authors	  hypothesised	   that	   cohesin	   might	   be	   involved	   in	   tissue-­‐specific	   gene	   expression	  programs	   mediated	   by	   tissue-­‐specific	   transcription	   factors.	   ChIP-­‐seq	   analysis	   of	  cohesin	   and	   CTCF	   in	   HepG2	   cells	   showed	   that	   cohesin	   non-­‐CTCF	   sites	   found	   in	  MCF-­‐7	   are	   mostly	   MCF-­‐7	   specific.	   A	   new	   subset	   of	   cohesin	   non-­‐CTCF	   peaks	  appeared	   in	  HepG2	  cells	  of	  which	  4,382	  and	  5,555	  co-­‐localised	  respectively	  with	  the	   liver-­‐specific	   transcription	   factors	   HNF4	   and	   CEBPA.	   This	   suggested	   that	  cohesin	   and	   cell-­‐type-­‐specific	   factors	   co-­‐localise	   and	   this	   co-­‐localisation	   tends	   to	  be	  cell-­‐type	  specific.	  Induction	  of	  MCF-­‐7	  cells	  with	  estrogen	  leads	  to	  an	  increase	  in	  the	  binding	  of	   cohesin	  at	   cohesin	  non-­‐CTCF	  sites	   compared	   to	   cohesin	  and	  CTCF	  sites	   showing	   that	   cohesin	   binding	   to	   ERE	   independently	   of	   CTCF	   is	   partly	  dependent	   on	   ER	   binding.	   In	   addition,	   the	   number	   of	   estrogen-­‐regulated	   genes	  bound	   by	   ER	   is	   1.4	   times	   higher	   than	   the	   number	   of	   genes	   not	   regulated	   by	  estrogen	  but	  bound	  by	  ER.	  On	  the	  contrary,	  the	  cohesin	  and	  ER	  co-­‐bound	  genes	  are	  more	  than	  twice	  as	  likely	  to	  be	  estrogen-­‐regulated.	  This	  led	  to	  the	  conclusion	  that	  genes	  that	  are	  bound	  by	  cohesin	  and	  ER	  independently	  of	  CTCF	  are	  more	  likely	  to	  be	  regulated	  by	  ER	  than	  genes	  bound	  by	  ER	  only.	  Since	  cohesin	  had	  been	  shown	  to	  be	   involved	   in	   long-­‐range	   interactions	  mediated	   by	   CTCF,	   the	   authors	   combined	  their	  cohesin,	  CTCF	  and	  ER	  ChIP-­‐seq	  data	  with	   the	  genome-­‐wide	  ER	   interactome	  and	  discovered	  that	  cohesin	  is	  significantly	  more	  enriched	  at	  ER	  events	  involved	  in	  long-­‐range	   interactions	  than	  non-­‐interacting	  ER	  events	  (Fullwood	  et	  al.	  2009).	   In	  summary,	   data	   by	   Schmidt	   and	   colleagues	   suggest	   that	   cohesin	   might	   also	   be	  
 44	  
involved	   in	   long-­‐range	   interactions	   mediated	   by	   tissue-­‐specific	   transcription	  factors	  independently	  of	  CTCF.	  	  	   The	   co-­‐localisation	   of	   cohesin	   with	   other	   factors	   in	   a	   CTCF-­‐independent	  manner	  was	  later	  confirmed	  in	  mouse	  ES	  cells	  (Kagey	  et	  al.	  2010).	  In	  the	  search	  for	  factors	  that	  are	  required	  for	  the	  maintenance	  of	   the	  mouse	  ES	  cell	  state,	   i.e.	  Oct4	  expression,	  Kagey	  and	  colleagues	  performed	  shRNA	  library	  screens	  and	  identified	  many	  mediator	  complex	  subunits,	  cohesin	  subunits	  and	  Nipbl.	  ChIP-­‐seq	  analysis	  of	  mediator	   subunits	   (Med1	   and	   Med12)	   binding	   profile	   showed	   that	   mediator	   is	  bound	  to	  60%	  of	  actively	  transcribed	  genes.	  For	  instance,	  mediator	  is	  bound	  to	  the	  well-­‐characterised	   enhancers	   of	  Oct4	   and	  Nanog	   and	   their	   core	  promoters	   along	  with	   RNA	   Pol	   II	   and	   TBP.	   ChIP-­‐seq	   analysis	   of	   the	   cohesin	   and	   CTCF	   binding	  profiles	   in	   ES	   cells	   showed	   that	   cohesin	   binds	   at	   the	   same	   mediator	   sites	   at	  enhancers	   and	  promoters	   independently	   of	   CTCF.	   Cohesin	   thus	   co-­‐localises	  with	  mediator	   and	  RNA	  Pol	   II	   independently	   of	   CTCF.	   In	   addition,	  Nipbl	   is	   present	   at	  those	  cohesin-­‐mediator	  sites.	  The	  association	  between	  Nipbl	  and	  mediator-­‐cohesin	  sites	   is	   highly	   significant	   while	   the	   association	   of	   NIPBL	   sites	   with	   cohesin	   and	  CTCF	  sites	  was	  close	  to	  random	  association.	  Of	  2,700	  genes	  that	  are	  co-­‐occupied	  by	  Nipbl,	   the	  mediator	  and	  cohesin	  complexes	  and	  RNA	  Pol	   II,	  700	  are	  de-­‐regulated	  upon	  knockdown	  of	  cohesin,	  Nipbl	  and	  mediator.	  Co-­‐IP	  experiments	  confirmed	  in	  
vivo	  interactions	  between	  Nipbl	  and	  the	  cohesin	  subunits	  SMC1	  and	  SMC3	  and	  the	  mediator	   subunit	   Med23.	   Since	   cohesin,	   Nipbl	   and	   mediator	   co-­‐localise	   at	  enhancers	  and	  promoters	  of	  active	  genes,	  Kagey	  and	  colleagues,	  using	  3C,	  showed	  that	  interactions	  between	  the	  enhancers	  and	  promoters	  of	  Oct4,	  Nanog,	  Phc1	  and	  
Lefty1	  occur	   in	   ES	   cells	  when	   these	   genes	   are	   active	   but	   do	   not	   occur	   in	  mouse	  embryonic	  fibroblasts	  (MEF)	  where	  they	  are	  inactive	  and	  do	  not	  exhibit	  cohesin	  or	  mediator	  presence.	  Furthermore,	  depletion	  of	  SMC1	  or	  Med12	  leads	  to	  decreased	  interactions	   in	   ES	   cells.	   The	   authors	   conclude	   that	   cohesin	   is	   involved	   in	  chromosomal	   interactions	   in	   a	   CTCF-­‐independent	   fashion	   at	   active	   genes,	   as	  suggested	   by	   Schmidt	   and	   colleagues.	  Moreover,	   cohesin-­‐mediator	   sites	   are	   cell-­‐type-­‐specific	   and	   tend	   to	   be	   present	   at	   cell-­‐type-­‐specific	   genes.	   Together,	   these	  results	   argue	   in	   favour	  of	   a	   role	   of	   cohesin	   in	   controlling	   gene	   expression,	   along	  with	   Nipbl	   and	   mediator,	   in	   a	   CTCF-­‐independent	   manner	   in	   mouse	   ES	   cells	   by	  bringing	  together	  enhancers	  and	  promoters.	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   Very	   recently,	   Nitzsche	   and	   co-­‐workers	   reported	   the	   co-­‐localisation	   of	  cohesin,	   independently	   of	   CTCF,	   with	   the	   pluripotency-­‐associated	   factors	   Oct4,	  Nanog,	   Sox2,	   Essrb	   and	   Klf4	   in	   ES	   cells	   (Nitzsche	   et	   al.	   2011).	   The	   authors	   had	  previously	  performed	  an	  RNAi	  screen	  in	  search	  for	  factors	  affecting	  the	  mouse	  ES-­‐cell	  identity	  using	  an	  Oct4	  reporter	  cell	  line	  in	  which	  the	  reporter	  GFP	  is	  under	  the	  control	   of	   the	   Oct4	   regulatory	   regions	   (Ding	   et	   al.	   2009).	   Cohesin	   subunits	   had	  been	   identified	   to	   be	   important	   in	   maintaining	   Oct4	   expression	   in	   ES	   cells,	   in	  agreement	   with	   the	   Kagey	   study.	   The	   authors	   performed	   Rad21	   ChIP-­‐seq	   and	  reported	  15,311	  cohesin	  binding	   sites	  and	  33,788	  CTCF	  binding	   sites	   in	  ES	   cells.	  Out	  of	   the	   total	  number	  of	   cohesin	  sites,	  73%	  co-­‐localise	  with	  CTCF.	  Thus,	  4,087	  cohesin	   peaks	   are	   CTCF-­‐independent.	   Inspection	   of	   the	   cohesin	   non-­‐CTCF	   sites	  showed	  that	  84%	  of	  cohesin	  non-­‐CTCF	  sites	  bear	  the	  CTCF	  binding	  motif,	   leaving	  667	   peaks	   without	   the	   CTCF	   consensus	   binding	  motif.	   This	   subset	   of	   peaks	   are	  enriched	   on	   the	   other	   hand	   for	   binding	   motifs	   that	   are	   binding	   sites	   for	   key	  pluripotency	  factors,	  such	  as	  Oct4,	  Nanog,	  Sox2,	  Klf4	  and	  Essrb.	  ChIP-­‐seq	  analysis	  confirmed	  their	  co-­‐localisation	  with	  cohesin	  independently	  of	  CTCF.	  Knockdown	  of	  cohesin	   subunits	   leads	   to	   loss	   of	   ES	   colony	   morphology,	   loss	   of	   alkaline	  phosphatase	   staining	  which	   is	   characteristic	   of	   ES	   cells,	   decreased	   expression	   of	  Oct4	  and	  Nanog	  and	  increased	  expression	  of	  differentiation	  markers,	  such	  as	  Fgf5	  (ectoderm),	  Bry	  (mesoderm)	  and	  FoxA2	  (endoderm).	  Microarray	  analysis	  of	  gene	  expression	   changes	   upon	   Rad21	   knockdown	   showed	   that	   Rad21	   knockdown	  results	  in	  a	  very	  similar	  pattern	  as	  the	  Nanog	  knockdown,	  with	  a	  large	  number	  of	  genes	  associated	  with	  the	  three	  germ	  layers	  and	  trophectoderm	  being	  upregulated.	  Furthermore,	   upon	   differentiation	   of	   ES	   cells	   into	   embryoid	   bodies	   (EB),	   the	  majority	  of	  the	  667	  cohesin	  non-­‐CTCF	  peaks	  not	  having	  the	  CTCF	  motif	  disappear,	  indicating	  that	  they	  are	  cell-­‐type	  specific.	  Finally,	  mass	  spectrometry	  confirmed	  the	  binding	  of	  Nanog	  and	  SA1	  and	  Wapl.	  The	  authors	  speculate	  that	  Nanog	  facilitates	  the	  positioning	  of	  cohesin	  at	  Nanog-­‐positive	  cohesin	  non-­‐CTCF	  sites.	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1.6.	  Epigenetic	  landscapes	  change	  during	  development	  affecting	  	  gene	  
expression	  	  	   Multicellular	  organisms	  are	  composed	  of	  very	  diversified	  cell	  types.	  Since	  all	  cells	   conforming	   an	   organism	   possess	   the	   same	   genome,	   diversification	   of	   cell	  function	   is	  made	  possible	  by	   controlled	  expression	  of	   a	   subset	  of	   genes	  encoded	  within	   this	   genome.	  The	   “identity”	   of	   a	   cell	  within	   the	   organism	   is	   controlled	  by	  two	  major	  mechanisms.	  One	  constitutes	  the	  specific	  transcription	  factors	  that	  are	  expressed	  in	  that	  cell	  at	  a	  certain	  point.	  The	  other	   is	  the	  group	  of	  heritable	  traits	  that	  are	  passed	  from	  cell	  generation	  to	  cell	  generation	  without	  modification	  of	  the	  underlying	   DNA	   sequence.	   These	   heritable	   traits	   are	   called	   epigenetics.	  Molecularly,	   epigenetic	   regulation	   of	   gene	   expression	   involves	  DNA	  methylation,	  posttranslational	   modification	   of	   histones,	   non-­‐coding	   RNAs	   and	   higher	   order	  chromatin	  organisation.	  	   Development	  of	  multicellular	  organisms	  occurs	  in	  a	  very	  orderly	  step-­‐wise	  process.	  During	  morphogenesis,	  totipotent	  cells	  differentiate	  into	  pluripotent	  cells,	  which	  in	  turn,	  differentiate	  into	  fully	  differentiated	  cells.	  During	  this	  process,	  cells	  acquire	   new	   transcriptional	   programs	   and	   new	   epigenetic	   states.	   Thus,	   cell	   fate	  within	   an	   organism	   is	   dependent	   on	   a	   very	   tightly	   controlled	   interplay	   between	  transcription	   factors	   and	   epigenetic	   mechanisms.	   Waddington	   metaphorically	  defined	   epigenetics	   landscapes	   as	   landscapes	  where	   a	   ball	   rolling	   down	   a	   valley	  would	   find	   it	   increasingly	   hard	   to	   “leap”	   to	   another	   valley.	   In	   this	   sense,	   during	  development	   and	   cell	   differentiation,	   cells	   become	  more	   and	  more	   committed	   to	  their	   fate	   and	   trans-­‐differentiation	   (as	   “leaping”	   to	   another	   valley)	   becomes	  increasingly	   difficult.	   In	   this	   sense,	   cells	   acquire	   new	   epigenetic	   profiles	   during	  differentiation	  (Meissner	  2010).	  	   As	  commented	  before,	  the	  majority	  of	  cohesin	  sites	  are	  CTCF-­‐positive.	  CTCF	  binding	   to	   DNA	   is	  methylation	   sensitive.	   Since	   DNA	  methylation	   changes	   during	  development	   and	   cell	   differentiation,	   one	   can	   hypothesise	   that	   changes	   in	   the	  binding	   of	   cohesin	   and	   CTCF	   will	   occur	   during	   development.	   In	   more	   general	  terms,	   alterations	   to	   the	   epigenetic	   profile	   during	   development	   could	   result	   in	  differential	   binding	   of	   cohesin	   and	   differential	   gene	   expression.	   It	   is	   thus	  interesting	   to	  understand	  what	   the	  mapping	  of	   cohesin	  binding	   sites	   in	  different	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developmental	  stages	  is	  and	  also	  its	  correlation	  with	  CTCF	  binding	  sites	  and	  with	  gene	  expression.	  During	  the	  performance	  of	  this	  work,	  several	  studies	  have	  shown	  that	   cohesin	   binding	   is	   recruited	   to	   sites	   by	   means	   of	   cell-­‐type-­‐specific	  transcription	   factors	   and	   the	   basal	   transcriptional	   machinery,	   independently	   of	  CTCF.	   This	   widens	   the	   range	   of	   putative	   cohesin	   interactors	   and	   the	   number	   of	  cell-­‐type	  specific	  cohesin	  binding	  sites.	  	  	   Thymocyte	   differentiation	   constitutes	   a	   well-­‐studied	   model	   of	  developmental	   regulation	   of	   gene	   expression.	   During	   this	   differentiation,	   gene	  segments	   millions	   of	   base	   pairs	   apart	   come	   into	   close	   proximity	   and	   are	  recombined	   to	   create	   different	   T	   cell	   receptors.	   Tcr	   rearrangement	   is	   tightly	  controlled	  by	  developmental	  stage-­‐specific	  epigenetic	  mechanisms	  and	  chromatin	  topology	  (Stanhope-­‐Baker	  et	  al.	  1996;	  Jhunjhunwala	  et	  al.	  2009;	  Michael	  S	  Krangel	  2009).	   CTCF	  binding	   has	   been	  described	   at	   the	  Tcrα	   locus.	  However,	   the	   role	   of	  cohesin	   in	   locus	   conformation	  and	   transcriptional	   control	  has	  not	  been	   reported	  up	  to	  date.	  	   Another	   well-­‐documented	   paradigm	   of	   epigenetic	   regulation	   of	   gene	  expression	  is	  XCI.	  	  	  
1.7.	  X	  chromosome	  inactivation:	  a	  model	  for	  the	  study	  of	  cohesin	  regulation	  
	   of	  gene	  expression	  
	   1.7.1.	  Overview	  of	  XCI	  	  	  	   To	  achieve	  equalisation	  of	  gene	  expression	  dosage	  from	  sex	  chromosomes,	  female	   cells,	   which	   have	   two	   X	   chromosomes,	   inactivate	   one	   of	   them	   through	   a	  process	  called	  XCI	  while	  male	  cells	  do	  not	  undergo	  XCI.	  In	  mouse,	  two	  forms	  of	  XCI	  are	  present.	  One	  is	  imprinted	  and	  in	  this	  sense,	  the	  paternal	  X	  (Xp)	  chromosome	  is	  always	   inactivated.	   Imprinted	  XCI	   is	   initiated	   very	   early	   in	   development,	   around	  the	   2-­‐	   to	   4-­‐cell	   stage	   and	   occurs	   up	   to	   the	  morula	   stage	   and	   in	   extra-­‐embryonic	  tissue	   (Huynh	  et	   al.	   2003;	  Okamoto	  et	   al.	   2004).	  At	   the	   time	  when	   the	   inner	   cell	  mass	  (ICM)	  is	  forming	  within	  the	  embryo,	  the	  Xp	  is	  reactivated	  so	  that	  cells	  in	  the	  ICM	  exhibit	  two	  active	  X	  chromosomes.	  The	  second	  form	  of	  XCI	  occurs	  in	  the	  ICM	  around	  5.5	  days	  post	  coitum	  (dpc)	  and	  is	  random,	  i.e.	  either	  the	  maternal	  (Xm)	  or	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the	   paternal	   X	   chromosome	   is	   inactivated	   with	   a	   50%	   chance	   (Rastan	   1982).	  Historically,	   random	   XCI	   has	   been	   studied	   in	   vitro	   by	   differentiating	   female	   ES	  cells,	  which	  are	  derived	   from	  the	  ICM	  and	  recapitulate	   the	  processes	  that	   lead	  to	  random	   XCI.	   XCI	   is	   triggered	   by	   the	   long	   non-­‐coding	   RNA	   X	   inactive	   specific	  transcript	   (Xist),	   which	   is	   expressed	   from	   the	   inactive	   X	   chromosome	   (Xi).	   Xist	  coats	   the	   inactive-­‐to-­‐be	   X	   chromosome	   and	   recruits	   many	   of	   the	   epigenetic	  features	  associated	  with	  heterochromatin,	  such	  as	  polycomb	  repressive	  complexes	  (PRCs),	  repressive	  histone	  modifications,	  histone	  variants,	  chromatin	  remodellers	  and	  DNA	  methylation	   (see	   section	  1.7.4.).	   The	   epigenetic	   status	   of	   the	  Xi	   is	   then	  clonally	  transmitted	  through	  each	  cell	  generation,	  giving	  rise	  to	  female	  adults	  that	  are	  mosaic	   for	  cells	  that	  have	  repressed	  one	  chromosome	  or	  the	  other.	  However,	  not	  all	  genes	  on	  the	  Xi	  are	  repressed.	  These	  are	  called	  escapees	  since	  they	  escape	  XCI.	  	  	  	  	   1.7.2.	  The	  X	  inactivation	  centre.	  	  	   The	   localisation	   of	   the	   X-­‐linked	   region	   that	  was	   crucial	   for	   X	   inactivation,	  named	  the	  X	  inactivation	  centre	  (XIC),	  was	  firstly	  described	  in	  humans	  by	  Brown	  and	   colleagues	   using	   cell	   hybrid	   assays	   and	   abnormal	   human	   X	   chromosomes	  (Brown	   et	   al.	   1991).	   Different	   translocations	   of	   the	   human	   X	   chromosomes	   and	  their	   inactivation	  status	  allowed	   the	  mapping	  of	  XIC	   to	  Xq13.	  The	  XIST	   gene	  was	  indentified	   as	   being	   important	   to	   XCI	   as	   it	   was	   located	   within	   the	   XIC	   and	   was	  expressed	  from	  the	  Xi	  (Brown	  et	  al.	  1991).	   In	  mouse,	  using	  different	  ES	  cell	   lines	  with	  truncated	  X	  chromosomes	  or	  translocations	  that	  were	  let	  to	  differentiate	  and	  were	  then	  stained	  with	  Giemsa,	   the	   localisation	  of	  Xist	  at	  the	  Xic	  was	  determined	  and	  also	  that	  Xist	  is	  only	  expressed	  from	  the	  Xi	  (Rastan	  et	  al.	  1985;	  Brockdorff	  et	  al.	  1991).	   The	   mouse	   Xist	   RNA	   is	   large	   (15Kb),	   spliced,	   poly-­‐adenylated	   and	   non-­‐translated	  due	  to	  the	  lack	  of	  an	  extensive	  ORF	  (Brockdorff	  et	  al.	  1992).	  Its	  absence	  from	   polysomes	   and	   its	   mainly	   nuclear	   presence	   further	   suggested	   it	   is	   a	   non-­‐coding	   RNA.	   Targeted	   deletion	   of	   Xist	   in	   the	   129	   X	   chromosome	   in	   female	   cells	  having	  one	  X	  chromosome	  from	  the	  129	  strain	  and	  the	  other	  from	  the	  PGK	  strain	  indicated	   that	  Xist	   presence	   is	   essential	   for	   XCI	   (Penny	   et	   al.	   1996).	   Indeed,	   the	  
 49	  
XT67E1	   clone	   having	   the	   deleted	   Xist	   in	   the	   129	   allele	   showed	   complete	   non-­‐random	  XCI	  of	  the	  PGK	  strain	  X	  chromosome,	  demonstrating	  that	  Xist	   is	  required	  in	   cis	   for	   XCI	   to	   occur.	   Moreover,	   artificial	   up-­‐regulation	   of	   an	   inducible	   Xist	  transgene	  integrated	  in	  chromosome	  11	  in	  male	  ES	  cells,	  resulted	  in	  repression	  of	  genes	   present	   on	   chromosome	   11	   (Wutz	   et	   al.	   2000).	   This	   repression	   was	  reversible	  as	  blocking	  Xist	   induction	  led	  to	  reactivation	  of	  chromosome	  11	  genes.	  Only	  when	  transgenic	  male	  ES	  cells	  where	   let	  to	  differentiate	  concomitantly	  with	  
Xist	  induction,	  silencing	  of	  chromosome	  11	  was	  stabilised.	  Xist	  is	  expressed	  at	  low	  levels	  from	  both	  active	  X	  chromosomes	  (Xa)	  in	  undifferentiated	  female	  ES	  cells	  as	  an	   unstable	   transcript	   (Sheardown	   et	   al.	   1997;	   Panning	   et	   al.	   1997).	   Only	  when	  female	  ES	  cells	  differentiate,	  the	  Xist	  transcript	  is	  stabilised	  and	  covers	  the	  Xi.	  	  	   Lee	   and	   co-­‐workers	   later	   described	   the	   presence	   of	   a	   non-­‐coding	   RNA	   in	  antisense	  of	  Xist	  using	  strand-­‐specific	  probes	  in	  RNA-­‐FISH	  experiments	  (Lee	  et	  al.	  1999).	   This	   antisense	   transcript	   was	   called	   Tsix	   (Figure	   1.3).	   It	   is	   40Kb-­‐long	   in	  mouse,	  initiates	  15Kb	  downstream	  of	  Xist	  and	  is	  transcribed	  across	  Xist.	  As	  Xist,	  it	  is	  non-­‐coding	  and	  localised	  to	  the	  nucleus.	  Before	  the	  onset	  of	  X	  inactivation,	  Tsix	  is	  expressed	  from	  both	  X	  chromosomes	  (Lee	  et	  al.	  1999).	  Upon	  differentiation	  of	  ES	  cells,	  Tsix	  expression	  becomes	  monoallelic	  and	  only	  arises	  from	  the	  future	  Xa.	  This	  led	   to	   the	  hypothesis	   that	  Tsix	   blocks	   the	  expression	  of	  Xist	   from	   the	  Xa.	   Indeed,	  targeted	  deletion	  of	   the	  Tsix	   promoter	   led	   to	  a	   complete	  bias	  of	  XCI	   towards	   the	  mutant	  allele	  (Lee	  and	  Lu	  1999).	  In	  another	  approach,	   insertion	  of	  a	  STOP	  codon	  downstream	  of	  the	  Tsix	  promoter	  showed	  similar	  results,	  clearly	  pointing	  to	  a	  role	  of	   Tsix	   antisense	   transcription	   in	   inhibition	   of	   Xist	   up-­‐regulation	   upon	  differentiation	   (Luikenhuis	   et	   al.	   2001).	   On	   the	   other	   hand,	   induction	   of	   Tsix	  transcription	   from	   one	   X	   chromosome	   leads	   to	   the	   targeted	   chromosome	   to	  remain	   always	   active.	   Hypertranscription	   of	   Tsix	   from	   the	   mutant	   chromosome	  inhibits	   up-­‐regulation	   of	   Xist	   in	   cis	   (Stavropoulos	   et	   al.	   2001;	   Luikenhuis	   et	   al.	  2001).	   It	  was	   later	  determined	  that	  Tsix	   is	  not	   important	   for	  direct	  repression	  of	  
Xist,	   but	   is	   important	   for	   creating	   a	   heterochromatic	   compartment	   over	   the	  Xist	  promoter	   (Navarro	   et	   al.	   2005,	   2006).	  Male	   ES	   cells	  with	   a	   truncated	   version	   of	  
Tsix	   exhibit	   abnormally	   higher	   levels	   of	   the	   active	   histone	   mark	   H3K4me2	  correlating	   with	   higher	   levels	   of	   RNA	   Pol	   II	   preinitiation	   complex	   (PIC)	   binding	  during	  differentiation,	  suggesting	  that	  Tsix	  might	  recruit	  chromatin	  remodelers	  to	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the	  Xist	  locus.	  In	  addition,	  Tsix	  triggers	  H3K9me3	  and	  DNA	  methylation	  in	  a	  2.5Kb	  region	  (from	  -­‐1Kb	  to	  +1.5Kb)	  around	  the	  Xist	  promoter	  in	  ES	  cells.	  In	  this	  context,	  at	   the	   onset	   of	   differentiation,	   monoallelic	   repression	   of	   Tsix	   creates	   a	  pseudoeuchromatic	   state	  on	  Xist	   in	  cis	   that	  poises	   it	   to	   activation	  by	  monoallelic	  recruitment	   of	   the	   PIC	   resulting	   in	   monoallelic	   up-­‐regulation	   of	   Xist.	   On	   the	  contrary,	  continued	  Tsix	   expression	   from	  the	  other	  X	  chromosome	  represses	  Xist	  up-­‐regulation	   by	   inducing	   repressive	   histone	  modification	   depositions	   and	   DNA	  methylation	  around	  the	  Xist	  promoter.	  This	  heterochromatic	  status	  is	  propagated	  on	   the	   Xa	   of	   female	   cells	   and	   on	   the	   X	   chromosome	   of	   male	   cells	   during	   cell	  division	  in	  the	  differentiation	  of	  ES	  cells.	  	   Further	  work	  has	  shed	  light	  on	  how	  the	  Xic	  is	  regulated	  by	  external	  factors.	  
	  
Figure	  1.3	  Schematic	  representation	  of	  the	  Xic	  and	  neighbouring	  genes.	  
Xist	  and	  Tsix	  are	  two	  antisense	  genes.	  Barakat	  et	  al.	  2010.	  	  	  	   1.7.3.	  Regulation	  of	  the	  Xic	  
	   	   1.7.3.1.	  By	  X-­linked	  factors	  	  	   Studies	   using	   tetraploid	   embryos	   showed	   that	   the	   majority	   of	   cells	  exhibited	  inactivation	  of	  two	  X	  chromosomes	  out	  of	  four	  (Webb	  et	  al.	  1992).	  This	  suggested	  that	  female	  cells	  have	  the	  capacity	  to	  “count”	  how	  many	  X	  chromosomes	  are	   present	   in	   the	   cell	   per	   pair	   of	   autosomes.	   In	   this	   sense,	   they	   inactivate	   all	   X	  chromosomes	   except	   one	   per	   diploid	   genome.	   Tetraploid	   males	   (XXYY)	   almost	  never	  undergo	  X	  chromosome	  inactivation	  (Webb	  et	  al.	  1992).	  The	  fact	  that	  Webb	  and	   colleagues	   detected	   a	   small	   percentage	   of	   cells	   with	   one	   Xi	   in	   female	  tetraploids,	   or	   three	   Xi,	   etc,	   suggested	   that	   all	   chromosomes	   have	   a	   certain	  probability	  of	  being	   inactivated	  and	  that	  only	  cells	   that	  have	   inactivated	  two	  will	  be	  viable.	  This	   is	   referred	   to	  as	   the	  stochastic	  model	  of	  XCI.	  Extrapolating	   this	   to	  normal	  diploid	  cells,	  XCI	  would	  result	  in	  the	  majority	  of	  the	  cells	  having	  one	  Xi	  and	  one	   Xa	   and	   a	   small	   proportion	   of	   cells	   would	   exhibit	   two	   Xi	   or	   none.	   This	   was	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indeed	  the	  case	  (Monkhorst	  et	  al.	  2008).	  Monkhorst	  and	  colleagues	  detected	  up	  to	  4%	  of	  cells	  with	  XiXi	  at	  day	  5	  of	  differentiation	  of	  normal	  diploid	   female	  cells.	   In	  addition,	  the	  authors	  detected	  all	  four	  possibilities	  of	  XCI	  during	  differentiation	  of	  tetraploid	  XXXX	  cells,	  i.e.	  no	  Xi,	  Xi,	  XiXi,	  XiXiXi	  or	  XiXiXiXi.	  Cells	  with	  XiXi	  where	  the	  most	   abundant,	   suggesting	   that	   all	   the	   other	   combinations	   are	   selected	   against	  during	   cell	   differentiation.	   Indeed,	   BrdU	  mostly	   stained	   XiXi	   suggesting	   that	   the	  cells	   with	   the	   other	   possibilities	   of	   XCI	   stop	   dividing	   and	   their	   proportion	   in	  comparison	   to	   XiXi	   is	   reduced	   with	   time.	   A	   similar	   scenario	   occurred	   with	  tetraploid	  XXXY	  cells,	  where	  the	  majority	  of	  the	  cells	  inactivate	  only	  one	  X	  so	  as	  to	  retain	   two	  Xa.	   In	   summary,	   these	   results	   postulated	   the	   existence	  of	   an	  X-­‐linked	  XCI	  activator.	  Female	  diploid	  cells	  would	  produce	  twice	  as	  much	  of	  this	  activator	  as	  male	  diploid	   cells.	  This	  would	   result	   in	  a	  higher	  probability	   in	   female	  ES	   cells	   to	  inactivate	   an	   X	   chromosome	   than	   male	   cells.	   Furthermore,	   since	   this	   potential	  activator	   is	   X-­‐linked,	   XCI	   would	   result	   in	   a	   drop	   of	   activator	   levels	   and	   thus	  inhibition	  of	   the	   inactivation	  of	   the	  other	  X	  chromosome.	  Moreover,	   the	   fact	   that	  only	   one	   X	   chromosome	   remains	   active	   per	   diploid	   genome	   also	   postulates	   the	  existence	   of	   an	   autosomally	   encoded	   factor	   that	   inhibits	   XCI.	   Further	   work	  demonstrated	  that	  Rnf12,	  an	  X-­‐linked	  gene	  coding	   for	  an	  E3	  ubiquitin	   ligase,	   is	  a	  dose-­‐dependent	  activator	  of	  XCI	  (Jonkers	  et	  al.	  2009).	  Integration	  in	  male	  ES	  cells	  of	  a	  bacterial	  artificial	  chromosome	  (BAC)	  encompassing	  the	  Rnf12	  gene	  results	  in	  an	   increased	   cell	   population	  with	   Xist	   clouds	  when	   let	   to	   differentiate	   for	   three	  days.	  The	  number	  of	  cells	  with	  Xist	   clouds	  correlates	  with	  the	  BAC	  copy	  number,	  suggesting	  a	  dose-­‐dependent	  effect	  of	  Rnf12.	  Almost	  all	   cell	   lines	  generated	  with	  extra	  copies	  of	  Rnf12	  inactivated	  upon	  differentiation	  the	  single	  X	  chromosome	  in	  the	   case	   of	   male	   cells	   or	   both	   X	   chromosomes	   in	   the	   case	   for	   female	   cells.	   In	  addition,	   Rnf12	   is	   upregulated	   upon	   differentiation	   of	   ES	   cells.	   It	   was	   later	  determined,	  using	   rescue	  experiments	   in	   female	  Rnf12+/-­‐	   cells,	   that	  Rnf12	  acts	   in	  
trans	  (Barakat	  et	  al.	  2011).	  Non-­‐rescued	  female	  Rnf12+/-­‐	  cells	  show	  decreased	  cell	  numbers	  of	  cells	  with	  one	  Xist	  cloud	  compared	  to	  wt	  cells,	  in	  accordance	  with	  the	  dose-­‐dependent	  capacity	  of	  Rnf12	  to	  activate	  XCI.	  Rescue	  with	  additional	  copies	  of	  
Rnf12	   results	   in	   an	   increased	  number	  of	   cells	  with	  one	  Xist	   cloud,	   close	   to	  wt	  or	  even	  more.	  Full	  Rnf12	  knockout	  female	  cells	  sporadically	  initiate	  XCI.	  These	  results	  supported	   the	   idea	   that	   Rnf12	   promotes	   Xist	   transcription	   or	   inhibits	   an	   XCI	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inhibitor	  (e.g.	  Tsix).	  Indeed,	  gene	  expression	  microarray	  analysis	  of	  Rnf12-­‐/-­‐	  female	  cells	  and	  wt	  cells	  differentiated	  for	  three	  days	  showed	  that	  Xist	  was	  substantially	  downregulated	  in	  Rnf12-­‐/-­‐	  cells.	  Altogether,	  these	  findings	  clearly	  situate	  Rnf12	  as	  an	  activator	  of	  XCI	  through	  regulation	  of	  Xist.	  	  	  	   	   1.7.3.2.	  By	  pluripotency	  factors	  	  	   Rnf12	  has	  thus	  been	  described	  as	  an	  X-­‐linked	  activator	  of	  XCI.	  The	  fact	  that	  only	   one	   X	   chromosome	   remains	   active	   per	   diploid	   genome	   also	   suggested	   the	  existence	  of	  an	  autosomally	  linked	  XCI	  inhibitor.	  Given	  the	  tight	  link	  between	  XCI	  and	   cell	   differentiation,	   it	  was	   hypothesised	   that	   pluripotency-­‐associated	   factors	  (such	   as	   Oct4,	   Nanog	   and	   Sox2)	   might	   be	   involved	   in	   repression	   of	   Xist	   or	  activation	   of	   Tsix	   as	   a	   means	   of	   repressing	   XCI	   in	   ES	   cells.	   Nanog-­‐null	   ES	   cells	  exhibit	   increased	  levels	  of	  Xist	   transcripts	  (Navarro	  et	  al.	  2008).	  Rescue	  of	  Nanog	  results	   in	   decreased	   Xist	   levels	   showing	   that	   Nanog	   and	   Xist	   expressions	   are	  inversely	   correlated.	   Binding	   of	   Nanog	  was	   further	   demonstrated	   at	   intron	   1	   in	  both	   female	   and	   male	   ES	   cells	   but	   not	   in	   differentiating	   ES	   cells	   or	   in	   mouse	  embryonic	   fibroblasts	   (MEFs).	   Since	   the	   up-­‐regulation	   of	   Xist	   upon	   Nanog	  knockout	   does	   not	   recapitulate	   the	   full	   up-­‐regulation	   of	  Xist	   during	   normal	   XCI,	  further	   analysis	  was	   done	   on	   other	   potential	   repressors	   such	   as	   Oct4	   and	   Sox2.	  Similarly,	   Oct4	   and	   Sox2	   bind	   to	   intron	   1	   at	   the	  Nanog	   site	   and	   their	   binding	   is	  Nanog-­‐independent	  as	  ChIP	  results	  confirmed	  binding	  of	  Oct4	  and	  Sox2	  in	  Nanog-­‐null	  ES	  cells.	  Tetracycline	  (Tc)	  treatment	  of	  male	  Tc-­‐repressible	  Oct4	  transgene	  ES	  cells	  triggers	  rapid	  down-­‐regulation	  of	  Oct4	  and	  cell	  differentiation.	  Xist	  expression	  consistently	   increases	   at	   24h,	   reaching	   levels	   similar	   to	   those	   achieved	   by	  differentiating	  wt	  ES	  cells,	  whereas	  Nanog	  and	  Sox2	  expressions	  decrease	  at	  48h.	  Binding	  of	  Nanog	  and	  Sox2	  was	  in	  any	  case	  reduced	  at	  24h	  of	  Tc	  treatment.	  As	  Tsix	  expression	  is	  unaffected	  during	  the	  first	  24h	  of	  Tc	  treatment,	  the	  authors	  conclude	  that	   the	   repression	   by	   the	   pluripotency	   factors	   of	   Xist	   is	   direct	   and	   not	   Tsix-­‐mediated.	   These	   results	  were	   not	   confirmed	   in	   an	   independent	   study	  where	   the	  Oct4/Nanog/Sox2	  binding	  sites	  were	  deleted	  (Barakat	  et	  al.	  2011).	  Female	  ES	  cells	  with	  an	  heterozygous	  deletion	  of	  Xist	  intron	  1	  differentiated	  and	  inactivated	  their	  X	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chromosome	  with	   the	  same	  kinetics	  as	  wt	  ES	  cells	   indicating	   that	   intron	  1	   is	  not	  required	  for	  repression	  of	  Xist,	  as	  suggested	  by	  Navarro	  and	  co-­‐workers	  (Navarro	  et	  al.	  2008;	  Barakat	  et	  al.	  2010).	  	   Very	   recently,	   it	   has	   been	   demonstrated	   the	   Oct4,	   Nanog	   and	   Sox2	   act	   in	  conjunction	  to	  inhibit	  Rnf12	  in	  ES	  cells	  (Navarro	  et	  al.	  2008;	  Barakat	  et	  al.	  2011).	  Nanog	   binds	   at	   two	   locations	   upstream	   of	   the	   Rnf12	   TSS.	   Moreover,	   Nanog-­‐overexpressing	  ES	  cells	  exhibit	  decreased	  Rnf12	  mRNA	  levels,	  whereas	  Nanog-­‐null	  cells	  show	  increased	  mRNA	  levels.	  This	  confirmed	  previous	  reports	  by	  Barakat	  and	  colleagues	   where,	   by	   IF,	   they	   showed	   an	   anticorrelation	   of	   Nanog	   and	   Rnf12	  protein	  levels	  in	  undifferentiated	  and	  differentiating	  female	  ES	  cells	  (Barakat	  et	  al.	  2011).	   In	   addition,	   using	   the	   male	   Tc-­‐repressible	   Oct4	   ES	   cells,	   rapid	   Oct4	  depletion	   leads	   to	   an	   up-­‐regulation	   of	   Rnf12	   to	   similar	   levels	   as	   female	  differentiating	   ES	   cells.	   The	   authors	   concluded	   that	   the	   pluripotency	   factors	  repress	  Rnf12	  in	  ES	  cells.	  Given	  that	  previous	  results	  had	  shown	  an	  up-­‐regulation	  of	   Xist	   upon	   depletion	   of	   Oct4	   and	   Nanog,	   and	   that	   intron	   1	   is	   not	   needed	   for	  repression	   of	   Xist,	   but	   also	   that	   Rnf12	   is	   upregulated	   upon	   Oct4	   and	   Nanog	  depletion,	   the	   authors	   now	   hypothesise	   that	   Oct4	   and	   Nanog	   repression	   of	   Xist	  might	  be	  indirect	  and	  due	  to	  repression	  of	  Rnf12.	  	   In	  addition,	  a	  role	  for	  the	  ES-­‐cell	  associated	  factors	  Rex1,	  Klf4	  and	  c-­‐Myc	  in	  activating	  Tsix	  has	  also	  been	  demonstrated	  (Navarro	  et	  al.	  2010).	  Binding	  of	  Rex1	  was	   described	   at	   the	   boundaries	   of	   the	   repetitive	   sequence	   DXPas34,	   which	   is	  downstream	   of	   the	   Tsix	   TSS	   (Figure	   1.3).	   Klf4	   and	   c-­‐Myc	   are	   bound	   between	  DXPas34	   and	   the	   Tsix	   TSS.	   Deletion	   of	   DXPas34	   abrogates	   binding	   of	   all	   three	  proteins	   and	   leads	   to	   a	   strong	  down-­‐regulation	  of	  Tsix	   and	  decreased	  binding	  of	  RNA	   Pol	   II.	   Stable	   knockdown	   of	   Rex1	   by	   shRNAs	   also	   leads	   to	   decreased	   Tsix	  transcript	  levels	  without	  change	  to	  Klf4	  and	  c-­‐Myc	  expressions.	  Moreover,	  Klf4	  and	  c-­‐Myc	  bindings	  are	  unmodified.	  In	  addition,	  RNA	  Pol	  II	  is	  still	  recruited	  to	  the	  Tsix	  promoter.	   Nevertheless,	   the	   presence	   of	   the	   elongating	   form	   of	   RNA	   Pol	   II	   is	  decreased	   upon	   Rex1	   knockdown,	   concluding	   that	   Rex1	   is	   necessary	   for	   proper	  elongation	  of	  the	  Tsix	  transcript.	  	   	  In	   summary,	   a	   cohort	   of	   pluripotency-­‐associated	   factors	   is	   important	   for	  inhibiting	  XCI	  in	  undifferentiated	  ES	  cells	  through	  repression	  of	  Xist,	  activation	  of	  
Tsix	   and	   repression	  of	  Rnf12.	  Upon	  differentiation,	   depletion	  of	   protein	   levels	   of	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pluripotency-­‐associated	   genes	   concomitantly	   leads	   to	   derepression	   of	   Xist,	  possibly	   directly	   and/or	   through	   derepression	   of	   Rnf12	   and	   depletion	   of	   Tsix	  activity	  (Figure	  1.4).	  In	  this	  sense,	  XCI	  is	  coupled	  to	  differentiation	  of	  ES	  cells.	  	  	  
	  
Figure	  1.4	  Network	  of	  Xist,	  Tsix	  and	  Rnf12	  regulation	  by	  the	  pluripotency-­associated	  factors.	  Oct4,	  Nanog,	  Sox2,	  Rex1,	  Klf4	  and	  c-­‐Myc	  control	  the	  Xic	  in	  ES	  cells	  through	  different	  mechanisms:	  by	  repressing	  Xist	  (Oct4,	  Nanog,	  Sox2),	  by	  activating	  Tsix	  (Rex1,	  Klf4,	  c-­‐Myc)	  or	  by	  repressing	  Rnf12	  (Nanog,	  Oct4,	  Sox2)(Navarro	  et	  al.	  2011).	  	  	  	  	   	   1.7.3.3.	  By	  CTCF	  	  	   Bioinformatic	   analysis	   of	   the	   DXPas34	   region	   showed	   that	   it	   is	   highly	  enriched	   for	   the	   CTCF	   motif,	   exhibiting	   up	   to	   40	   CTCF	   consensus	   binding	  sequences	   (Chao	   et	   al.	   2002).	   In	   vitro	  binding	   assays	   further	   demonstrated	   that	  CTCF	   is	   able	   to	   bind	   to	   these	   sequences.	   Mutation	   of	   the	   CTCF	   binding	   sites	  abrogates	  CTCF	  binding.	  Because	  of	  the	  high	  repetitiveness	  nature	  of	  the	  DXPas34	  region,	   only	   DXPas34-­‐external	   CTCF	   binding	   sites	   could	   be	   tested	   in	   vivo	   using	  ChIP.	   Indeed,	   CTCF	   binds	   those	   two	   external	   regions	   of	   DXPas34.	  Moreover,	   the	  
Tsix	   CTCF	   sites	   act	   as	   enhancer	   blockers	   in	   enhancer	   blocking	   assays.	   It	   was	  postulated	   that	  CTCF	  could	  be	  acting	  as	  an	  enhancer	  blocker	  when	  bound	   to	   the	  
Tsix	   DXPas34	   in	   the	   Xa,	   whereas	   in	   the	   Xi,	   CTCF	   would	   not	   be	   bound	   and	   the	  enhancer	  could	  reach	  the	  Xist	  promoter.	  CTCF	  was	  later	  demonstrated	  to	  regulate	  
Tsix	   and	   Xist	   expression	   in	   differentiating	   male	   ES	   cells	   (Donohoe	   et	   al.	   2007).	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Depletion	   of	   CTCF	   leads	   to	   decreased	   levels	   of	  Tsix	   and	   increased	   levels	   of	   Xist,	  phenocopying	  depletion	  of	  Yy1.	  The	  authors	  suggest	  that	  CTCF,	  in	  conjunction	  with	  Yy1,	   is	   required	   for	   proper	   expression	   of	   Xist	   and	   Tsix	   in	   ES	   cells	   and	  differentiating	  ES	  cells.	  	   CTCF	  has	  also	  been	  involved	  in	  X-­‐X	  pairing	  at	  the	  onset	  of	  XCI.	  X-­‐X	  pairing	  was	   firstly	  described	   in	  differentiating	  wt	   female	  ES	   cells	   and	  male	  ES	   cells	  with	  additional	   copies	   of	   Xist	   (Bacher	   et	   al.	   2006).	   This	   co-­‐localisation	  was	   either	   by	  physical	   interaction	   or	   by	   closed	   proximity	   within	   the	   same	   nuclear	   sub-­‐compartment	  of	  both	  Xic	   in	  female	  cells.	  The	  authors	  postulated	  that	   in	  this	  way,	  female	  cells	  are	  able	  to	  count	  how	  many	  Xic	  there	  are	  in	  a	  given	  cells.	  Surprisingly,	  a	  single	  copy	  transgene	  of	  Xic	  on	  an	  autosome	  in	  male	  cells	  did	  not	   interact	  with	  the	   endogenous	   Xic.	   This	   suggested	   the	   existence	   of	   additional	   X-­‐linked	   pairing	  regions.	   Later,	   a	   novel	   region,	   called	   X-­‐pairing	   region	   (Xpr)	  was	   described	   to	   be	  crucial	   for	   interactions	   (Augui	   et	   al.	   2007).	   Xpr	   lies	   several	   hundreds	   base	   pairs	  upstream	   of	   Xist.	   In	   female	   cells,	   insertion	   of	   an	   additional	   Xpr	   increases	   the	  proportion	  of	  cells	  with	  Xist	  clusters,	  to	  around	  30%,	  even	  in	  undifferentiated	  cells.	  This	   suggested	   that	   ectopic	   copies	   of	   Xpr	   alleviate	   Xist	   repression	   in	  undifferentiated	   ES	   cells.	   Indeed,	   presence	   of	   an	   additional	   copy	   of	   Xpr	   in	  male	  cells	  results	  in	  pairing	  with	  the	  endogenous	  Xpr	  and	  nullisomy,	  possibly	  to	  strong	  counterselection	  of	  cells	  with	  high	   levels	  of	  Xist.	  A	   trans-­‐acting	   factor	   involved	   in	  pairing	  is	  CTCF.	  Depletion	  of	  CTCF	  at	  day	  4	  differentiating	  female	  ES	  cells	  reduces	  pairing	   frequency	   to	  background	   levels	   as	   in	   the	  undifferentiated	   state	   (Xu	  et	   al.	  2007).	   It	   is	   possible	   that	   CTCF,	  with	   the	   help	   of	   other	   factors,	   stabilises	   inter-­‐X-­‐chromosome	  interactions.	  Since	  cohesin	  is	  needed	  for	  cohesion	  and	  for	  many	  CTCF	  functions,	   one	   can	   hypothesise	   that	   cohesin	   might	   be	   important	   for	   transient	   X	  chromosome	  interactions.	  	   In	   addition,	   ChIP-­‐on-­‐chip	   analysis	   of	   cohesin	   binding	   showed	   that	   it	   co-­‐localises	  with	  CTCF	  at	  the	  Xic	  (Parelho	  et	  al.	  2008).	  It	  is	  possible	  that	  cohesin	  might	  be	  involved	  in	  the	  regulation	  of	  the	  Xic	  at	  the	  onset	  of	  XCI.	  What	  happens	  after	  XCI	  has	  been	  triggered?	  What	  are	  the	  epigenetic	  marks	  that	  are	  set	  on	  the	  Xi	  that	  lead	  to	  stable	  repression	  of	  gene	  expression?	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   1.7.4.	  Processes	  in	  XCI	  	  	   When	  XCI	  has	  been	  triggered	  and	  Xist	  transcript	  levels	  increase,	  Xist	  spreads	  along	   the	   inactive-­‐to-­‐be	   X	   chromosome.	   Ectopic	   expression	   of	   Xist	   triggers	  silencing	   when	   a	   Xist	   transgene	   is	   inserted	   in	   chromosome	   11	   even	   in	  undifferentiated	   ES	   cells	   as	   described	   previously	   (see	   section	   1.7.2.)(Wutz	   et	   al.	  2000).	  Only	  when	  the	  cells	  are	  let	  to	  differentiate,	  repression	  is	  fully	  stabilised.	  The	  authors	   found	   that	   only	   after	   3	   days	   of	   differentiation,	   repression	   of	   gene	  expression	   on	   the	   Xi	   is	   irreversible.	   Moreover,	   if	   Xist	   is	   expressed	   ectopically	  before	   the	   third	   day	   of	   differentiation	   and	   subsequently	   shut	   down,	   XCI	   is	   not	  stable	  and	  genes	  are	  not	  repressed.	  Ectopic	  Xist	  expression	  in	  male	  cells	  after	  three	  days	  of	  differentiation	  did	  not	  result	  in	  silencing	  of	  genes.	  Together,	  these	  results	  suggest	   the	   existence	   of	   two	   early	   steps	   during	   XCI,	   one	   is	   primary	   inactivation	  dependent	  on	  Xist	  and	  reversible	  and	  the	  other	  is	  irreversible	  inactivation	  after	  3	  days	   of	   differentiation.	   Xist	   is	   thus	   required	   to	   trigger	   inactivation,	   but	   is	   not	  needed	   for	   inactivation	   at	   later	   stages	   of	   differentiation.	   Conversely,	   ectopic	  expression	   of	   Xist	   in	   differentiated	   cells	   does	   not	   inactivate	   the	   chromosome	  (Clemson	   et	   al.	   1998;	   	   a	   Wutz	   et	   al.	   2000).	   However,	   some	   adult	   B-­‐	   and	   T-­‐cell	  progenitors	  retain	  the	  capacity	  to	   inactivate	  the	  X	  chromosome	  upon	  ectopic	  Xist	  expression	  (Savarese	  et	  al.	  2006).	  Induction	  of	  Xist	  in	  males	  in	  late	  embryogenesis	  causes	   severe	   anemia	   and	   hypocellularity	   in	   the	   thymus	   suggesting	   a	   defect	   in	  haematopoiesis.	  In	  the	  thymus,	  all	  T	  cell	  subsets	  decrease	  rapidly	  with	  induction	  of	  
Xist.	   B-­‐lymphocyte	   haematopoiesis	   is	   also	   affected,	   suggesting	   that	   ectopic	   Xist	  expression	  in	  transgenic	  males	  is	  deleterious	  for	  the	  hematopoietic	   lineages.	  This	  was	   probably	   due	   to	   silencing	   of	   the	   X	   chromosome	   in	   lineage-­‐committed	  immature	  cells	  of	  hematopoietic	  lineages	  as	  Northern	  Blot	  analysis	  demonstrated,	  pointing	   to	   a	   “permissive	   window”	   for	   XCI	   to	   occur	   in	   immature	   hematopoietic	  cells	  in	  mice.	  This	  led	  them	  to	  investigate	  whether	  a	  factor	  involved	  in	  the	  silencing	  machinery	   is	   exclusively	   expressed	   in	  Xist-­‐responsive	   cells.	   For	   this	   they	   used	   a	  thymic	  leukemia	  model	  (Agrelo	  et	  al.	  2009).	  Upon	  Xist	  induction,	  thymic	  leukemias	  regressed.	   However,	   they	   cultured	   in	   vitro	   tumour	   cells	   so	   as	   to	   obtain	   Xist-­‐resistant	   cells.	   In	   this	   sense,	   these	   cells	   acquired	   or	   lost	   a	   factor	   or	   factors	   that	  made	  them	  resistant	  to	  Xist	  and	  XCI.	  Gene	  expression	  analysis	  showed	  that	  levels	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of	   SATB1,	   a	   nuclear	   matrix	   factor,	   were	   decreased	   in	   Xist-­‐resistant	   tumours.	  Indeed,	   expression	   of	   SATB1	   in	   immature	   CD4+CD8+	   double	   positive	   (DP)	  thymocytes	  is	  high,	  correlating	  with	  the	  window	  of	  XCI	  permissiveness.	  Expression	  of	  SATB1	  in	  a	  Xist-­‐resistant	  tumour	  cell	  line	  showed	  strong	  reduced	  survival	  upon	  
Xist	   induction.	   By	   RNA-­‐FISH	   immunofluorescence,	   it	   was	   shown	   that	   Xist	   and	  SATB1	  do	  not	  co-­‐localise	  in	  CD4+CD8+	  DP	  T	  cells.	  But	  their	  localisation	  seem	  to	  be	  dependent	  on	  each	  other	  as	  Xist	  induction	  from	  both	  X	  chromosomes	  in	  transgenic	  female	  cells	  changed	  the	  pattern	  of	  SATB1	  localisation.	  The	  authors	  postulate	  that	  SATB1	   is	   important	   for	  Xist	   localisation	   and	   chromosomal	   structure.	   If	   and	   how	  SATB1	  is	  required	  for	  Xist	   localisation	  and	  inactivation	  in	  early	  development	  is	  to	  be	  elucidated.	  	   How	   the	   Xist	   transcript	   spreads	   along	   the	   chromosome	   is	   not	   fully	  understood.	  Mary	  Lyon	  postulated	  that	  long-­‐interspersed	  elements	  (LINE-­‐1)	  could	  act	   as	   “way	   stations”	   for	   the	   spreading	   of	   Xist	   since	   they	   are	   enriched	   on	   the	   X	  chromosome	   compared	   to	   autosomes	   and	   because	   LINE-­‐1	   density	   correlates	   in	  autosomes	   with	   autosomal	   inactivation	   in	   X:autosome	   translocations	   and	   Xic	  transgene	  studies	  (Boyle	  et	  al.	  1990;	  Lyon	  2003).	  Recently,	  Chow	  and	  co-­‐workers	  show	   that	   one	   of	   the	   earliest	   events	   in	   XCI	   is	   the	   co-­‐localisation	   of	   silent	   LINE	  elements	  within	  the	  Xist	  cloud,	  prior	  to	  gene	  inactivation	  (Chow	  et	  al.	  2010).	  This	  confirmed	  previous	  work	  where	  genes	  that	  are	   to	  be	   inactivated	  are	  recruited	  to	  the	  Xist	  compartment	  (Chaumeil	  et	  al.	  2006).	  Interestingly,	  a	  small	  subset	  of	  young	  LINE-­‐1	   elements	   (Tf	   and	  Gf	   LINEs)	   is	   specifically	   expressed	   in	   the	   inactivating	  X	  chromosome	   (Chow	   et	   al.	   2010).	   Xist-­‐mediated	   silencing	   actually	   promotes	  transcription	   of	   the	   X-­‐linked	   young	   LINES,	   as	   heterochromatinisation	   of	   an	  autosome	  upon	  insertion	  of	  a	  Xist	  copy	  increases	  the	  expression	  of	  the	  autosomally	  linked	   young	   LINEs.	   How	   the	   young	   LINEs	   are	   still	   expressed	   from	   the	  heterochromatic	   compartment	   is	   still	   unclear.	   These	   transcribed	   young	   LINEs	  drive	   heterochromatinisation	   of	   neighbouring	   genes.	   In	   this	   sense,	   continued	  expression	   of	   the	   young	   LINEs	   may	   help	   spread	   heterochromatin	   along	   the	   X	  chromosome,	  eventually	  getting	  silenced	  themselves	  too.	  	   Spreading	   of	   the	  Xist	   transcript	   along	   the	   Xi	   signals	   the	   starting	   point	   for	  recruitment	  of	  proteins	  and	  establishment	  of	  repressive	  marks	  to	  maintain	  the	  Xi	  in	  a	  stable	  repressive	  state.	  Over	  the	  past	  decade,	  a	  growing	  number	  of	  repressive	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histone	   modifications	   have	   been	   associated	   with	   the	   Xi.	   H3K27me3	   and	  H2AK119Ub1	  deposition	  is	  catalysed	  by	  the	  PRC2	  and	  PRC1	  complexes	  and	  is	  an	  early	  characteristic	  of	  the	  Xi	  (Plath	  et	  al.	  2003;	  de	  Napoles	  et	  al.	  2004).	  Usage	  of	  a	  
Xist	   transgene	   that	   has	   a	   deletion	   of	   the	   repeat	   A	   sequence	   so	   that	   it	   is	   able	   to	  localise	  and	  spread	  on	   the	  Xi	  but	  not	   to	  silence	   it,	  determined	   that	  H3K27me3	   is	  still	   present	  on	   the	  Xi,	   surprisingly	  uncoupling	  H3K27me3	  with	  gene	   repression.	  
Xist	  expression	   is	   in	  any	  case	  needed	  for	  H3K27me3	  deposition	  (Kohlmaier	  et	  al.	  2004).	  A	  large-­‐scale	  analysis	  of	  H3K27me3	  deposition	  in	  female	  and	  male	  ES	  and	  differentiating	   ES	   cells	   using	   the	   XT67E1	   cells	   previously	   described	   (see	   section	  1.7.2.)	  where	  one	  chromosome	  is	  from	  the	  129	  background	  whereas	  the	  other	  one	  is	   from	   the	   PGK	   background,	   showed	   that	   female	   differentiating	   ES	   cells	   exhibit	  chromosome-­‐wide	  increased	  levels	  of	  H3K27me3	  on	  the	  Xi	  (Marks	  et	  al.	  2009).	  In	  addition,	  deposition	  of	  H3K27me3	  at	  active	  genes	  is	  accompanied	  by	  a	  decrease	  in	  H3K4me3	   at	   the	   promoter,	   possibly	   through	   PRC2-­‐dependent	   recruitment	   of	  Kdm5a,	   the	   H3K4me3	   demethylase	   (Pasini	   et	   al.	   2008).	   Other	   marks	   that	   are	  characteristic	  of	  the	  Xi	  are	  H4K20me1	  and	  H3K9me2	  (Kohlmaier	  et	  al.	  2004).	  The	  previously	  described	  insertion	  of	  a	  Xist	  transgene	  in	  chromosome	  11	  of	  male	  cells,	  upon	   ectopic	   Xist	   expression	   and	   differentiation,	   results	   in	   increased	   levels	   of	  H4K20me1	  on	  chromosome	  11	  (Kohlmaier	  et	  al.	  2004).	  Indeed,	  by	  IF	  with	  an	  anti-­‐H4K20me1	  antibody	  on	  undifferentiated	  male	  ES	  cells	  expressing	  ectopic	  Xist,	  half	  of	   the	  cell	  population	  exhibits	  strong	  signals	  of	  H4K20me1	  co-­‐localising	  with	   the	  
Xist	  cloud.	  H3K9	  methylation	  deposition	  is,	  as	  H3K27me3,	  a	  very	  early	  event	  in	  XCI	  and	   mirrors	   the	   accumulation	   of	   Xist	   suggesting	   that	   Xist	   recruits	   the	   enzymes	  required	   for	   H3K9	   methylation	   deposition	   (Mermoud	   et	   al.	   2002;	   Peters	   et	   al.	  2002).	   Association	   of	  macroH2A1.2	   and	   the	   a-­‐thalassemia	  mental	   retardation	   X-­‐linked	  protein	  (ATRX)	  with	  the	  Xi	  have	  also	  been	  described	  to	  happen	  during	  later	  stages	  of	  XCI	  (Mermoud	  et	  al.	  1999;	  Baumann	  et	  al.	  2009;	  De	  La	  Fuente	  et	  al.	  2011).	  	   One	   of	   the	   latest	   repressive	   marks	   to	   be	   deposited	   on	   the	   Xi	   is	   DNA	  methylation.	  Work	  by	  Lock	  and	  colleagues	  have	  shown	  that	  the	  intronic	  sequence	  of	   the	  X-­‐linked	  gene	  subject	   to	  XCI	  Hprt	   is	  not	  methylated	   in	  undifferentiated	  ES	  cells,	   whereas	   at	   6.5dpc	   in	   embryos	   it	   is	   lowly	   methylated	   (Lock	   et	   al.,	   1987).	  Methylation	   at	   10.5dpc	   is	   higher	   than	   at	   6.5dpc.	   Since	   XCI	   takes	   place	   before	  6.5dpc,	  the	  authors	  concluded	  that	  methylation	  might	  not	  be	  required	  for	  early	  XCI	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but	   for	   the	  maintenance	   of	   the	   repressive	   state.	   Genetic	   studies	   using	   knockout	  mice	  for	  the	  DNA-­‐methyl	  transferase	  Dnmt1,	  showed	  that	  random	  XCI	  was	  normal	  in	   early	   development	   in	   females	   although	   in	   later	   stages,	   the	   Xi	   is	   reactivated	  confirming	  that	  DNA	  methylation	  is	  required	  for	  stable	  maintenance	  of	  XCI	  (Sado	  et	  al.	  2000).	  Later,	  Blewitt	  and	  co-­‐workers	  determined	  that	  SmcHD1,	  a	  member	  of	  the	   SMC	   family,	   is	   required	   for	   gene	   silencing	   and	   DNA	   methylation	   on	   the	   Xi	  (Blewitt	  et	  al.	  2008).	  
	  
Figure	  1.5	  Processes	  during	  random	  XCI	  in	  female	  differentiating	  ES	  cells.	  SATB1/2	   possibly	   create	   a	   repressive	   Xist	   compartment	   at	   the	   beginning	   of	   XCI.	   Xist	   coats	   the	  inactive-­‐to-­‐be	   X	   chromosome	   in	   cis.	   RNA	   Pol	   II	   is	   excluded	   from	   the	   inactivating	   chromosome.	  Repetitive	   sequences	   are	   silenced,	   except	   young	   LINE	   elements	   whose	   burst	   in	   expression	  correlates	   with	   gene	   silencing.	   Eventually,	   all	   repetitive	   sequences	   are	   silenced.	   Active	   histone	  methylation	  marks	   are	   lost	   whereas	   repressive	   histone	  marks	   are	   gained	   due	   to	   recruitment	   of	  PRC1	  and	  PRC2.	  Gene	  expression	  commences	  to	  be	  downregulated.	  Stable	  maintenance	  of	  silencing	  correlates	  with	  macroH2A	  association,	  ATRX	  recruitment	  and	  finally,	  DNA	  methylation	  at	  5’	  ends	  of	  genes	  (Chow	  et	  al.	  2009).	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   In	   summary,	   a	   profusion	   of	   different	  mechanisms	   act	   in	   a	  well-­‐controlled	  spatiotemporal	   fashion	   to	   inactivate	   one	   and	   only	   one	   X	   chromosome	   in	   diploid	  differentiating	   female	  ES	  cells	   (Figure	  1.5).	   In	   this	  way,	  X-­‐linked	  genes	  are	  solely	  expressed	   from	   the	   active	   X	   chromosome.	   Exceptions	   to	   this	   rule,	   that	   is,	   genes	  being	  expressed	  from	  both	  the	  Xa	  and	  the	  Xi,	  have	  been	  reported.	  These	  genes	  are	  called	  “escapees”	  since	  they	  “escape”	  XCI.	  	  	  	   1.7.5.	  Escapism	  	  	   In	  humans,	  up	  to	  15%	  of	  X-­‐linked	  genes	  escape	  XCI	  whereas	  in	  mouse,	  3%	  do	   (Carrel	   et	   al.	   2005;	   Yang	   et	   al.	   2010).	  Analysis	   of	   human	   genes	   that	   escape	  X	  inactivation	  was	  possible	  using	  rodent	  x	  human	  hybrid	  lines	  that	  retained	  a	  human	  Xi.	  Cell-­‐to-­‐cell	  variability	   in	  genes	  that	  were	  expressed	  from	  the	  human	  Xi	  can	  be	  high,	   although	   genes	   that	   were	   replicably	   expressed	   from	   the	   Xi	   in	   different	  hybrids	  were	   considered	   to	   be	   escapees	   (Carrel	   et	   al.	   1999;	   Carrel	   et	   al.	   2005).	  Yang	   and	   colleagues	   took	   advantage	   of	   a	  mouse	   cell	   line	   exhibiting	   skewed	   XCI,	  derived	  from	  a	  cross	  between	  two	  different	  mouse	  species,	  that	  is,	  the	  Mus	  spretus	  X	   is	  always	  active	  while	  the	  Mus	  musculus	  X	   is	  always	  inactive	  (Yang	  et	  al.	  2010).	  Coupling	  RNA	  extraction	  with	  high	  throughput	  sequencing	  (RNA-­‐seq),	  the	  authors	  were	   able	   to	   detect	   12	   genes	   expressed	   from	   the	   Xi	   to	   different	   amounts	   (apart	  from	  Xist).	  These	  12	  genes	  are	  not	  clustered	  and	  are	  scattered	  across	  the	  entirety	  of	  the	  chromosome	  (Figure	  1.6).	  Since,	  H3K27me3	  is	  a	  histone	  mark	  typical	  of	  the	  Xi,	   the	   authors	  measured	   the	   levels	   of	   H3K27me3	   deposition	   in	   and	   around	   the	  some	  of	  the	  escapees	  by	  ChIP-­‐on-­‐chip	  in	  adult	  livers	  and	  12.5dpc	  female	  and	  male	  embryos.	  While	  most	  of	  the	  escapees	  were	  depleted	  of	  the	  repressive	  mark,	  in	  both	  female	  and	  male	  embryos	  and	  in	  adult	  livers,	  the	  neighbouring	  genes,	  which	  do	  not	  escape	   XCI,	   were	   specifically	   enriched	   for	   H3K27me3	   only	   in	   females.	  Furthermore,	   two	   escapees	   had	   different	   patterns	   of	  H3K27me3	   in	   female	   adult	  livers	   compared	   to	   embryos,	   confirming	   earlier	   reports	   that	   escapism	   can	   be	  developmentally	  regulated	  (Sheardown	  et	  al.	  1996;	  Yang	  et	  al.	  2010).	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Figure	   1.6	   Localisation	   of	   genes	   subject	   to	   XCI	   and	   XCI	   escapees	   on	   the	   mouse	   X	  
chromosome.	  Mouse	  escapees	  are	  represented	  in	  blue	  while	  some	  genes	  subject	  to	  XCI	  are	  represented	  in	  green.	  
Xist	  is	  in	  red.	  Escapees	  from	  F.	  Yang	  et	  al.	  2010.	  	  	   What	   are	   the	   molecular	   mechanisms	   underlying	   XCI	   escapism?	   Escapees	  seem	   devoid	   of	  Xist	   RNA	   coating	   and	   correlate	  with	   low-­‐density	   areas	   of	   LINE1	  elements	   again	   supporting	   the	   idea	   that	   LINE-­‐1	   elements	   act	   as	   signalling	   and	  spreading	   signals	   for	   Xist	   (Murakami	   et	   al.	   2009;	   Chow	   et	   al.	   2010).	   The	  localisation	   of	   escapees	   with	   respect	   to	   the	   Xist	   repressive	   compartment	   also	  correlates	   with	   their	   capacity	   to	   escape	   XCI.	   Genes	   that	   undergo	   XCI,	   as	  commented	  before,	  are	  recruited	  to	  the	  Xist	  repressive	  compartment	  (Chaumeil	  et	  al.	   2006).	   On	   the	   other	   hand,	   the	   escapee	   Kdm5c	   (also	   called	   Jarid1c	   or	   Smcx),	  which	  encodes	  an	  H3K4	  demethylase,	  is	  localised	  to	  the	  outside	  or	  the	  outer	  edge	  of	  the	  Xist	  cloud,	  indicating	  that	  localisation	  with	  respect	  to	  the	  Xist	  cloud	  might	  be	  critical	  in	  XCI	  or	  escapism.	  Moreover,	  since	  escapees	  represent	  “islands”	  of	  activity	  within	   large	   heterochromatic	   areas	   on	   the	   Xi,	   it	   was	   postulated	   that	   boundary	  elements	   could	   be	   positioned	   between	   escapees	   and	   neighbouring	   inactivated	  genes.	   CTCF,	   being	   reported	   to	   act	   as	   a	   boundary	   element	   at	   other	   loci,	   was	   a	  potential	  candidate.	  Indeed,	  binding	  of	  CTCF	  has	  been	  reported	  at	  the	  5’	  end	  of	  the	  two	   escapees	   Kdm5c	   and	   Eif2s3x	   in	   mouse,	   and	   EIF2S3X	   in	   humans,	   which	   are	  positioned	  beside	  genes	  subject	  to	  XCI	  and	  thus	  at	  the	  edge	  of	  transition	  domains	  (Filippova	  et	  al.	  2005).	  On	  the	  other	  hand,	  CTCF	  binding	  at	  the	  5’	  end	  of	  the	  human	  
KDM5C	   could	   not	   be	   detected,	   which	   correlated	   with	   the	   neighbouring	   gene	  (IQSEC2)	   also	   being	   an	   escapee	   in	   humans.	   The	   authors	   hypothesised	   that	   CTCF	  could	   act	   as	   a	   chromatin	   boundary	   at	   the	   5’	   ends	   of	   the	  Kdm5c	  and	  Eif2s3x	   and	  


















edge	  of	  the	  repressive	  Xist	  compartment,	  are	  reminiscent	  of	  the	  role	  of	  CTCF	  and	  cohesin	   in	  segregating	  different	  chromatin	  domains	  by	   loop	   formation.	  However,	  the	   link	   between	   CTCF	   and	   escapism	   has	   so	   far	   been	   correlative	   and	   the	  involvement	  of	  cohesin	  in	  escapism	  has	  not	  been	  reported	  either.	  	  	  
1.8.	  Aims	  of	  this	  study	  	  	   This	  work’s	  aim	  is	  to	  study	  the	  developmental	  regulation	  of	  cohesin	  binding	  to	   mammalian	   chromosomes.	   For	   this,	   we	   will	   generate	   genome-­‐wide	   cohesin	  binding	   profiles	   in	   two	   different	   developmental	   systems	   and	   assess	   the	   role	   of	  cohesin	  in	  regulating	  gene	  expression.	  	  	   We	   want	   to	   elucidate	   what	   the	   binding	   profile	   of	   cohesin	   is	   and	   its	  relationship	  with	   CTCF	   in	   pluripotent	   cells	   and	   in	   lineage-­‐committed	   cells	   using	  ChIP-­‐seq.	  Comparison	  of	  these	  datasets	  will	  allow	  us	  to	  determine	  whether	  cohesin	  binding	   is	   developmentally	   regulated.	   In	   addition,	   we	   will	   study	   the	   CTCF-­‐independent	  binding	  profile	  of	  cohesin	  and	  whether	  cohesin	  co-­‐localises	  with	  cell-­‐type-­‐specific	  transcription	  factors	  as	  has	  been	  suggested.	  Moreover,	  we	  will	  study	  the	   relationship	   of	   cohesin	   with	   the	   CTCF	   paralogue,	   BORIS,	   using	   FLAG-­‐tagged	  BORIS	  ES	  cells.	  	   We	  will	  also	  determine	  whether	  gene	  expression	  patterns	  correlate	  with	  the	  binding	  of	  cohesin	  in	  mammalian	  cells	  by	  combining	  gene	  expression	  microarrays	  with	  the	  ChIP-­‐seq	  data.	  Usage	  of	  Rad21	  conditional	  knockout	  ES	  cells	  will	  allow	  us	  to	  study	  gene	  expression	  changes	  upon	  rapid	  cohesin	  depletion	  and	  compare	  them	  with	  published	  datasets	  of	  cohesin	  knockdowns.	  Moreover,	  we	  will	  elucidate	  what	  the	  role	  of	  cohesin	  is	  in	  two	  different	  developmental	  systems,	  Tcrα	  rearrangement	  and	  XCI.	  The	  role	  of	  cohesin	   in	  different	  stages	  of	  XCI,	  mainly	  the	  control	  of	  gene	  expression	  of	  XCI	  players	  and	  chromatin	  boundary	  formation	  around	  XCI	  escapees	  will	  be	  studied	  using	  the	  Rad21	  conditional	  knockout	  ES	  cells.	  	  	  	  	  	  	  
 63	  
Chapter	  2:	  Materials	  and	  Methods	  
	  
	  
2.1.	  Cell	  Culture:	  
	   2.1.1.	  ES	  cell	  derivation	  and	  culture	  	  	   Scc1	   lox/lox	   mice	   were	   a	   kind	   gift	   from	   Kim	   Nasmith.	   Blastocysts	   were	  obtained	   from	   superovulated	   females	   and	   grown	   for	   2	   to	   3	   days	   in	   Neurobasal	  medium,	  DMEM/F12	  1:1,	   L-­‐glutamine	   (2mM),	  100	  Units/ml	  Penicillin,	   100µg/ml	  Streptomycin,	   nonessential	   amino	   acids	   (NEAA),	   100mM	   β-­‐mercaptoethanol,	   N2	  supplement	   (Invitrogen),	   B27	   supplement	   (Invitrogen),	   1000U/ml	   of	   leukaemia	  inhibitory	   factor	   (LIF)	   and	   GSK3β	   and	   MEK	   inhibitors	   (Miltenyi	   Biotech,	  N2B27+2i).	  	   After	   the	   zona	  pellucida	  were	   shed,	   single	  blastocysts	  were	   transferred	   to	  laminin-­‐coated	  4	  wells	  and	  let	  to	  stick	  for	  some	  days	  until	  the	  inner	  cell	  mass	  (ICM)	  outgrew	   the	   blastocyst.	   The	   ICM	   were	   then	   picked,	   gently	   trypsinised	   and	  transferred	  to	  laminin-­‐coated	  96	  well	  dishes.	  	  	   Scc1	   ES	   cells	  were	   grown	   in	   N2B27+2i	   in	   laminin-­‐coated	  wells	   and	  were	  treated	  with	  4’-­‐hydroxytamoxifen	  (4’	  OHT)	  at	  a	  final	  concentration	  of	  80nM	  for	  the	  specified	  time.	  	   46C	  and	  ZHBTc4	  ES	  cells	  were	  grown	  in	  Knockout	  DMEM	  medium	  plus	  10%	  fetal	  calf	  serum	  (FCS),	  NEAA,	  L-­‐glutamine	  (2mM),	  100mM	  β-­‐mercaptoethanol,	  100	  Units/ml	  Penicillin,	  100µg/ml	  Streptomycin	  and	  1000U/ml	  of	  LIF	  (ES	  medium)	  in	  0.1%	  gelatin-­‐coated	  well.	  46C	  FLAG-­‐BORIS	  ES	  cells	  were	  grown	  as	  the	  46C	  ES	  cells	  in	  the	  presence	  of	  1µg.ml-­‐1	  Puromycin	  (Sigma).	  ZHBTc4	  ES	  cells	  were	  treated	  with	  Doxycycline	  for	  12h	  (1µg.ml-­‐1,	  Sigma).	  	  
	  
	   2.1.2.	  ES	  cell	  differentiation	  	  	   For	  short-­‐term	  assays,	  Scc1	  ES	  cells	  were	  seeded	  at	  500x103	  cells/well	  of	  a	  laminin-­‐coated	   6-­‐well	   dish	   and	   were	   let	   to	   differentiate	   as	   a	   monolayer	   for	   the	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specified	  time	  in	  Neural	  Differentiation	  media,	   identical	  to	  N2B27+2i	  but	  without	  the	  2i,	  LIF	  and	  with	  twice	  as	  much	  N2	  and	  B27	  supplements	  (N2B27-­‐2i).	  	  	   For	   long-­‐term	  assays	  (>9days),	  seeding	  density	  was	  50-­‐100x103	  cells/well	  of	  a	  laminin-­‐coated	  6-­‐well	  dish.	  Cells	  were	  trypsinised	  and	  split	  1/5-­‐1/6	  into	  new	  poly-­‐L-­‐ornithine-­‐	   and	   laminin-­‐coated	   6	   well	   dishes.	   4’OHT	   was	   added	   at	   a	   final	  concentration	  of	  400nM	  at	  day	  9	  of	  differentiation.	  	  	  
	   2.1.3.	  B	  cell	  culture	  	  	   Primary	  pre-­‐B	  cells	  were	  extracted	  from	  15dpc-­‐embryo’s	  livers.	  Livers	  were	  removed,	  passed	   through	  a	  21G	  needle	  and	  cells	  were	   then	   transferred	   to	  6	  well	  dishes,	  one	  liver	  per	  well	  containing	  Iscove’s	  modified	  Dulbecco’s	  medium	  (IMDM)	  (Gibco)	  supplemented	  with	  10%	  foetal	  calf	  serum,	  L-­‐glutamine,	  antibiotics	  and	  IL-­‐7	  (5ng/ml).	  After	  3-­‐4	  days,	  cells	  were	  transferred	  to	  wells	  containing	  stroma	  cells	  (ST2).	  Cells	  in	  suspension	  were	  stained	  for	  the	  µ	  chain	  and	  CD19	  to	  confirm	  pre-­‐B	  cell	  stage.	  	  	   Primary	   pro-­‐B	   cells	   from	  Rag1-­‐/-­‐	   fetal	   livers	  were	   extracted	   and	   grown	   in	  the	   same	   way	   as	   wild-­‐type	   pre-­‐B	   cells.	   Lack	   of	   µ	   chain	   and	   presence	   of	   CD19	  confirmed	  pro-­‐B	  cell	  stage.	  	  	   Mouse	  B3	  pre-­‐B	  cells	  were	  grown	  as	  primary	  pre-­‐B	  and	  primary	  pro-­‐B	  cells	  although	  in	  the	  absence	  of	  ST2	  cells.	  	  	  
2.2.	  BORIS	  cloning	  strategy	  	   Total	   RNA	   was	   extracted	   from	   46C,	   random	   primed	   and	   reverse	  transcribed.	   cDNA	   was	   amplified	   using	   Phusion	   Taq	   (NEB)	   in	   a	   50μl	   reaction	  volume	  with	  primers	  with	  restriction	  enzymes	  (RE)	  Bgl2	  and	  Not1	  sites	  overhangs.	  Amplified	  cDNA	  was	  then	  digested	  with	  Bgl2	  and	  Not1,	  ligated	  to	  pFLAG-­‐cDNA	  III	  vector	  constructed	  by	  Dr.	  B.	  Cobb	  so	   that	   the	  Boris	   cDNA	  would	  be	   in	   frame	  and	  tagged	  with	  a	  double	  FLAG	  epitope	  at	   its	  5`end.	  cDNA	  clones	  were	  sequenced	  by	  the	  MRC	  Genomics	  Core	  Facility.	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FlagBoris	  was	  then	  amplified	  using	  primers	  with	  restriction	  enzymes	  XhoI	  and	  NotI	   sites	   overhangs.	  Amplified	  product	  was	   introduced	   into	   the	  pCAGIPuro	  vector	   between	   the	   chicken	   β-­‐actin	   promoter	   (pCBA)	   and	   an	   internal	   ribosome	  entry	  site	  (pIRES)	  upstream	  of	  the	  puromycin	  resistance	  gene	  (Figure	  2.1).	  
FlagBoris-­‐pCAGIPuro	   and	  pCAGIPuro	   control	   vectors	  were	   sequenced	   and	  then	  transfected	  in	  46C	  wt	  ES	  cells.	  1x106	  cells	  were	  transfected	  with	  4µg	  of	  DNA	  in	   10µl	   lipofectamine	   (Invitrogen),	   800µl	   Optimem	   medium.	   800ul	   of	   the	  DNA/lipofectamine/Optimem	   mixture	   were	   applied	   on	   the	   cells	   for	   4.5hrs	   and	  rinsed	  off	  afterwards.	  New	  ES	  medium	  without	  antibiotics	  was	  then	  added.	  After	  2	  days,	  serial	  dilutions	  of	  the	  bulk	  population	  were	  done	  and	  cells	  were	  grown	  in	  ES	  medium	   with	   1µg.µl-­‐1	   puromycin	   for	   10	   days.	   Colonies	   were	   then	   picked	   and	  grown	  separately	  for	  screening	  by	  RNA	  and	  anti-­‐Flag	  Western	  Blot	  (WB).	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  


















2.3.	  SiRNA	  kd	  of	  CTCF	  and	  cohesin	  	  	   SiRNA	   oligonucleotides	   for	   CTCF,	   Rad21	   and	   negative	   control	   #2	   were	  purchased	   from	  Dharmacon.	   7.5x105	   cells	  were	   plated	   per	   gelatinised	  well	   4hrs	  before	   transfection.	   A	   mixture	   of	   CTCF	   or	   Rad21	   siRNAs	   (120µl)	   were	   applied	  overnight	   at	   a	   final	   concentration	   of	   0.4µM,	  with	   30µl	   5X	   siBuffer,	   438µl	   serum-­‐free	  ES	  medium,	  12µl	  of	  Dharmafect	  Reagent	  #1	  and	  2.4mls	  of	  antibiotic-­‐free	  ES	  medium.	  Cells	  were	  then	  grown	  in	  normal	  ES	  medium	  for	  an	  additional	  day.	  RNA	  and	  protein	  samples	  were	  collected	  for	  analysis,	  48h	  after	  transfection.	  	  	  
2.4.	  Western	  Blot	  	  	   Cells	  were	   lysed	   in	   sample	   buffer	   (SB;	   100mM	  Tris	   pH	  6.8,	   2%	   SDS,	   20%	  glycerol,	  0.002%	  bromophenol	  blue,	  1.43M	  β-­‐mercaptoethanol)	  and	  denatured	  at	  95°C	   for	  5	  minutes.	  The	   equivalent	   volume	   to	  2-­‐5x105	   cells	  was	   loaded	  per	   lane	  loaded	  on	  an	  (BioRad)	  stacking	  gel	  [4%	  (w/v)	  acrylamide,	  0.125	  M	  Tris	  (pH	  6.8),	  0.1%	   (w/v)	   SDS,	   0.1%	   (w/v)	   ammonium	  persulphate,	   and	   0.1%	   (v/v)	  N,N,N’,N’-­‐tetramethylethylenediamine]	   and	   separated	   in	   a	   8%	   acrylamide	   resolving	   gel	  [8%(w/v)	   acrylamide,	   0.4	   M	   Tris	   (pH	   8.8),	   0.1%	   (w/v)	   SDS,	   0.1%	   (w/v)	  ammonium	   persulphate,	   and	   0.1%	   (v/v)	   N,N,N’,N’-­‐tetramethylethylenediamine]	  using	   Tris-­‐glycine	   electrophoresis	   buffer	   [1.5%	   (w/v)	   Tris,	   7.2%	   glycine,	   0.5%	  (w/v)	   SDS]	   for	   1h30min	   at	   130V.	   Proteins	   were	   then	   transferred	   on	   a	   Protan	  nitrocellulose	   transfer	   membrane	   (Schleicher	   &	   Schuell	   Bioscience,	   Dassel,	  Germany)	   in	   transfer	  buffer	   (48	  mM	  Trizma	  base,	  39	  mM	  glycine,	  0.037%	  (w/v)	  SDS	   and	   20%	   (v/v)	   methanol)	   using	   the	   trans-­‐blot	   semi-­‐dry	   75	   electrophoretic	  transfer	  apparatus	  (BioRad).	  The	  membranes	  were	  incubated	  for	  1h	  with	  blocking	  buffer	   [10%	   (w/v)	   fat	   free	   milk	   powder	   (Marvel),	   1.2	   g/L	   Tris	   pH7.4,	   8.75	   g/L	  NaCl],	  followed	  by	  primary	  antibody	  incubation	  diluted	  in	  blocking	  buffer	  for	  1h	  at	  room	  temperature,	  with	  agitation.	  After	  washing	  3	   times	   in	  wash	  buffer	   [1.2	  g/L	  Tris	   pH7.4,	   8.75	   g/L	   NaCl]	   for	   10min,	   the	   immunoblots	   were	   probed	   with	  secondary	   antibodies	   conjugated	   to	   horseradish	   peroxidase	   in	   blocking	   solution	  for	  1h	  at	  room	  temperature,	   followed	  by	  three	  10min	  washes	  in	  wash	  buffer	  and	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developed	  using	  ECL	  plus	  detection	  system	  (Amersham	  Bioscience)	  following	  the	  manufacturer’s	  protocol.	  	  	   Antibodies	  used	  were	  rabbit	  anti-­‐CTCF	  (1:1000,	  Upstate),	  rabbit	  anti-­‐Rad21	  (1:1000,	  Abcam),	  mouse	  anti-­‐Flag	  (1:1000,	  Sigma),	  goat	  anti-­‐laminB	  C-­‐20	  (1:5000,	  Sigma)	   and	   anti-­‐rabbit,	   anti-­‐mouse	   and	   anti-­‐goat	   Ig	   coupled	   to	   horseradish	  peroxidase	  (1:5000,	  GE	  Healthcare	  UK	  Limited	  and	  Santa	  Cruz)	  .	  	  	  
2.5.	  Propidium	  Iodide	  Staining	  
	  	   10x106	   cells	  were	  washed	   in	   PBS	   (-­‐Ca/-­‐Mg)	   and	   resuspended	   in	   950µl	   of	  PBS	   (-­‐Ca/-­‐Mg),	   50µl	   of	   Propidium	   Iodide	   (PI,	   1mg.ml-­‐1,	   Sigma),	   10µl	   NP-­‐40	   5%,	  100µl	  RNAse	  A	  (10mg.ml-­‐1,	  Invitrogen)	  for	  20min	  at	  RT.	  	  	  	  
2.6.	  ChIP	  
	  
	   100x106	  cells	  were	  fixed	  with	  1%	  formaldehyde	  for	  10min	  at	  37ºC.	  Fixation	  was	  stopped	  adding	  glycine	  at	  0.125M	  final	  concentration	  for	  5min,	  RT.	  Cells	  were	  pelleted	  at	  2000rpm,	  5min,	  4ºC	  and	  washed	  twice	  with	  cold	  PBS.	  Cells	  were	  lysed	  with	  wash	  buffer	  1	  (10mM	  HEPES	  pH7.5,	  10mM	  EDTA,	  0.5mM	  EGTA,	  0.75%	  Triton	  X-­‐100).	  Nuclei	  were	  washed	  in	  nuclei	  wash	  buffer	  2	  (10mM	  HEPES	  pH7.5,	  200Mm	  NaCl,	  1mM	  EDTA,	  0.5mM	  EGTA)	  and	  then	  lysed	  and	  sonicated	  in	  sonication	  buffer	  3	  (150mM	  NaCl,	  25mM	  Tris	  pH7.5,	  5mM	  EDTA,	  1%	  Triton	  X-­‐100,	  0.1%SDS,	  0.5%	  deoxycholate).	  All	  buffers	   contained	  protease	   inhibitors	  1:25	   (Roche).	  Chromatin	  was	   sonicated	   2	   times	   for	   15min	   at	   4ºC	   using	   Bioruptor	   (Diagenode),	   30sec	  ON/OFF	  intervals.	  Chromatin	  fragment	  size	  was	  assessed	  on	  1%	  agarose	  gels	  and	  was	  of	  the	  order	  of	  300	  -­‐	  1000	  bp.	  Insoluble	  proteins	  and	  debris	  were	  removed	  by	  centrifugation	  at	  14000	  rpm	  for	  30min,	  4ºC	  and	  DNA	  content	  was	  determined	  by	  spectrophotometric	   analysis.	   150µg	   of	   chromatin	   were	   used	   per	  immunoprecipitation.	   150µg	  were	   diluted	   to	   final	   volume	   of	   500µl	   of	   sonication	  buffer	   3	   and	   pre-­‐cleared	   by	   incubation	   with	   25µl	   Protein	   G	   –coupled	   magnetic	  beads	   for	   3hrs.	   Protein	   G	  magnetic	   beads	  were	   previously	   blocked	  with	   salmon	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sperm	  DNA	  (10µg.µl-­‐1)	   and	  BSA	   (100X	  NEB	  stock)	  at	  a	   ratio	  of	  100:4:10	   for	  1hr,	  4ºC.	   25µl	   beads	  were	   incubated	  with	   5µg	  primary	   antibody	   for	   3hrs,	   4ºC.	   Beads	  coupled	  with	  antibody	  were	  added	  on	  pre-­‐cleared	  chromatin	  and	  left	  overnight	  to	  IP.	  1.5µg	  of	  chromatin	  were	  kept	  as	  input	  sample.	  	  Beads	  were	  washed	  twice	  with	  1ml	  wash	  buffer	  A	  (50mM	  Tris	  pH8.0,	  150mM	  NaCl,	  0.1%	  SDS,	  0.5%	  deoxycholate,	  1%	  NP40,	  1mM	  EDTA	  and	  protease	  inhibitors),	  the	  second	  wash	  leaving	  the	  tubes	  rotating	   in	   the	   cold	   room	   for	   10min,	   once	   in	   wash	   buffer	   B	   (50mM	   Tris	   pH8.0,	  500mM	  NaCl,	  0.1%	  SDS,	  0.5%	  deoxycholate,	  1%	  NP40,	  1mM	  EDTA	  and	  protease	  inhibitors)	   10min	   rotating	   in	   the	   cold	   room,	   once	   in	  wash	   buffer	   C	   (50mM	   Tris	  pH8.0,	   250mM	   LiCl,	   0.5%	   deoxycholate,	   1%	   NP40,	   1mM	   EDTA	   and	   protease	  inhibitors)	  10min	  in	  the	  cold	  room	  ,	  once	  in	  1X	  TE	  buffer	  (100mM	  Tris-­‐HCl,	  1mM	  EDTA)	   and	   finally	   eluted	   by	   incubation	   in	   450	   µl	   elution	   buffer	   (1%	   SDS,	   0.1	  M	  NaHCO3,	  220	  µg	  proteinase	  K	  and	  50	  µg	  RNaseA)	  for	  2	  hours	  at	  37°C	  and	  overnight	  at	  65°C,	  shaking	  at	  1000rpm	  for	  30sec	  intervals	  every	  minute.	  For	  Flag	  ChIP,	  beads	  coupled	   to	   the	   antibody	   and	   the	   chromatin	  were	   eluted	   twice	  with	   0.2µgxµl-­‐1	   of	  Flag	   tripeptide	   (Sigma)	   and	   then	   proteinase	   K	   and	   RNase	   A	   were	   added	   to	   the	  eluate.	  DNA	  was	  Phenol-­‐Chloroform	  extracted	  and	  precipitated	  in	  EtOH,	  NaAcetate	  and	   glycogen	   for	   1hr	   at	   -­‐80ºC.	   After	   centrifugation	   at	   14000rpm,	   30min,	   4ºC,	  pellets	  were	  washed	  with	   70%	  EtOH	   and	   resuspended	   in	   40	   µl	   TE.	   0,5	   µl	   of	   the	  sample	  was	  used	  per	  qPCR	  well.	  Table	  I.ii	  lists	  the	  primers	  for	  ChIP-­‐qPCR.	  
	  
	  
2.7.	  ChIP-­seq	  library	  preparation	  
	  
	   10µg	  of	   INPUT	  DNA	  was	  phenol-­‐chloroform	  extracted,	  reverse	  crosslinked	  and	   run	   on	   a	   1%	   agarose	   gel	   to	   check	   DNA	   size	   in	   the	   chromatin.	   When	   the	  majority	  of	   the	  DNA	  population	  was	  between	  100bp	  and	  250bp	   in	   size,	  ChIPs	  of	  cohesin,	   CTCF	   or	   FLAG-­‐BORIS	   were	   performed,	   pooled,	   and	   ChIP’d	   DNA	   was	  concentrated	   using	   the	   speed-­‐vac	  machine	   to	   approximately	   15µl.	   Concentration	  was	  determined	  using	  Qubit	  at	  the	  MRC	  Genomics	  Core	  Facility.	  10ng	  were	  used	  as	  starting	   material	   for	   library	   generation	   following	   the	   Illumina	   ChIP-­‐seq	   sample	  Library	   Generation	   Protocol.	   In	   brief,	   DNA	   overhangs	   were	   converted	   into	  
 69	  
phosphorylated	  blunt	  ends,	   an	  A	  base	  was	  added	   to	   the	  3’	   end	  of	   the	  blunt	  DNA	  fragments,	   adapters	   with	   a	   T	   overhang	   where	   then	   ligated	   to	   the	   ChIP’d	   DNA.	  When	  the	  starting	  material	  was	  less	  than	  10ng,	  1:20	  dilution	  of	  the	  adapters	  was	  used	   instead	  of	  1:10.	  The	  adapter-­‐ligated	  DNA	  fragments	  were	  then	  run	  on	  a	  2%	  agarose	  gel	  for	  1h	  at	  120V	  and	  DNA	  was	  size-­‐selected.	  The	  gel	  was	  cut	  from	  150bp	  to	  300bp.	  DNA	  was	  purified	  and	  PCR-­‐amplified	  for	  18	  cycles	  using	  primers	  specific	  to	   the	   adapters	   (Primer	   1.1	   and	   2.1).	   The	   PCR	   product	   was	   subsequently	   size-­‐selected	  again	  from	  150bp	  to	  300bp	  on	  a	  2%	  agarose	  gel.	  DNA	  was	  repurified	  and	  concentrated	   to	   15µl.	   2µl	   were	   taken	   to	   perform	   an	   RT-­‐PCR	   to	   assess	   bias	  introduced	   by	   the	   protocol.	   2	   positive	   control	   sites	   (17:16298	   and	   IL4-­‐6)	   and	   2	  negative	   sites	   (Igf2r-­‐2	   and	   Xist7Na)	   were	   used.	   When	   the	   negative	   site	   signals	  reached	  the	  signal	  threshold	  later	  than	  the	  positive	  site	  signals	  in	  the	  RT-­‐PCR,	  the	  library	  was	   said	   to	   be	   “unbiased”.	   1µl	   of	   the	   library	  was	   then	   taken	   to	   the	  MRC	  Genomics	   Core	   Facility	   to	   be	   run	   on	   a	   1000x	   DNA	   Agilent	   hypersensitive	   DNA	  Bioanalyser	  Chip	  to	  assess	  size-­‐distribution	  and	  concentration	  of	  the	  library.	  When	  the	   libraries	  passed	  all	   these	  quality	  controls,	   it	  was	  given	   for	  sequencing	  on	   the	  Ilumina	  Platform.	  	   Peak	  extraction	  was	  performed	  with	  FindPeaks.	  Usage	  of	  Venn	  diagrams	  for	  data	   viewing	   might	   generate	   different	   peak	   numbers	   depending	   on	   how	   many	  datasets	  are	  compared,	  since	  one	  peak	  in	  one	  dataset	  can	  overlap	  with	  more	  than	  a	  single	  peak	  in	  another	  dataset.	  Depending	  on	  the	  “direction”	  of	  the	  comparison,	  the	  number	  of	  peaks	  will	  be	  different.	  	  	  
2.8	  RNA	  extraction,	  cDNA	  synthesis,	  PCR	  and	  qPCR	  analysis	  
	   	  	   RNA	   was	   extracted	   from	   5x106	   cells	   with	   the	   Qiagen	   RNA	   Extraction	   kit	  following	  the	  manufacturer’s	  instructions.	  Residual	  DNA	  was	  eliminated	  using	  the	  DNA-­‐free	  kit	  (Ambion,	  	  Austin,	  TX)	  according	  to	  manufacturer’s	  instructions.	  1μg	  of	  RNA	   was	   then	   reverse	   transcribed	   using	   SuperscriptTM	   First-­‐Strand	   Synthesis	  system	  (Invitrogen).	  The	  μg	  of	  RNA	  was	  brought	   to	  11μl	  with	  RNAse-­‐free	  water,	  1μl	   of	   random	   primers	   (200ng.μl-­‐1)	   and	   1μl	   of	   dNTPs	   10mM.	   The	   mixture	   was	  incubated	  at	  65ºC	  for	  5min,	  brought	  to	  4ºC	  for	  1min	  and	  then	  1μl	  of	  0.1M	  DTT,	  4μl	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of	  5X	  first	  strand	  buffer,	  1μl	  of	  RnaseOUT	  (Invitrogen)	  and	  0.5μl	  of	  SuperscriptIII	  were	  added	  so	  that	  the	  final	  volume	  was	  20μl.	  cDNA	  was	  then	  diluted	  1/6	  to	  120μl	  with	  water.	  	  Real-­‐time	  PCR	  of	  cDNA	  was	  performed	  using	  the	  following	  program,	  unless	  otherwise	  stated,	  95ºC	  15min	  then	  40	  cycles	  95ºC	  30sec,	  60ºC	  30sec,	  72ºC	  30sec,	  using	  the	  Opticon	  Monitor	  software	  (MJ	  Research	  Inc.)	  PCR	  reactions	  included	  2X	  Sybr-­‐Green	  PCR	  Mastermix	  (Qiagen),	  1mM	  primers	  and	  2µl	  of	   template	   in	  a	  20µl	  reaction	  volume.	  Ubc	  and	  Ywhaz	  where	  used	  as	  housekeeping	  genes	  to	  normalised	  gene	   expression.	   As	   Xist	   and	   Tsix	   are	   two	   antisense	   transcripts,	   strand-­‐specific	  reverse	   transcription	   was	   performed	   as	   described	   by	   Nesterova	   and	   colleagues	  (Nesterova	   et	   al.,	   2003).	   β-­‐actin	   housekeeping	   gene	   expression	   was	   used	   to	  normalise	  Xist	  and	  Tsix	  expression	  levels.	  Real-­‐time	  PCR	   analysis	   of	   ChIP	   samples	  was	   carried	   out	   as	   the	   cDNA	  RT-­‐PCR	  except	  that	  0.5µl	  of	  DNA,	  2X	  SYBR-­‐Green	  PCR	  Mastermix	  (Biorad)	  and	  a	  3min	  enzyme	  activation	  period	  were	  used	  instead.	  Table	  I.i	  lists	  the	  primers	  for	  gene	  expression.	  	  	  
2.9.	  Microarray	  	  	   mRNA	  was	  extracted	  as	  described	  in	  section	  2.8.	  Microarray	  samples	  were	  prepared	   following	   Affymetrix	   instructions.	   First	   Cycle:	   First	   Strand	   cDNA	  synthesis:	  0.2µl	  of	  T7-­‐(N)6	  primers,	  0.1µl	  of	  diluted	  poly	  A+	  Controls	  and	  1.7µl	  of	  RNase	  free	  water	  were	  added	  to	  200ng	  of	  Total	  RNA	  to	  a	  final	  volume	  of	  5µl.	  The	  sample	  was	  then	  heated	  at	  70ºC	  for	  5min,	  cooled	  at	  4ºC	  for	  2min	  and	  left	  on	  ice	  for	  not	  more	  than	  10min.	  2µl	  5X	  First	  Strand	  Buffer,	  1µl	  0.1M	  DTT,	  0.5µl	  10mM	  dNTP	  mix,	  0.5µl	  RNase	  Inhibitor	  and	  0.5µl	  Superscript	  II	  (added	  last)	  were	  added	  to	  the	  reaction	  tube.	  The	  sample	  was	  then	  subjected	  to	  10min	  25ºC,	  1h	  42ºC,	  10min	  70ºC	  and	   2min	   4ºC.	   We	   then	   followed	   onto	   the	   First	   Cycle:	   Second	   Strand	   cDNA	  synthesis.	   A	   mastermix	   of	   4.8µl	   RNase	   free	   dH2O,	   4µl	   of	   17.5mM	   MgCl2,	   0.4µl	  10mM	  dNTP	  Mix,	  0.6µl	  DNA	  polymerase	  I	  (added	  last),	  0.2µl	  RNase	  H	  (added	  last)	  was	  prepared.	  10µl	  of	   the	  mastermix	  were	  mixed	  with	  the	  sample	  and	  incubated	  for	  2h	  at	  16ºC	  without	  heated	  lid	  option.	  Then	  for	  10min	  at	  80ºC	  with	  heated	  lid	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option	  (95ºC)	  and	  for	  2min	  at	  4ºC.	  We	  then	  followed	  onto	  the	  cRNA	  synthesis.	  5µl	  10X	   IVT	   Buffer,	   20µl	   IVT	   NTP	   Mix	   and	   5µl	   IVT	   Enzyme	   Mix	   (added	   last)	   were	  added	   to	   the	   sample	   and	   incubated	   for	   16h	   at	   37ºC	  with	   heated	   led	   option	   and	  then	  kept	  at	  4ºC.	  cRNA	  was	  then	  column	  purified	  and	  cleaned	  and	  eluted	  in	  13.5µl.	  The	  260nm	  and	  280nm	  absorbance	  were	  then	  measured.	  The	   first	  cycle	  of	  cRNA	  yield	  should	  be	  >	  16µg.	  We	  then	  proceeded	  to	  the	  Second	  Cycle:	  First	  Strand	  cDNA	  Synthesis.	  1.5µl	  of	  3µg.µl-­‐1	  random	  primers	  were	  added	  to	  10µg	  of	  single	  stranded	  cRNA	  from	  previous	  step.	  Final	  volume	  was	  brought	  to	  8µl	  with	  RNase	  free	  dH2O.	  The	  mix	  was	  heated	  for	  5min	  at	  70ºC,	  then	  transferred	  to	  25ºC	  for	  5min	  and	  4ºC	  for	   2min.	   4µl	   5X	   First	   Strand	  Buffer,	   2µl	   0.1M	  DTT,	   1.25µl	   10mM	  dNTP	  +	   dUTP,	  4.75µl	   Superscript	   (added	   last)	  were	   then	   added	   to	   the	   sample	  which	  was	   then	  transferred	  to	  25ºC	  for	  10min,	  42ºC	  for	  90min,	  70ºC	  for	  10min	  and	  4ºC	  for	  2min.	  Subsequently,	  we	  performed	  the	  hydrolysis	  of	  the	  cRNA	  by	  adding	  1µl	  of	  RNase	  H	  to	   the	   sample	   and	   incubating	   it	   for	   37ºC	   for	   45min,	   95ºC	   for	   5min	   and	   4ºC	   for	  2min.	  We	  then	  proceeded	  to	  the	  clean-­‐up	  of	  the	  single-­‐stranded	  cDNA,	  which	  was	  eluted	  in	  28µl.	  We	  measured	  the	  260nm	  and	  280nm	  absorbances	  and	  checking	  the	  single	   stranded	   cDNA	   yield	   was	   >5.5µg.	   An	   aliquot	   of	   1.5µl	   was	   kept	   for	   size	  analysis	   using	   the	   Agilent	   2100	   Bioanalyser.	   We	   then	   proceeded	   to	   the	  fragmentation	  of	  the	  single	  stranded	  cDNA.	  To	  5.5µg	  of	  single	  stranded	  cDNA,	  we	  added	   10µl	   RNase	   free	   H2O,	   4.8µl	   10X	   cDNA	   Fragmentation	   Buffer,	   1µl	   10U.µl-­‐1	  UDG,	  1µl	  1,000U.µl-­‐1	  APE	  1	  and	  subjected	  the	  sample	  to	  37ºC	  for	  60min,	  93ºC	  for	  2min	  and	  4ºC	  for	  2min.	  An	  1.5µl	  aliquot	  of	  the	  fragmented	  cDNA	  sample	  was	  kept	  for	  size	  analysis	  using	  the	  Agilent	  2100	  Bioanalyser.	  Fragment	  size	  should	  be	  40-­‐70bp.	  We	  then	  proceeded	  to	  the	  labelling	  of	  the	  fragmented	  single-­‐stranded	  DNA.	  For	  this,	   to	  45µl	  of	   the	  sample,	  we	  added	  12µl	  of	  5X	  TdT	  Buffer,	  2µl	  TdT	  and	  1µl	  5mM	  DNA	  Labelling	  Reagent.	  The	  sample	  was	  then	  put	  at	  37ºC	  for	  60min,	  70ºC	  for	  10min	  and	  finally	  at	  4ºC	   for	  2min.	  The	  samples	   is	  now	  ready	   for	  sequencing	  and	  was	  brought	  to	  the	  Microarray	  Centre	  at	  the	  Genomics	  Laboratory.	  An	  Affymetrix	  GeneChip	   Mouse	   Gene	   1.0	   ST	   Array	   was	   used.	   Microarray	   	  	   images	   	  	   were	   	  	  processed	  	  	  and	  	  	  analysed	  	  	  for	  	  	  differential	  	  expression	  	  by	  	  Dr.	  Tom	  Carroll	  (MRC,	  	  CSC)	  	  using	  	  the	  	  Bioconductor	  	  Package	  	  for	  	  R.	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2.10.	  Bisulfite	  sequencing	  
	  	   Genomic	   DNA	   was	   isolated	   using	   100µl	   of	   Lysis	   buffer	   (1M	   NaCl,	   10mM	  EDTA,	  40mM	  Tris	  pH	  8.1,	  0.5%	  SDS,	  proteinase	  K	  and	  RNAseA	  in	  water)	  /	  1x106	  cells.	   Cells	   were	   lysed	   overnight	   in	   a	   50ºC	   water	   bath	   and	   gDNA	   was	   phenol-­‐chlorophorm	  extracted,	  precipitated,	  washed,	  dried	  and	  resuspended	  in	  100µl	  TE	  for	   10min	   at	   37ºC.	   gDNA	  was	   quantified	   and	   1µg	   of	   DNA	  was	   used	   for	   bisulfite	  treatment	   following	  manufacturer’s	   instructions	  (Zymo	  Research).	   In	  brief,	  gDNA	  was	   bisulfite	   treated	   overnight	   for	   16hr	   so	   that	   all	   non-­‐methylated	   CpGs	   were	  converted	  into	  uracils,	  bisulfite-­‐treated	  DNA	  was	  then	  washed	  and	  eluted	  in	  10µl	  of	   elution	   buffer.	   3µl	   were	   used	   per	   PCR	   reaction	   using	   primers	   specific	   to	   the	  bisulfite-­‐treated	   DNA	   and	   not	   containing	   CpGs	   in	   their	   sequence.	   DNA	  was	   PCR	  amplified	  (section	  2.8)	  and	  cloned	  into	  TOPO-­‐A	  vector	  (Invitrogen).	  DH5α	  bacteria	  were	  transformed,	  plated	  and	  let	  to	  grow	  overnight	  at	  37ºC	  on	  LB-­‐agar	  plates	  with	  ampicillin	  (final	  concentration	  50µg.µl-­‐1).	  24	  clones	  per	  condition	  were	  randomly	  selected	   and	   grown	   in	   parallel	   overnight.	   Plasmid	  DNA	  was	   then	   extracted	   from	  each	   clone	   following	   the	   manufacturer	   instructions	   (Promega)	   and	   sent	   for	  sequencing	  to	  the	  MRC	  Genomics	  Core	  Facility.	  Table	  I.iii	  lists	  primers	  used	  the	  for	  bisulfite	  sequencing.	  	  	  
2.11.	  RNA	  FISH	  	  
	   2.11.1	  Probe	  preparation	  
	  	   RNA	   FISH	   probes	   include	   a	   19	   kb	   genomic	   lambda	   clone	   (510)	   to	   detect	  Xist,	  and	  BACs	  to	  detect	  Jarid1c	  (RP24-­‐148H21),	  Utx	  (RP23-­‐174N2),	  Lamp2	  (RP24-­‐173A8),	  and	  Huwe1	  (RP24-­‐157H12).	  Probes	  were	  labelled	  by	  Nick	  Translation	  Kit	  (VYSIS;	   Abbott),	   using	   2µg	   of	   DNA	   per	   50	   µl	   reaction,	   according	   to	   the	  manufacturer's	  instructions.	  Probes	  were	  labelled	  with	  either	  Spectrum	  Red-­‐dUTP	  or	   Spectrum	  Green-­‐dUTP	   (ENZO).	   5uL	   from	   a	   standard	   nick	   translation	   reaction	  (50ng	  for	  Xist;	  100-­‐200ng	  for	  X-­‐linked	  genes)	  were	  ethanol	  precipitated	  together	  with	  10	  µg	  of	  salmon	  sperm	  (10mg/mL;	  Invitrogen),	  and	  5ug	  of	  mouse	  Cot1-­‐DNA	  (1mg/mL;	   Gibco	   Invitrogen)	   per	   18x18mm	   coverslip.	   Probes	   were	   washed	   two	  
 73	  
times	  in	  70%	  ethanol,	  and	  resuspended	  thoroughly	  in	  5uL	  formamide	  (Sigma),	  by	  pipetting.	   Probes	   were	   then	   denatured	   for	   7	   minutes	   at	   75°C,	   and	   incubated	   at	  37°C	  for	  20	  minutes.	  5uL	  of	  2x	  Hybridization	  Buffer	  (4xSSC,	  40%	  dextran	  sulphate,	  2mg/mL	   BSA,	   400mM	   Vanadyl	   Ribonucleoside	   Complex)	   were	   added	   to	   the	  probes,	  which	  were	  kept	  on	  ice	  until	  the	  cell	  samples	  were	  ready.	  	  	  
	   2.11.2	  RNA	  FISH	  	  
	  	   RNA	   FISH	   was	   performed	   according	   to	   Chaumeil	   et	   al.,	   2008	   with	   some	  modifications	   .	  Shortly,	  cells	  were	  washed	  in	  Rnase-­‐free	  1X	  PBS	  (Invitrogen),	  and	  pre-­‐fixed	  in	  1%	  paraformaldehyde	  (Sigma)	  for	  3	  minutes	  at	  room	  temperature.	  105	  cells	   were	   cytospun	   (Cytospin3,	   Shandon)	   at	   12000rpm	   into	   each	   positively	  charged	   slide	   (Super	   Frost	   Plus,	   VWR).	   Samples	   were	   permeabilized	   in	   freshly	  made	  CSK	  buffer	  (100mM	  NaCl,	  300mM	  sucrose,	  3mM	  MgCl2,	  10nM	  PIPES	  pH	  6.8)	  /	  0.5%	  Triton	  X-­‐100	  containing	  an	  RNase	  inhibitor	  (2mM	  Vanadyl	  Ribonucleoside	  Complex)	   for	   7	   min	   on	   ice.	   Samples	   were	   post-­‐fixed	   in	   freshly	   made	   4%	  paraformaldehyde	   for	  10	  min	  on	   ice.	   Slides	  with	   cell	   samples	  were	   then	  washed	  two	  times	  in	  70%	  ethanol	  for	  5	  minutes	  each,	  and	  further	  dehydrated	  in	  a	  series	  of	  80%,	   95%,	   100%	   ethanol,	   for	   3	   min	   each.	   Slides	   were	   allowed	   to	   air	   dry	  completely.	  Probes	  that	  were	  kept	  on	  ice	  were	  added	  to	  the	  samples.	  Hybridization	  was	   performed	   overnight	   at	   37°C	   in	   a	   dark	   and	   humid	   chamber	   (with	   50%	  formamide	  /	  2X	  Saline	  Sodium	  Citrate	   -­‐SSC	  solution).	  Samples	  were	  washed	   tree	  times	  in	  50%	  formamide	  /	  2X	  SSC	  (adjusted	  to	  pH	  7.2)	  for	  5	  min	  each	  at	  42°C,	  and	  then	  washed	  tree	  times	  in	  2X	  SSC	  for	  5	  min	  each	  at	  42°C.	  Slides	  were	  mounted	  with	  vectashield	  mounting	  media	  containing	  DAPI	  to	  counterstain	  DNA	  (Vector).	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Chapter	  3:	  Genome-­wide	  mapping	  of	  cohesin	  
binding	  sites	  in	  pluripotent	  and	  lineage-­committed	  
cells	  	  	  
Generation	  of	  ChIP-­seq	  libraries	  and	  assessment	  of	  cohesin	  binding	  
	  	   3.1	  Overview	  
	   	  	   To	  understand	  the	  developmental	  regulation	  of	  cohesin	  binding,	  we	  firstly	  need	  to	  map	  cohesin	  binding	  sites.	  We	  describe	  here	   the	  steps	   taken	  to	  generate	  genome-­‐wide	   cohesin	   binding	   profiles	   in	   pluripotent	   ES	   cells	   and	   lineage-­‐committed	  pre-­‐B	  cells.	  We	  have	  immunoprecipitated	  cohesin,	  CTCF	  and	  BORIS	  and	  generated	   libraries	   following	   Illumina’s	   protocol.	   Upon	   sequencing,	   we	   see	   that	  cohesin	  binding	  sites	  overlap	  substantially	  with	  CTCF	  binding	  sites.	  In	  addition,	  we	  observe	   cohesin	   sites	   that	   are	   independent	   of	   CTCF	   although	   upon	   careful	  examination,	   low	   enrichment	   of	   CTCF	   is	   detected.	   We	   also	   see	   cohesin	   binding	  sites	   that	   are	  present	   in	  pluripotent	   cells	   and	  not	   in	  differentiated	   cells	   and	  vice	  versa.	  However,	  some	  of	  these	  overlap	  with	  non-­‐developmentally	  regulated	  CTCF	  sites	  arguing	   in	   favour	  of	  a	  developmentally	  regulated	  mechanism	  that	  precludes	  binding	  of	  cohesin	  to	  a	  subset	  of	  CTCF	  sites	   in	  ES	  cells.	  Moreover,	  we	   investigate	  the	   relationship	   of	   BORIS	   with	   cohesin	   and	   CTCF	   and	   preliminary	   experiments	  suggest	  that	  BORIS,	  unlike	  CTCF,	  does	  not	  recruit	  cohesin	  to	  chromatin.	  	  	  
	   3.2.	  Generation,	  sequencing	  and	  peak	  extraction	  of	  ChIP-­seq	  libraries	  	   	   3.2.1.	  ChIP	  in	  mouse	  ES	  cells	  and	  pre-­B	  cells	  	  	   The	  mapping	   of	   the	   binding	   pattern	   of	   a	   protein	   of	   interest	   to	   chromatin	  using	   the	   ChIP-­‐seq	   technique	   requires	   the	   evaluation	   of	   ChIP	   efficiency	   and	  enrichment	   in	   the	   cell	   types	   to	   be	   studied.	   Comparing	   the	   signal	   at	   a	   previously	  established	  positive	   site	   to	   the	   signal	   at	   a	  negative	   site	   assesses	   the	  efficiency	  of	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ChIP.	  On	  the	  other	  hand,	  the	  enrichment	  is	  assessed	  by	  the	  ratio	  between	  the	  signal	  at	   a	   positive	   site	   and	   the	   signal	   given	   by	   an	   arbitrary	   amount	   of	   INPUT	   sample,	  which	   is	   un-­‐enriched	   chromatin.	   For	   this	   study,	   1%	  of	   the	   amount	   of	   chromatin	  used	   for	   ChIP	   is	   taken	   as	   an	   INPUT	   sample.	   Figure	   3.1	   shows	   the	   binding	   of	   the	  cohesin	  subunit	  Rad21	  to	   two	  positive	  sites	  and	  two	  negatives	  sites	   in	  mouse	  ES	  and	   primary	   pre-­‐B	   cells.	   Pre-­‐B	   cells	   have	   always	   more	   enrichment	   of	   cohesin	  compared	   to	   INPUT	   than	   ES	   cells	   at	   previously	   defined	   17:16298	   and	   IL4-­‐6	  positive	   sites	   (Parelho	  et	  al.	  2008).	  This	  may	  be	  due	   to	  differences	   in	   chromatin,	  sonication,	   etc	   or	   can	  be	  due	   to	  developmental	   differences	   in	   cohesin	  binding	   to	  those	  sites	   (see	  discussion).	   In	  general	   terms,	  Rad21	  ChIP	  works	  reproducibly	   in	  both	  cell	  types.	  	  
	  
Figure	  3.1	  ChIP	  efficiencies	  in	  mouse	  ES	  cell	  line	  46C	  and	  in	  primary	  mouse	  pre-­B	  cells.	  











































Analyser®	  sequencer	  for	  ChIP,	  RNA	  and	  genomic	  DNA	  high-­‐throughput	  analysis.	  As	  we	  were	  interested	  in	  sequencing	  ChIP	  samples,	  we	  collaborated	  in	  establishing	  an	  on-­‐site	   facility.	   We	   provided	   the	   first	   ChIP-­‐seq	   samples	   to	   test	   the	   new	   Solexa	  machine	  and	  set-­‐up	  the	  sequencing	  process	  by	  the	  facility.	  	   An	   Illumina	   library	   is	   generated	   as	   follows.	   A	   small	   fraction	   of	   sonicated	  chromatin	   is	   de-­‐crosslinked	   and	   the	   resulting	   DNA	   is	   run	   on	   an	   agarose	   gel	   to	  confirm	  the	  size	  of	  the	  DNA	  population	  (Figure	  3.2.a).	  Chromatin	  should	  consist	  of	  DNA	   fragments	   between	   100	   and	   250bp.	   Sonicated	   chromatin	   is	   then	  immunoprecipitated	   and	   subsequently	   de-­‐crosslinked.	   The	   resulting	   DNA	  molecules	  will	  consist	  of	  blunt	  ended	  fragments	  but	  mostly	  overhanging	  ends.	  The	  first	  step	  of	  the	  ChIP-­‐seq	  library	  generation	  following	  Illumina’s	  protocol	  is	  to	  fill	  in	  the	  overhangs	  to	  create	  a	  population	  of	  DNA	  molecules	  with	  phosphorylated	  blunt	  ends	  (see	  section	  3.2.4.	  Figure	  3.4.a).	  An	  adenosine	  is	  then	  added	  to	  each	  3’	  end	  of	  the	   double	   stranded	   DNA.	   Illumina	   adapters	   consist	   of	   small	   DNA	   molecules	  required	  for	  the	  sequencing	  process.	  They	  have	  thymine	  overhangs	  at	  the	  their	  3’	  end	   and	   are	   ligated	   to	   the	   DNA	   molecules	   with	   the	   adenosine	   overhangs.	   The	  ligated	   product	   is	   then	   run	   on	   an	   agarose	   gel	   and	   fragments	   (which	   cannot	   be	  visualised	  due	  to	  the	  small	  starting	  amount)	  are	  purified	  (Figure	  3.2.b).	  This	  size-­‐selection	  stage	  is	  critical.	  Only	  DNA	  fragments	  between	  150	  and	  300bp	  in	  size	  after	  addition	  of	  the	  Illumina	  adapters	  are	  used	  for	  sequencing.	  This	  is	  why	  the	  original	  chromatin	   has	   to	   be	   between	   100	   and	   250bp	   as	   noted	   before.	   As	   a	   control,	   the	  same	  area	  of	   the	  gel	   from	  a	   lane	  where	  DNA	  has	  not	  been	  run	   is	   cut	  out	   (Figure	  3.2.b).	   This	   allows	   for	   the	   assessment	   of	   external	   DNA	   contaminations	   in	   our	  samples	   that	  can	  be	  amplified	   in	   the	  next	  step	  and	   interfere	  with	   the	  sequencing	  result.	   The	   purified	   adapter-­‐ligated	   DNA	   fragments	   are	   then	   amplified	   using	  adapter-­‐specific	  primers.	  The	  resulting	  material	  is	  then	  analysed	  on	  an	  agarose	  gel	  to	  ensure	  that	  no	  primer	  dimers	  or	  adapter	  oligomerisation	  products	  are	  present	  in	   the	   sample.	  The	   library,	  which	   is	   now	  visible,	   is	   cut	   from	   the	   gel	   and	  purified	  (Figure	  3.2.b).	  Note	  in	  Figure	  3.2.b,	  an	  additional	  band	  around	  70bp.	  This	  band	  also	  appears	   in	   the	   negative	   control	   lane	   and	   is	   caused	   by	   the	   formation	   of	   primer	  dimers	   during	   the	   PCR	   reaction.	   To	   control	   for	   technical	   biases	   that	   could	   be	  introduced	   in	   the	   library	   generation	   (e.g.	   sonication),	   an	   INPUT	   library	   is	   also	  created	  for	  each	  different	  cell	  type.	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Figure	   3.2	   Agarose	   gel	   pictures	   of	   sonicated	   and	   de-­crosslinked	   sonicated	   chromatin	   and	  
ChIP-­seq	  library.	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   3.2.3.	  Library	  quality	  controls	  	  	   Sequence	   bias	   can	   occur	   during	   the	   amplification	   step	   of	   the	   library	  generation	   process.	   To	   address	   this	   possibility,	   a	   small	   portion	   of	   the	   library	   is	  reanalysed	   by	   qPCR	   for	   the	   same	   positive	   and	   negative	   primer	   sites	   used	   to	  analyse	  the	  ChIP	  efficiency.	  The	  ChIP-­‐seq	  library	  is	  considered	  unbiased	  when	  the	  two	  cohesin	  positive	  sites	  17:16298	  and	  IL4-­‐6	  are	  amplified	  at	  lower	  C(t)s	  than	  the	  two	   negative	   sites	   Ifng1	   and	   Xist7Na	   (Figure	   3.3.a	   and	   b).	   Of	   course,	   this	   result	  should	  be	  taken	  with	  caution,	  as	  this	  assumption	  is	  only	  based	  on	  four	  primer	  sets	  and	  PCR	  biases	  could	  arise	  at	  other	  genomic	  locations.	  In	  the	  case	  of	  the	  INPUT,	  the	  sample	   is	   considered	   unbiased	   if	   the	   variation	   between	   amplification	   curves	   for	  the	  four	  primer	  sets	  are	  identical	  before	  and	  after	  library	  generation	  (Figure	  3.3.a	  and	  b).	  	   As	   suggested	   by	   Illumina,	   the	   samples	   were	   run	   on	   an	   Agilent	   2100	  Bioanalyzer	  high	   sensitivity	  dsDNA	  chip	   for	   accurate	   sizing	  and	  quantification	  of	  the	   DNA.	   The	   technology	   consists	   of	   capillary	   electrophoresis	   on	   a	   chip	   device.	  Figure	  3.3.c	  shows	  the	  trace	  for	  the	  pre-­‐B	  Rad21	  ChIP	  library.	  Fragments	  should	  be	  between	   100	   and	   300bp,	   as	   isolated	   from	   the	   agarose	   gel	   and	   ideally	   form	   a	  Gaussian	  distribution.	  	  	   Together,	  these	  control	  measures	  provide	  an	  evaluation	  of	  the	  quality	  of	  the	  libraries	  generated	  and	  the	  reliability	  of	  the	  data	  generated	  after	  sequencing.	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Figure	  3.3	  Library	  quality	  controls	  by	  qPCR	  analysis	  and	  Bioanalyzer	  analysis.	  














	   	   3.2.4.	  Sequencing	  
	  	   The	  sequencing	  process	  consists	  in	  accurately	  measuring	  the	  concentration	  of	  the	  samples,	  generating	  clonal	  clusters	  from	  single	  DNA	  molecules,	  detection	  of	  the	   fluorescent	   signals,	   quality	   control	   of	   the	   generated	   sequences,	   also	   called	  reads,	  and	  finally,	  alignment	  to	  the	  mouse	  genome	  in	  this	  case	  (Figure	  3.4).	  	  	  
	   	  
Figure	  3.4	  Illumina	  library	  preparation	  and	  sequencing	  workflow.	  













































	   The	   average	   size	   of	   the	   library	   was	   measured	   as	   an	   additional	   means	   to	  calculate	  the	  concentration	  of	  the	  sample	  to	  assure	  a	  correct	  number	  of	  clusters	  is	  generated	  during	   the	   cluster	   generation	  process.	  Theoretically,	   one	   can	   calculate	  an	  estimate	  of	  the	  sample’s	  concentration	  by	  using	  the	  average	  size	  and	  molecular	  mass	  of	  the	  four	  DNA	  bases.	  For	  added	  precision,	  the	  amount	  of	  library	  to	  be	  used	  is	   determined	   by	   extrapolation	   of	   the	   sample’s	   PCR	   amplification	   signal	   from	   a	  standard	  curve.	  The	  standard	  curve	  is	  generated	  by	  plotting	  the	  PCR	  amplification	  signals	   of	   serial	   dilutions	   of	   a	   known	   sample	   versus	   the	   number	   of	   clusters	  generated	   for	   each	   dilution	   of	   this	   known	   sample.	   These	   curves	   have	   been	  generated	   by	   the	   Genomics	   Laboratory.	   The	   sample	   is	   denatured	   in	   basic	  conditions	   and	   then	   injected	   onto	   the	   flow	   cell,	   which	   is	   covered	   by	   adapter	  molecules	  attached	  to	  the	  bottom	  surface	  of	  the	  cell.	  Single	  DNA	  molecules	  attach	  to	  the	  adapters	  and	  the	  flow	  cell	  is	  then	  subject	  to	  an	  in	  situ	  PCR	  reaction	  to	  create	  clonal	  populations	  or	  clusters	  from	  the	  original	  single	  molecules.	  This	  is	  the	  cluster	  generation.	  The	  higher	  the	  concentration	  of	  the	  sample,	  the	  denser	  the	  clusters	  will	  be	  on	  the	  flow-­‐cell.	  The	  denser	  the	  clusters	  on	  the	  flow-­‐cell,	  the	  harder	  it	  will	  be	  for	  the	  detector	  to	  distinguish	  between	  clusters	  and	  information	  output	  will	  drop.	  The	  clusters	  are	  then	  sequenced	  by	  synthesis.	  Briefly,	  each	  base,	  bearing	  a	  terminator	  and	  a	  fluorophore,	  is	  added	  in	  each	  cycle.	  Only	  one	  base	  is	  incorporated	  per	  cluster	  due	   to	   the	  presence	  of	   the	   terminator,	   its	   fluorescence	   is	   read,	   the	   terminator	   is	  removed	   and	   the	   next	   cycle	   is	   started.	   In	   this	   way,	   the	   sequence	   of	   each	   DNA	  molecule	   can	   be	   evaluated.	   We	   performed	   runs	   of	   36	   to	   39bp	   during	   the	  generation	  of	  this	  ChIP-­‐seq	  data,	  but	  sequencing	  can	  now	  go	  up	  to	  75	  to	  100bp	  on	  the	  Illumina	  platform.	  The	  number	  of	  lanes	  that	  are	  to	  be	  used	  for	  each	  sample	  is	  dependent	  upon	  how	  many	  times	  your	  protein	  of	  interest	  binds	  to	  chromatin.	  The	  more	  binding	   sites,	   the	  more	   surface	   is	   required	   to	  have	  a	   clearer	  picture	  of	   the	  genome-­‐wide	  binding	  pattern.	  The	  number	  of	  lanes	  is	  also	  related	  to	  the	  efficiency	  of	   the	   antibody,	   as	   a	   ChIP	  with	   an	   antibody	   rendering	   a	   higher	   background	  will	  need	   to	  be	  sequenced	  more	   to	   improve	   the	  signal	   to	  noise	  ratio.	  At	   the	   time	   this	  project	  was	  started,	  the	  sequencing	  coverage	  per	  lane	  was	  1Gb.	  We	  estimated	  two	  lanes	  per	  ChIP	  would	  be	  enough	   to	   cover	  with	  enough	  depth	  all	   cohesin	  binding	  sites	  genome-­‐wide.	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   The	  density	  of	  clusters,	  quality	  of	  the	  sequences	  or	  reads	  and	  alignment	  to	  the	  genome	  are	  then	  assessed.	  ELAND,	  the	  default	  computer	  program	  provided	  by	  Illumina	  that	  aligns	  reads	  to	  the	  genome	  was	  used.	  	  	  	  	   	   3.2.5.	  Peak	  extraction	  	  	   Peak	   extraction	   consists	   of	   defining	   binding	   regions	   depending	   on	   the	  number	   of	   reads	   that	   align	   to	   a	   particular	   area	   of	   the	   genome	   compared	   to	   the	  INPUT	  library.	  A	  concentration	  of	  reads	  in	  a	  particular	  genomic	  location,	  present	  in	  the	   ChIP	   sample	   above	   that	   in	   the	   INPUT	   sample,	   creates	   an	   enrichment	   above	  background	  that	  translates	  into	  a	  peak	  or	  binding	  site.	  In	  this	  sense,	  the	  reads	  that	  form	   a	   peak	  will	   have	   different	   starting	   base	   pair	   positions,	   forward	   or	   reverse	  orientations	  and	  will	  align	  with	  each	  other.	  Duplicates,	  clonal	  reads	  which	  have	  the	  same	   starting	   position,	   direction	   and	   length,	   are	   considered	   a	   technical	   problem	  that	  arises	  at	  the	  PCR	  stage	  of	  the	  library	  preparation	  and	  tend	  to	  occur	  when	  the	  amount	  of	  starting	  material	   is	   low.	   	  A	   library	  with	   less	   than	  10%	  of	  duplicates	   is	  considered	   to	   be	   good.	   Usually,	   duplicates	   are	   informatically	   removed	   from	   the	  peak	  extraction	  process.	  	  	   Different	  peak	  extraction	  programs	  exist	   (e.g.	   FindPeaks,	   SWEMBL,	  MACS,	  PeakFinder,	   BayesPeaks,	   etc).	   They	   are	   all	   based	   on	   different	   computational	  algorithms.	  Some	  take	  into	  account	  the	  INPUT	  samples,	  some	  do	  not.	  For	  historical	  reasons,	  we	  decided	  to	  use	  FindPeaks	  as	  a	  starting	  point	  since	  it	  was	  one	  of	  the	  few	  peak-­‐calling	  programs	  that	  took	  into	  consideration	  the	  INPUT	  sample	  in	  the	  ChIP	  analysis.	   No	   FDR	   was	   used	   since	   FindPeaks	   recommended	   not	   using	   it	   when	   a	  control	   sample,	   that	   is	   INPUT,	   is	   used.	   We	   have	   sequenced	   different	   libraries	  during	  the	  performance	  of	  this	  work	  and	  see	  that	  in	  general	  terms,	  increasing	  the	  number	  of	  reads	  results	  in	  increased	  called	  peaks	  (data	  not	  shown),	  although	  the	  number	   of	   peaks	   obtained	   for	   each	   library	   does	   not	   correlate	   perfectly	  with	   the	  number	  of	  reads.	  We	  have	  not	  generated	  saturation	  curves	  to	  assess	  at	  which	  point	  increasing	   the	   number	   of	   reads	   (that	   is,	   by	   increasing	   the	   number	   of	   sequenced	  lanes)	   does	   not	   result	   in	   an	   increased	   number	   of	   peaks.	   The	   bioinformaticians	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Anna	   Terry	   and	   Tom	   Carroll	   have	   performed	   the	   bioinformatic	   analyses	   of	   the	  genome-­‐wide	  data	  presented	  in	  this	  study.	  	  	  	   3.3.	  Genome-­wide	  relationship	  of	  cohesin	  with	  CTCF	  	  
	   	   3.3.1.	  Cohesin	  and	  CTCF	  largely	  overlap	  in	  ES	  cells	  and	  pre-­B	  	  
	   	   	   cells	  	  	   In	  mammalian	  cells,	   several	  works	  have	  shown	  that	  cohesin	  and	  CTCF	  co-­‐localise	  and	  that	  CTCF	  recruits	  cohesin	  to	  specific	  sites	  although	  is	  dispensable	  for	  cohesin	   loading	   onto	   chromosomes	   (Parelho	   et	   al.	   2008;	   Wendt	   et	   al.	   2008;	  Stedman	  et	  al.	  2008).	  In	  addition,	  cohesin	  binding	  is	  independent	  of	  transcriptional	  activity.	  However,	   these	  studies	  were	  done	  using	  the	  ChIP-­‐on-­‐chip	  technique	  and	  thus	  do	  not	  account	  for	  the	  whole	  genome.	  	   We	  set	  out	   to	  understand	   the	  relationship	  of	  cohesin	  with	  CTCF	   in	  a	   truly	  genome-­‐wide	  scale	   in	  pluripotent	  cells	  and	  differentiated	  cells	  using	  ChIP-­‐seq.	  As	  previously	  described,	  we	  generated	  Rad21	  and	  CTCF	  ChIP-­‐seq	  libraries	  in	  ES	  and	  pre-­‐B	  cells.	  We	  identified	  34,031	  cohesin	  peaks	  and	  37,631	  CTCF	  peaks	  in	  ES	  cells	  (Figure	  3.5.a).	  In	  pre-­‐B	  cells,	  we	  observed	  18,678	  cohesin	  peaks	  and	  23,013	  CTCF	  peaks	   (Figure	   3.5.b).	   In	   ES	   cells,	   28,418	   sites	   were	   co-­‐occupied	   by	   cohesin	   and	  CTCF,	  representing	  84%	  of	  all	  cohesin	  peaks	  and	  77%	  of	  all	  CTCF	  peaks.	  Binding	  sites	   were	   designated	   as	   overlapping	   when	   peaks	   shared	   at	   least	   1bp.	   In	   pre-­‐B	  cells,	   15,408	   sites	   where	   bound	   by	   both	   proteins,	   corresponding	   to	   82%	   of	   the	  total	   number	   of	   cohesin	   peaks	   and	   67%	   of	   all	   CTCF	   peaks	   in	   these	   cells.	   These	  percentages	  are	  very	  similar	  to	  previously	  reported	  results	  in	  mouse	  pre-­‐B	  cells	  by	  ChIP-­‐on-­‐chip	  analysis	  (Parelho	  et	  al.	  2008).	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Figure	  3.5	  80%	  of	  cohesin	  peaks	  overlap	  with	  CTCF	  peaks	  in	  ES	  cells	  and	  pre-­B	  cells.	  



























































































































	   	   3.3.2.	  CTCF-­independent	  binding	  of	  cohesin	  	  	   Three	  recent	  reports	  describe	  the	  existence	  of	  cohesin	  binding	  sites	  that	  are	  independent	  of	  CTCF	  (Schmidt	  et	  al.	  2010;	  Kagey	  et	  al.	  2010;	  Nitzsche	  et	  al.	  2011).	  Schmidt	  and	  colleagues	  report	  that	  around	  30%	  of	  all	  cohesin	  peaks	  are	  not	  bound	  by	  CTCF	   (roughly	  16,000	  out	  of	  57,000	  peaks)	   in	  human	  breast	   cancer	  and	   liver	  cells	   (Schmidt	   et	   al.	   2010).	   Furthermore,	   Kagey	   and	   colleagues	   describe	   that	  around	  43%	  of	  the	  cohesin	  subunit	  Smc1a	  peaks	  are	  not	  bound	  by	  CTCF	  (roughly	  19,000	   out	   of	   44,000	   peaks)	   in	  mouse	   ES	   cells	  whereas	  Nitzsche	   and	   colleagues	  defend	  that	  28%	  of	  all	  cohesin	  peaks	  are	  not	  bound	  by	  CTCF	  (roughly	  4,000	  out	  of	  15,300	  peaks)(Kagey	   et	   al.	   2010;	  Nitzsche	   et	   al.	   2011).	  As	   shown	   in	  Figure	  3.5.a	  and	  b,	  the	  number	  of	  cohesin	  peaks	  that	  we	  find	  are	  independent	  of	  CTCF	  in	  mouse	  ES	  and	  pre-­‐B	  cells	   is	  16%	  and	  18%	  respectively.	  The	  striking	  difference	  between	  the	  Kagey	  and	  Nitzsche	  data	  and	  our	  data	  could	  be	  due	  to	  using	  different	  ES	  cells,	  different	  antibodies,	  different	  ChIP	  protocols,	  different	  peak-­‐calling	  algorithms,	  etc.	  Nevertheless,	  we	  do	  detect	  cohesin	  non-­‐CTCF	  binding	  events	  in	  both	  ES	  cells	  and	  pre-­‐B	  cells	  by	  ChIP-­‐seq.	  Visualisation	  of	  the	  ES	  cohesin	  and	  ES	  CTCF	  ChIP-­‐seq	  data	  tracks	  uploaded	  onto	  the	  UCSC	  Genome	  Browser	  shows	  that	  ES	  cohesin	  non-­‐CTCF	  peaks	  are	  of	  low	  enrichment	  (Figure	  3.6).	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   To	   validate	   ES	   cohesin	   non-­‐CTCF	   peaks,	   we	   picked	   16	   candidates	   that	  overlapped	  with	  known	  Oct4,	  Nanog	  and/or	  Sox2	  binding	  sites	  in	  ES	  cells	  (Chen	  et	  al.	  2008).	  Since	  Schmidt	  and	  colleagues	  have	  shown	  that	  cohesin	  co-­‐localises	  with	  cell-­‐type-­‐specific	   transcription	   factors	   in	   a	   CTCF-­‐independent	  manner	   and	   since	  Oct4,	  Nanog	  and	  Sox2	  are	  ES-­‐cell	  specific,	  we	  hypothesised	  that	  cohesin	  might	  co-­‐localise	  with	  these	  factors	  at	  cohesin	  non-­‐CTCF	  sites	  (Schmidt	  et	  al.	  2010).	  We	  thus	  assessed	  the	  binding	  of	  cohesin	  and	  the	  absence	  of	  CTCF	  at	  these	  sites.	  Indeed,	  the	  enrichment	   of	   cohesin	   at	   those	   sites	   is	   very	   low	   (from	   1	   to	   5-­‐fold	   above	  background	   levels)(Figure	   3.7,	   compare	   it	   to	   Figure	   3.5.a).	   At	   some	   sites,	   e.g.	  Esradsp11,	  15,	  16,	   the	  enrichment	   is	   as	   low	  as	   the	   two	  negative	   controls	   Igf2r-­‐2	  and	  Xist7Na.	  Surprisingly,	  although	  those	  sites	  were	  defined	  as	  CTCF-­‐negative	  by	  ChIP-­‐seq	   analysis,	   CTCF	   is	   also	   enriched	   above	  background	   levels	   by	  ChIP-­‐qPCR,	  albeit	   very	   low.	   It	   seems	   that	   cohesin	   enrichment	   always	   correlates	   with	   CTCF	  enrichment,	  even	  at	  cohesin	  sites	  defined	  to	  be	  CTCF-­‐negative	  by	  ChIP-­‐seq.	   	  
	   	  
Figure	   3.7	   CTCF	   is	   enriched	   above	   background	   levels	   by	   ChIP-­qPCR	   at	   cohesin	   non-­CTCF	  



































































































	   We	  next	  investigated	  the	  binding	  motif	  under	  the	  cohesin	  non-­‐CTCF	  peaks.	  Schmidt	   and	   colleagues	   have	   shown	   that	   cohesin	   non-­‐CTCF	   binding	   sites	   are	  enriched	   for	   tissue-­‐specific	   transcription	   factor	   motifs.	   In	   fact,	   tissue-­‐specific	  transcription	  factors	  co-­‐localised	  with	  cohesin	  independently	  of	  CTCF	  (Schmidt	  et	  al.	  2010).	  	  We	  set	  out	  to	  investigate	  if	  the	  cohesin	  non-­‐CTCF	  peaks	  in	  our	  data	  sets	  where	  enriched,	  firstly,	  for	  the	  CTCF	  binding	  motif	  and	  secondly,	  for	  transcription	  factors	   important	   for	   the	   cell	   identity	   of	   ES	   cells	   or	   pre-­‐B	   cells.	  We	   conducted	   a	  search	   for	   the	   CTCF	   binding	   motif	   under	   the	   ES	   cohesin	   and	   CTCF	   peaks,	   ES	  cohesin	   non-­‐CTCF	  peaks,	   pre-­‐B	   cohesin	   and	  CTCF	  peaks	   and	  pre-­‐B	   cohesin	   non-­‐CTCF	   peaks	   using	   Position	   Weight	   Matrices	   (PWM).	   Random	   sequences	   in	   the	  genome	  were	   used	   as	   negative	   control.	   PWM	   assign	   to	   each	   nucleotide	  within	   a	  sequence	  a	  weight	  corresponding	  to	  the	  frequency	  of	  occurrence	  of	  that	  nucleotide	  at	   that	   position	   within	   a	   set	   of	   known	   motifs.	   Scanning	   the	   DNA	   sequences	   at	  binding	  sites	  assigns	  scores	  to	  each	  sequence.	  The	  score	  of	  each	  target	  sequence	  is	  then	  compared	  to	  the	  score	  of	  the	  set	  of	  known	  motifs.	  We	  then	  plot	  the	  proportion	  of	  peaks	  that	  have	  a	  binding	  sequence	  with	  a	  PWM	  score	  above	  70%.	  	  ES	  cohesin	  and	   CTCF	   peaks	   and	   pre-­‐B	   cohesin	   and	   CTCF	   peaks	   are	   highly	   enriched	   for	   the	  CTCF	   consensus	   binding	   motif	   (0.70	   and	   0.65	   respectively),	   compared	   to	  background	  (0.18)(Figure	  3.8.a).	  In	  addition,	  ES	  cohesin	  non-­‐CTCF	  peaks	  and	  pre-­‐B	  cohesin	  non-­‐CTCF	  peaks	  are	  also	  highly	  enriched	  for	  the	  CTCF	  motif	  compared	  to	  background	  (0.64	  and	  0.56	  respectively	  versus	  0.18),	  although	  to	  a	  slightly	  lesser	  extent	  than	  the	  cohesin	  and	  CTCF	  peaks.	  We	  then	  went	  to	  look	  for	  the	  presence	  of	  transcription	  factor	  binding	  motifs	  that	  are	  present	  in	  ES	  and	  pre-­‐B	  cells,	  such	  as	  Oct4,	  Sox2	  and	  Nanog	  in	  the	  case	  of	  ES	  cells,	  and	  E2A,	  EBF	  and	  PU.1	  in	  the	  case	  of	  pre-­‐B	   cells.	   ES	   cohesin	   and	   CTCF	   peaks	   showed	   less	   enrichment	   of	   the	   Oct4	  binding	   motif	   than	   background	   levels,	   suggesting	   that	   they	   do	   not	   co-­‐localise	  (Figure	   3.8.b).	   They	   show	   less	   enrichment	   than	   pre-­‐B	   cohesin	   and	   CTCF	   peaks	  where	  Oct4	   is	   not	   expressed.	  Moreover,	   ES	   cohesin	   non-­‐CTCF	   peaks	   again	   show	  less	  enrichment	  than	  genomic	  sequences	  picked	  at	  random.	  This	  suggests	  that	  ES	  cohesin	   non-­‐CTCF	   sites	   do	   not	   bind	   Oct4.	   A	   similar	   result	   is	   seen	   for	   Sox2	   and	  Nanog.	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Figure	  3.8	  Cohesin	  non-­CTCF	  peaks	  are	  not	  enriched	  for	  transcription	  factors	  binding	  motifs	  
important	  for	  cell	  identity	  of	  ES	  and	  pre-­B	  cells.	  PWM	  were	   used	   to	   assess	   the	   proportion	   of	   ES	   cohesin	   and	   CTCF	   peaks,	   ES	   cohesin	   non-­‐CTCF	  peaks,	   pre-­‐B	   cohesin	   and	   CTCF	   peaks	   and	   pre-­‐B	   cohesin	   non-­‐CTCF	   peaks	   that	   exhibit	   a	   similar	  binding	   motif	   to	   the	   CTCF	   (a.),	   to	   the	   Oct4,	   Sox2	   and	   Nanog	   (b.)	   and	   to	   the	   PU.1	   and	   EBF	   (c.)	  consensus	  binding	  sequences.	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   In	   terms	   of	   lymphoid	   specific	   factors,	   we	   assessed	   the	   enrichment	   of	   the	  transcription	  factor	  PU.1,	  important	  for	  myeloid	  and	  lymphoid	  cell	  development.	  In	  this	  case,	  PWM	  scores	  above	  80%	  were	  used,	  as	  70%	  was	  too	  lax	  and	  resulted	  in	  very	  high	   levels	  of	  enrichment	  of	   the	  motif	   in	   the	  random	  sample.	  All	  ES	  cohesin	  and	  CTCF,	  ES	  cohesin	  non-­‐CTCF,	  pre-­‐B	  cohesin	  and	  CTCF	  and	  pre-­‐B	  cohesin	  non-­‐CTCF	  binding	  sites	  showed	  an	  enrichment	  for	  the	  consensus	  binding	  sequence	  of	  PU.1	   compared	   to	   background	   (Figure	   3.8.c).	   Nevertheless,	   pre-­‐B	   cohesin	   non-­‐CTCF	   peaks	   exhibited	   less	   enrichment	   than	   pre-­‐B	   cohesin	   and	   CTCF	   peaks.	   A	  similar	   picture	   was	   seen	   for	   EBF,	   transcription	   factor	   critical	   for	   B-­‐cell	  development	  (Lin	  et	  al.	  1995).	  In	  summary,	  our	  data	  shows	  that	  cohesin	  non-­‐CTCF	  peaks	   are	  highly	   enriched	   for	   the	  CTCF	  motif	   and	  are	  not	   enriched	   for	   cell-­‐type-­‐specific	   transcription	   factor	   motifs.	   Nitzsche	   and	   colleagues	   confirmed	   these	  results	  when	   they	   evaluated	   the	  presence	   of	   the	  CTCF	  motif	   under	   cohesin	  non-­‐CTCF	  binding	  sites	   (Nitzsche	  et	  al.	  2011).	  They	  see	   that	  84%	  of	   the	  cohesin	  non-­‐CTCF	  peaks	  were	  enriched	  for	  the	  CTCF	  motif	  and	  the	  rest	  of	  the	  cohesin	  non-­‐CTCF	  peaks	  (667	  peaks)	  were	  enriched	  for	  key	  pluripotency	  associated	  factors,	  such	  as	  Oct4,	   Nanog,	   Sox2,	   Klf4	   and	   Essrb.	   It	   is	   thus	   possible	   that	   in	   our	   analysis,	   the	  majority	  of	   cohesin	  non-­‐CTCF	   sites	   enriched	  with	   the	  CTCF	  motif	   is	  masking	   the	  cohesin	  non-­‐CTCF	  sites	  that	  are	  not	  enriched	  with	  the	  CTCF	  motif.	  	  	   Cohesin	  non-­‐CTCF	  sites	  have	  been	  described	  in	  three	   independent	  reports	  (Schmidt	  et	  al.	  2010;	  Kagey	  et	  al.	  2010;	  Nitzsche	  et	  al.	  2011).	  However,	  CTCF	  ChIP-­‐qPCR	  results	  at	  cohesin	  non-­‐CTCF	  sites	  to	  confirm	  the	  ChIP-­‐seq	  data	  have	  not	  been	  published.	  It	  is	  possible	  that	  we	  have	  focused	  our	  attention	  (in	  the	  validation	  step)	  on	   cohesin	   non-­‐CTCF	   peaks	   enriched	   for	   the	   CTCF	   motif	   although	   they	   were	  defined	  as	  being	  Oct4-­‐,	  Nanog-­‐	  and	  Sox2-­‐positive.	  A	  more	  thorough	  analysis	  of	  our	  ChIP-­‐seq	  data	  in	  terms	  of	  cohesin	  non-­‐CTCF	  peaks	  non-­‐enriched	  for	  the	  CTCF	  motif	  might	   shed	   more	   light	   on	   our	   understanding	   of	   this	   particular	   type	   of	   cohesin	  peaks.	  This	  will	  be	  discussed	  further	  in	  the	  discussion	  (see	  section	  3.10.).	  	   To	  investigate	  whether	  Oct4	  recruits	  cohesin	  to	  ES	  cohesin	  non-­‐CTCF	  Oct4-­‐positive	   sites,	   we	   immunoprecipitated	   cohesin	   in	   Oct4	   conditional	   knockout	   ES	  cells	   (ZBHTc4).	   Upon	   12h	   of	   doxycycline	   treatment,	   Oct4	   protein	   levels	   are	  substantially	  reduced	  (Figure	  3.9.b).	  We	  selected	  several	  of	  the	  most	  enriched	  sites	  from	   Figure	   3.7	   and	   observed	   that	   cohesin	   recruitment	   to	   those	   sites	   is	   not	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impaired	  upon	  Oct4	  depletion,	  arguing	  against	  the	  recruitment	  of	  cohesin	  by	  Oct4	  to	  ES	  cohesin	  Oct4-­‐positive	  non-­‐CTCF	  sites	  (Figure	  3.9.a).	  	  
	  
Figure	  3.9	  Oct4	  does	  not	  recruit	  cohesin	  to	  cohesin	  Oct4-­positive	  non-­CTCF	  sites.	  
a.	  Rad21	  ChIP	  in	  non-­‐doxycycline-­‐treated	  (black)	  and	  doxycycline-­‐treated	  ZHBT4c	  cells	  (red).	  Data	  has	  been	  normalised	  to	  IL4-­‐6,	  which	  does	  not	  bind	  Oct4.	  n=3,	  error	  bars=SD.	  b.	  WB	  showing	  Oct4	  protein	  levels	  in	  ZHBTc4	  cells	  treated	  for	  12h	  with	  doxycycline	  	  	  	   3.4.	  Comparison	  of	  cohesin	  binding	  sites	  across	  different	  stages	  of	  	  
	   	   development	  	   	   3.4.1.	  Cohesin	  binding	  sites	  are	  shared	  between	  cell	  types	  but	  	  


































































customised	  array	  that	  cohesin	  binding	  can	  be	  shared	  between	  thymocytes	  and	  pre-­‐B	  cells	  but	  also	  that	   there	  are	  thymocyte-­‐specific	  sites	  and	  pre-­‐B	  specific	  cohesin	  sites	  (Parelho	  et	  al.	  2008).	  We	  brought	  a	  similar	  analysis	  genome-­‐wide	  comparing	  the	   ChIP-­‐seq	   ES	   cell	   dataset	   and	   the	   ChIP-­‐seq	   pre-­‐B	   cell	   dataset.	  We	   found	   that	  around	   15,000	   cohesin	   peaks	   are	   found	   in	   both	   ES	   cells	   and	   pre-­‐B	   cells.	   Shared	  cohesin	   peaks	   represent	   44%	   of	   the	   pool	   of	   ES	   cohesin	   peaks	   whereas	   they	  represent	  almost	  80%	  of	  the	  pool	  of	  pre-­‐B	  cohesin	  peaks	  (Figure	  3.10.a).	  Some	  of	  these	  have	  already	  been	  validated	  (Figure	  3.5.a	  and	  b).	  In	  a	  similar	  fashion,	  around	  20,000	  CTCF	  peaks	   are	   also	   shared	  between	   the	   two	   cell	   types.	   These	   represent	  54%	  of	  all	  CTCF	  peaks	  in	  ES	  cells	  and	  85%	  of	  all	  CTCF	  peaks	  in	  pre-­‐B	  cells.	  	   Since	  the	  overlap	  between	  the	  ES	  cohesin	  peak	  subset	  and	  the	  pre-­‐B	  cohesin	  peaks	   subset	   is	   not	   perfect,	   both	   ES	   cells	   and	   pre-­‐B	   cells	   have	   cell-­‐type-­‐specific	  cohesin	  peaks.	  ES	  cells	  have	  approximately	  19,000	  peaks	   	   (56%	  of	  all	  ES	  cohesin	  peaks)	   that	   are	   ES	   specific	   at	   least	   with	   regards	   to	   pre-­‐B	   cells	   (Figure	   3.10.a).	  These	  numbers	  are	  higher	  than	  with	  pre-­‐B	  cells,	  which	  exhibit	  3,700	  cell-­‐specific	  peaks	   that	   correspond	   to	  20%	  of	   all	  pre-­‐B	   cohesin	  peaks.	  We	  validated	  by	  ChIP-­‐qPCR	  some	  of	   the	  ES-­‐specific	  and	  pre-­‐B-­‐specific	  cohesin	  peaks	  (Figure	  3.10.c).	   In	  terms	  of	  CTCF,	  there	  are	  also	  many	  CTCF	  peaks	  that	  are	  specific	  for	  one	  cell	  type	  or	  the	  other	  (Figure	  3.10.b).	  Again,	  as	  with	  cohesin,	  there	  are	  many	  more	  ES-­‐specific	  CTCF	  peaks	  (around	  17,500).	  	  	  	   We	  then	  overlapped	  the	  four	  ES	  cohesin,	  ES	  CTCF,	  pre-­‐B	  cohesin	  and	  pre-­‐B	  CTCF	  peak	  subsets,	  visualising	   the	  output	  with	  a	   four-­‐way	  Venn	  diagram	  (Figure	  3.10.d).	  When	  we	   take	   into	   consideration	  CTCF,	   12,226	   cohesin	   and	  CTCF	  peaks	  are	   shared	   between	   cell	   types.	   In	   addition,	   cohesin	   binding	   is	   developmentally	  regulated	   together	  with	  CTCF.	   	   Indeed,	   9,026	   cohesin	   and	  CTCF	  peaks	   are	   found	  only	  in	  ES	  cells	  but	  are	  not	  found	  in	  pre-­‐B	  cells	  and	  1,181	  cohesin	  and	  CTCF	  peaks	  are	  only	  present	  in	  pre-­‐B	  cells.	  	   Moreover,	  our	  ChIP-­‐seq	  data	  shows	  that	  ES	  cohesin	  non-­‐CTCF	  peaks	  tend	  to	  be	  specific	  to	  ES	  cells:	  from	  5,599	  cohesin	  non-­‐CTCF	  peaks	  that	  are	  present	  in	  ES	  cells,	   4,518	   are	   ES-­‐cell	   specific	   (Figure	   3.11.a).	   The	   inverse	   situation,	   that	   is	   the	  comparison	   between	   pre-­‐B	   cohesin	   non-­‐CTCF	   peaks	   and	   ES	   cohesin,	   shows	   that	  out	  of	  3,247	  pre-­‐B	  cohesin	  non-­‐CTCF	  peaks,	  1,753	  are	  pre-­‐B-­‐specific,	  whereas	  the	  rest,	   1,494,	   are	   also	   found	   in	   ES	   cells	   (Figure	   3.11.b).	   These	   results	   confirm	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Figure	   3.10	   Cohesin	   and	   CTCF	   overlaps	   across	   development	   and	   cell-­type-­specific	   cohesin	  
peaks.	  
























































































































































(dark	  red)	  and	  ES	  cells	  (green)	  c.	  Rad21	  ChIP	  signals	   in	  ES	  cells	  (orange)	  and	  in	  pre-­‐B	  cells	  (dark	  
brown)	  at	  a	  shared	  cohesin	  site	  (left	  panel,	  17:16458)	  and	  two	  negative	  sites	  (Igf2r-­2	  and	  Xist7Na),	  at	  pre-­‐B	  specific	  sites	  (middle	  panel)	  and	  ES-­‐specific	  sites	  (right	  panel).	  Control	  (IgG)	  ChIPs	  at	  all	  those	  sites	  in	  ES	  cells	  (dark	  blue)	  and	  in	  pre-­‐B	  cells	  (pink).	  n=3,	  error	  bars=SD.	  d.	  Four-­‐way	  Venn	  diagram	  of	  ES	  cohesin	  peaks,	  ES	  CTCF	  peaks,	  pre-­‐B	  cohesin	  peaks	  and	  pre-­‐B	  CTCF	  peaks.	  In	  yellow,	  one	   subset;	   in	   light	   orange,	   two-­‐way	   comparison;	   in	  dark	   orange,	   three-­‐way	   comparison;	   in	   red,	  four	  way	  comparison.	  Areas	  are	  not	  proportional	  to	  the	  number	  of	  peaks.	  	  	  
	   	   	   	  
Figure	  3.11	  Cohesin	  non-­CTCF	  peaks	  tend	  to	  be	  cell-­type-­specific.	  




	   	   3.4.2.	  Cohesin	  binding	  is	  developmentally	  regulated	  at	  non-­	  
	   	   	   developmentally	  regulated	  CTCF	  sites.	  	  
	  
At	  the	  Xic	  	   	  	   We	   have	   shown	   that	   cohesin	   binding	   can	   be	   developmentally	   regulated.	  These	   developmental	   differences	   correlate	   with	   developmental	   differences	   in	  CTCF	  binding.	  As	  discussed	  further	  in	  this	  study	  (see	  Chapter	  4),	  we	  are	  interested	  in	  assessing	  whether	  cohesin	  plays	  a	  role	  in	  XCI.	  One	  approach	  that	  we	  have	  taken	  is	   to	  map	   the	   binding	   of	   cohesin	   across	   the	   Xic	   in	  male	   ES	   cells	   and	  male	   pre-­‐B	  cells.	  Numerous	  reports	  have	  shown	  that	  CTCF	  binds	  at	  distinct	  parts	  of	  the	  locus,	  mainly	   around	   the	   Tsix	   promoter	   and	   the	   repetitive	   sequence	   Dxpas34	   and	  upstream	  and	  downstream	  of	  the	  Xist	  promoter	  (Navarro	  et	  al.	  2006;	  N.	  Xu	  et	  al.	  2007).	  We	  extracted	   chromatin	   and	   immunoprecipitated	   cohesin	   and	  CTCF	   from	  male	  ES	  cells,	  where	  both	  genes	  are	  expressed	  (although	  Xist	   is	  expressed	  at	   low	  levels),	  and	  in	  male	  pre-­‐B	  cells,	  where	  both	  genes	  are	  repressed.	  We	  also	  designed	  primers	   against	   novel	   regions	   bound	   by	   CTCF	   found	   by	   ChIP-­‐seq,	   like	   position	  +12Kb	  (Figure	  3.12).	  CTCF	  binds	  thus	  to	  the	  Xic	  upstream	  of	  Tsix	  (positions	  -­‐7	  and	  -­‐5Kb),	   around	   the	   Xist	   promoter	   (positions	   +30,	   +34	   and	   +36Kb),	   within	   Xist	  (position	  +24Kb)	  and	  just	  downstream	  of	  Xist	  (position	  +12Kb).	  Some	  of	  the	  CTCF	  binding	   sites	   are	   clearly	   developmentally	   regulated,	   such	   as	   +12Kb,	   +24Kb	   and	  34Kb,	  downstream	  of	  the	  Tsix	  promoter.	  In	  addition,	  some	  sites	  are	  bound	  in	  male	  ES	  cells	  and	  male	  pre-­‐B	  cells	  with	  very	  similar	  levels	  of	  enrichment	  (-­‐7,	  -­‐5,	  +30	  and	  +36Kb),	   suggesting	   that	   CTCF	   presence	   is	   similar	   in	   these	   two	   cell	   types,	  independently	  of	  expression	  of	  the	  locus.	  In	  terms	  of	  cohesin	  binding,	  cohesin	  only	  readily	  binds	  in	  ES	  cells	  upstream	  of	  the	  Tsix	  promoter	  at	  positions	  -­‐7Kb	  and	  -­‐5Kb	  and	  the	  rest	  of	  the	  locus	  is	  practically	  devoid	  of	  any	  cohesin.	  Surprisingly,	  in	  pre-­‐B	  cells,	  around	  the	  Xist	  promoter	  at	  positions	  +30Kb	  and	  +36Kb,	  cohesin	  is	  recruited	  to	  pre-­‐existing	  CTCF	  sites.	  This	  means	  that	  cohesin	  is	  developmentally	  recruited	  to	  those	  sites	  in	  male	  pre-­‐B	  cells	  whereas	  CTCF	  is	  not.	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Figure	  3.12	  Cohesin	   is	   specifically	   recruited	   in	  differentiated	  cells	   to	  non-­developmentally	  
regulated	  CTCF	  sites	  at	  the	  Xic.	  On	  top,	  schematic	  gene	  representation	  of	  the	  Xic.	  Top	  panel,	  CTCF	  ChIP	  in	  male	  ES	  cells	  (pink)	  and	  in	  male	  B3	  pre-­‐B	  cells	  (green).	  Bottom	  panel,	  Rad21	  ChIP	   in	  male	  ES	  cells	  (black)	  and	  in	  male	  B3	  pre-­‐B	   cells	   (red).	   Data	   have	   been	   normalised	   to	   17:16298.	   Primer	   locations	   are	   shown	   and	   are	  referenced	  to	  the	  Tsix	  TSS.	  n=3,	  error	  bars=SD.	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Figure	  3.13	  Cohesin	   is	   specifically	   recruited	   in	  differentiated	  cells	   to	  non-­developmentally	  












































































































































































































	  	   This	   implies	   that	   these	   developmentally	   regulated	   cohesin	   sites	   at	   non-­‐developmentally	  regulated	  CTCF	  sites	  are	  thus	  not	  specific	  of	  only	  the	  Xic,	  but	  are	  a	  more	  general	  feature	  of	  the	  developmental	  binding	  capacity	  of	  cohesin.	  	   Altogether,	   these	   results	   suggest	   the	   existence	   of	   a	   mechanism	   that	  precludes	   the	  binding	  of	  cohesin	   to	  CTCF	  sites	   in	  ES	  cells,	  while	   in	  differentiated	  cells,	  the	  absence	  of	  this	  mechanism	  permits	  cohesin	  recruitment	  to	  this	  particular	  subset	  of	  CTCF	  peaks.	  Conversely,	  cohesin	  could	  be	  specifically	  recruited	  to	  those	  CTCF	  sites	  in	  differentiated	  cells	  by	  an	  unknown	  mechanism.	  A	  similar	  dynamic	  of	  this	   type	  of	   developmentally	   regulated	  binding	  of	   cohesin	  has	   just	   been	   recently	  described.	  Binding	  of	  cohesin	  at	   the	  constitutive	  CTCF	  site	  CBS5	  within	  the	  HoxA	  locus	   in	   ES	   cells	   is	   impeded	   by	   binding	   of	   Oct4	   (Y.	   J.	   Kim	   et	   al.	   2011).	   In	  differentiated	  cells,	  Oct4	  is	  not	  expressed	  and	  cohesin	  is	  allowed	  to	  bind	  to	  CBS5.	  The	   authors	   defend	   an	   Oct4/cohesin	   antagonism	   at	   a	   subset	   of	   CTCF	   sites	   that	  preclude	   the	   binding	   of	   cohesin	   whenever	   Oct4	   is	   expressed.	   We	   assessed	   the	  binding	  of	  cohesin	  at	  the	  CBS5	  site	  and	  the	  +30Kb	  and	  +36Kb	  Xic	  sites	  in	  ZHBTc4	  cells.	  If	  Oct4	  impedes	  the	  binding	  of	  cohesin	  to	  those	  CTCF	  sites	  in	  ES	  cells,	  removal	  of	  Oct4	  would	  result	  in	  an	  increase	  in	  cohesin	  binding.	  This	  is	  not	  the	  case	  for	  the	  +30Kb	  and	  +36Kb	  sites	  (Figure	  3.14).	  Moreover,	  cohesin	  enrichment	  at	  the	  HoxA	  cluster	  site	  CBS5	   is	  very	  high	  and	  not	  negative	  as	  has	  been	  reported	  by	  Kim	  and	  colleagues.	  The	  Smc1	  and	  Smc3	  ChIP-­‐seq	  datasets	  by	  Kagey	  and	  co-­‐workers	  also	  show	  strong	  binding	  of	  these	  cohesin	  subunits	  (data	  not	  shown).	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Figure	  3.14	  Cohesin	  and	  Oct4	  do	  not	  compete	  for	  CTCF	  binding	  sites	  HoxA	  cluster	  site	  CBS5	  
and	  the	  +30Kb	  and	  +36Kb	  Xic	  sites	  in	  ES	  cells.	  Rad21	   ChIP	   in	   non-­‐doxycycline-­‐treated	   (black)	   and	   doxycycline-­‐treated	   ZHBT4c	   cells	   (red).	   Data	  has	  been	  normalised	  to	  17:16298	  which	  does	  not	  bind	  Oct4.	  n=3,	  error	  bars=SD.	  
	  




























As	   already	   stated	   in	   the	   introduction,	   BORIS	   and	   CTCF	   exhibit	   high	   sequence	  similarity	  in	  the	  Zn-­‐finger	  domain	  but	  dissimilar	  flanking	  domains,	  which	  suggests	  common	   targets	   with	   different	   outcomes	   (Loukinov	   et	   al.,	   2002).	   It	   has	   been	  shown	   that	   CTCF	   is	   able	   to	   homodimerise,	   possibly	   through	   interactions	   of	   Zn	  finger	  domains,	  hinting	  to	  a	  possible	  heterodimerisation	  of	  CTCF	  and	  BORIS	  in	  cells	  where	  they	  are	  co-­‐expressed	  such	  as	  ES	  cells	  and	  cancer	  cells	  (D.	  I.	  Loukinov	  et	  al.	  2002;	   Yusufzai	   et	   al.	   2004;	   Vatolin	   et	   al.	   2005;	   D’Arcy	   et	   al.	   2008).	   It	   is	   thus	  interesting	   to	  know	  whether	  BORIS	  and	  CTCF	  can	  co-­‐localise,	  precluding	  cohesin	  binding	   to	   CTCF	   sites	   in	   ES	   cells,	   whereas	   in	   differentiated	   cells,	   the	   absence	   of	  BORIS	  would	  permit	  cohesin	  binding.	  Up	  to	  date,	  no	  data	  of	  BORIS	  binding	  and	  its	  mechanistic	  function	  is	  available	  in	  ES	  cells,	  prompting	  us	  to	  study	  the	  function	  of	  BORIS	   in	   ES	   cells	   to	   accurately	   understand	   the	   relationship	   between	   CTCF	   and	  cohesin	  binding.	  	  	  
Genome-­wide	  mapping	   of	   BORIS	   in	   ES	   cells	   and	   its	   relationship	   to	   cohesin	  
recruitment	  
	  
	   3.5.	  Overview	  	  	   We	  set	  out	  to	  understand	  what	  the	  relationship	  of	  BORIS	  with	  cohesin	  and	  CTCF	  binding	  in	  ES	  cells	   is.	  For	  this,	  we	  have	  generated	  tagged-­‐BORIS-­‐expressing	  ES	   cells	   and	   mapped	   BORIS	   at	   a	   panel	   of	   sites	   and	   genome-­‐wide.	   We	   present	  evidence	   that	  BORIS	  can	  co-­‐localise	  with	  CTCF	  but	  also	  cohesin,	  excluding	   it	  as	  a	  potential	  factor	  that	  hinders	  cohesin	  binding	  to	  CTCF	  sites	  in	  ES	  cells.	  In	  addition,	  we	  observe	  CTCF-­‐independent	  BORIS	  binding	  sites.	  We	  have	  also	  evaluated	  what	  the	  effect	  of	  BORIS	  overexpression	  in	  CTCF	  and	  cohesin	  recruitment	  at	  a	  panel	  of	  sites	   is	   and	   seen	   that	  BORIS	   overexpression	  does	  not	   result	   in	  major	   changes	   of	  CTCF	   and	   cohesin	   binding	   at	   cohesin/CTCF/BORIS	   sites,	   also	   excluding	   a	  competitive	  mechanism	  between	  BORIS	  and	  CTCF	  in	  ES	  cells	  as	  has	  been	  suggested	  to	  occur	   in	  cancer	  cells	   (Klenova	  et	  al.	  2002).	   In	  addition,	  CTCF	  removal	   from	  ES	  cells	   expressing	   tagged-­‐BORIS	   results	   in	   loss	   of	   cohesin	   recruitment	   to	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cohesin/CTCF/BORIS	   sites	   suggesting	   that,	   unlike	   CTCF,	   BORIS	   is	   not	   able	   to	  recruit	  cohesin.	  	  	  	   3.6.	  Characterisation	  of	  FLAG-­BORIS	  ES	  cells	  	   	  	   The	   absence	   of	   a	   commercially	   available	   antibody	   against	   mouse	   BORIS	  prompted	  us	  to	  generate	  an	  ES	  cell	  line	  that	  expresses	  a	  tagged	  version	  of	  BORIS.	  Mouse	  Boris	   cDNA	  was	   isolated	   from	   ES	   cells,	   amplified	   and	   sequenced.	   Human	  BORIS	   has	   up	   to	   23	   isoforms	   expressed	   during	   gametogenesis	   and	   in	   different	  cancer	   cell	   lines	   (E.	   M.	   Pugacheva	   et	   al.	   2010).	   The	   isoform	   that	   was	   tagged	   in	  mouse	  ES	  cells	  was	  the	  full-­‐length	  coding	  sequence,	  bearing	  the	  11	  Zinc	  fingers	  but	  10	  amino	  acids	  (aa599-­‐aa608)	  more	  than	  the	  reference	  sequence	   in	  NCBI.	  BORIS	  was	  tagged	  with	  two	  FLAG	  sequences	  and	  FLAG-­‐BORIS	  ES	  cells	  were	  generated	  by	  transfection	  of	  ES	   cells	  with	  a	  puromycin-­‐resistance	  vector	   containing	   the	  FLAG-­‐BORIS	   sequence.	   Colonies	  were	   picked	   and	   screened	   by	   anti-­‐FLAG	  WB	   and	  RNA	  levels.	   Several	   clones	   expressed	   truncated	   versions	   of	   the	   protein,	   e.g.	   clone	   37,	  whilst	  two	  clones,	  clones	  51	  and	  55	  expressed	  BORIS	  with	  a	  similar	  size	  to	  FLAG-­‐BORIS	  overexpressed	  in	  293T	  human	  embryonic	  kidney	  cells	  (Figure	  3.15.a).	  Clone	  1	   had	   been	   transfected	   with	   an	   empty	   vector	   and	   was	   used	   in	   subsequent	  experiments	  as	  a	  negative	  control.	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Figure	  3.15	  FLAG-­BORIS	  ES	  cells	  express	  normal	  levels	  of	  pluripotency-­associated	  factors.	  
a.	  1-­‐3,	  ES	  cell	  clones	  expressing	  truncated	  (clone37)	  or	  full-­‐length	  (clones	  51	  and	  55)	  FLAG-­‐BORIS.	  4,	   Control	   clone	   1	   transfected	   with	   the	   empty	   vector.	   5,	   ES	   cell	   unselected	   bulk	   population	  transfected	  with	  FLAG-­‐BORIS,	   or	  6,	  with	   the	   control	   vector.	   7,	   293T	  cells	   transfected	  with	  FLAG-­‐BORIS	  and	  8,	  with	  the	  control	  vector.	  b.	  RNA	  relative	  expression	  of	  ES	  cell	  markers	  (Oct4,	  Nanog,	  Rex1)	  and	  differentiation	  markers	   (primitive	  endoderm,	  Gata4;	  mesoderm,	  Bry;	  Ectoderm,	  Sox1).	  Untransfected	   wt	   ES	   cells	   were	   used	   as	   positive	   controls	   for	   the	   ES	   cell	   markers	   and	   primitive	  endoderm,	  embryoid	  bodies	  at	  day4	  of	  differentiation	  and	  the	  head	  of	  an	  E16.5	  mouse	  were	  used	  as	  positive	  controls	  for	  endoderm,	  mesoderm	  and	  ectoderm,	  respectively.	  	  	   The	  expression	  of	  pluripotent-­‐	  and	  differentiation-­‐associated	  markers	  was	  further	   assessed.	   All	   three	   clones,	   clone	   1,	   clone	   51	   and	   clone	   55,	   express	   Oct4,	  Nanog	   and	   Rex1	   at	   similar	   levels	   as	   the	   parental	   untransfected	   cells	   	   (Figure	  
























































































































3.15.b).	   The	   expression	   of	   primitive	   endoderm-­‐,	   mesoderm-­‐	   and	   ectoderm-­‐associated	  markers	  is	  similar	  to	  the	  parental	  cell	  line	  and	  low	  compared	  to	  positive	  controls.	  
	   	   	  



























similar	   levels	   to	   CTCF,	   although	   this	   clone	   forms	   less	   round	   undifferentiated	  looking	  colonies	  (data	  not	  shown),	  and	  only	  FLAG-­‐BORIS-­‐expressing	  ES	  cell	  clone	  55	  has	  been	  used	  in	  subsequent	  experiments.	  	   Having	  now	  an	  ES	  cell	  line	  that	  expresses	  a	  FLAG-­‐tagged	  version	  of	  BORIS,	  we	  can	  map	  the	  binding	  sites	  of	  BORIS	  in	  ES	  cells.	  	  	  	   	  	   3.7.	  BORIS,	  CTCF	  and	  cohesin	  have	  distinct	  binding	  profiles	  in	  ES	  	  
	   	   cells	  	   	   3.7.1.	  Verification	  of	  BORIS	  binding	  sites	  using	  a	  candidate	  	  
	   	   	   approach	  	  	   To	  understand	  what	  the	  relationship	  of	  cohesin	  and	  BORIS	  in	  ES	  cells	  is,	  we	  firstly	   assessed	   the	   efficiency	   of	   the	   FLAG-­‐BORIS	   ChIP	   and	   addressed	   whether	  CTCF	  and	  BORIS	  co-­‐occupy	  the	  same	  sites	  in	  ES	  cells.	  	   BORIS	  binding	  to	  chromatin	  using	  ChIP	  has	  been	  reported	  in	  human	  cancer	  cell	  lines	  such	  as	  H1299	  (lung	  carcinoma),	  NCCIT	  (embryonic	  carcinoma),	  HCT116	  (colon	   carcinoma)	   and	   Tera-­‐1	   (testicular	   teratocarcinoma)	   at	   the	  MAGEA-­1,	  NY-­
ESO-­1,	  MYC-­N,	  BAG1,	  BRCA1	  promoters	  and	  the	  H19	  ICR	  (Vatolin	  et	  al.	  2005;	  Sun	  et	  al.	  2008;	  Nguyen	  et	  al.	  2008	  a.	  ;	  Nguyen	  et	  al.	  2008	  b.	  ;	  Hong	  et	  al.	  2005).	  Binding	  of	  BORIS	  to	  mouse	  chromatin	  has	  been	  described	  in	  mouse	  adult	  testis	  and	  15.5dpc	  testis	   at	   the	   Gtl2	   DMR	   (Jelinic	   et	   al.	   2006).	   As	   CTCF	   and	   BORIS	   share	   a	   highly	  similar	  Zn	  finger	  domain,	   it	  has	  been	  suggested	  that	  CTCF	  and	  BORIS	  can	  bind	  to	  similar	  sequences.	  Therefore,	  we	  carried	  out	  ChIP	  using	  an	  anti-­‐FLAG	  antibody	  in	  FLAG-­‐BORIS	  ES	  cells	  using	  primers	   that	   specifically	  amplify	   sites	  bound	  by	  CTCF	  (Parelho	  et	  al.	  2008).	   In	  addition,	  primers	   for	   the	  mouse	  H19	   ICR,	  Gtl2	  DMR,	  and	  the	  Bag-­1	  and	  Boris	  promoters	  were	  also	  used	  as	  potential	  binding	  sites	  of	  BORIS.	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a.	  
	  b.	   	   	   	   	   	  
	  
Figure	  3.17	  The	  binding	  profiles	  of	  CTCF	  and	  BORIS	  in	  ES	  cells	  are	  clearly	  different	  at	  a	  panel	  
of	  sites.	  























































































































































	   We	  see	  that	  the	  BORIS	  and	  CTCF	  binding	  profiles	  are	  clearly	  different	  in	  ES	  cells.	   17:16298	   exhibits	   very	   high	   enrichment	   of	   CTCF	   whereas	   the	   BORIS	  enrichment	   is	   minimal	   (e.g.	   Igf2r-­‐2	   and	   Xist7Na)(Figure	   3.17.a	   and	   b).	   Peak5,	  which	  shows	  a	  lower	  CTCF	  enrichment	  than	  17:16298,	  has	  a	  higher	  enrichment	  of	  BORIS.	  Multiple	  sites	  at	   the	  H19	   ICR	  have	  been	  reported	  to	  be	  bound	  by	  CTCF	   in	  mouse	  and	  human	  cells	  and	  to	  be	  important	  to	  its	  insulation	  function	  (Hark	  et	  al.	  2000;	  Kanduri	  et	  al.	  2000).	  The	  MS1	  site	  but	  not	  MS4	  were	  bound	  in	  vitro	  by	  CTCF	  (Hark	  et	  al.	  2000).	  In	  our	  ES	  cells,	  CTCF	  is	  not	  bound	  to	  the	  H19	  ICR	  region.	  This	  is	  surprising,	  as	  imprinting	  at	  the	  H19/Igf2	  locus	  occurs	  in	  ES	  cells.	  It	  is	  possible	  that	  loss	  of	  CTCF	  binding	  to	  the	  H19	  ICR	  is	  due	  to	  aberrant	  methylation	  on	  the	  maternal	  allele,	  preventing	  CTCF	  from	  binding	  (see	  section	  1.3.),	  or	  alternatively,	  due	  to	  loss	  of	  the	  maternal	  chromosome	  7	  in	  these	  ES	  cells.	  	   The	  Gtl2/Dlk1	  locus	  shares	  many	  features	  with	  the	  H19/Igf2	  locus,	  Gtl2	  and	  
H19	   are	   both	   maternally	   expressed	   and	   non-­‐coding	   while	   Dlk1	   and	   Igf2	   are	  paternally	   expressed	   (Takada	   et	   al.	   2000).	   They	   both	   show	  DNA	   imprinting,	   via	  paternal	  hypermethylation	  of	  the	  H19	  and	  Gtl2	  DMRs	  (Takada	  et	  al.	  2002).	  A	  highly	  conserved,	  putative	  CTCF	  binding	  site	  has	  been	  identified	  in	  the	  first	  intron	  of	  Gtl2	  and	  has	  been	  shown	  to	  bind	  CTCF	  and	  cohesin	  in	  vivo	  very	  recently	  (Paulsen	  et	  al.	  2001;	  Lin	  et	  al.	  2011).	  On	   the	  contrary,	  BORIS	  binding	   to	   the	  Gtl2	  DMR	  has	  been	  reported	  in	  mouse	  testis	  (Jelinic	  et	  al.	  2006).	  In	  our	  ES	  cells,	  both	  CTCF	  and	  BORIS	  bind	  the	  Gtl2	  DMR	  (Figure	  3.17	  a	  and	  b).	  	   CTCF	   has	   been	   shown	   to	   bind	   alternative	   promoters	   of	   Boris	   in	   normal	  human	   fibroblasts	   and	   cancer	   cell	   lines,	   in	   inverse	   correlation	   to	   the	   expression	  coming	  from	  each	  of	  the	  promoters	  (Renaud	  et	  al.	  2007).	  In	  mouse	  ES	  cells,	  we	  do	  see	  binding	  of	  CTCF	  to	  the	  Boris	  promoter.	  In	  addition,	  binding	  of	  BORIS	  to	  its	  own	  promoter	  was	  very	  strong.	  This	  result	  hints	  at	  the	  possibility	  that	  BORIS	  binding	  to	  its	   own	   promoter	   drives	   its	   own	   expression	   in	   a	   positive	   feed	   back	   loop	   as	  suggested	  previously	  in	  section	  3.6.	  (Figure	  3.16).	  	   This	   candidate-­‐based	   approach	   shows	   that	   CTCF	   and	  BORIS	   have	   distinct	  binding	   profiles	   in	   ES	   cells.	   Some	   sites	   exhibit	   CTCF	   binding	   but	   not	   BORIS	   and	  some	  sites	  are	  co-­‐occupied	  by	  both	  proteins.	  How	  BORIS	  and	  CTCF	  can	  co-­‐occupy	  the	  same	  sites	  simultaneously	  is	  not	  known.	  As	  mentioned	  previously,	  CTCF	  is	  able	  to	   interact	  with	   itself	   in	  vivo	   and	   in	  vitro	   and	  since	  BORIS	  and	  CTCF	  display	  high	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similarity	   in	   their	  Zn-­‐finger	  domain,	   it	   is	   thus	  possible	   that	  CTCF	  and	  BORIS	  also	  interact,	   form	   heterodimers	   and	   bind	   to	   the	   same	   site	   at	   the	   same	   time.	   On	   the	  other	  hand,	   it	  needs	   to	  be	  noted	   that	  ChIP	  assesses	   the	  binding	  of	   a	  protein	  at	   a	  population	  level;	  it	  cannot	  discriminate	  between	  different	  cells.	  	  These	  differences	  in	   CTCF	   and	   BORIS	   binding	   could	   be	   due	   to	   one	   fraction	   of	   the	   cell	   population	  having	  CTCF	  binding	  at	  a	  particular	  site,	  but	  not	  BORIS,	  and	  another	  fraction	  of	  the	  cell	  population	  showing	  BORIS	  binding,	  but	  not	  CTCF.	  	  	   In	  order	  to	  have	  a	  broader	  picture	  of	  the	  binding	  profile	  of	  BORIS	  in	  ES	  cells	  and	   its	   relationship	   to	  CTCF	  and	  cohesin,	  we	  have	  brought	   the	  binding	  profile	  of	  BORIS	  in	  ES	  cells	  to	  a	  genome-­‐wide	  scale	  using	  ChIP-­‐seq.	  	  	  	   	   3.7.2.	  Genome-­wide	  binding	  of	  BORIS	  in	  ES	  cells	  	  	  	   Analysis	  of	  the	  FLAG-­‐BORIS	  ChIP-­‐seq	  dataset	  using	  FindPeaks	  showed	  that	  BORIS	  binds	   to	   the	  genome	  at	  14,923	  sites	   in	  ES	  cells,	  of	  which	  1,831	  (12%)	  are	  also	   bound	   by	   CTCF	   only,	   675	   (5%)	   by	   cohesin	   only	   and	   7,442	   (50%)	   are	   also	  bound	   by	   cohesin	   and	   CTCF.	   The	   rest	   	   (4975,	   33%)	   corresponds	   to	   BORIS-­‐only	  sites	  (Figure	  3.18).	  Confirming	  the	  previous	  ChIP-­‐qPCR	  results	  at	  the	  panel	  of	  sites,	  BORIS	  and	  CTCF	  can	  co-­‐localise	  (Figure	  3.17	  and	  Figure	  3.19).	  The	  majority	  of	  the	  BORIS	   CTCF-­‐positive	   sites	   are	   also	   cohesin-­‐positive	   (7,442	   versus	   4,975),	  suggesting	  that	  BORIS	  does	  not	  impede	  cohesin	  binding	  to	  CTCF	  in	  ES	  cells	  as	  we	  hypothesised	   before	   (see	   section	   3.4.2.).	   Interestingly,	   a	   subset	   of	   BORIS	   sites	   is	  not	   bound	   by	   CTCF	   or	   cohesin	   pointing	   to	   an	   additional	   CTCF-­‐	   and	   cohesin-­‐independent	  role	  of	  BORIS	  in	  ES	  cells	  and	  possibly	  a	  consensus	  binding	  motif	  that	  is	  different	  to	  that	  of	  CTCF.	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Figure	  3.18	  50%	  of	  BORIS	  peaks	  overlap	  with	  cohesin	  and	  CTCF	  peaks	   in	  ES	  cells	  whereas	  
33%	  of	  BORIS	  sites	  are	  BORIS-­only	  sites.	  Venn	  diagram	  representing	   the	  overlap	  between	  ES	  BORIS	  peaks,	  ES	  CTCF	  peaks	  and	  ES	  cohesin	  peaks.	  	  	  
	  



















Figure	  3.20	  The	  consensus	  sequence	  under	  BORIS	  non-­CTCF	  peaks	   is	   similar	   to	  half	  of	   the	  
CTCF	  consensus	  sequence.	  




	   3.8.	  The	  cohesin	  and	  CTCF	  binding	  patterns	  are	  not	  substantially	  	  
	   	   changed	  at	  a	  panel	  of	  sites	  after	  BORIS	  overexpression	  
	   	   3.8.1.	  The	  binding	  of	  cohesin	  and	  CTCF	  does	  not	  change	  after	  	  
	   	   	   BORIS	  overexpression	  except	  at	  the	  H19/Igf2	  and	  	   	  
	   	   	   Gtl2/Dlk1	  loci	  	  	   BORIS	  expression	  in	  CTCF-­‐expressing	  cells	  has	  been	  postulated	  to	  promote	  tumourigenesis	   through	   aberrant	   epigenetic	   and	   gene	   expression	   changes	   by	  competing	  with	  sites	  occupied	  by	  CTCF	  in	  normal	  cells	  (Hong	  et	  al.	  2005;	  Vatolin	  et	  al.	   2005),	   suggesting	   that	   overexpression	   of	   BORIS	   in	   normal	   cells	   results	   in	  changes	   in	   the	   CTCF	   binding	   pattern	   and	   subsequently,	   cohesin	   recruitment	   to	  chromatin.	  	   To	   investigate	  whether	  BORIS	  overexpression	  modifies	   the	  binding	  profile	  of	  CTCF	  and	  cohesin,	  we	  have	  immunoprecipitated	  CTCF	  and	  cohesin	  in	  Control	  ES	  cells	   and	   FLAG-­‐BORIS	   ES	   cells.	   CTCF-­‐positive	   BORIS	   sites	   (IL4-­‐6,	   Peak5,	   Peak10,	  the	  Bag-­1	   promoter	   and	   the	  Boris	   promoter)	   recruit	   CTCF	   to	   a	   similar	   extent	   in	  both	  Control	   and	  FLAG-­‐BORIS	  ES	   cells	   (Figure	  3.21.a).	  An	   identical	   conclusion	   is	  valid	  for	  cohesin	  recruitment	  to	  those	  sites	  (Figure	  3.21.b).	  Thus,	  CTCF	  and	  cohesin	  binding	  to	  chromatin	  is	  not	  weakened	  or	  compromised	  at	  this	  panel	  of	  cohesin	  and	  CTCF	   sites	   when	   BORIS	   is	   overexpressed,	   excluding	   a	   potential	   competition	  between	  CTCF	  and	  BORIS.	  	   	  
 113	  
	  
Figure	   3.21	   CTCF	   and	   cohesin	   binding	   does	   not	   substantially	   change	   upon	   ectopic	   BORIS	  
expression	  
a.	   CTCF	  ChIP	   signals	   at	   a	  panel	  of	   sites	   in	  Control	  ES	   cells	   in	  blue	   and	   in	  FLAG-­‐BORIS	  ES	   cells	   in	  





























































































































































	   At	   the	  H19	   ICR	   and	  Gtl2	  DMR,	  both	  CTCF	  and	   cohesin	  binding	   is	   two-­‐fold	  increased	   upon	   BORIS	   overexpression.	   The	  H19	   ICR	   does	   not	   bind	   BORIS,	   or	   at	  least	   to	   a	   very	   small	   extent	   (Figure	   3.17)	   whereas	   the	   Gtl2	   DMR	   readily	   binds	  BORIS.	  Since	  CTCF	  and	  BORIS	  might	  heterodimerise	  and	  BORIS	  binds	   to	   the	  Gtl2	  DMR,	  the	  increase	  of	  CTCF	  could	  be	  explained	  by	  a	  possible	  heterodimerisation	  at	  this	   locus.	  However,	   this	  hypothesis	  does	  not	  hold	  up	   in	   the	   case	  of	   the	  H19	   ICR	  MS4	  and	  MS1	  as	  very	  little	  BORIS	  binding	  is	  observed	  (Figure	  3.17).	  Furthermore,	  BORIS	   expression	   has	   been	   correlated	   with	   genome-­‐wide	   DNA	   demethylation	  during	  male	  germ	  cell	  development	  (Loukinov	  et	  al.	  2002)	  and	  CTCF	  is	  known	  to	  interact	  with	  unmethylated	  DNA	  (Bell	  et	  al.	  2000;	  Hark	  et	  al.	  2000).	  A	  decrease	  in	  DNA	  methylation	  at	  these	  binding	  loci	  as	  a	  consequence	  of	  BORIS	  expression	  could	  result	  in	  increased	  CTCF	  and	  cohesin	  binding.	   	  	   Taken	   together,	   these	   results	   at	   this	   panel	   of	   sites	   show	   that	   CTCF	   and	  cohesin	   binding	   is	   generally	   unchanged	   upon	   BORIS	   overexpression,	   which	  challenges	  the	  idea	  that	  BORIS	  and	  CTCF	  compete	  for	  their	  binding	  sites	  when	  co-­‐expressed.	  	   Previously,	   we	   showed	   that	   cohesin	   binding	   could	   be	   developmentally	  regulated	   at	   non-­‐developmentally	   regulated	   CTCF	   Xic	   sites.	   We	   postulated	   the	  existence	  of	  a	  mechanism	  present	  in	  ES	  cells	  that	  precluded	  the	  binding	  of	  cohesin	  to	  those	  CTCF	  sites	  involving	  BORIS.	  In	  addition,	  we	  have	  shown	  that	  BORIS,	  CTCF	  and	  cohesin	  co-­‐localise	  and	   that	   increased	  BORIS	  expression	  does	  not	   result	   in	  a	  decrease	   in	   cohesin	   binding	   to	   chromatin,	   discarding	   BORIS	   as	   a	   potential	  competitor	  of	  cohesin	  for	  CTCF	  sites	  in	  ES	  cells.	  Indeed,	  FLAG	  ChIP	  in	  FLAG-­‐BORIS	  ES	  cells	  at	  the	  Xic	  shows	  that	  BORIS	  binds	  across	  the	  entire	  locus	  (Figure	  3.22).	  It	  binds	   to	  position	  +36kb	  where	  cohesin	  did	  not	  bind	   in	  ES	  cells	  although	   it	  binds	  weakly	   to	   the	   other	   developmentally	   regulated	   cohesin	   site,	   +30Kb	   (Figure	   3.22	  and	  Figure	  3.12	  bottom	  panel).	  The	  binding	  of	  BORIS	  to	  the	  Xic	  does	  not	  correlate	  then	  with	  exclusion	  of	  cohesin	  at	  non-­‐developmentally	  regulated	  CTCF	  sites	  in	  ES	  cells.	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Figure	   3.22	   BORIS	   binding	   does	   not	   preclude	   cohesin	   binding	   to	   non-­developmentally	  
regulated	  CTCF	  sites	  at	  the	  Xic	  in	  ES	  cells.	  	  FLAG-­‐BORIS	  ChIP	  in	  FLABORIS	  ES	  cells	  (orange)	  and	  Control	  ES	  cells	  (green).	  Control	  (IgG)	  ChIP	  in	  FLAG-­‐BORIS	   ES	   cells	   (red)	   and	   Control	   ES	   cells	   (purple).	   Primer	   sites	   are	   indicated	   and	   are	  referenced	  to	  the	  Tsix	  TSS.	  n=2,	  error	  bars=SD.	  	  	  	  	   	   3.8.2.	  Ectopic	  BORIS	  expression	  is	  accompanied	  by	  lower	   DNA	  	  
	   	   	   methylation	  levels	  at	  the	  Gtl2	  DMR	  and	  the	  BORIS	  	   	  



























Figure	  3.23	  DNA	  methylation	  statuses	  of	  the	  H19	  and	  GTL2	  DMRs	  and	  the	  BORIS	  promoter.	  DNA	  methylation	  statuses	  of	  the	  H19	  ICR	  MS4	  and	  MS1,	  the	  Gtl2	  DMR	  and	  the	  BORIS	  promoter	  in	  Control	  ES	   cells,	   left,	   or	  FLAG-­‐BORIS	  ES	   cells,	  right.	   Each	   line	  of	   circles	   represents	  a	   single	   clone.	  Filled	   circles	   represent	   methylated	   CpGs,	   open	   circles,	   un-­‐methylated	   CpGs.	   Schematics	   of	   each	  locus	  are	  to	  the	  right	  of	  the	  figure.	  Big	  black	  bars	  represent	  DMRs.	  Small	  bars	  represent	  sequenced	  positions.	  	  



















	   In	   Control	   ES	   cells,	   the	   H19	   ICR	   MS4	   and	   MS1	   loci	   are	   completely	  methylated	   (Figure	   3.23).	   ES	   cells	   grown	   for	   prolonged	   periods	   of	   time	   acquire	  aberrant	  methylation	  at	  CpGs.	  The	  H19	  DMR	  can	  get	  hypermethylated	   leading	   to	  loss	  of	   imprinting	  and	  differential	  H19	   expression	   (Humpherys	  et	   al.	   2001).	  This	  could	   explain	   why	   the	   H19	   ICR	   is	   hypermethylated	   in	   our	   ES	   cells.	   Another	  possibility	   is	   that	   these	   ES	   cells	   have	   an	   abnormal	   karyotype	   and	   have	   lost	   the	  maternal	   chromosome	   that	   is	  normally	  non-­‐methylated.	  Aberrant	  methylation	  at	  
H19	  ICR	  MS4	  and	  MS1	  correlates	  well	  with	  the	  absence	  of	  CTCF	  binding	  in	  Control	  ES	  cells	  (Figure	  3.17).	  Upon	  ectopic	  BORIS	  expression,	  the	  methylation	  of	  H19	  ICR	  MS4	  is	  not	  changed,	  but	  H19	  ICR	  MS1’s	  is	  slightly	  reduced.	  This	  slight	  reduction	  in	  CpG	   methylation	   could	   explain	   why	   CTCF	   and	   cohesin	   binding	   at	   this	   site	   is	  increased	   in	   FLAG-­‐BORIS	   ES	   cells	   (Figure	   3.21).	   Nevertheless,	   DNA	  methylation	  does	  not	  explain	  the	  increased	  binding	  of	  CTCF	  and	  cohesin	  at	  H19	  ICR	  MS4.	  	  	   The	  Gtl2	  DMR	  is	  differentially	  methylated	  in	  Control	  ES	  cells.	  The	  first	  four	  analysed	  CpGs	  of	  the	  Gtl2	  DMR	  are	  50%	  methylated	  although	  globally,	  33%	  of	  the	  CpGs	  are	  methylated	  in	  Control	  ES	  cells	  (Figure	  3.23).	  In	  FLAG-­‐BORIS	  ES	  cells,	  DNA	  methylation	   is	   reduced	   to	   10%.	   Since	   CTCF	   and	   cohesin	   binding	   is	   increased	   in	  FLAG-­‐BORIS	  ES	   cells	   and	  BORIS	   binds	   to	   the	   same	   site	   (Figure	   3.	   17	   and	   Figure	  3.21),	  it	  is	  tempting	  to	  suggest	  that	  increased	  levels	  of	  BORIS	  and	  its	  binding	  to	  the	  
Gtl2	  DMR	  produce	  substantial	  DNA	  de-­‐methylation,	  leading	  to	  an	  increase	  in	  CTCF	  and	  cohesin	  binding.	  	  	   In	  light	  of	  these	  results	  and	  previous	  reports	  linking	  BORIS	  expression	  and	  DNA	  de-­‐methylation,	  we	  also	  wanted	  to	  assess	  the	  methylation	  status	  of	  the	  BORIS	  endogenous	  promoter	  upon	   ectopic	  BORIS	   expression.	  We	  have	   seen	   that	   FLAG-­‐BORIS	  expression	  results	  in	  an	  up-­‐regulation	  of	  endogenous	  BORIS	  and	  that	  FLAG-­‐BORIS	   binds	   very	   strongly	   to	   its	   endogenous	   promoter	   (Figure	   3.16	   and	   Figure	  3.17).	  The	  DNA	  methylation	  analysis	  of	  the	  promoter	  shows	  a	  very	  strong	  decrease	  in	  methylated	  DNA,	  from	  56%	  to	  4%,	  correlating	  with	  FLAG-­‐BORIS	  binding	  to	  the	  endogenous	  Boris	  promoter,	  promoting	  DNA	  de-­‐methylation	  and	  up-­‐regulation	  of	  endogenous	  Boris	  in	  a	  positive	  feedback	  loop.	  	   Taken	   together,	   these	   results	   support	   a	   correlation	   between	   BORIS	  expression	   and	   site-­‐specific	   DNA	   de-­‐methylation.	   Although	   this	   mechanism	   has	  only	  been	  observed	  at	  the	  H19	  and	  Gtl2	  DMRs	  and	  the	  Boris	  promoter,	  it	  is	  possible	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that	   BORIS	   binding	   at	   additional	   imprinted	   loci	   could	   promote	   DNA	   de-­‐methylation	  and	  subsequently	  an	  increase	  in	  CTCF	  and	  cohesin	  binding.	  	  	  	   3.9.	  Does	  BORIS	  recruit	  cohesin	  to	  chromatin?	  	  	   Numerous	   reports	   have	   shown	   that	   CTCF	   recruits	   cohesin	   to	   DNA	   in	   a	  variety	  of	  cell	   types	  (Parelho	  et	  al.	  2008;	  Wendt	  et	  al.	  2008;	  Stedman	  et	  al.	  2008;	  Rubio	  et	  al.	  2008).	  It	  is	  currently	  unknown	  whether	  BORIS	  can	  also	  recruit	  cohesin.	  ES	   cells,	   albeit	   at	   low	   levels,	   express	   BORIS	   in	   addition	   to	   CTCF.	   To	   investigate	  whether	  BORIS	  recruits	  cohesin,	  different	  approaches	  can	  be	  used.	  	   One	  approach	   is	   to	  assess	  the	  recruitment	  of	  cohesin	  to	  cohesin	  and	  CTCF	  sites	   in	   CTCF-­‐depleted	   ES	   cells	   and	   test	  whether	  BORIS	   can	   “take	   over”	   CTCF	   in	  recruiting	   cohesin.	   We	   can	   also	   assess	   whether	   cohesin	   is	   recruited	   to	  cohesin/CTCF/BORIS	  sites	  upon	  CTCF	  depletion.	  A	  different	  approach	  is	  to	  assess	  the	  recruitment	  of	  cohesin	  to	  cohesin	  and	  CTCF	  sites	  and	  to	  cohesin/CTCF/BORIS	  sites	   in	  CTCF-­‐depleted	  FLAG-­‐BORIS	  ES	  cells	   (not	  expressing	  CTCF	  but	  expressing	  high	  levels	  of	  FLAG-­‐BORIS).	  A	  final	  approach	  is	  to	  study	  the	  binding	  of	  cohesin	  at	  cohesin	   BORIS-­‐positive	   non-­‐CTCF	   sites	   and	   assess	   whether	   the	   increased	  expression	  of	  BORIS	   in	  FLAG-­‐BORIS	  ES	  cells	  allows	   for	  a	  stronger	  recruitment	  of	  cohesin	  to	  those	  sites.	  	  	  	   	   3.9.1.	  Endogenous	  levels	  of	  BORIS	  do	  not	  rescue	  cohesin	  	   	  
	   	   recruitment	  in	  CTCF-­deficient	  ES	  cells.	  	   	  	   We	  used	  siRNA	  oligos	  to	  knock	  down	  CTCF	  in	  wild	  type	  ES	  cells	  followed	  by	  cohesin	  ChIP.	  Wild	  type	  ES	  cells	  transfected	  with	  a	  non-­‐targeting	  siRNA	  were	  used	  as	  control.	  We	  additionally	  performed	  an	  H3	  ChIP	  to	  control	  for	  the	  quality	  of	  the	  chromatin.	  Figure	  3.24.d	  shows	   that	  CTCF	   is	  properly	  knocked	  down	   in	   these	  ES	  cells,	   and	   accordingly,	   CTCF	   ChIP	   signals	   are	   reduced	   across	   all	   positive	   CTCF	  binding	  sites,	  although	  to	  different	  extents.	  CTCF	  depletion	  from	  cells	  that	  express	  BORIS	  at	  endogenous	  levels	  reduces	  cohesin	  binding	  at	  CTCF/cohesin	  sites	  (IL4-­‐6,	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Peak5,	  Peak10,	  Gtl2	  DMR;	  Figure	  3.24.a	  and	  b)	  as	  previously	  observed	   in	  BORIS-­‐non-­‐expressing	   cells,	   suggesting	   that	   BORIS	   is	   not	   able	   to	   recruit	   cohesin	   in	   the	  absence	  of	  CTCF.	  These	  results	  argue	  against	  a	  role	  for	  BORIS	  in	  recruiting	  cohesin.	  
	  
Figure	  3.24	  BORIS,	  expressed	  at	  endogenous	   levels,	   is	  not	  able	   to	   recruit	   cohesin	   in	  CTCF-­
deficient	  ES	  cells.	  
a.	  CTCF	  ChIP	   in	  wild	   type	  ES	  cells	   transfected	  with	  Control	  siRNA	  is	   in	  blue,	  or	  with	  CTCF	  siRNA,	  





















































































































	   	   3.9.2.	  High	  levels	  of	  BORIS	  do	  not	  rescue	  cohesin	  recruitment	  	  
	   	   	   in	  CTCF-­deficient	  ES	  cells.	  
	  	   In	  order	  to	  investigate	  if	  cohesin	  can	  be	  recruited	  to	  cohesin	  and	  CTCF	  sites	  and	   to	   cohesin/CTCF/BORIS	   sites	   in	   the	   absence	  of	  CTCF	  and	   in	   the	  presence	  of	  high	   levels	   of	   BORIS,	   we	   knocked	   down	   CTCF	   in	   FLAG-­‐BORIS	   ES	   cells	   and	   then	  performed	  CTCF,	  cohesin,	  BORIS	  and	  H3	  ChIPs.	  Figure	  3.25.a	  shows	  that	  binding	  of	  CTCF	   to	   all	   sites	   studied	   is	   reduced	   upon	   knockdown	   as	   expected.	   Again,	   as	  happened	   in	  wild	   type	  ES	   cells	   upon	  CTCF	  knockdown,	   cohesin	   is	   also	   lost	   from	  cohesin	   and	   CTCF	   sites	   and	   from	   cohesin/CTCF/BORIS	   sites	   in	   FLAG-­‐BORIS	   ES	  cells	   (Figure	   3.25.b).	   Interestingly,	   CTCF	   removal	   results	   in	   increased	   BORIS	  binding	  to	  almost	  all	  cohesin	  and	  CTCF	  sites	  except	  at	  the	  H19	  ICR	  sites,	  the	  Bag-­1	  and	   the	   Boris	   promoters	   (Figure	   3.25.c).	   This	   suggests	   that	   CTCF	   in	   some	   way	  precludes	  or	  inhibits	  BORIS	  binding	  to	  cohesin	  and	  CTCF	  non-­‐BORIS	  binding	  sites	  and	   cohesin/CTCF/BORIS	   binding	   sites.	   In	   addition,	   although	   BORIS	   binding	   is	  increased	  upon	  depletion	  of	  CTCF	  at	  cohesin/CTCF/BORIS	  sites,	  such	  as	  Peak5	  and	  the	  Gtl2	  DMR,	  cohesin	  binding	  is	  still	  lost,	  again	  arguing	  against	  a	  role	  for	  BORIS	  in	  recruiting	  cohesin	  to	  chromatin.	  	   What	  happens	  then	  at	  cohesin	  and	  BORIS	  non-­‐CTCF	  sites?	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Figure	  3.25	  Cohesin	  recruitment	  is	  impaired	  in	  CTCF-­deficient	  FLAG-­BORIS	  ES	  cells.	  
a.	  CTCF	  ChIP	  in	  FLAG-­‐BORIS	  ES	  cells	  transfected	  with	  Control	  siRNA	  in	  blue,	  or	  with	  CTCF	  siRNA,	  

























































































































































































































































































































siRNA,	  purple.	   b.	  Rad21	  ChIP	   in	  FLAG-­‐BORIS	  ES	   cells	   transfected	  with	  Control	   siRNA	   in	  black,	   or	  with	  CTCF	  siRNA,	  red.	  c.	  FLAG-­‐BORIS	  ChIP	  in	  FLAG-­‐BORIS	  ES	  cells	  transfected	  with	  Control	  siRNA	  in	  orange,	  or	  with	  CTCF	  siRNA,	  grey.	  d.	  H3	  ChIP	   in	  FLAG-­‐BORIS	  ES	  cells	   transfected	  with	  Control	  siRNA	  in	  light	  brown,	  or	  with	  CTCF	  siRNA,	  dark	  brown.	  n=3,	  error	  bars=	  SD.	  e.	  Western	  Blot	  of	  CTCF,	  Rad21,	  FLAG-­‐BORIS	  and	  loading	  control	  Tubulin.	  	  
	  	  	   	   3.9.3.	  BORIS	  does	  not	  recruit	  cohesin	  to	  cohesin	  and	  BORIS	  	  
	   	   	   non-­CTCF	  sites.	  	   	   	  	   As	   previously	   noted,	   ChIP-­‐qPCR	   results	   at	   cohesin	   non-­‐CTCF	   sites	   do	   not	  agree	  with	  the	  ChIP-­‐seq	  data,	  showing	  that	  CTCF	  might	  be	  weakly	  bound	  to	  those	  sites.	  We	  have	  still	  performed	  qPCR	  analysis	  at	  sites	  that	  are	  bound	  by	  both	  BORIS	  and	   cohesin	   but	   not	   CTCF	   in	   the	   ChIP-­‐seq	   analysis	   and	   checked	   if	   increased	  expression	  of	  BORIS	  results	  in	  an	  increase	  in	  cohesin	  binding.	  We	  randomly	  picked	  cohesin	   and	  BORIS	   sites	   from	   the	   analysis	   of	   the	   overlaps	   of	   cohesin	   and	   FLAG-­‐BORIS	   ChIP-­‐seq	   data	   in	   ES	   cells.	   Again,	   CTCF	   binding	   was	   detected	   above	  background	   at	   those	   sites	   by	   qPCR	   (Figure	   3.26).	   FLAG-­‐BORIS	   expression	   in	   ES	  cells	  did	  not	  result	  again	  in	  major	  changes	  to	  CTCF	  and	  cohesin	  enrichment,	  except	  at	  site	  esBoradsp4.	  Indeed,	  increased	  binding	  of	  cohesin	  at	  site	  esBoradsp4	  is	  also	  accompanied	  by	  an	  increase	  in	  binding	  of	  CTCF.	  	   Altogether,	  these	  results	  confirm	  the	  presence	  of	  CTCF	  at	  ChIP-­‐seq	  cohesin	  non-­‐CTCF	  sites	  and	  that	  overexpression	  of	  BORIS	  does	  not	  increase	  the	  binding	  of	  cohesin	  without	  changes	  in	  CTCF	  binding.	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Figure	   3.26	   Increased	   binding	   of	   BORIS	   does	   not	   increase	   the	   binding	   of	   cohesin	  without	  
changes	  in	  CTCF	  binding	  at	  cohesin	  and	  BORIS	  non-­CTCF	  sites.	  	  


























































































































































































































	   3.10.	  Discussion	  	   	   3.10.1.	  Cohesin	  binding	  is	  developmentally	  regulated	  
	  	   Data	  produced	  by	  our	  laboratory	  and	  others	  have	  shown	  that	  cohesin	  plays	  a	  major	  role	  in	  regulating	  gene	  expression	  in	  mammalian	  cells,	  independent	  of	  its	  role	   in	  chromatid	  cohesion	  and	  segregation	  and	  DNA	  repair	  (Parelho	  et	  al.	  2008;	  Wendt	  et	  al.	  2008;	  Stedman	  et	  al.	  2008;	  Kagey	  et	  al.	  2010;	  Nitzsche	  et	  al.	  2011).	  To	  address	   the	   relationship	   between	   cohesin	   binding	   and	   gene	   expression	   on	   a	  genome-­‐wide	   scale	   we	   decided	   to	   establish	   the	   technique	   of	   ChIP-­‐seq	   and	   map	  cohesin	  binding	  sites	  in	  pluripotent	  ES	  cells	  and	  lineage-­‐committed	  pre-­‐B	  cells.	  We	  have	  described	  here	  how	   to	  generate	  a	  ChIP-­‐seq	   library,	  mainly	  by	  polishing	   the	  ends	   of	   sonicated	   immunoprecipitated	   DNA,	   ligating	   adapters,	   size	   selecting	   the	  library,	  amplifying	  the	  library	  using	  adapter-­‐specific	  primers	  and	  purifying	  it.	  The	  library	   is	   then	   subject	   to	   several	   quality	   controls,	   such	   as	   qPCR	   and	   capillary	  electrophoresis.	  	   In	  this	  way,	  we	  have	  found	  that	  ES	  cells	  have	  approximately	  34,000	  cohesin	  binding	   sites	   and	   38,000	   CTCF	   binding	   sites,	   whereas	   pre-­‐B	   cells	   have	   around	  19,000	  cohesin	  sites	  and	  23,000	  CTCF	  sites.	  We	  have	  been	  able	  to	  confirm	  a	  broad	  co-­‐localisation	  of	  cohesin	  with	  CTCF	  on	  mammalian	  chromosomes	  in	  both	  ES	  cells	  and	  pre-­‐B	  cells.	  In	  both	  cell	  types,	  cohesin	  is	  found	  at	  around	  70	  to	  80%	  of	  all	  CTCF	  sites	  and	  CTCF	   is	   found	  at	  around	  70	  to	  80%	  of	  all	  cohesin	  sites.	  These	  numbers	  are	  very	  similar	   to	  published	  results	   in	  mouse	  cells	  and	  are	  conserved	   in	  human	  cells	  (Parelho	  et	  al.	  2008;	  Wendt	  et	  al.	  2008).	  Nevertheless,	  Kagey	  and	  colleagues	  describe	  44,000	  peaks	  of	  cohesin	   in	  mouse	  ES	  cells,	  43%	  of	  which	  are	  non-­‐CTCF,	  while	  Nitzsche	  and	  colleagues	  report	  15,000	  cohesin	  peaks,	  of	  which	  26%	  are	  non-­‐CTCF	   (Kagey	   et	   al.	   2010;	   Nitzsche	   et	   al.	   2011).	   There	   could	   be	   several	   reasons	  accounting	   for	   the	   differences	   between	   these	   studies.	   First	   of	   all,	   Kagey	   and	  colleagues	   target	  different	  cohesin	  subunits,	  Smc1	  and	  Scm3.	  The	  antibodies	  will	  thus	   be	   different	   and	   have	   different	   efficiencies	   in	   ChIP.	   Moreover,	   the	   CTCF	  antibodies	   used	   in	   the	   Kagey	   study	   and	   our	   study	   are	   different.	   The	   usage	   of	   a	  different	   ES	   cell	   line	   might	   also	   yield	   different	   results	   in	   the	   number	   and	  localisation	  of	  peaks,	  although	  presumably	  not	  to	  a	  significant	  degree.	  In	  addition,	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the	   differences	   in	   number	   of	   peaks	   and	   overlaps	   can	   be	   due	   to	   the	   usage	   of	  different	  peak-­‐calling	  algorithms.	  	  	   Cohesin	  also	  regulates	  gene	  expression	  by	  bringing	  together	  enhancers	  and	  promoters,	   through	   the	   interaction	  with	   its	   loading	   factor,	   NIPBL,	   and	  mediator	  (Kagey	  et	  al.	  2010).	  We	  have	  assessed	  the	  existence	  of	  cohesin	  non-­‐CTCF	  peaks	  in	  ES	   cells	   and	  pre-­‐B	   cells	   and	  have	   found	   that	  peaks	  defined	  by	  ChIP-­‐seq	  as	  being	  cohesin	   non-­‐CTCF	   peaks	   are	   of	   low	   enrichment,	   confirming	   previous	   reports	  (Schmidt	   et	   al.	   2010;	   Kagey	   et	   al.	   2010).	   We	   validated	   some	   cohesin	   non-­‐CTCF	  peaks	  by	  overlapping	  published	  Oct4,	  Nanog	  and	  Sox2	  ChIP-­‐seq	  data	  in	  mouse	  ES	  cells	  with	  our	  cohesin	  and	  CTCF	  ChIP-­‐seq	  data	  and	  selected	  cohesin	  non-­‐CTCF	  sites	  that	   overlapped	   with	   Oct4,	   Nanog	   and/or	   Sox2	   peaks	   (Chen	   et	   al.	   2008).	  Surprisingly,	  we	  do	  detect	  enrichment	  of	  CTCF	  at	  those	  sites	  by	  ChIP-­‐qPCR.	  When	  we	   analysed	   the	   underlying	   sequence	   of	   all	   cohesin	   non-­‐CTCF	   peaks,	   a	   strong	  enrichment	   of	   the	   CTCF	   motif	   could	   be	   detected,	   almost	   as	   similar	   as	   with	   the	  cohesin	  and	  CTCF	  peaks.	  Schmidt	  and	  colleagues	  have	  demonstrated	  that	  the	  DNA	  sequence	  under	  cohesin	  non-­‐CTCF	  peaks	  is	  enriched	  for	  cell-­‐specific	  transcription	  factor	  binding	  motifs	   (Schmidt	  et	  al.	  2010).	  On	   the	  contrary,	  we	  could	  not	  detect	  enrichment	  for	  motifs	  of	  ES	  cell	  or	  pre-­‐B	  cell	  specific	  transcription	  factors,	  such	  as	  Oct4,	  Nanog,	   EBF,	   etc.	   Very	   recently,	  Nitzsche	   and	   colleagues	   have	   shown	   that	   a	  great	  majority	   of	   cohesin	   non-­‐CTCF	   peaks	   do	   bear	   the	   CTCF	  motif.	   Only	   a	   small	  percentage	  of	  cohesin	  non-­‐CTCF	  binding	  sites	  are	  not	  enriched	  for	  the	  CTCF	  motif	  (Nitzsche	   et	   al.	   2011).	   It	   is	   thus	   possible	   that	   we	   might	   have	   masked	   the	   truly	  cohesin	  non-­‐CTCF	  peaks	  lacking	  the	  CTCF	  binding	  motif	  by	  combining	  all	  cohesin	  non-­‐CTCF	   peaks	   in	   the	   analysis.	   A	  more	   thorough	   analysis	   of	   our	   data	   could	   be	  performed	   to	   filter	   those	   cohesin	   non-­‐CTCF	   peaks	   lacking	   the	   CTCF	   motif	   and	  determine	  if	  the	  pluripotency-­‐associated	  factor	  motifs	  are	  present.	  	  	   Since	  we	  have	  selected	  cohesin	  non-­‐CTCF	  sites	  that	  were	  positive	  for	  Oct4,	  Nanog	   and/or	   Sox2,	   we	   would	   expect	   no	   detection	   of	   CTCF	   enrichment,	   or	   the	  CTCF	  binding	  motif.	   It	   is	  possible	   that	   these	   sites	  exhibit	   the	  CTCF	  binding	  motif	  beside	  the	  pluripotency-­‐associated	  factor	  binding	  motifs.	  This	  would	  explain	  why	  CTCF	  is	  enriched	  at	  those	  sites	  as	  well	  as	  Oct4,	  Nanog	  and/or	  Sox2.	  This	  would	  also	  suggest	  that	  ChIP-­‐seq	  analysis	  is	  not	  as	  sensitive	  as	  ChIP-­‐qPCR	  and	  those	  sites	  are	  ChIP-­‐seq	   false	  negative	  CTCF	  sites.	   It	  would	  be	   interesting	   to	   immunoprecipitate	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CTCF	  at	  cohesin	  non-­‐CTCF	  peaks	  without	  the	  CTCF	  motif	  to	  evaluate	  the	  binding	  of	  CTCF	  to	  those	  sites.	  Or	  deplete	  CTCF	  in	  these	  ES	  cells	  and	  evaluate	  the	  binding	  of	  cohesin	  at	  cohesin	  non-­‐CTCF	  sites	  lacking	  the	  CTCF	  binding	  motif.	  	  	   In	   addition,	   since	   cohesin	   broadly	   interacts	   with	   CTCF	   on	   chromatin,	   the	  CTCF	  ChIP-­‐qPCR	  signals	  that	  we	  are	  detecting	  at	  cohesin	  non-­‐CTCF	  peaks	  might	  be	  due	  to	  this	  interaction	  and	  not	  because	  CTCF	  is	  present	  at	  those	  sites	  and	  actively	  recruiting	   cohesin.	   It	   is	   possible	   that	   one	   cohesin	  molecule	   interacts	   with	   other	  transcription	   factors	   and/or	  NIPBL	   and	  mediator	   at	   those	   sites,	   but	   at	   the	   same	  time,	   bridges	   to	   another	   cohesin	   site	   that	   is	   CTCF-­‐bound.	   By	   crosslinking	   the	  chromatin,	  CTCF	  would	  seem	  to	  be	  present	  at	  NIBPL/mediators	  sites,	  but	  in	  reality	  it	  is	  not.	  	   We	  have	  also	  shown	  that	  many	  cohesin	  and	  CTCF	  peaks	  are	  shared	  between	  the	  two	  cell	  types.	  It	  is	  striking	  that	  ES	  cells	  exhibit	  many	  more	  cohesin	  and	  CTCF	  binding	   sites	   than	   pre-­‐B	   cells.	   What	   could	   be	   the	   reason	   for	   this?	   Firstly,	   it	   is	  possible	  that	  the	  chromatin	  in	  some	  way	  is	  less	  accessible	  to	  the	  antibodies	  in	  pre-­‐B	  cells	  and	  thus	  yielding	  a	  lower	  number	  of	  peaks.	  We	  have	  also	  performed	  cohesin	  ChIP-­‐seq	  in	  pro-­‐B	  cells	  and	  the	  number	  of	  peaks	  is	  quite	  similar	  to	  the	  number	  in	  pre-­‐B	  cells	  (23,500).	  Strikingly,	  cohesin	  ChIP-­‐seq	  in	  CD4+CD8+	  double	  positive	  (DP)	  thymocytes	  produced	  43,000	  peaks	   (see	   section	  4.2.).	   It	   is	   thus	  possible	   that	   the	  lower	   number	   of	   peaks	   in	   pre-­‐B	   and	   pro-­‐B	   cells	   is	   characteristic	   of	   B	   lymphoid	  cells	   in	   general.	   It	   can	   also	   be	   due	   to	   technical	   issues	   with	   the	   sequencing	  procedure	  although	  we	  do	  not	  believe	  this	  to	  be	  the	  case	  as	  the	  number	  of	  cohesin	  and	  CTCF	  peaks	  is	  very	  similar	  per	  cell	  type.	  More	  interestingly,	  the	  differences	  in	  cohesin	  and	  CTCF	  binding	  across	  different	  cell	  types	  could	  be	  biologically	  relevant.	  As	  cohesin	  has	  been	  shown	  to	  be	   involved	   in	  gene	  expression,	   it	   is	   thus	  possible	  that	  differences	  in	  cohesin	  binding	  between	  different	  cell	  types	  are	  at	  the	  base	  of	  different	   gene	   expression	   patterns.	   It	  would	   be	   interesting	   to	   know	   if	   there	   is	   a	  correlation	   between	   our	   cell-­‐type-­‐specific	   cohesin	   peaks	   and	   cell-­‐type-­‐specific	  gene	  expression.	  	  	   We	   have	   described	   the	   presence	   of	   different	   types	   of	   developmentally	  regulated	  cohesin	  binding	  sites.	  Many	  cell-­‐type-­‐specific	  cohesin	  sites	  are	  also	  cell-­‐type-­‐specific	  CTCF	  sites.	  As	  cohesin	  is	  recruited	  by	  CTCF,	  and	  the	  binding	  of	  CTCF	  to	   chromatin	   is	   dependent	   on	   the	   epigenetic	   status	   of	   its	   binding	   site,	   it	   is	   thus	  
 127	  
possible	   that	   epigenetic	   changes	   occurring	   during	   development	   result	   in	  differential	  binding	  of	  CTCF,	  and	  thus	  cohesin,	  as	  suggested	  previously	  (Parelho	  et	  al.	  2008).	  In	  addition,	  we	  have	  also	  shown	  that	  there	  are	  cohesin	  binding	  sites	  that	  seem	  independent	  of	  CTCF	  by	  ChIP-­‐seq	  and	  are	  developmentally	  regulated.	  These	  types	  of	  peaks	  could	  be	  explained	  by	  the	  co-­‐occurrence	  at	  those	  sites	  of	  cell-­‐type-­‐specific	  factors	  (Schmidt	  et	  al.	  2010;	  Kagey	  et	  al.	  2010;	  Nitzsche	  et	  al.	  2011).	  In	  this	  way,	  absence	  of	  that	  cell-­‐type-­‐specific	  factor	  at	  another	  developmental	  stage	  would	  eliminate	   cohesin	   binding.	  We	   hypothesised	   that	   Oct4	   could	   be	   one	   such	   factor.	  Using	   Oct4	   conditional	   knockout	   ES	   cells,	   we	   have	   shown	   that	   Oct4	   does	   not	  recruit	  cohesin	  to	  cohesin	  Oct4-­‐positive	  non-­‐CTCF	  sites.	  	  	   Finally,	  we	  have	  also	  described	  the	  existence	  of	  developmentally	  regulated	  cohesin	   sites	   that	   are	   CTCF-­‐dependent,	   although	   CTCF	   is	   not	   developmentally	  regulated.	  Several	  reports	  have	  described	  similar	  results	  at	  other	  loci	  (Degner	  et	  al.	  2009;	  Kim	  et	  al.	  2011).	  Interestingly,	  Kim	  and	  colleagues	  find	  that	  Oct4	  binding	  to	  the	  CTCF	  site	  CBS5	  within	  the	  HOXA	  locus	  in	  ES	  cells	  precludes	  binding	  of	  cohesin.	  In	   differentiated	   human	   fibroblast	   cells,	   Oct4	   is	   not	   expressed	   and	   cohesin	   is	  bound	   to	   the	   CTCF	   sites.	   Overexpression	   of	   Oct4	   in	   fibroblasts	   results	   in	   a	  significant	  decrease	   in	   the	  binding	  of	   cohesin	  but	  not	  of	  CTCF.	  They	  suggest	   that	  CTCF	  and	  Oct4	  interact	  at	  that	  site	  abrogating	  cohesin	  recruitment	  by	  CTCF	  in	  ES	  cells.	   This	   scenario	   at	   the	  HOXA	   cluster	   seems	   implausible	   since	  we	   detect	   very	  strong	  enrichment	  of	  cohesin	  at	  the	  CBS5	  site	  and	  is	  unmodified	  when	  we	  deplete	  Oct4	   from	   ES	   cells.	   Nevertheless,	   we	   checked	   the	   binding	   of	   cohesin	   at	   the	  developmentally	  regulated	  cohesin	  sites	  of	  the	  Xic	  and	  observed	  that	  depletion	  of	  Oct4	   does	   not	   change	   the	   enrichment	   of	   cohesin.	   The	   question	   whether	   other	  factors	  preclude	  the	  binding	  of	  cohesin	  to	  CTCF	  sites	  is	  still	  open.	  One	  such	  factor	  could	  be	  BORIS.	  	  	  	   	   3.10.2.	  Unlike	  CTCF,	  BORIS	  does	  not	  recruit	  cohesin	  to	  	   	  
	   	   chromatin	  in	  ES	  cells.	  	  	   We	  have	  investigated	  the	  relationship	  of	  BORIS	  with	  CTCF	  and	  cohesin	  in	  ES	  cells.	  We	  have	  created	  two	  ES	  cell	  lines	  that	  express	  FLAG-­‐tagged	  BORIS	  to	  similar	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levels	   as	   CTCF	   and	   have	   assessed	   the	   DNA	   binding	   profile	   of	   BORIS	   in	   ES	   cells.	  Initial	  results	  at	  a	  panel	  of	  sites	  show	  that	  CTCF	  and	  BORIS	  occupy	  the	  same	  sites,	  in	  disagreement	  with	  previous	  reports	  describing	  a	  competition	  for	  their	  common	  binding	   sites	   (Hong	   et	   al.,	   2005;	   Nguyen	   et	   al.,	   2008	   a;	   Vatolin	   et	   al.,	   2005).	  Inherent	   to	   the	  population-­‐wide	   level	  of	  ChIP	  analysis,	   it	   is	  not	  possible	   to	  know	  whether	  co-­‐occupancy	  of	  BORIS	  and	  CTCF	  at	  their	  common	  binding	  sites	  occurs	  in	  the	   same	   cell.	   Since	   CTCF	   is	   able	   to	   homodimerise,	   BORIS	   and	   CTCF	   could	   be	  heterodimerising	  at	  common	  sites.	  Co-­‐immunoprecipitation	  could	  address	  in	  vitro	  CTCF	   and	   BORIS	   heterodimerisation.	   Additionally,	   in	   vivo	   analysis	   of	   BORIS	   and	  CTCF	   heterodimerisation	   could	   be	   evaluated	   by	   sequential	   ChIP.	   Genome-­‐wide	  analysis	   of	   the	   BORIS	   binding	   profile	   in	   ES	   cells	   shows	   that	   BORIS	   has	   its	   own	  subset	   of	   sites	   that	   are	   CTCF-­‐independent.	   We	   analysed	   the	   consensus	   binding	  motif	  under	  the	  1000	  most	  enriched	  BORIS	  non-­‐CTCF	  peaks	  and	  found	  one	  motif	  that	  was	  highly	  similar	  to	  one	  half	  of	   the	  CTCF	  consensus	  binding	  sequence.	  This	  raises	   the	   interesting	   question	  whether	   BORIS	   binding	   to	   the	   CTCF	  motif	   is	   less	  stringent	  than	  CTCF	  itself	  and	  is	  allowed	  to	  bind	  this	  subset	  of	  sites	  whereas	  CTCF	  is	  not,	  due	  to	  the	  absence	  of	  half	  of	  the	  motif.	  It	  is	  to	  be	  noted	  that	  overexpression	  of	   a	   protein	   can	   generate	   artifacts	   in	   the	   binding	   profile,	   that	   is,	   sites	   that	   are	  bound	  by	  the	  protein	  when	  it	  is	  overexpressed	  but	  are	  not	  bound	  when	  the	  protein	  is	  expressed	  at	  endogenous	  levels.	  	   We	  then	  analysed	  the	  binding	  properties	  of	  CTCF	  and	  cohesin	  at	  some	  sites	  when	   BORIS	   is	   ectopically	   expressed	   at	   high	   levels.	   Competition	   of	   CTCF	   and	  BORIS	   for	   their	  binding	   sites	  would	   thus	   result	   in	  a	  decrease	   in	  CTCF	  binding	   to	  DNA.	   This	   did	   not	   occur;	   CTCF	   binding	   and	   cohesin	   binding	   were	   mostly	  unchanged	   in	  ES	   cells	  upon	  BORIS	  overexpression.	   	  Only	   at	   the	  H19	   ICR	  and	   the	  
Gtl2	  DMR	  did	  we	  see	  an	  increase	  in	  CTCF	  and	  cohesin	  binding.	  As	  CTCF	  binding	  is	  dependent	  on	  the	  methylation	  status	  of	  its	  binding	  site	  and	  BORIS	  had	  been	  linked	  to	  genome-­‐wide	  de-­‐methylation	   in	  germ	  cells,	  we	  postulated	  that	  overexpression	  of	  BORIS	   resulted	   in	   a	  decrease	   in	  DNA	  methylation	   at	   those	   sites,	   leading	   to	   an	  increase	  in	  CTCF	  and	  cohesin	  binding.	  This	  was	  indeed	  the	  case	  for	  the	  Gtl2	  DMR	  and	  maybe	  for	  the	  H19	  ICR.	  No	  demethylase	  activity	  for	  BORIS	  has	  been	  described	  although	  BORIS	  expression	  in	  spermatogenesis	  correlates	  with	  low	  global	  levels	  of	  methylated	   CpGs	   (D.	   I.	   Loukinov	   et	   al.	   2002).	   BORIS	   could	   act	   as	   a	   recruiting	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platform	   for	   proteins	   involved	   in	  DNA	  demethylation.	  On	   the	   other	   hand,	   BORIS	  could	  be	  inhibiting	  the	  binding	  of	  DNA	  methyltransferases	  after	  replication	  leading	  to	   decreased	   levels	   of	   CpG	   methylation.	   It	   would	   also	   be	   interesting	   to	   know	  whether	  increased	  binding	  of	  CTCF	  to	  the	  Gtl2	  DMR	  occurs	  monoallelically	  or	  CTCF	  binds	  de	  novo	  to	  demethylated	  regions	  on	  the	  previously	  methylated	  allele.	  Usage	  of	   cells	   with	   single	   nucleotide	   polymorphisms	   (SNP)	   could	   be	   useful	   to	   assess	  allelic	  binding	  of	  CTCF	  but	  also	  allelic	  expression	  of	  Gtl2.	  Altogether,	  BORIS	  binding	  is	   compatible	   with	   CTCF	   and	   especially	   cohesin,	   proving	   that	   BORIS	   binding	   to	  CTCF	  sites	  does	  not	  preclude	  the	  binding	  of	  cohesin	  at	  developmentally	  regulated	  cohesin	  sites	  as	  had	  been	  hypothesised	  to	  happen	  at	  the	  Xic.	  	   We	  then	  assessed	  whether	  BORIS,	  like	  CTCF,	  is	  able	  to	  recruit	  cohesin	  in	  ES	  cells.	  Previous	  work	  on	  cohesin	  recruitment	  by	  CTCF	  has	  been	  performed	  in	  cells	  that	  do	  not	  express	  BORIS.	  It	  was	  thus	  interesting	  to	  know	  whether	  the	  presence	  of	  BORIS	  at	  endogenous	  levels	  in	  ES	  cells	  affects	  the	  recruitment	  capacity	  of	  cohesin	  by	  CTCF.	  CTCF	  was	  thus	  knocked	  down	  and	  cohesin	  was	  immunoprecipitated.	  Loss	  of	   CTCF	   resulted	   in	   loss	   of	   cohesin	   binding,	   as	   in	   previous	   reports	   with	   BORIS-­‐negative	  cells.	  Subsequently,	  we	  evaluated	  whether	  BORIS	  can	  “take	  over”	  the	  role	  of	   CTCF	   in	   recruiting	   cohesin	   to	   chromatin.	  We	   depleted	   ES	   cells	   of	   CTCF	  while	  simultaneously	   overexpressing	   BORIS.	   Again,	   as	   with	   the	   previous	   scenario,	  cohesin	  was	  lost	  from	  its	  binding	  sites.	  Interestingly,	  BORIS	  binding	  to	  most	  of	  its	  CTCF-­‐shared	   sites	   as	   well	   as	   CTCF-­‐specific	   sites	   was	   increased	   upon	   CTCF	  depletion.	   This	   suggests	   that	   CTCF	   can	   hinder	   BORIS	   binding	   to	   some	   common	  sites,	  maybe	  through	  steric	  hindrance.	  Similarly,	  BORIS	  binds	  to	  the	  paternal	  allele	  of	  the	  H19	  DMR	  because	  CTCF	  can	  only	  bind	  to	  the	  unmethylated	  maternal	  allele	  (Nguyen	  et	  al.	  2008	  b).	  Consequently,	  BORIS	  can	  bind	  to	  the	  unmethylated	  allele	  in	  some	  tumour	  cells	  only	  when	  CTCF	  is	  displaced.	  We	  also	  evaluated	  the	  binding	  of	  cohesin	  at	  cohesin	  BORIS-­‐positive	  non-­‐CTCF	  sites	  hypothesising	  that,	  were	  BORIS	  able	  to	  recruit	  cohesin,	  we	  would	  see	  an	  increase	  in	  cohesin	  binding	  upon	  BORIS	  overexpression.	  We	  observed	   that	  cohesin	  BORIS-­‐positive	  non-­‐CTCF	  sites	  exhibit	  low	  enrichment	  of	  CTCF	  by	  ChIP-­‐qPCR	  and	  also	  that	  the	  overexpression	  of	  BORIS	  does	  not	   result	   in	  an	   increase	   in	   cohesin	  binding	   to	   chromatin.	  Altogether,	   these	  results	   suggest	   that	   BORIS	   is	   not	   able	   to	   recruit	   cohesin	   to	   chromatin	   as	   its	  paralogue	  CTCF.	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   We	   acknowledge	   the	   fact	   that	   this	   work	   has	   been	   performed	   in	   ES	   cells	  where	   the	  endogenous	  expression	  of	  BORIS	   is	   low	  compared	   to	  CTCF.	  Moreover,	  these	  ES	  cells	  exhibit	  an	  aberrant	  pattern	  of	  methylation	  at	  the	  H19	  ICR.	  We	  thus	  believe	  this	  system	  might	  not	  be	  ideal	  to	  strictly	  study	  the	  role	  of	  BORIS	  in	  ES	  cells.	  On	  the	  other	  hand,	  one	  of	  the	  open	  questions	  in	  the	  BORIS/CTCF	  field	  is	  whether	  BORIS	  is	  able	  to	  recruit	  cohesin.	  This	  system	  though,	  despite	  its	  shortcomings,	  can	  be	  used	  to	  address	  that	  question.	  Indeed,	  we	  have	  shown	  that	  BORIS,	  unlike	  CTCF	  is	  not	  able	  to	  recruit	  cohesin	  to	  cohesin	  and	  CTCF	  sites	  and	  to	  BORIS-­‐positive	  non-­‐CTCF	  cohesin	  sites.	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Chapter	  4:	  Role	  of	  cohesin	  in	  gene	  expression	  	  	  
4.1	  Correlation	  of	  cohesin	  binding	  and	  gene	  expression	  
	   4.1.1.	  Overview	  	  	   In	  the	  previous	  chapter,	  we	  have	  shown	  that	  cohesin	  and	  CTCF	  co-­‐localise	  genome-­‐wide	   in	  mouse	   cells,	   that	   the	   binding	   of	   cohesin	   at	   some	   sites	   is	   shared	  across	  development	  but	  is	  also	  developmentally	  regulated	  at	  other	  sites.	  	  We	  have	  also	  seen	  that	  the	  number	  of	  cohesin	  sites	  is	  different	  between	  ES	  cells	  and	  pre-­‐B	  cells	  and	  wondered	  whether	  these	  differences	  were	  at	  the	  base	  of	  differential	  gene	  expression.	  In	  this	  sense,	  we	  have	  compared	  the	  binding	  sites	  of	  cohesin	  in	  ES	  cells	  and	  pre-­‐B	  cells	  with	  their	  gene	  expression	  patterns.	  We	  show	  here	  that	  genes	  that	  exhibit	  shared	  cohesin	  and	  CTCF	  sites	  between	  ES	  cells	  and	  pre-­‐B	  cells	  tend	  to	  be	  developmentally	   regulated.	   In	   addition,	   genes	   that	   contain	   cell-­‐type-­‐specific	  cohesin	  and	  CTCF	  peaks	  also	  tend	  to	  be	  developmentally	  regulated.	  We	  have	  used	  a	   genetic	   approach	   to	   efficiently	   deplete	   cohesin	   in	   ES	   cells	   in	   a	   short	   period	   of	  time	   and	   assess	   gene	   expression	   changes.	   Upon	   cohesin	   depletion	   in	   ES	   cells,	  hundreds	  of	   genes	  are	   significantly	  deregulated	  and	   tend	   to	  be	  bound	  by	   shared	  cohesin	   and	   CTCF	   sites	   as	   well	   as	   ES-­‐specific	   cohesin	   sites,	   but	   not	   with	   pre-­‐B-­‐specific	   cohesin	   sites.	   Moreover,	   gene	   expression	   changes	   using	   this	   genetic	  approach	  correlate	  better	  with	  binding	  of	  cohesin,	  Nipbl,	  mediator	  and	  RNA	  Pol	  II	  independently	   of	   CTCF,	   than	   gene	   expression	   changes	   upon	   knockdown	   of	   the	  cohesin	  subunit	  Smc1	  for	  an	  extended	  period	  of	  time	  (Kagey	  et	  al.	  2010).	  	  	  	  	   4.1.2.Genes	  with	  shared	  cohesin	  and	  CTCF	  sites	  tend	  to	  be	  	   	  
	   	   developmentally	  regulated	  	  	   Genome-­‐wide	  analysis	  in	  yeast	  of	  cohesin	  binding	  using	  ChIP-­‐on-­‐chip	  shows	  that	   cohesin	   tends	   to	   accumulate	   at	   intergenic	   regions	   between	   convergent	  transcription	   units	   as	   a	   result	   of	   the	   transcription	   machinery	   pushing	   cohesin	  along	   the	  DNA	   (Lengronne	   et	   al.	   2004;	   Glynn	   et	   al.	   2004).	   In	  mouse	   and	   human	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cells	  however,	  cohesin	  binding	  is	  compatible	  with	  gene	  transcription	  (Parelho	  et	  al.	  2008;	  Wendt	  et	  al.	  2008).	  For	   instance,	   it	  binds	  to	   the	   IFNG	  gene	  both	   in	  naïve	  T	  and	   TH1	   cells	   where	   the	   gene	   is	   silent	   and	   activated	   respectively	   (Hadjur	   et	   al.	  2009).	  Moreover,	  cohesin	  has	  been	  shown	  in	  ES	  cells	  to	  promote	  transcription	  of	  pluripotency-­‐associated	   genes,	   such	   as	   Oct4	   and	   Nanog	   (Kagey	   et	   al.	   2010;	  Nitzsche	   et	   al.	   2011).	  We	   set	   out	   to	   understand	   the	   relationship	   of	   the	   genome-­‐wide	  cohesin	  binding	  profile	  with	  gene	  expression.	  For	  this,	  we	  obtained	  in-­‐house	  ES	  cell	  gene	  expression	  data	  and	  publicly	  available	  pre-­‐B	  cell	  gene	  expression	  data	  (Krivtsov	   et	   al.	   2008)	   and	   used	   a	   gene-­‐centric	   approach	   to	   correlate	   gene	  expression	  with	  cohesin	  binding.	  We	  fix	  a	  gene	  and	  then	  assess	  the	  binding	  and	  the	  type	  of	  binding	  (shared,	  cell-­‐type-­‐specific,	  with	  or	  without	  CTCF)	  of	  cohesin	  in	  and	  10Kb	  upstream	  and	  downstream	  of	  the	  gene.	  One	  obvious	  reason	  for	  this	  is	  that	  by	  taking	  a	  gene-­‐centric	  point	  of	  view,	  we	  define	  peaks	  by	  being	  there	  or	  not.	  Had	  we	  taken	  a	  peak-­‐centric	  approach,	  the	  expression	  of	  the	  gene	  would	  have	  been	  more	  subjective	   as	   being	   ON	   or	   OFF,	   or	   low	   and	   highly	   expressed,	   etc.	   We	   firstly	  classified	  the	  number	  of	  genes	  on	  the	  Affymetrix	  arrays	  as	  containing	  ES	  and	  pre-­‐B	  cohesin	   and	   CTCF	   peaks	   (shared),	   ES-­‐specific	   cohesin	   and	   CTCF	   peaks,	   pre-­‐B-­‐specific	   cohesin	   and	   CTCF	   peaks,	   ES-­‐specific	   cohesin	   non-­‐CTCF	   peaks,	   pre-­‐B-­‐specific	  cohesin	  non-­‐CTCF	  peaks	  and	  finally	  shared	  cohesin	  non-­‐CTCF	  peaks,	  non	  exclusively	  (Table	  4.1).	  	  
	   	   	  









	  	   The	  distribution	  of	   the	  different	   types	  of	   cohesin	  peaks	  within	   these	  gene	  windows	  is	  represented	  in	  Figure	  4.1.	  As	  previously	  reported,	  cohesin	  peaks	  close	  to	  genes	  tend	  to	  accumulate	  nearer	  to	  genes	  (Parelho	  et	  al.	  2008).	  This	  is	  not	  the	  case	   with	   pre-­‐B	   specific	   cohesin	   non-­‐CTCF	   peaks	   and	   shared	   cohesin	   non-­‐CTCF	  peaks	   and	   might	   be	   due	   to	   the	   lower	   number	   of	   genes	   and	   thus	   not	   being	  statistically	  robust.	  In	  terms	  of	  localisation	  within	  genes,	  cohesin	  peaks	  accumulate	  more	  at	  introns.	  Possibly,	  this	  is	  due	  to	  introns	  being	  longer	  in	  average	  than	  exons.	  In	  conclusion,	  without	  taking	  into	  consideration	  the	  expression	  status	  of	  the	  gene,	  the	  frequency	  of	  cohesin	  peaks	  close	  to	  genes	  declines	  with	  distance	  from	  the	  gene.	  	  	  Shared	  cohesin	  and	  CTCF	  peaks	  
	  ES-­‐specific	  cohesin	  and	  CTCF	  peaks	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Pre-­‐B-­‐specific	  cohesin	  and	  CTCF	  peaks	  
	  ES-­‐specific	  cohesin	  non-­‐CTCF	  
Pre-­‐B-­‐specific	  cohesin	  non-­‐CTCF	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Shared	  cohesin	  non-­‐CTCF	  
	  




Figure	  4.2	  Genes	  with	  shared	  cohesin	  and	  CTCF	  peaks	  tend	  to	  be	  developmentally	  regulated.	  Density	  plot	  representing	  the	  density	  of	  genes	  with	  shared	  cohesin	  and	  CTCF	  peaks	  versus	  the	  rank	  of	  log2	  fold	  change	  between	  ES	  cells	  and	  pre-­‐B	  cells.	  All	  the	  remaining	  genes	  not	  containing	  shared	  cohesin	  and	  CTCF	  peaks	  are	  represented	  with	  the	  red	  curve.	  The	  values	  on	  the	  y-­‐axis	  can	  therefore	  be	  considered	  the	  frequency	  of	  genes	  with	  shared	  cohesin	  and	  CTCF	  peaks	  within	  a	  window	  along	  the	  ranks	  divided	  by	  the	  total	  number	  of	  genes	  within	  that	  window.	  Considering	  the	  surrounding	  windows	  along	  the	  x-­‐axis	  smoothes	  the	  curve.	  	  	  	   We	   performed	   a	   Kolmogorov-­‐Smirnov	   (KS)	   test	   to	   evaluate	   whether	   the	  difference	  between	  a	  set	  of	  genes	  with	  a	  certain	  type	  of	  cohesin	  peak	  and	  a	  set	  with	  the	  remaining	  genes	   is	  significant.	  A	  KS	  test	  determines	   if	   the	  two	  datasets	  differ	  significantly.	   We	   obtain	   a	   p-­‐value	   that	   if	   greater	   than	   0.05,	   means	   the	   null	  hypothesis	  (that	  is	  “there	  is	  no	  difference	  between	  our	  data	  set	  and	  the	  remaining	  gene	  dataset”)	  is	  valid.	  If	  the	  p-­‐value	  is	  lower	  than	  0.05,	  there	  is	  a	  difference	  with	  the	  remaining	  gene	  dataset	  and	  thus	  an	  enrichment	  of	  those	  genes	  with	  a	  certain	  type	  of	  cohesin	  peak	  compared	  to	  the	  remaining	  genes.	  Again,	  all	  genes	  with	  peaks	  were	  ranked	  by	  log2	  fold	  change	  in	  expression	  and	  the	  distribution	  of	  genes	  with	  shared	   cohesin	   and	   CTCF	   peaks	   was	   compared	   with	   the	   distribution	   of	   the	  remaining	   genes.	   In	   agreement	   with	   the	   density	   plots,	   we	   observe	   a	   significant	  correlation	   of	   shared	   cohesin	   and	   CTCF	   peaked	   genes	   with	   genes	   being	   more	  expressed	  in	  ES	  cells	  or	  in	  pre-­‐B	  cells,	  3.35x10-­‐05	  and	  0.00099	  respectively	  (Table	  4.2)	  In	  conclusion,	  genes	  that	  have	  shared	  cohesin	  and	  CTCF	  sites	  will	   tend	  to	  be	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developmentally	   regulated.	   This	   indicates	   that	   the	   presence	   of	   a	   shared	   cohesin	  and	   CTCF	   peak	   does	   not	   dictate	  whether	   the	   neighbouring	   gene	   is	   expressed	   or	  not.	  	  	  	  	  	  
	  
Table	  4.2	  Significant	  correlation	  of	  shared	  cohesin	  and	  CTCF	  peaked	  genes	  with	  genes	  being	  
more	  expressed	  in	  ES	  cells	  or	  in	  pre-­B	  cells.	  KS	  test	  of	  genes	  bound	  by	  shared	  cohesin	  and	  CTCF	  peaks	  with	  genes	  showing	  a	  greater	  expression	  in	  ES	  cells	  compared	  to	  pre-­‐B	  cells	  and	  vice	  versa.	  	  	  	   4.1.3.	  Genes	  with	  cell-­type-­specific	  cohesin	  sites	  tend	  to	  be	  	   	  
	   	   developmentally	  regulated	  	  	  	   With	  regards	  to	  genes	  with	  cell-­‐type-­‐specific	  cohesin	  and	  CTCF	  peaks,	  there	  is	   a	   clear	   correlation	  between	  binding	   and	  gene	  expression	   (Figure	  4.3.a).	  Genes	  with	  ES-­‐specific	  cohesin	  and	  CTCF	  peaks	  will	  tend	  to	  be	  more	  expressed	  in	  ES	  cells.	  On	  the	  other	  hand,	  genes	  with	  pre-­‐B	  specific	  cohesin	  and	  CTCF	  peaks	  will	  tend	  to	  be	  more	  expressed	  in	  pre-­‐B	  cells.	  There	  is	  a	  clear	  positive	  correlation	  of	  cell-­‐type-­‐specific	  cohesin	  and	  CTCF	  peaks	  with	  gene	  expression,	  suggesting	  a	  possible	  role	  of	  cohesin	  and	  CTCF	  in	  driving	  their	  expression.	  In	  relationship	  to	  cell-­‐type-­‐specific	  cohesin	   non-­‐CTCF	   peaks,	   there	   is	   a	   tendency	   of	   these	   genes	   to	   be	   differentially	  expressed	  (Figure	  4.3.b).	  Genes	  with	  ES-­‐specific	  cohesin	  non-­‐CTCF	  peaks	  will	  tend	  to	  be	  more	  expressed	  in	  ES	  cells	  compared	  to	  pre-­‐B	  cells,	  whereas	  genes	  with	  pre-­‐B-­‐specific	  cohesin	  non-­‐CTCF	  peaks	  will	   tend	  to	  be	  more	  expressed	   in	  pre-­‐B	  cells,	  again	   hinting	   to	   a	   possible	   role	   of	   cohesin	   non-­‐CTCF	   peaks	   in	   the	   positive	  regulation	  of	  developmentally	  regulated	  genes.	  	  	  	  
Type	  of	  peak	  
p-­value	  




genes	  with	  lower	  
expression	  
	  (pre-­B>ES)	  





Figure	  4.3	  Genes	  with	  cell-­type-­specific	  cohesin	  and	  CTCF	  peaks	  or	  cohesin	  non-­CTCF	  peaks	  
are	  cell-­type-­specifically	  expressed.	  
a.	   Density	   plot	   of	   genes	   with	   ES-­‐specific	   cohesin	   and	   CTCF	   peaks	   (black)	   or	   with	   pre-­‐B-­‐specific	  cohesin	   and	  CTCF	  peaks	   (red).	   b.	  Density	  plot	   of	   genes	  with	  ES-­‐specific	   cohesin	  non-­‐CTCF	  peaks	  (black)	  or	  with	  pre-­‐B-­‐specific	  cohesin	  non-­‐CTCF	  peaks	  (red).	  	  	   Subsequently,	   we	   performed	   a	   KS	   test	   on	   genes	   with	   cell-­‐type-­‐specific	  cohesin	   and	   CTCF	   peaks,	   cell-­‐type-­‐specific	   cohesin	   non-­‐CTCF	   peaks	   and	   shared	  cohesin	  non-­‐CTCF	  peaks.	  Indeed,	  the	  correlation	  of	  genes	  with	  ES-­‐specific	  cohesin	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and	   CTCF	   peaks	  with	   genes	   being	  more	   expressed	   in	   ES	   cells	   is	   very	   strong	   (p-­‐value=3.89E-­‐14)	  and	  does	  not	  correlate	  at	  all	  with	  genes	  being	  more	  expressed	  in	  pre-­‐B	  cells	  (p-­‐value=1)(Table	  4.3).	  Pre-­‐B-­‐specific	  cohesin	  and	  CTCF	  peaked	  genes	  and	  genes	  being	  more	  expressed	  in	  pre-­‐B	  cells	  also	  show	  a	  strong	  correlation	  (p-­‐value=2.20E-­‐16),	   but	   not	   with	   genes	   that	   are	   more	   expressed	   in	   ES	   cells	   (p-­‐value=1).	  In	  summary,	  cell-­‐type-­‐specific	  cohesin	  non-­‐CTCF	  peaked	  genes	  correlate	  with	   developmentally	   regulated	   genes.	   On	   the	   other	   hand,	   shared	   cohesin	   non-­‐CTCF	  peaked	  genes	  do	  not	  show	  correlation	  with	  genes	  being	  more	  expressed	   in	  ES	  cells	  or	   in	  pre-­‐B	  cells.	  Again,	   this	  might	  be	  due	  to	  the	   low	  number	  of	  genes	   in	  this	  subset.	  	   	  	  
Type	  of	  peak	  
p-­value	  	  




genes	  with	  lower	  
expression	  	  
	  (pre-­B>ES)	  
ES-­specific	  coh+CTCF	   3.89E-­‐14	   1	  
pre-­B-­specific	  coh+CTCF	   1	   2.20E-­‐16	  
ES-­specific	  coh	  non-­CTCF	   3.91E-­‐07	   0.9987	  
pre-­B-­specific	  coh	  non-­CTCF	   0.9548	   4.25E-­‐05	  
Shared	  coh	  non-­CTCF	   0.6781	   0.1592	  
	  
Table	   4.3	   Significant	   correlations	   of	   cell-­type-­specific	   cohesin	   peaks	   with	   genes	   more	  
expressed	  in	  ES	  cells	  or	  in	  pre-­B	  cells.	  KS	  test	  correlating	  the	  different	  cell-­‐type-­‐specific	  cohesin	  peaks	  with	  genes	  more	  expressed	  in	  ES	  cells	  or	  in	  pre-­‐B	  cells.	  P-­‐values	  are	  shown.	  	  	  	   4.1.4.	  Usage	  of	  a	  genetic	  approach	  to	  rapidly	  deplete	  cohesin	  in	  ES	  cells	  
	   	   results	  in	  misregulation	  of	  hundreds	  of	  genes.	  
	  	   ES	   cells	   exhibit	   a	   shorter	   cell	   cycle	   compared	   to	   differentiated	   cells.	   As	  cohesin	   is	   essential	   for	   proper	   chromatid	   cohesion	   and	  DNA	   repair,	   depletion	   of	  cohesin	   in	  cycling	  cells	  will	   cause	  cellular	   stress	  and	  be	  deleterious	   for	   cell	   cycle	  progression	  and	  survival.	  Moreover,	  RNAi-­‐mediated	  knockdowns	  of	  an	  mRNA	  can	  have	  non-­‐target	  effects.	  With	  this	  in	  mind,	  in	  order	  to	  get	  a	  clear	  picture	  of	  which	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genes	  are	  regulated	  by	  cohesin	  in	  ES	  cells,	  we	  took	  advantage	  of	  Rad21	  conditional	  knockout	   ES	   cells	   derived	   in	   the	   laboratory.	   This	   tool	   allows	   us	   to	   deplete	   the	  levels	  of	   cohesin	   in	  ES	   cells	  within	  a	   short	   time	   frame,	   avoiding	   cell	   cycle	  effects	  and	   cellular	   stress.	   Deleting	   a	   single	   gene	   is	   also	   more	   targeted	   than	   an	   RNAi-­‐mediated	  knockdown.	  	   Kim	  Nasmyth	   provided	   us	  with	   a	  Rad21lox	   allele	   in	  which	   loxP	   sites	   flank	  exons	  5	  and	  6	  of	  Rad21.	  Rad21	  conditional	  knockout	  ES	  cells	  were	  derived	   from	  mice	   in	  N2B27	  +	  2i	   conditions	   (Ying	  et	  al.	  2008).	  Two	   lox/lox	   female	  clones	  and	  four	  male	  clones,	  positive	  for	  Cre	  recombinase	  fused	  to	  the	  ligand-­‐binding	  domain	  of	   estrogen	   receptor	   (Rad21lox/lox,	   ERt2-­Cre	   +),	   were	   isolated.	   Upon	   addition	   of	  4’OHT	   to	   the	   medium,	   the	   ERt2-­‐fused	   Cre	   will	   translocate	   to	   the	   nucleus	   and	  recombine	  the	  loxP	  sites.	  Recombination	  of	  the	  loxP	  sites	  will	  excise	  exons	  5	  and	  6	  of	   the	   cohesin	   subunit	   Rad21,	   introduce	   STOP	   codons	   and	   result	   in	   decreased	  Rad21	   protein	   levels.	   Three	   wild-­‐type	   female	   clones,	   positive	   for	   ERt2-­‐Cre	  (Rad21wt/wt,	   ERt2-­Cre	   +),	   were	   also	   isolated.	   These	   will	   control	   for	   the	   effect	   of	  4’OHT	  on	   the	  cells.	  Cells	  untreated	  with	  4’OHT	  are	   treated	  with	  EtOH,	   the	  4’OHT	  carrier.	  	   We	  have	   characterised	   different	   time	  points	   of	   4’-­‐OHT	   treatment	   so	   as	   to	  maximise	   the	   reduction	   of	   Rad21	   levels	   without	   compromising	   cell	   cycle	  progression	  and	  inducing	  stress-­‐related	  responses.	  Figure	  4.4.a	  shows	  the	  protein	  levels	  of	  Rad21	  after	  4’OHT	  for	  24h,	  36h	  and	  48h.	  24h	  of	  4’OHT	  treatment	  reduces	  Rad21	  protein	   levels	  by	  80%.	  By	  48h,	  Rad21	  protein	   levels	  are	  reduced	  by	  95%.	  The	   cell	   cycle	   profile	   of	   4’OHT-­‐treated	   and	   untreated	  Rad21lox/lox	   and	  Rad21wt/wt	  cells	  was	   assessed	   by	   PI	   staining.	  Rad21lox/lox	   cells	   strongly	   accumulate	   in	   G2/M	  phase	  after	  48h	  of	  4’OHT	  treatment	  (Figure	  4.4.b).	  This	  is	  not	  4’OHT	  related	  since	  
Rad21wt/wt	   cells	   show	   a	   normal	   PI	   profile.	   This	   tendency	   to	   accumulate	   already	  appears	   at	   36h,	   whereas	   at	   24h	   of	   4’OHT	   treatment,	   the	   cell	   cycle	   profile	   is	  indistinguishable	   from	   the	   control	   cells’	   profile.	   In	   conclusion,	   substantial	  depletion	  of	  cohesin	  for	  24h	  does	  not	  modify	  the	  cell	  cycle	  profile	  of	  ES	  cells.	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Figure	  4.4	  Fast	  depletion	  of	  Rad21	  after	  24h	  treatment	  of	  Rad21lox/lox	  ERt2-­Cre	  with	  4’OHT.	  




































































of	   half	   of	   the	   cell	   population.	   Comparatively,	   treatment	   for	   24h	   reduces	   Rad21	  protein	   levels	   by	   80%,	   does	   not	   result	   in	   a	   clear	   cell	   stress	   response,	   does	   not	  change	  the	  cell	  cycle	  profile	  and	  is	  accompanied	  by	  little	  cell	  death.	  This	  prompted	  us	   to	   use	   24h	   of	   4’OHT	   treatment	   to	   significantly	   deplete	   Rad21	   in	   cycling	  
Rad21lox/lox	  ES	  cells.	  	   We	   efficiently	   deleted	   Rad21	   from	   three	   biological	   replicates	   of	   ES	   cells	  after	   24h	   of	   4’OHT	   treatment,	   extracted	   RNA	   and	   prepared	   the	   samples	   for	  hybridisation	   on	   an	   Affymetrix	   microarray.	   Three	   biological	   replicates	   of	  
Rad21wt/wt	   ERt2Cre-­‐positive	   ES	   cells	   were	   treated	   with	   4’OHT	   for	   24h.	   Out	   of	  18,905	  genes	  present	  in	  the	  microarray	  dataset,	  598	  are	  significantly	  (adjusted	  p-­‐value<0.05,	   Benjamini-­‐Hochberg)	   and	   differentially	   expressed	   upon	   cohesin	  depletion	   in	   ES	   cells.	   Out	   of	   those,	   247	   are	   upregulated,	   whereas	   341	   are	  downregulated	  (including	  Rad21,	  Figure	  4.5).	  	  	  	   	   	   	  
	  
Figure	  4.5	  Log2	  Fold	  Change	  distribution	  of	  significantly	  differentially	  expressed	  genes	  upon	  

























































	   Table	  4.4	  shows	  the	  number	  of	  differentially	  expressed	  genes	  that	  exhibit	  a	  certain	  type	  of	  peak.	  We	  then	  calculated	  the	  odds	  ratio	  or	  degree	  of	  enrichment	  of	  differentially	   expressed	   genes	   with	   a	   certain	   type	   of	   peak	   among	   the	   pool	   of	  differentially	   expressed	   genes	   compared	   to	   the	   number	   of	   genes	   with	   a	   certain	  type	  of	  peak	  among	  the	  total	  number	  of	  genes	  on	  the	  microarray.	  The	  odds	  ratio	  for	  differentially	  expressed	  genes	  with	  shared	  cohesin	  and	  CTCF	  peaks	  is	  1.47	  and	  significant,	   p-­‐value=1.11x10-­‐06	   (Table	   4.4).	   In	   addition,	   the	   odds	   ratio	   for	  differentially	  expressed	  genes	  with	  ES-­‐specific	  cohesin	  and	  CTCF	  peaks	   is	  1.5423	  and	   significant,	   p-­‐value=7.05x10-­‐07.	   Moreover,	   the	   odds	   ratio	   for	   differentially	  expressed	  genes	  with	  ES-­‐specific	  cohesin	  non-­‐CTCF	  peaks	   is	  highest,	  2.0331,	  and	  highly	   significant,	   p-­‐value=6.75x10-­‐09.	   However,	   the	   odds	   for	   differentially	  expressed	   genes	   with	   pre-­‐B-­‐specific	   cohesin	   and	   CTCF	   peaks	   and	   pre-­‐B-­‐specific	  cohesin	  non-­‐CTCF	  peaks	  are	  not	  significant	  (0.0937	  and	  0.2699	  respectively).	  The	  differentially	  expressed	  genes	  are	  enriched	   for	  genes	   that	  exhibit	   shared	  cohesin	  and	  CTCF,	  ES-­‐specific	  cohesin	  and	  CTCF	  and	  ES-­‐specific	  cohesin	  non-­‐CTCF	  peaks.	  	  	  






Odds	   p-­value	  
Shared	  coh+CTCF	   7884	   292	   1.4736	   1.11E-­‐06	  
ES-­specific	  coh+CTCF	   4445	   183	   1.5423	   7.05E-­‐07	  
pre-­B-­specific	  coh+CTCF	   862	   32	   1.2473	   0.093667653	  
ES-­specific	  coh	  non-­CTCF	   1465	   83	   2.0331	   6.75E-­‐09	  
pre-­B-­specific	  coh	  non-­
CTCF	   263	   9	   1.1392	   0.269945797	  
Shared	  coh	  non-­CTCF	   243	   8	   1.0952	   0.310559051	  
	  
Table	   4.4	   Correlation	   of	   differentially	   expressed	   genes	   upon	   cohesin	   depletion	   in	   ES	   cells	  
and	  types	  of	  cohesin	  peak.	  The	  number	  of	  peaked	  genes,	  differentially	  expressed	  genes	  with	  peaks,	  odds	  ratios	  and	  associated	  p-­‐values	  are	  shown.	  P-­‐values	  have	  been	  obtained	  using	  a	  hypergeometric	  test.	  	  	  	   Kagey	   and	   colleagues	   evaluated	   gene	   expression	   changes	   in	  ES	   cells	   upon	  shRNA-­‐mediated	  depletion	  of	  Smc1	  for	  five	  days	  (Kagey	  et	  al.	  2010).	  Since	  cohesin	  is	   essential	   for	   cell	   cycle	   progression,	   depletion	   of	   cohesin	   for	   such	   an	   extended	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period	  of	   time	  will	   significantly	   affect	   the	   survival	   of	   cells	   and	  will	   have	   indirect	  effects	   on	   gene	   expression.	   We	   assessed	   whether	   the	   genetic	   approach	   that	   we	  have	   taken	   with	   fast	   depletion	   of	   Rad21	   for	   24h	   correlates	   better	   with	   cohesin	  binding	  than	  the	  Kagey	  approach.	  Since	  the	  authors	  describe	  a	  correlation	  between	  cohesin,	   Nipbl,	   mediator	   and	   active	   genes	   (RNA	   Pol	   II)	   and	   we	   define	   cohesin	  binding	   as	   being	   just	   non-­‐CTCF,	   we	   compared	   our	   microarray	   dataset	   and	   the	  Kagey	   microarray	   dataset	   with	   the	   cohesin	   non-­‐CTCF	   binding	   defined	   by	   them:	  Smc1/Nibpl/Med12/Pol	  II.	  For	  this,	  we	  ranked	  all	  genes	  in	  our	  microarray	  or	  the	  Kagey	   microarray	   by	   p-­‐value	   and	   plotted	   the	   density	   of	   genes	   bound	   by	  Smc1/Nipbl/Med12/Pol	   II	  within	  windows	  of	  p-­‐values	  (Figure	  4.6.a).	  Genes	  with	  lowest	  p-­‐values	  in	  our	  microarray	  dataset	  (in	  red),	  and	  thus	  with	  highly	  significant	  changes,	  seem	  to	  be	  more	  enriched	  for	  genes	  bound	  by	  Smc1/Nipbl/Med12/Pol	  II	  compared	   to	   their	  dataset	   (in	  green).	   Indeed,	  we	  assessed	   the	  significance	  of	   the	  correlation	   between	   the	   two	   microarray	   datasets	   and	   genes	   bound	   by	  Smc1/Nipbl/Med12/Pol	  II	  and	  found	  that	  our	  microarray	  dataset	  correlates	  better	  (4.44x10-­‐50,	  Wilcoxon	  Gene	  Set	  Test)	  with	  genes	  bound	  by	  Smc1/Nipbl/Med12/Pol	  II	   than	   the	  Kagey	  microarray	  dataset	   (5.69x10-­‐38,	  Wilcoxon	  Gene	  Set	  Test,	  Figure	  4.6.b).	  	  	   Furthermore,	  not	  all	  Smc1/Nipbl/Med12	  sites	  are	  RNA	  Pol	   II	  positive.	  Out	  of	   4,591	   genes	   that	   are	   bound	   by	   Smc1/Nipbl/Med12,	   3,078	   are	   RNA	   Pol	   II	  positive	  (which	  differs	  from	  the	  published	  2,700	  genes	  presumably	  due	  to	  different	  gene	  databases)	  and	  1,513	  are	  RNA	  Pol	  II	  negative.	  If	  we	  plot	  the	  genes	  bound	  by	  Smc1/Nipbl/Med12	  but	  not	  RNA	  Pol	  II	  (that	  is,	  presumably	  inactive	  genes)	  versus	  the	   rank	   of	   p-­‐values	   of	   all	   genes	   in	   the	   two	   microarrays,	   these	   genes	   tend	   to	  slightly	   correlate	  with	   genes	   that	   highly	   significantly	   change	   in	   both	  microarray	  datasets	  (Figure	  4.6.c).	  However,	  they	  are	  scattered	  across	  most	  of	  the	  rank	  of	  p-­‐values,	   suggesting	   that	   upon	   cohesin	   removal,	   in	   general	   terms,	   their	   expression	  changes	   are	   not	   significant	   and	   thus	   that	   this	   subset	   of	   peaks	   are	   not	   always	  involved	  in	  transcriptional	  regulation	  in	  ES	  cells.	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Figure	  4.6	  Our	  microarray	  dataset	  correlates	  better	  than	  the	  Kagey	  microarray	  dataset	  with	  
genes	  bound	  by	  Smc1/Nipbl/Med12	  and	  RNA	  Pol	  II.	  


























































	   We	   then	   assessed	   whether	   the	   genes	   that	   are	   not	   bound	   by	  Smc1/Nipbl/Med12/Pol	  II	  but	  are	  only	  bound	  by	  Rad21	  and	  CTCF	  correlate	  with	  gene	   expression	   changes	   in	   our	   microarray	   and	   the	   Kagey	   microarray.	   Both	  density	  plots	   look	  similar	  and	  there	   is	  no	  enrichment	   for	  any	  specific	  range	  of	  p-­‐values	  (Figure	  4.7),	  suggesting	  that	  the	  sole	  binding	  of	  Rad21	  and	  CTCF	  peaks	  do	  not	  define	  genes	  that	  will	  change	  upon	  cohesin	  depletion	  and	  therefore	  suggesting	  that	   cohesin	   binding	   with	   CTCF	   does	   not	   always	   have	   to	   be	   involved	   in	  transcriptional	  regulation	  of	  gene	  expression.	  
	   	   	  
Figure	   4.7	   No	   correlation	   between	   genes	   with	   cohesin	   and	   CTCF	   peaks	   and	   expression-­























in	   cell	  differentiation	  and	  development.	  We	  calculated	   the	  p-­‐values	  associated	   to	  GO	   TERMS	   within	   the	   microarrays	   and	   observed	   that	   the	   GO	   TERMS	   for	   genes	  involved	   in	   developmental	   processes,	   anatomical	   structure	   development	   and	  multicellular	  organismal	  development,	  among	  others,	  are	  highly	  significant	  in	  the	  Smc1	  shRNA	  dataset	  compared	  to	  our	  Rad21-­‐/-­‐	  dataset	  (Figure	  4.8).	  This	  was	  also	  clear	   when	   we	   only	   considered	   genes	   that	   change	   in	   all	   three	   Smc1,	   Nipbl	   and	  Med12	  shRNA	  datasets.	  Moreover,	  these	  GO	  TERMS	  are	  not	  as	  significant	  when	  we	  consider	  only	  the	  genes	  bound	  by	  Smc1/Nipbl/Med12	  and	  RNA	  Pol	  II	  and	  change	  in	   the	   Smc1	   shRNA	   dataset,	   suggesting	   that	   the	   gene	   expression	   changes	  associated	  with	  several	  processes	  in	  development	  are	  not	  directly	  due	  to	  cohesin	  removal.	   However,	   some	   developmental	   processes,	   such	   as	   embryonic	   organ	  development,	  stem	  cell	  differentiation	  are	  slightly	  more	  significant	   in	  our	  dataset	  compared	   to	   the	   Kagey	   dataset.	   Moreover,	   gene	   expression	   changes	   of	   genes	  within	   DNA	   repair	   pathways	   and	   cell	   stress	   related	   responses	   are	   clearly	   more	  significant	   in	   the	   Smc1	   shRNA	   dataset	   compared	   to	   our	   Rad21-­‐/-­‐	   dataset	   or	   the	  Smc1	   shRNA	   dataset	   with	   only	   the	   Smc1/Nipbl/Med12	   and	   RNA	   Pol	   II	   peaked	  genes	  (Figure	  4.8).	  Furthermore,	  ES	  cells	  subject	  to	  stress	  will	  tend	  to	  differentiate	  (T.	   Lin	   et	   al.	   2005).	   In	   this	   sense,	   activation	   of	   cell-­‐stress	   related	   responses	  will	  again	   bias	   the	   gene	   expression	   changes	   analysis	   towards	   genes	   expressed	   in	  differentiated	   cells.	   The	   knock	   down	   strategy	   for	   five	   days	   generates	   gene	  expression	   changes	   that	   are	   not	   directly	   cohesin-­‐driven.	   Altogether,	   we	   believe	  that	   the	   24h	   Rad21	   conditional	   knockout	   strategy	   is	   more	   sensible	   in	  understanding	  the	  role	  of	  cohesin	  in	  regulating	  gene	  expression	  in	  ES	  cells.	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Figure	   4.8	   The	   Kagey	  microarray	   dataset	   is	   enriched	   for	   developmental,	   DNA	   repair	   and	  
cellular	  stress	  processes,	  although	  they	  are	  not	  directly	  cohesin-­dependent.	  Heat	  map	  shows	  –	  Log10	  of	  the	  p-­‐values	  for	  each	  GO	  TERM	  within	  the	  different	  datasets,	  with	  0.0	  	  (blue)	  being	  not	  significant	  and	  9.0	  (yellow),	  being	  highly	  significant.	  P-­‐values	  have	  been	  obtained	  with	  a	  Fisher	   test.	  The	  different	  datasets	  are	  genes	  significantly	  changing	   in	  Smc1	  shRNA	  dataset	  (p-­‐value<0.01,	   1st	   column),	   genes	   significantly	   changing	   in	   the	   Smc1,	   Nipbl	   and	   Med12	   shRNA	  datasets	   (p-­‐value<0.01,	   2nd	   column),	   genes	   significantly	   changing	   in	   our	   Rad21-­‐/-­‐	   dataset	   (adj.	   p-­‐value<0.05,	   Benjamini-­‐Hochberg,	   3rd	   column)	   and	   genes	   bound	   by	   Smc1/Nipbl/Med12	   and	   RNA	  Pol	  II	  and	  significantly	  changing	  in	  the	  Smc1	  shRNA	  dataset	  (p-­‐value<0.01,	  last	  column).	  	  	  
4.2.	  Cohesin	  regulates	  Tcrα 	  rearrangement	  and	  thymocyte	  differentiation.	  	  	   I	   collaborated	   with	   Thais	   Lavagnolli,	   PhD	   student,	   in	   the	   project	   of	   Vlad	  Seitan,	  PostDoc	   in	   the	   laboratory,	  and	  Matthias	  Merkenschlager	  about	   the	  role	  of	  cohesin	  in	  Tcrα	  rearrangement	  and	  T	  cell	  differentiation	  (Seitan	  et	  al.	  2011).	  	   Thymocytes	   cycle	   during	   the	   late	   double	   negative	   (DN)	   stage	   and	   arrest	  shortly	  after	  they	  start	  expressing	  the	  CD4	  and	  CD8	  cell-­‐surface	  markers	  and	  lose	  expression	   of	   the	   transferrin	   receptor	   CD71	   (Figure	   4.10.a).	   They	   have	   become	  small	  CD4+CD8+	  double	  positive	   (DP)	   thymocytes	  and	  undergo	  several	   rounds	  of	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SP)	  and	  CD4-­‐CD8+	   single	  positive	   (CD8	  SP)	   thymocytes,	   all	   this	  with	  minimal	   cell	  division	   (Figure.4.10.a).	  Non-­‐proliferating	   thymocytes	   constitute	   a	   system	  where	  to	  study	  the	  role	  of	  cohesin	  in	  gene	  regulation,	  avoiding	  side	  effects	  in	  mitosis	  due	  to	   cohesin	   depletion.	   We	   were	   interested	   in	   understanding	   if	   and	   how	   cohesin	  regulates	  differentiation	  of	  thymocytes.	  	   In	  order	  to	  investigate	  the	  role	  of	  cohesin	  in	  Tcrα	  rearrangement,	  Thais	  and	  I	   mapped	   cohesin	   binding	   sites	   genome-­‐wide	   in	   CD4+CD8+	   DP	   thymocytes.	   We	  obtained	  thymocytes	  from	  a	  3.5-­‐week-­‐old	  MHC	  class	  II	  knockout	  male	  mouse.	  The	  thymocyte	  population	  in	  MHC	  class	  II	  knockout	  mice	  is	  highly	  enriched	  (>90%)	  in	  CD4+CD8+	   DP	   cells.	   We	   extracted	   chromatin,	   performed	   the	   Rad21	   ChIP	   and	  created	   a	   ChIP-­‐seq	   library	   that	   was	   subsequently	   sequenced.	   In	   this	   way,	   using	  FindPeaks,	   CD4+CD8+	   DP	   thymocytes	   exhibit	   around	   43,000	   peaks	   of	   cohesin	  (Figure	   4.9.a),	   of	   which	   25,258	   are	   shared	   with	   ES	   cells	   and	   17,889	   with	   pre-­‐B	  cells,	   showing	   again	   clear	   distinctions	   in	   the	   cohesin	   binding	   profiles	   between	  different	   cell	   types.	   Moreover,	   ChIP-­‐seq	   revealed	   that	   cohesin	   binds	   to	   key	  positions	  of	  the	  Tcrα	  locus.	  It	  strongly	  binds	  the	  locus	  between	  the	  Tcrα	  enhancer,	  Ea,	  and	  the	  housekeeping	  gene	  Dad1	  (Figure	  4.9.b).	  This	  position	  is	  critical	  as	  it	  has	  been	   described	   to	   have	   insulator	   functions	   (Zhong	   et	   al.	   1999;	   Magdinier	   et	   al.	  2004).	   In	   addition,	   it	   also	   separates	   the	   Tcrα	   TEA	   promoter	   from	   the	   Tcrd	  enhancer,	  Ed.	  The	  Ed	  enhancer	  controls	  the	  expression	  of	  the	  Tcrd	  locus,	  which	  is	  embedded	   within	   the	   Tcrα	   locus	   and	   is	   expressed	   at	   a	   different	   developmental	  stage.	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Figure	  4.9.	  Rad21	  binding	  profile	  in	  CD4+CD8+	  DP	  thymocytes.	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   b.	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Figure	  4.10	  Rad21	  conditional	  knockout	  thymocyte	  system.	  



























































































































	  	   Analysis	   of	   RNA	   transcripts	   coming	   from	   the	   Tcrα	   region	   using	   RNA-­‐seq	  showed	  that	  distal	  (3’)	  Ja	  elements	  were	  preferentially	  transcribed	  in	  control	  cells	  while	  proximal	   (5’)	  elements	  were	  preferentially	   transcribed	   in	  cohesin-­‐depleted	  cells.	   This	   correlated	  with	   lower	   levels	   of	   H3K4me3	   at	   distal	   Ja	   elements,	   again	  correlating	  with	  defective	   recruitment	  of	  Rag1	  and	  Rag2,	   recombinases	  essential	  for	  rearrangement.	  Furthermore,	  rearrangement	  of	  the	  distal	  Ja	  elements	  in	  small	  CD4Cre	   Rad21lox/lox	   CD4+CD8+	   DP	   thymocytes	   was	   impaired,	   resulting	   in	   lower	  copy	   number	   of	   spliced	   transcripts	   spanning	   distal	   Ja	   elements	   and	   the	   Tcrα	  constant	   region	   Ca.	   Altered	   transcription	   across	   the	   region	   was	   due	   to	   cohesin	  depletion	   and	   not	   due	   to	   defective	   rearrangement	   due	   to	   lower	   Rag1	   and	   Rag2	  recruitment	  since	  Rag1-­‐deficient	  CD4-­‐Cre	  Rad21lox/lox	  thymocytes	  at	  the	  CD4+CD8+	  DP	  stage	  also	   showed	  defective	   transcription	  across	   the	   locus.	   Indeed,	   cohesin	   is	  essential	  for	  transcription	  as	  cohesin	  depletion	  in	  CD4+CD8+	  DP	  thymocytes	  leads	  to	  reduced	  interactions	  between	  the	  Ea	  enhancer	  and	  the	  TEA	  promoter,	  similar	  to	  pre-­‐B	  cells	  were	  the	  locus	  is	  transcriptionally	  silent.	  The	  aberrant	  rearrangement	  of	   the	  Tcrα	   locus	   is	   causally	   linked	   to	   inefficient	  differentiation	  as	  provision	  of	   a	  transgenic	   rearranged	   TCR	   to	   CD4+CD8+	   DP	   thymocytes	   partially	   rescues	   it.	   In	  summary	   cohesin	   is	   important	   for	   long-­‐range	   interactions	   between	   regulatory	  regions	   of	   the	   Tcrα	   locus	   that	   are	   essential	   for	   proper	   transcription	   across	   the	  locus,	   proper	   deposition	   of	   H3K4me3	   and	   subsequent	   recruitment	   of	   Rag	  recombinases,	   proper	   Tcrα	   rearrangement	   and	   ultimately	   thymocyte	  differentiation.	  	  	  
4.3.	  The	  role	  of	  cohesin	  in	  different	  stages	  of	  XCI.	  	   4.3.1.	  Overview	  	  	   The	   involvement	   of	   CTCF	   in	   XCI	   and	   CTCF	   binding	   sites	   in	   Xist	   and	   Tsix,	  major	  players	  of	  XCI,	  have	  been	  described	  (Chao	  et	  al.	  2002;	  Pugacheva	  et	  al.	  2005;	  Donohoe	  et	  al.	  2007;	  Navarro	  et	  al.	  2006).	  Donohoe	  et	  al.	  report	  that	  CTCF	  down-­‐regulation	   in	  male	   differentiating	   ES	   cells	   produces	   an	   up-­‐regulation	   of	  Xist	   and	  down-­‐regulation	   of	  Tsix	   (Donohoe	   et	   al.	   2007).	   Down-­‐regulation	   of	   CTCF	   affects	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pairing	   of	   the	   X	   chromosomes	   at	   the	   onset	   of	   XCI	   (Donohoe	   et	   al.	   2009).	   In	  addition,	  CTCF	  has	  been	  postulated	  to	  act	  as	  a	  chromatin	  barrier	  at	   the	  5’	  end	  of	  escapees,	  such	  as	  Kdm5c	  and	  Eif2s3x,	  when	  adjacent	   to	   inactivated	  genes	  but	  not	  when	  the	  escapees	  are	  embedded	  in	  large	  escape	  domains	  (Galina	  N.	  Filippova	  et	  al.	  2005).	  Since	  cohesins	  are	  linked	  to	  CTCF,	  we	  wanted	  to	  understand	  the	  role	  of	  cohesin	  in	  XCI,	  studying	  its	  function	  in	  the	  early	  stages	  of	  XCI,	  in	  terms	  of	  Xist,	  Tsix	  and	  the	  Xist	  activator	  Rnf12	  expression,	  and	  also	   in	  the	  segregation	  of	   facultative	  heterochromatin	   from	   euchromatic	   areas	   on	   the	   Xi.	   Male	   and	   female	   Rad21	  conditional	  knockout	  ES	  cells	  provided	  us	  with	  the	  necessary	  tools	  to	  answer	  these	  questions.	  We	  present	  evidence	  that	  cohesin	  regulates	  the	  expression	  of	  Rnf12	  in	  ES	  cells	  and	  possibly	  indirectly	  Xist.	  On	  the	  contrary,	  cohesin	  is	  not	  important	  for	  Rnf12	  expression	  in	  early	  differentiating	  ES	  cells	  but	  is	  for	  Xist	  expression.	  We	  also	  present	   evidence	   suggesting	   the	   importance	   of	   cohesin	   for	   proper	   chromosome-­‐wide	  gene	  expression	  inactivation	  on	  the	  Xi.	  	  	  	   4.3.2.	  CTCF	  and	  cohesin	  regulation	  of	  XCI	  players	  	   	   	   In	  male	  and	  female	  ES	  cells	  	  	   We	  set	  out	  to	  investigate	  the	  role	  of	  cohesin	  in	  the	  regulation	  of	  Xist	  and	  Tsix	  in	  male	  and	  female	  mouse	  ES	  cells.	  The	  first	  approach	  we	  used	  is	   to	  knock	  down	  cohesin	  with	  RNAi	  and	  assess	  the	  levels	  of	  Xist	  and	  Tsix	  transcripts.	  Since	  Xist	  and	  
Tsix	   are	   two	   antisense	   genes,	   strand-­‐specific	   reverse	   transcription	   was	   used	  (Nesterova	   et	   al.	   2003).	   Depletion	   of	   CTCF	   or	   cohesin	   in	   male	   ES	   cells	   did	   not	  change	  the	  expression	  of	  Xist	  or	  Tsix	  (Figure	  4.11).	  This	  excluded	  a	  role	  of	  cohesin	  and	  CTCF	  in	  the	  regulation	  of	  Xist	  and	  Tsix	  expression	  in	  male	  ES	  cells.	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Figure	  4.11	  CTCF	  and	  cohesin	  do	  not	  regulate	  Xist	  and	  Tsix	  expressions	  in	  wild-­type	  male	  ES	  
cells.	  Anti-­‐CTCF	  WB	   to	   the	   left	   and	   anti-­‐Rad21	  WB	   to	   the	   right.	   LaminB	  was	   used	   as	   loading	   control.	  Expression	  of	  Xist	  and	  Tsix	  were	  obtained	  after	  strand-­‐specific	  reverse	   transcription.	  Expressions	  were	  normalised	  to	  β-­‐actin.	  n=3,	  error	  bars=SD.	  	  	   The	   second	   approach	   was	   to	   use	   male	   and	   female	   Rad21	   conditional	  knockout	   ES	   cells	   described	   earlier	   (Figure	   4.4).	   We	   depleted	   Rad21	   levels	   in	  female	   Rad21lox/lox	   ES	   cells	   for	   24h	   (Figure	   4.12.a)	   and	   checked	   the	   expression	  levels	   of	   Xist	   and	   Tsix.	   In	   addition,	   we	   also	   checked	   the	   mRNA	   levels	   of	   the	  pluripotency-­‐associated	  factor	  Rex1	  and	  of	  the	  activator	  of	  Xist,	  Rnf12.	  Depletion	  of	  cohesin	   in	   female	   ES	   cells	   results	   in	   an	   increase	   of	   Rnf12	   and	   concomitantly	   an	  increase	   of	  Xist	   (Figure	   4.12.b).	   Rex1	   and	  Tsix	   expressions	   are	   unmodified.	  Male	  





























































chromosomes	   (and	   thus	   two	  Rnf12	  gene	   copies)	   in	   female	   cells	   and	  one	   in	  male	  cells.	   The	   up-­‐regulation	   of	  Rnf12	   in	  male	   ES	   cells	   upon	   cohesin	   depletion	  would	  thus	   not	   be	   sufficient	   to	   trigger	   overexpression	   of	  Xist.	  Moreover,	   assuming	   that	  the	   binding	   of	   cohesin	   to	   the	   Xic	   in	   female	   cells	   is	   similar	   to	  male	   cells,	   cohesin	  does	   not	   bind	   in	   ES	   cells	   to	   the	   Xist	   promoter	   as	   previously	   described	   (Figure	  3.12).	  This	  suggests	  again	  that	  up-­‐regulation	  of	  Xist	  is	  cohesin-­‐independent.	  
	  
Figure	  4.12	  Upregulation	  of	  Rnf12	  and	  Xist	  in	  female	  ES	  cells	  upon	  cohesin	  depletion	  for	  24h.	  
a.	   Schematic	   of	   the	   experiment.	   Cells	  were	   grown	   in	  ES	   cell	   conditions,	  N2B27	  +2i	   +LIF,	   for	   24h	  while	   treated	  with	  4’OHT	  or	  EtOH	   for	  24h.	  b.	  Relative	  expression	  of	  Rad21,	  Rex1,	  Rnf12,	  Xist	   and	  
Tsix	   in	   female	  and	  male	  Rad21lox/lox	  and	   female	  Rad21wt/wt	  ES	  cells	  upon	  24h	  of	  4’OHT	  treatment.	  
Rad21,	  Rex1	   and	  Rnf12	   expression	   levels	  were	   normalised	   to	   the	   average	   expression	   of	  Ubc	   and	  
Ywhaz.	  Xist	   and	  Tsix	   expressions	  were	   normalised	   to	  b-­actin.	   n=3	   to	   5.	   error	   bars=SD.	   *,	   p-­‐value	  Rad21<6x10-­‐8,	  Rnf12	  and	  Xist<0.02.	  












































































	   Is	  the	  effect	  of	  cohesin	  on	  Rnf12	  direct?	   As	   already	   stated,	   cohesin	  regulates	   the	   expression	   of	   pluripotency	   factors	   by	   interacting	   with	   NIPBL	   and	  mediator	  and	  functionally	  connecting	  enhancers	  and	  promoters	  (Kagey	  et	  al.	  2010;	  Nitzsche	   et	   al.	   2011).	   In	   this	   sense,	   depletion	   of	   cohesin	   in	   both	   the	   Kagey	   and	  Nitzsche	   systems	   results	   in	   ES	   cell	   differentiation.	   In	   our	   system,	   depletion	   of	  cohesin	  in	  ES	  cells	  for	  24	  hours	  to	  20%	  of	  the	  normal	  levels	  reduces	  significantly	  the	  levels	  of	  mRNA	  of	  the	  pluripotency-­‐associated	  factor	  Nanog,	  but	  not	  Oct4	  and	  Rex1	  (Figure	  4.12.b	  and	  Figure	  4.13).	  	  	  
	   	   	  
Figure	  4.13	  Nanog,	   but	  not	  Oct4,	   is	   significantly	  downregulated	  upon	   cohesin	  depletion	   in	  
female	  ES	  cells.	  Cells	  were	  grown	  in	  ES	  cell	  conditions	  and	  treated	  with	  4’OHT	  or	  EtOH	  for	  24h.	  Relative	  expression	  levels	   were	   normalised	   to	   the	   average	   expression	   of	   Ubc	   and	   Ywhaz.	   n=5.	   error	   bars=SD.	   *,	   p-­‐value<0.001.	  	  
	  	  
Figure	  4.14	  Cohesin	  binds	  10Kb	  upstream	  and	  40Kb	  downstream	  of	  the	  mouse	  Rnf12	  (Rlim)	  
































	   Rnf12	  and	  Xist	  are	  upregulated	  upon	  female	  ES	  cell	  differentiation	  (Jonkers	  et	  al.	  2009).	  Two	  different	  explanations	  might	  account	  for	  the	  effect	  on	  Rnf12	  and	  
Xist	   that	   we	   detect	   upon	   cohesin	   depletion.	   The	   first	   is	   that	   cohesin	   regulates	  directly	   and	   negatively	   the	   expression	   of	   Rnf12	   in	   ES	   cells,	   so	   that	   depletion	   of	  cohesin	  results	  in	  an	  increase	  of	  Rnf12	  and	  associated	  Xist	  up-­‐regulation	  in	  female	  cells	   independently	   of	   differentiation.	   This	   is	   supported	   by	   the	   Rad21	   ChIP-­‐seq	  results	  in	  male	  ES	  cells	  where	  cohesin	  binds	  10Kb	  upstream	  of	  the	  Rnf12	  promoter	  (Figure	  4.13).	  The	  second	  points	  to	  an	  indirect	  role	  of	  cohesin	  in	  regulating	  Rnf12:	  cohesin	   positively	   regulates	   the	   pluripotency-­‐associated	   factors,	   so	   that	   upon	  cohesin	   depletion,	   ES	   cells	   start	   to	   differentiate	   and	   consequently	   upregulate	  Rnf12	   in	  both	   females	  and	  males	  cells	  but	  only	  Xist	   in	   female	  cells.	   In	   this	   sense,	  Rnf12	  and	  Xist	  could	  be	  regarded	  as	  very	  early	  markers	  of	  differentiation.	  Whether	  the	   effect	   on	   Rnf12	   is	   direct	   or	   indirect	   is	   unclear,	   although	   the	   fact	   that	   the	  expression	  levels	  of	  the	  pluripotency	  factors	  Oct4	  and	  Rex1	  are	  not	  reduced	  upon	  cohesin	   depletion	   suggests	   that	   the	   effect	   on	   Rnf12	   is	   direct	   (and	   not	   due	   to	   a	  subpopulation	   of	   differentiating	   ES	   cells),	   especially	   its	   showing	   a	   two-­‐fold	   up	  regulation.	  This	  would	  result	   in	  an	   indirect	  effect	  of	   cohesin	  on	  Xist	   in	   female	  ES	  cells.	  	   	  	  	  	  	  	  	  	  	  	   	  	   	   	   In	  male	  and	  female	  differentiating	  ES	  cells	  	  	   CTCF	   has	   been	   involved	   in	   the	   regulation	   of	   both	   Xist	   and	   Tsix	   in	  differentiating	   male	   ES	   cells	   (Donohoe	   et	   al.	   2007).	   Donohoe	   and	   colleagues	  differentiated	  male	   ES	   cells	   into	   EB	   for	   two	   days	   and	   then	   knocked	   down	   CTCF	  with	   CTCF-­‐specific	   siRNA	  molecules	   for	   two	  more	   days,	   when	   they	   checked	   the	  expression	   of	   Xist	   and	   Tsix.	   Xist	   was	   upregulated	   8-­‐fold	   whereas	   Tsix	   was	  downregulated	  0.5-­‐fold.	  	  	   Whether	   cohesin	   is	   involved	   in	   the	   early	   stages	   of	   XCI,	   within	   24h	   of	  differentiation,	   or	   some	  days	   after	   the	   initiation	   of	   differentiation,	  when	  XCI	   has	  been	   triggered,	   is	   unknown.	   We	   set	   out	   to	   assess	   if	   cohesin	   regulates	   the	  expression	   of	   the	   XCI	   players	   at	   the	   onset	   of	   XCI	   and	   during	   XCI	   itself.	  Differentiation	   was	   carried	   out	   by	   removing	   the	   inhibitors	   and	   LIF.	   The	   cells	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automatically	   start	   differentiating	   due	   to	   the	   presence	   of	   retinoic	   acid	   in	   the	  N2B27	  medium.	  We	  decided	   to	  check	   firstly	   if	   these	   female	  cells	   that	  we	  have	   in	  hand	  properly	  inactivate	  their	  X	  chromosome.	  We	  assessed	  this	  by	  measuring	  the	  levels	   of	  Xist	   and	  Tsix	   transcript	   levels	   at	   different	   time	  points	   of	   differentiation.	  Differentiation	   for	   24h	   increased	   the	   expression	   of	   Xist	   by	   30-­‐fold.	   By	   day	   3	   of	  differentiation,	  Xist	   was	   upregulated	   300-­‐	   to	   400-­‐fold	   compared	   to	   the	   +2i	   +LIF	  condition	   (Figure	   4.15).	   This	   confirms	   that	   both	   our	   Rad21lox/lox	   and	   Rad21wt/wt	  female	   ES	   cells	   undergo	   XCI	   upon	   differentiation.	   In	   addition,	  Tsix	   expression	   is	  reduced	   upon	   differentiation	   (J	   T	   Lee,	   L	   S	  Davidow,	   et	   al.	   1999).	   In	   our	   case,	   its	  behaviour	   is	  more	   erratic	   but	   in	   general	   terms,	  Tsix	   is	   gradually	   downregulated	  upon	  differentiation.	  
	  
Figure	   4.15	  Xist	   is	   rapidly	   upregulated	   in	   female	  Rad21lox/lox	   and	  Rad21wt/wt	   ES	   cells	   upon	  
differentiation.	  Cells	  were	  let	  to	  differentiate	  for	  specified	  times.	  Relative	  expression	  levels	  were	  normalised	  to	  b-­‐actin.	  Single	  representative	  experiment.	  
+
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   We	  then	  assessed	  whether	  cohesin	   is	   involved	  in	  the	  regulation	  of	   the	  XCI	  players	   at	   the	   onset	   of	   XCI,	   within	   24h	   of	   differentiation.	   Cells	   were	   thus	   let	   to	  differentiate	  for	  24h	  and	  treated	  with	  4’OHT	  or	  EtOH	  (Figure	  4.16.a).	  Figure	  4.16.b	  shows	   that	   Rad21	   expression	   is	   reduced	   to	   similar	   levels	   as	  with	   24h	   of	   4’OHT	  treatment	   in	   the	  ES	  cell	   stage.	  Rad21	  depletion	   in	  differentiating	  ES	  cells	  did	  not	  result	   in	  an	   increase	  of	  Rnf12,	  whether	   in	   female	  or	  male	   cells.	   Surprisingly,	  Xist	  expression	  was	   increased	   in	   both	   female	   and	  male	   cells	   compared	   to	   the	   EtOH-­‐treated	   cells;	   this	   effect	   is	   thus	  Rnf12-­‐independent.	   In	   addition,	   Rex1	   expression	  was	   reduced	   in	   both	   female	   and	   male	   Rad21lox/lox	   cells	   upon	   cohesin	   deletion.	  Again,	  Tsix	  expression	  was	  unmodified.	  Since	  Rex1	  is	  downregulated	  upon	  cohesin	  depletion,	   it	   is	   possible	   that	   the	   downregulation	   of	   the	   pluripotency	   network	  releases	  the	  repression	  on	  Xist	  and	  results	  in	  increased	  levels	  of	  Xist.	  On	  the	  other	  hand,	  cohesin	  might	  be	  directly	  involved	  in	  Xist	  repression	  in	  both	  female	  and	  male	  differentiating	  ES	  cells	  in	  an	  Rnf12-­‐independent	  manner.	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Figure	  4.16	  Non-­Rnf12-­dependent	  upregulation	  of	  Xist	  in	  female	  24h-­differentiating	  ES	  cells	  
upon	  cohesin	  depletion.	  
a.	  Schematic	  of	  the	  experiment.	  Cells	  were	  grown	  in	  ES	  cells	  differentiation	  conditions,	  N2B27	  -­‐2i	  -­‐LIF,	  for	  24h	  while	  treated	  with	  4’OHT	  or	  EtOH	  for	  24h.	  b.	  Relative	  expression	  of	  Rad21,	  Rex1,	  Rnf12,	  
Xist	   and	   Tsix	   in	   female	   and	  male	  Rad21lox/lox	   and	   female	  Rad21wt/wt	   ES	   cells	   upon	   24h	   of	   4’OHT	  treatment.	  Rad21,	  Rex1	  and	  Rnf12	  expression	  levels	  were	  normalised	  to	  the	  average	  expression	  of	  
Ubc	  and	  Ywhaz.	  Xist	  and	  Tsix	  expressions	  were	  normalised	  to	  b-­actin.	  n=3	  to	  5.	  error	  bars=SD.	  *,	  p-­‐value	  Rad21<3x10-­‐10,	  Rex1<0.008,	  Xist<0.02.	  	  	   We	   next	  wanted	   to	   evaluate	  whether	   cohesin	   regulates	   the	   expression	   of	  
Xist	  and	  Tsix	   in	  ES	  cells	  that	  have	  already	  started	  to	  differentiate.	   In	  this	  way,	  we	  are	  able	   to	  assess	   the	  role	  of	  cohesin	   in	  sustaining	  the	  expression	  of	  Xist	  when	   it	  has	   already	   been	   upregulated.	   We	   treated	   Rad21lox/lox	   and	   Rad21wt/wt	   cells	   with	  







































































4’OHT	  or	  EtOH	  for	  24h	  from	  day	  2	  of	  differentiation	  (Figure	  4.17.a).	  MRNA	  levels	  of	   Rad21	   were	   down	   by	   95%,	   similarly	   as	   in	   ES	   cell	   and	   the	   -­‐2i	   -­‐LIF	   for	   24h	  conditions	   (Figure	   4.17.b).	   Conversely	   to	   the	   previous	   situations,	   none	   of	   the	  expressions	   of	   the	   studied	   genes	   were	  modified	   upon	   Rad21	   deletion	   in	   female	  cells,	   excluding	   a	   role	   for	   cohesin	   in	   regulating	   any	   of	   the	   XCI	   players	   when	  inactivation	  has	  been	  already	  triggered.	  
	   	  
Figure	  4.17	  Cohesin	  depletion	  has	  no	  effect	  on	  the	  XCI	  players	  RNA	  expression	  after	  XCI	  has	  
been	  triggered.	  
a.	  Schematic	  of	  the	  experiment.	  Cells	  were	  grown	  in	  ES	  cells	  differentiation	  conditions,	  N2B27	  -­‐2i	  -­‐LIF,	  for	  3d	  while	  treated	  with	  4’OHT	  or	  EtOH	  for	  the	  last	  24h.	  b.	  Relative	  expression	  of	  Rad21,	  Rex1,	  
Rnf12,	   Xist	   and	   Tsix	   in	   female	   and	  male	  Rad21lox/lox	   and	   female	   Rad21wt/wt	   ES	   cells	   upon	   24h	   of	  4’OHT	   treatment.	   Rad21,	   Rex1	   and	   Rnf12	   expression	   levels	   were	   normalised	   to	   the	   average	  expression	  of	  Ubc	  and	  Ywhaz.	  Xist	  and	  Tsix	  expressions	  were	  normalised	  to	  b-­actin.	  n=3	  to	  4.	  error	  bars=SD.	  *,	  p-­‐value<0.0001.	  	  















































































	   4.3.3.	  Cohesin’s	  role	  in	  escapism	  of	  XCI	  	  	  	   CTCF	   has	   been	   postulated	   to	   act	   as	   a	   chromatin	   barrier	   at	   the	   5’	   end	   of	  escapees,	   such	   as	  Kdm5c	   and	   Eif2s3x,	   by	   preventing	  methylation	   of	   DNA	   of	   the	  promoters	   and	   possibly	   the	   spread	   of	   heterochromatin	   associated	   with	   the	   Xi	  (Galina	  N.	  Filippova	  et	  al.	  2005;	  F.	  Yang	  et	  al.	  2010).	  The	  escapee	  Kdm5c	  is	  localised	  outside	   or	   in	   the	   outer	   edge	   of	   the	   Xist	   cloud	   in	   differentiating	   female	   ES	   cells	  (Chaumeil	  et	  al.	  2006),	  suggestive	  of	  a	  mechanism	  where	   localisation	  of	   the	  gene	  outside	   of	   the	   repressive	   compartment	   allows	   it	   to	   escape	   XCI.	   Together,	   it	   is	  tempting	   to	   speculate	   that	   CTCF	   and	   cohesin	   might	   be	   involved	   in	   segregating	  areas	  that	  escape	  XCI	   from	  heterochromatin	  of	   the	  Xi.	  To	  study	  this	  question,	  we	  need	  to	  use	  systems	  that	  fulfil	  different	  criteria.	  The	  first	  is	  that	  cells	  should	  not	  be	  cycling;	  as	  with	  the	  T-­‐cell	  lymphocyte	  system,	  we	  want	  to	  avoid	  any	  cell	  cycle	  effect	  that	  cohesin	  removal	  might	  have	  on	  cycling	  cells.	  The	  second	  is	  that	  cells	  have	  to	  have	  achieved	  XCI,	  so	  that	  heterochromatin	  is	  in	  place	  on	  the	  Xi	  and	  concomitantly,	  the	  expression	  of	  a	  gene	  subject	  to	  XCI	  is	  extinguished.	  The	  third	  criterion	  is	  that	  XCI	   and	   the	   repressive	  marks	   on	   the	  Xi	   still	   need	   to	   be	   dynamic,	   plastic,	   so	   that	  removal	  of	  cohesin	  in	  these	  systems	  will	  have	  detectable	  effects.	  We	  consider	  that	  two	  different	  systems	  fulfil	  all	  these	  criteria.	  	  	  	   	   4.3.3.1.	  Systems	  
CD4+CD8+	  DP	  and	  CD4+CD8-­	  SP	  thymocytes	  	  	   We	   have	   previously	   shown	   that	   small	   CD4+CD8+	   DP	   and	   CD4+CD8-­‐	   SP	  thymocytes	  are	  non-­‐cycling	  cells.	  These	  cells	  fulfil	  the	  first	  criterion.	  CD4+CD8+	  DP	  and	  CD4+CD8-­‐	  SP	  thymocytes	  are	  differentiated	  and	  female	  cells	  will	  have	  achieved	  XCI	   to	   compensate	   gene	   dosage	   from	   the	   X	   chromosomes,	   fulfilling	   the	   second	  criterion.	  Previous	  work	  by	  Savarese	  and	  colleagues	  has	  shown	  that	  CD4+CD8+	  DP	  and	  CD4+CD8-­‐	  SP	  thymocytes	  shortly	  re-­‐establish	  the	  epigenetic	  pathways	  needed	  for	   XCI.	   Ectopic	   expression	   of	   Xist	   in	   transgenic	   males	   results	   in	   a	   significant	  increase	  of	  H3K27me3	  foci	  and	  concomitant	  silencing	  of	  Pgk1	  and	  Hprt	  (Savarese	  et	  al.	  2006).	  This	  pattern	  is	  not	  seen	  in	  hematopoietic	  stem	  cells	  or	  in	  mature	  blood	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cells.	   In	   addition,	   female	   CD4+CD8+	   DP	   thymocytes	   do	   not	   exhibit	   Xist	   clouds	  whereas	   only	   one	   fourth	   of	   female	   CD4+CD8-­‐	   SP	   thymocytes	   do.	   None	   of	   these	  populations	   show	   H3K27me3	   foci	   although	   genes	   on	   the	   Xi	   are	   not	   reactivated	  meaning	   that	  dosage	  compensation	   is	  maintained.	  The	  authors	  conclude	   that	  XCI	  can	  be	  initiated	  in	  hematopoietic	  precursors.	  This	  is	  of	  particular	  interest	  since	  we	  need	  a	  system	  where	  the	  repressive	  marks	  on	  the	  Xi	  are	  still	  plastic,	  then	  fulfilling	  the	   third	   criterion.	   In	   addition,	   cohesin	   can	   be	   easily	   removed	   from	   Rad21lox/lox	  small	  CD4+CD8+	  DP	  and	  CD4+CD8-­‐	  SP	  thymocytes	  as	  shown	  before	  (Figure	  4.10).	  	  	  
Differentiating	  cohesin	  conditional	  knockout	  ES	  cells	  	  	   Female	   cells	   in	   the	   ICM	   have	   two	   active	   X	   chromosomes	   of	   which	   one	   is	  inactivated	  upon	  differentiation.	  This	  is	  a	  multistep	  process	  where	  full	  repression	  of	   the	   Xi	   is	   achieved	   by	   5.5dpc	   (Rastan	   1982).	   This	   multistep	   process	   can	   be	  recapitulated	  in	  vitro	  by	  differentiating	  ICM-­‐derived	  ES	  cells.	  Differentiation	  of	  ES	  cells	   in	   the	  presence	  of	   retinoic	  acid	   in	  neuron-­‐promoting	  conditions	  results	   in	  a	  significantly	   enriched	  population	  of	  postmitotic	  neurons	   (Figure	  4.18	   and	  Figure	  4.19)(Ying	  et	  al.	  2003).	  Female	  and	  male	  Rad21lox/lox	  and	  female	  Rad21wt/wt	  ES	  cells	  were	   differentiated	   for	   12	   days	   in	   N2B27	   -­‐2i.	   Neurons	   obtained	   from	   this	  differentiation	   do	   not	   express	   pluripotency-­‐associated	   markers	   such	   as	   Oct4,	  Nanog	   and	  Rex1,	   do	   not	   express	   endoderm-­‐	   and	  mesoderm-­‐	   associated	  markers	  such	   as	   Gata4	   and	   Gata6,	   and	   Bry	   respectively.	   They	   express	   the	   ectoderm-­‐associated	  marker	  Sox1	  (Figure	  4.19.b).	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Figure	  4.18	  Schematic	  of	  ES	  cell	  differentiation	  into	  neurons	  in	  N2B27	  -­2i	  -­LIF.	  Female	  ES	   cells	  were	  differentiated	   for	   12	  days	   in	  N2B27	  without	   the	   two	   inhibitors.	   Cells	  were	  treated	  with	  4’OHT	  from	  day	  9	  to	  day	  12.	  	  	   These	  neurons	  are	  arrested	  in	  G0/	  G1	  as	  the	  PI	  profile	  shows	  (Figure	  4.19.a)	  and	   have	   fully	   inactivated	   the	   X	   chromosome	   (see	   section	   4.3.3.2.,	   Figure	   4.22).	  Whether	  facultative	  heterochromatin	  on	  the	  Xi	  is	  still	  plastic	  in	  this	  system	  is	  not	  known.	   Deposition	   of	   histone	   modifications	   associated	   with	   repression,	   such	   as	  H3K27me3	  and	  H3K9me2/me3,	   is	  one	  of	   the	  earliest	  marks	  of	   the	  Xi,	   starting	  at	  day	   2	   of	   differentiation	   (Plath	   et	   al.	   2003).	   The	   timing	   of	   DNA	   methylation	  appearance	  at	  the	  promoters	  of	  X-­‐linked	  genes	  subject	  to	  XCI	  is	  poorly	  understood.	  Embryos	  at	  6.5dpc,	  after	  initiation	  of	  XCI,	  show	  low	  levels	  of	  methylation	  at	  Hprt,	  although	   high	   levels	   of	  methylation	   are	   seen	   at	   10.5dpc	   (Lock	   et	   al.	   1987).	   DNA	  methylation	  has	  been	  suggested	  to	  be	  important	  in	  long-­‐term	  maintenance	  of	  XCI.	  We	   do	   not	   know	   what	   the	   status	   of	   DNA	   methylation	   on	   the	   Xi	   at	   day	   12	   of	  differentiation	  of	  female	  ES	  cells	  is	  although	  it	  is	  possible	  that	  the	  establishment	  of	  this	  modification	  has	  not	  been	  fully	  achieved.	  	   In	   this	   sense,	   we	   have	   an	   additional	   system	   where	   Rad21	   conditional	  knockout	   cells	   are	   arrested	   in	   G1/G0,	   have	   inactivated	   the	   chromosome	   and	  inactivation	  might	  still	  be	  plastic.	  









Figure	   4.19	   Differentiation	   of	   ES	   cells	   for	   12	   days	   in	   N2B27	   -­2i	   –LIF	   generates	   an	  
homogenous	  population	  of	  G1-­arrested	  Sox1-­expressing	  neurons.	  
a.	   PI	   staining	  profiles	  of	  ES	   cells	   and	  ES-­‐derived	  neurons.	  b.	  Relative	  expression	  of	  ES	   cell	   (Oct4,	  










































































	   	   4.3.3.2.	  Expression	  dependence	  on	  cohesin	  of	  XCI	  escapees	  and	  	  
	   	   	   genes	  subject	  to	  XCI	  
In	  male	  and	  female	  CD4+CD8+	  DP	  and	  CD4+CD8-­	  SP	  thymocytes	   	  	  	   An	  initial	  approach	  to	  assess	  the	  role	  of	  cohesin	  in	  boundary	  formation	  is	  to	  measure	   the	   RNA	   levels	   of	   escapees	   and	   genes	   subject	   to	   XCI	   upon	   cohesin	  deletion.	  We	   hypothesised	   that	   if	   cohesin	   acts	   as	   a	   chromatin	   boundary	   around	  these	   escapees,	   removal	   of	   cohesin	   will	   eliminate	   the	   boundaries	   and	  heterochromatin	  will	  invade	  the	  escapees,	  extinguishing	  their	  expression	  from	  the	  Xi.	  At	  most,	  the	  reduction	  of	  the	  escapees’	  expression	  will	  be	  50%,	  as	  they	  will	  be	  expressed	   from	   the	   Xa	   too.	   Male	   cells	   can	   be	   used	   as	   a	   control	   of	   the	   effect	   of	  cohesin	  removal	  on	  the	  Xa.	  Rad21	  RNA	  levels	   in	  both	   female	  and	  male	  CD4+CD8+	  DP	   and	   CD4+CD8-­‐	   SP	   thymocytes	   were	   down	   to	   20%	   (Figure	   4.20.a	   and	   b).	  Expression	   of	   the	   genes	   subject	   to	   XCI	  Huwe1	   and	   Lamp2	   was	   unchanged	   upon	  cohesin	  deletion	  when	  comparing	  Rad21lox/lox	  and	  Rad21wt/wt.	  When	  comparing	  the	  expression	  of	  the	  escapees	  Ddx3x,	  Kdm5c	  and	  Eif2s3x	  (F.	  Yang	  et	  al.	  2010)	  between	  female	   Rad21lox/lox	   and	   Rad21wt/wt	   cells,	   no	   change,	   or	   at	   least	   no	   significant	  decrease,	  was	  observed	  for	  any	  of	  the	  escapees.	  Another	  escapee	  (1810030O07Rik)	  and	  other	  controls	  subject	  to	  XCI	  (Hprt,	  Pgk1	  and	  MeCP2)	  exhibited	  similar	  results	  (data	  not	  shown).	   In	  conclusion	  Rad21	  deletion	   in	   thymocytes	  does	  not	  decrease	  the	   expression	   of	   escapees	   in	   female	   cells.	   The	   absence	   of	   decreased	   escapees’	  expression	   upon	   cohesin	   deletion	   in	   thymocytes	   can	   be	   interpreted	   in	   three	  different	   ways.	   Firstly	   and	   simply,	   it	   is	   possible	   that	   cohesin	   does	   not	   act	   as	   a	  chromatin	   boundary	   around	   them.	   Secondly,	   as	   escapism	   can	   be	   tissue	   specific,	  another	   possibility	   is	   that	   these	   escapees	   are	   actually	   not	   escaping	   from	   XCI	   in	  female	   CD4+CD8+	   DP	   and	   CD4+CD8-­‐	   SP	   cells	   (S	   Sheardown	   et	   al.	   1996).	   Similar	  levels	   of	   expression	   by	   qRT-­‐PCR	   in	   female	   and	   male	   cells	   suggest	   this	   (Figure	  4.20.a	   and	   b).	   Thirdly,	   it	   is	   possible	   that	   the	   downregulation	   of	   escapees	   upon	  cohesin	   deletion,	   being	   very	   subtle,	   cannot	   be	   assessed	   by	   qRT-­‐PCR.	   Allelic	  discrimination,	   by	   using	   RNA-­‐FISH	   or	   SNP	   analysis,	   would	   shed	   some	   light	   into	  these	  issues.	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Figure	  4.20	  Relative	  expression	  of	  escapees	  and	  genes	  subject	  to	  XCI	  upon	  cohesin	  depletion	  
in	  female	  and	  male	  CD4+CD8+	  DP	  and	  CD4+CD8-­	  SP	  thymocytes.	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In	  male	  and	  female	  differentiating	  ES	  cells	   	   	  	  	   We	  then	  set	  out	  to	  investigate	  if	  in	  differentiating	  ES	  cells,	  when	  cells	  have	  reached	   the	   neuron	   stage,	   thus	   being	   in	   G1/G0,	   cohesin	   acts	   as	   a	   chromatin	  boundary	   around	   escapees.	   By	   qRT-­‐PCR,	   Rad21	   RNA	   and	   protein	   levels	   were	  substantially	   reduced	   after	   three	   days	   of	   4’OHT	   treatment	   from	   day	   9	   (Figure	  4.21.a).	  Expression	  of	  control	  genes	  subject	  to	  XCI	  (Huwe1,	  Lamp2	  and	  Hprt)	  was	  unchanged	  (Figure	  4.21.b).	  In	  contrary,	  expression	  of	  escapees	  Ddx3x,	  Kdm5c	  and	  
2610029G23Rik	   were	   reduced	   in	   cohesin-­‐depleted	   female	   neurons,	   although	  cohesin-­‐depleted	   male	   neurons	   also	   had	   decreased	   levels	   of	   Ddx3x	   and	  




Figure	  4.21	  Relative	  expression	  of	  escapees	  and	  genes	  subject	  to	  XCI	  upon	  cohesin	  depletion	  
in	  female	  and	  male	  ES	  cells	  differentiated	  for	  12	  days.	  
a.	  WB	  of	  ES	  cells	  differentiated	  for	  12	  days	  in	  N2B27	  -­‐2i	  in	  the	  presence	  or	  absence	  of	  4’OHT	  from	  day	   9.	  b.	  Expression	   of	   Rad21	   (black),	   control	   genes	   subject	   to	   XCI	   (green)	   and	   escapees	   (blue).	  Expressions	   have	   been	   normalised	   to	   the	   average	   of	   expression	   of	   Ubc	   and	   Ywhaz,	   and	   then	  normalised	  to	  the	  –	  4’OHT	  condition.	  *	  ,	  p-­‐value<0.05.	  n=3	  to	  5.	  	  	   	  

































































































	   In	   order	   to	   understand	   if	   the	   expression	   decrease	   of	   Kdm5c	   is	   due	   to	  repression	  of	   the	  escapee	  on	   the	  Xi,	  we	  will	  have	   to	  make	  use	  of	   techniques	   that	  discriminate	  between	  alleles,	  such	  as	  RNA-­‐FISH.	  Thais	  Lavagnolly,	  PhD	  student	  in	  our	  laboratory	  performed	  all	  RNA-­‐FISH	  experiments.	  	   RNA-­‐FISH	  probes	  for	  genes	  subject	  to	  XCI	  Huwe1	  and	  Lamp2	  and	  escapees	  
Kdm5c	  and	  Utx	  were	  kindly	  provided	  by	  Edith	  Heard.	  Chow	  and	  colleagues	  show	  that	   ES	   cells	   let	   to	   differentiate	   for	   8/10	   days	   exhibit	   virtual	   monoallelic	  expression	   of	  Huwe1	   and	   Lamp2,	   and	   that	   50-­‐75%	   of	   the	   cells	   are	   biallelic	   for	  
Kdm5c	  (Jarid1c)	  and	  Utx	  (Chow	  et	  al.	  2010).	  In	  our	  experiments,	  differentiation	  of	  female	  Rad21lox/lox	  cells	  for	  12	  days	  shows	  roughly	  90%	  of	  cells	  having	  monoallelic	  expression	   of	  Huwe1	   and	   Lamp2	   (Figure	   4.22).	   In	   addition,	   the	   escapees	  Kdm5c	  and	  Utx	   are	  generally	  biallelically	  expressed	  at	  day	  12	  of	  differentiation	  (~85%),	  showing	  they	  are	  escaping	  XCI	  in	  this	  system.	  Upon	  4’OHT	  treatment	  from	  day	  9	  of	  differentiation	   and	   concomitant	   decrease	   in	   cohesin	   levels,	   the	   number	   of	   cells	  with	  a	  biallelic	  signal	  for	  the	  escapees	  decreases	  slightly	  although	  not	  to	  a	  very	  big	  extent,	   10%	   for	   both	   Utx	   and	   Kdm5c,	   suggesting	   cohesin	   might	   be	   acting	   as	   a	  chromatin	   boundary	   around	   these	   escapees	   inhibiting	   the	   spread	   of	  heterochromatin	   on	   the	   Xi,	   in	   line	   with	   the	   previous	   qRT-­‐PCR	   results.	  Unexpectedly,	  cohesin	  removal	  resulted	  in	  a	  very	  strong	  increase	  in	  the	  number	  of	  cells	  exhibiting	  biallelic	  signals	  of	  the	  genes	  subject	  to	  XCI	  Huwe1	  and	  Lamp2,	  from	  5%	  to	  60%	  (Figure	  4.22).	  This	  cannot	  be	  due	  to	  cells	  accumulating	  in	  G2	  and	  thus	  having	   two	   signals	   from	   the	   active	   X	   chromosome	   as	   the	   PI	   profile	   shows	   that	  mostly	  all	  cells	  are	   in	  G1/G0	  (Figure	  4.19.a)	  and	  in	  addition,	  the	  escapees	  exhibit	  two	  signals	  and	  not	  four.	  The	  reasons	  why,	  upon	  cohesin	  depletion,	  the	  number	  of	  cells	  exhibiting	  biallelic	  signals	  for	  otherwise	  inactivated	  genes	  can	  be	  several.	  One	  is	   that	  removal	  of	  cohesin	  reactivates	   the	  Xi.	   In	   this	  sense,	  cohesin	   is	  required	   to	  keep	   the	   inactive	   chromosome	   inactive.	   	   Another	   reason	   is	   that,	   although	   the	  chromosome	   has	   been	   inactivated	   in	   almost	   all	   untreated	   cells	   by	   day	   12,	   it	   is	  possible	  that	  by	  day	  9,	  when	  4’OHT	  is	  added,	  not	  all	  cells	  have	  inactivated	  their	  X	  chromosome	   and	   thus,	   the	   effect	   that	   we	   see	   at	   day	   12	   is	   due	   to	   a	   block	   of	  inactivation.	  In	  this	  sense,	  cohesin	  is	  required	  for	  the	  process	  of	  inactivation	  of	  the	  X	  chromosome.	  Finally,	  another	  reason	   is	   that	  cohesin	  removal	   is	  deleterious	   for	  cells	  that	  have	  fully	  inactivated	  one	  of	  their	  X	  chromosomes,	  resulting	  at	  day	  12	  in	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an	   increased	   proportion	   of	   cells	   exhibiting	   biallelic	   signals.	   This	   simply	   means	  there	  is	  a	  selection	  process	  occurring	  upon	  cohesin	  removal.	  	   	  	  	  	  	  	  	  
	  	  	  	  	   	  
Figure	   4.22	   Depletion	   of	   cohesin	   in	   ES-­derived	   neurons	   increases	   the	   population	   with	  
biallelic	  RNA	  signals	  of	  X-­linked	  genes	  subject	  to	  XCI.	  














































	   Whether	   the	   result	   that	   we	   are	   obtaining	   is	   a	   consequence	   of	   the	  reactivation	   of	   the	   Xi,	   a	   block	   in	   XCI	   or	   a	   selection	   process	   favouring	   cells	  displaying	  biallelic	  expression	  of	  genes	  subject	  to	  XCI	  is	  presently	  unknown.	  	   We	   then	  wanted	   to	   examine	  what	   could	   be	   the	  molecular	  mechanism	   for	  this	  expression	  arising	  from	  the	  Xi.	  Intuitively,	  we	  could	  look	  into	  any	  of	  the	  marks	  that	  occur	  during	  and	  are	  required	  for	  XCI,	  that	  is	  Xist	  expression,	  exclusion	  of	  RNA	  Pol	   II,	  deposition	  of	  histone	  methylation	  marks,	  DNA	  methylation	  marks,	  etc.	  We	  have	   already	   shown	   that	  Xist	   expression	   is	   not	   cohesin	   dependent	   after	  Xist	   up-­‐regulation	  has	  been	  triggered	  (Figure	  4.17.b).	  In	  addition,	  Xist	  expression	  becomes	  dispensable	   for	   inactivation	   after	   72h	   of	   differentiation	   (Wutz	   et	   al.	   2000).	  Altogether,	   these	   results	   suggest	   that	   the	   increase	   in	   biallelic	   expression	   of	   the	  genes	  subject	  to	  XCI	  upon	  cohesin	  depletion	  might	  not	  due	  to	  the	  extinguishment	  of	  Xist	  expression	  from	  the	  Xi.	  It	  was	  thus	  surprising	  to	  detect	  Xist	  transcript	  levels	  reduced	  upon	  cohesin	  removal	  (Figure	  4.23).	  	  
	   	   	  	  
Figure	   4.23	   Reduced	   levels	   of	   Xist	   transcript	   levels	   in	   ES-­derived	   neurons	   after	   cohesin	  
depletion.	  Expression	  of	  Xist	  and	  Tsix	  upon	  3	  days	  of	  4’OHT	  treatment	  of	  Rad21lox/lox	  ES	  cells	  differentiated	  for	  12	   days.	   Expressions	   have	   been	   normalised	   to	   b-­actin,	   and	   then	   normalised	   to	   the	   –	   4’OHT	  condition.	  *,	  p-­‐value<0.02.	  n=4,	  error	  bars=SD.	  	  	  	   We	   then	   analysed	   the	   histone	   modification’s	   profile	   at	   the	   promoters	   of	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extracted	   and	   ChIP	   against	   H3K4me3	   was	   performed.	   Primers	   for	   the	   Oct4	  promoter	  were	   used	   as	   a	   negative	   control,	   and	   primers	   for	   the	  Gapdh	   promoter	  were	  used	  as	  a	  positive	  control.	  Primers	  for	  the	  promoters	  and	  the	  first	  introns	  of	  
Huwe1	  and	  Lamp2	  and	  for	  the	  promoters	  of	  Utx	  and	  Kdm5c	  were	  designed.	  Utx	  and	  
Kdm5c	  are	  expressed	  from	  both	  chromosomes	  and	  are	  both	  positive	  for	  H3K4me3	  (Figure	   4.24).	  Huwe1	   and	  Lamp2	   are	   repressed	   on	   the	   Xi	   although	   they	   are	   also	  expressed	  from	  the	  active	  X.	  This	  means	  they	  should	  also	  be	  positive	  for	  H3K4me3,	  which	  they	  are.	  When	  cells	  are	  depleted	  of	  cohesin,	  an	  increase	  in	  H3K4me3	  is	  not	  detected	  at	  the	  promoters	  of	  Huwe1	  and	  Lamp2,	  discarding	  a	  change	  in	  H3K4me3	  as	  the	  mechanism	  for	  their	  biallelic	  expression.	  	   H3K27me3	   is	   a	   clear	  mark	  of	   the	   inactivating	  X	   chromosome	  although	   its	  deposition	   is	   independent	  of	   silencing	   (Plath	   et	   al.	   2003;	  Kohlmaier	   et	   al.	   2004).	  Nevertheless,	   we	   assessed	   what	   the	   levels	   of	   H3K27me3	   are	   on	   the	   X	  chromosomes	   upon	   cohesin	   depletion.	   Being	  Gapdh	   expressed	   in	   these	   cells,	  we	  consider	   its	   promoter	   as	   a	   negative	   control	   for	   the	   repressive	  mark	  H3K27me3.	  	  Indeed,	  its	  levels	  are	  low	  compared	  to	  Huwe1	  and	  Lamp2,	  one	  of	  their	  alleles	  being	  repressed	  on	  the	  Xi	  (Figure	  4.24).	  Furthermore,	  the	  promoters	  of	  the	  escapees	  Utx	  and	   Kdm5c	   show	   no	   H3K27me3	   mark,	   in	   line	   with	   their	   escapee	   status	   and	  previously	  published	  results	  (F.	  Yang	  et	  al.	  2010).	  Upon	  deletion	  of	  Rad21,	  there	  is	  no	  decrease	  in	  H3K27me3	  at	  the	  promoters	  of	  Huwe1	  and	  Lamp2	  that	  would	  have	  explained	  an	  increase	  in	  the	  number	  of	  cells	  exhibiting	  biallelic	  signals.	  	  	   In	  addition,	  Kohlmaier	  and	  colleagues	  report	  that	  ectopic	  expression	  of	  Xist	  from	  chromosome	  11	  in	  male	  cells	  results	  in	  an	  increase	  of	  H4K20me1	  by	  IF	  and	  by	   ChIP	   (Kohlmaier	   et	   al.	   2004)	   suggesting	   H4K20me1	   is	   a	   mark	   of	   the	   Xi.	   We	  performed	  the	  H4K20me1	  ChIP	  in	  these	  cells.	  The	  Gapdh	  promoter	  is	  positive	  for	  H4K20me1	   compared	   to	   the	  Oct4	   promoter	   (Figure	   4.24).	   All	   the	   loci	   on	   the	   X	  chromosomes	  had	  the	  same	  enrichment	  of	  H4K20me1	  as	  the	  Oct4	  promoter.	  The	  expression	   status	   of	   the	   X-­‐linked	   genes	   did	   not	   correlate	   with	   the	   levels	   of	  H4K20me1,	  Huwe1	  and	  Lamp2	  being	  repressed	  on	  the	  Xi	  and	  Utx	  and	  Kdm5c	  being	  expressed	  from	  both	  chromosomes.	  Whether	  the	  H4K20me1	  levels	  at	  the	  X-­‐linked	  genes	  and	  Oct4	  correspond	  to	  basal	  levels	  is	  unknown.	  To	  test	  this,	  primers	  against	  a	  non-­‐X-­‐chromosome	  locus	  and	  non-­‐promoter,	  such	  as	  Igf2r-­‐2,	  could	  be	  used.	  PR-­‐Set7	   catalyses	   the	   transfer	   of	   one	   methyl	   group	   onto	   H4K20	   (Rice	   et	   al.	   2002;	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Nishioka	  et	  al.	  2002).	  PR-­‐set7	  knockout	  cells	  could	  be	  used	  to	  check	  whether	  the	  levels	   that	   are	   observed	   here	   are	   basal	   levels	   or	   not.	   In	   addition,	   the	   levels	   of	  H4K20me1	  are	  minimal	  during	  G1,	  increase	  in	  S	  and	  are	  maximal	  during	  M	  phase	  (Rice	   et	   al.	   2002).	  Neurons,	   being	   in	  G1/G0,	  will	   intrinsically	   show	   low	   levels	   of	  H4K20me1	  marks,	  making	  the	  H4K20me1	  ChIP	  more	  difficult	  in	  these	  cells.	  In	  any	  case,	  upon	  cohesin	  depletion,	  levels	  of	  H4K20me1	  are	  not	  altered,	  again	  discarding	  a	   loss	   of	   H4K20me1	   from	   the	   Huwe1	   and	   Lamp2	   promoters	   as	   the	   molecular	  mechanism	   resulting	   in	   an	   increased	   proportion	   of	   cells	   being	   biallelic	   for	   these	  genes.	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Figure	   4.24	   No	   change	   of	   histone	   methylation	   levels	   in	   Rad21lox/lox	   neurons	   depleted	   of	  
















































































































4.4.	  Discussion	  	   4.4.1.	  Correlation	  of	  cohesin	  binding	  and	  gene	  expression.	  	  	   We	  have	  previously	  shown	  that	  cohesin	  and	  CTCF	  co-­‐localise	  genome-­‐wide	  at	  thousands	  of	  sites.	  In	  addition,	  this	  co-­‐localisation	  can	  be	  shared	  between	  very	  different	  cell	  types,	  such	  as	  pluripotent	  ES	  cells	  and	  lineage-­‐committed	  pre-­‐B	  cells.	  We	  have	  now	  shown	  that	  the	  frequency	  of	  cohesin	  peaks	  near	  to	  genes	  decreases	  with	  distance	  to	  the	  gene,	  confirming	  previous	  reports	  (Parelho	  et	  al.	  2008).	  Genes	  that	  exhibit	   shared	  cohesin	  and	  CTCF	  sites	   tend	   to	  be	  developmentally	   regulated	  and	  thus	  the	  binding	  of	  cohesin	  and	  CTCF	  is	  independent	  of	  transcription.	  Previous	  work	  in	  our	  lab	  has	  shown	  that	  TH1,	  TH2,	  non-­‐polarised	  CD4-­‐T	  cells	  and	  embryonic	  kidney	  293T	  cells	  exhibit	  binding	  of	  cohesin	  and	  CTCF	  at	  and	  in	  the	  vicinity	  of	  the	  
IFNG	   locus	  (Hadjur	  et	  al.	  2009).	   Interestingly,	   the	  binding	  of	  cohesin	   in	  TH1	  cells,	  where	  the	  gene	  is	  inducible,	  is	  stronger	  than	  in	  the	  other	  cell	  types	  where	  the	  gene	  is	   non-­‐inducible	   and	   repressed.	   Stronger	   cohesin	   binding	   correlates	   with	   cell-­‐specific	   long-­‐range	   interactions.	   Those	   cohesin	   and	   CTCF	   peaks	   are	   thus	   shared	  between	   different	   cell	   types	   but	   the	   abundance	   correlates	  with	   gene	   expression	  permissibility.	  In	  a	  similar	  way,	  our	  analysis	  shows	  that	  developmentally	  regulated	  genes	   are	   enriched	   for	   shared	   cohesin	   and	   CTCF	   peaks	   although	   we	   have	   not	  assessed	  whether	   the	   abundance	   of	   cohesin	   at	   those	   sites	   is	   stronger	   when	   the	  genes	  are	  active.	  In	  this	  sense,	  it	  would	  be	  interesting	  to	  know	  whether	  there	  is	  a	  correlation	  between	  the	  enrichment	  of	  cohesin	  (“height”	  of	  the	  cohesin	  peaks)	  and	  gene	  expression.	  Also,	  as	  gene	  expression	  is	  also	  driven	  by	  epigenetic	  factors,	  such	  as	   histone	  modifications,	   it	  would	   be	   interesting	   to	   know	  whether	   the	   height	   of	  cohesin	   peaks	   and	   in	   more	   general	   terms,	   cohesin	   binding,	   correlates	   with	  deposition	  of	  post-­‐translational	  modifications	  of	  histones,	   for	   instance	  H3K4me3,	  etc.	  	  	   Genes	  with	  cell-­‐type-­‐specific	  cohesin	  sites	  also	  tend	  to	  be	  developmentally	  regulated.	   There	   is	   a	   clear	   correlation	   of	   cell-­‐type-­‐specific	   cohesin	   and	   CTCF	  binding	  with	  cell-­‐type-­‐specific	  gene	  expression.	  This	   is	  also	  true	   for	  cohesin	  non-­‐CTCF	  peaked	  genes.	  Altogether,	   these	  results	  clearly	  point	   to	  a	   role	  of	  cohesin	   in	  regulating	  gene	  expression	  in	  mammalian	  cells.	  Indeed,	  cohesin	  removal	  in	  ES	  cells	  using	   conditional	   knockout	   ES	   cells	   results	   in	   hundreds	   of	   genes	   being	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misregulated,	  positively	  and	  negatively.	  The	  genes	  that	  change	  tend	  to	  be	  enriched	  in	  genes	  that	  are	  bound	  by	  shared	  cohesin	  and	  CTCF	  sites,	  ES-­‐specific	  cohesin	  and	  CTCF	  sites	  and	  ES-­‐specific	  cohesin	  non-­‐CTCF	  sites	  but	  not	  in	  genes	  bound	  by	  pre-­‐B-­‐specific	   cohesin	   and	   CTCF	   peaks	   or	   pre-­‐B-­‐specific	   cohesin	   non-­‐CTCF	   peaks.	  While	  we	  were	  performing	  this	  work,	  Kagey	  and	  colleagues	  published	  microarray	  datasets	  of	  ES	  cells	  where	   the	  cohesin	  subunit	  Smc1	  had	  been	  knocked	  down	  by	  shRNA	  during	  five	  days	  (Kagey	  et	  al.	  2010).	  Since	  cohesin	  depletion	  is	  deleterious	  for	  cell	  division	  and	  ES	  cells	  cycle	  rapidly,	  removal	  of	  cohesin	  for	  a	  long	  time	  will	  enrich	   the	   cell	   population	   for	   more	   differentiated	   slow-­‐cycling	   cells.	   The	   gene	  expression	   changes	   will	   thus	   be	   biased	   towards	   genes	   expressed	   during	   cell	  differentiation	   and	   development.	   We	   correlated	   the	   binding	   of	   cohesin,	   Nipbl,	  mediator	   and	  RNA	  Pol	   II	  with	   our	   gene	   expression	   changes	   and	   the	  Kagey	   gene	  expression	  changes	  and	  saw	  that	  our	  dataset	  correlates	  better	  with	  the	  binding	  of	  cohesin,	  Nipbl,	  mediator	  and	  RNA	  pol	  II	  independently	  of	  CTCF,	  suggesting	  that	  our	  genetic	  approach	  seems	  more	  accurate	  to	  detect	  gene	  expression	  changes	  that	  are	  directly	  dependent	  on	  cohesin.	  Moreover,	  genes	  with	  Smc1/Nipbl/Med12	  but	  not	  RNA	   pol	   II	   do	   not	   show	   a	   clear	   correlation	   with	   significant	   gene	   expression	  changes	   in	   our	   microarray	   dataset	   or	   the	   Kagey	   microarray	   dataset.	   Gene	  expression	   changes	   associated	   with	   developmental	   processes	   are	   clearly	   more	  significant	   in	   the	   five-­‐day	   Smc1	   shRNA	   approach	   compared	   to	   fast	   removal	   of	  Rad21	   for	   one	  day.	   These	   effects	   are	  not	   directly	   cohesin-­‐driven,	   or	   at	   least,	   not	  Smc1/Nipbl/Med12/Pol	  II-­‐driven,	  since	  the	  significance	  of	  the	  expression	  changes	  of	   the	   genes	   bound	   by	   Smc1/Nipbl/Med12/Pol	   II	  within	   these	   processes	   is	   low.	  Moreover,	  removal	  of	  cohesin	  for	  such	  a	  long	  time	  activates	  DNA	  repair	  pathways	  and	   generates	   cellular	   stress,	   processes	  which	   are	   clearly	   enriched	   in	   the	   Kagey	  microarray	   dataset	   but	   not	   in	   our	   microarray	   dataset.	   Since	   ES	   cells	   subject	   to	  stress	   tend	   to	   differentiate,	   the	   Kagey	   microarray	   dataset	   will	   again	   be	   biased	  towards	  genes	  that	  are	  expressed	  in	  differentiated	  cells.	   	  Altogether,	  these	  results	  indicate	   that	   the	  authors’	   conclusion	  of	   the	  role	  of	   cohesin	   in	  maintaining	   the	  ES	  cell	   expression	   program	   and	   that	   removal	   of	   cohesin	   pushes	   the	   cell	   towards	  differentiation	   might	   be	   based	   on	   indirect	   effects	   of	   cohesin	   removal	   in	   cycling	  cells.	   In	  this	  sense,	  we	  consider	  that	  the	  genetic	  approach	  we	  have	  undertaken	  is	  
 178	  
more	   sensible	   in	   the	  understanding	  of	   the	  direct	   involvement	  of	   cohesin	   in	   gene	  expression.	  	  	  	   4.4.2.	  Cohesin	  regulates	  thymocyte	  differentiation	  and	  Tcrα 	   	  
	   	   rearrangement	  	  	   Successful	   rearrangement	   of	   the	   Tcrα	   locus	   is	   critical	   for	   proper	  differentiation	   of	   CD4+CD8+	   DP	   thymocytes	   into	   CD4+CD8-­‐	   SP	   and	   CD4-­‐CD8+	   SP	  thymocytes.	  We	  were	  interested	  in	  understanding	  the	  role	  of	  cohesin	  in	  regulating	  this	  process.	   	   For	   this,	  we	  have	   created	  Rad21	   conditional	   knockout	  mice	  where	  Cre	  recombinase	  is	  under	  the	  control	  of	  the	  CD4	  promoter.	  In	  this	  way,	  upon	  Cre	  expression	   in	   CD4+CD8+	   DP	   thymocytes,	   Rad21	   is	   properly	   deleted	   at	   the	   small	  stage	   of	   CD4+CD8+	   DP	   thymocytes.	   Cohesin-­‐depleted	   CD4+CD8+	   DP	   thymocytes	  show	  impaired	  differentiation	  towards	  CD4+CD8-­‐	  SP	  and	  CD4-­‐CD8+	  SP	  thymocytes,	  not	   because	   of	   increased	   cell	   death.	   We	   have	   mapped	   cohesin	   binding	   sites	   in	  CD4+CD8+	   DP	   thymocytes	   and	   found	   a	   strikingly	   high	   number	   of	   cohesin	   sites	  compared	  to	  ES	  cells	  and	  pre-­‐B	  cells.	  It	  would	  be	  interesting	  to	  know	  whether	  the	  genes	   that	   are	   bound	   by	   cohesin	   only	   in	   DP	   thymocytes	   are	   expressed	   in	  thymocytes	  and	  not	   in	  ES	  cells	  or	  pre-­‐B	  cells.	  Cohesin	   is	  also	  bound	  to	   important	  locations	  of	  the	  Tcrα	  locus.	  It	  binds	  between	  the	  housekeeping	  gene	  Dad1	  and	  the	  Ea	  enhancer,	  critical	  for	  expression	  from	  the	  TEA	  promoter.	  This	  cohesin	  site	  has	  been	   described	   to	   have	   CTCF-­‐dependent	   insulator	   function.	   Indeed,	   the	   ratios	  between	   the	  expression	  of	   the	   constant	   region	  Cα	   and	  Dad1	   are	  perturbed	  upon	  cohesin	   depletion.	   Cohesin	   also	   binds	   between	   the	   Ed	  enhancer	   and	   the	   TEA	  promoter.	   	   Upon	   cohesin	   depletion	   in	   CD4+CD8+	   DP	   thymocytes,	   the	   pattern	   of	  transcription	  across	  the	  Ja	  elements	  changes	  and	  transcription	  is	  skewed	  towards	  the	  proximal	  elements.	  Lower	  transcription	  across	  the	  distal	  Ja	  elements	  results	  in	  defective	   deposition	   of	   H3K4me3,	   which	   in	   its	   turn,	   results	   in	   defective	  recruitment	   of	   Rag	   recombinases,	   and	   thus	   less	   double	   strand	   breaks	   and	   less	  rearrangement	  of	   the	  distal	  elements.	  Lower	   transcription	  precedes	  all	   the	  other	  events	  as	  Rag1/Rad21	  conditional	  double	  knockouts	  also	  exhibit	  less	  transcription	  and	  H3K4me3	  deposition	  across	  the	  distal	  elements.	  Moreover,	  cohesin	  is	  essential	  
 179	  
for	  the	  interaction	  between	  the	  Ea	  	  enhancer	  and	  the	  TEA	  promoter	   in	  CD4+CD8+	  DP	   thymocytes.	   In	   this	   sense,	   we	   have	   proven	   that	   cohesin	   is	   essential	   for	   the	  proper	   architecture,	   transcription	   and	   rearrangement	   of	   the	  Tcrα	   locus	   to	   allow	  proper	  progression	  of	  CD4+CD8+	  DP	   thymocytes	   into	  CD4+CD8-­‐	  SP	  and	  CD4-­‐CD8+	  SP	   thymocytes.	   This	   system	   provides	   a	   good	   example	   of	   cohesin	   regulation	  independent	  of	  its	  role	  in	  chromatid	  cohesion	  and	  DNA	  repair.	  
	  
	   4.4.3.	  Cohesin	  regulates	  different	  steps	  of	  the	  XCI	  process.	  	  	   Xist,	  Tsix	   and	  Rnf12	  are	   three	  major	   regulators	  of	  XCI.	  Their	  expression	   is	  tightly	  controlled	  in	  ES	  cells	  and	  during	  differentiation	  of	  ES	  cells.	  Different	  factors	  play	  a	  role	  in	  XCI,	  such	  as	  the	  pluripotency	  factors	  Oct4,	  Nanog,	  Sox2	  and	  Rex1,	  and	  CTCF.	   Oct4,	   Nanog,	   Sox2	   and	   Rex1	   have	   been	   implicated	   in	   the	   transcriptional	  regulation	  of	  Xist,	  Tsix	  and	  Rnf12	  (Navarro	  et	  al.	  2008,	  2010,	  2011).	  CTCF	  has	  been	  implicated	  in	  the	  regulation	  of	  Xist	  and	  Tsix	  in	  differentiating	  male	  ES	  cells	  and	  in	  X	  chromosome	   pairing	   (Donohoe	   et	   al.	   2007;	   N.	   Xu	   et	   al.	   2007).	   We	   set	   out	   to	  investigate	  the	  role	  of	  cohesin	  in	  regulating	  the	  different	  stages	  of	  the	  XCI	  process	  in	   ES	   and	   differentiating	   ES	   cells.	   So	   far,	   no	   study	   has	   implicated	   cohesin	   in	   the	  regulation	  of	  Xist,	  Tsix	  and	  Rnf12.	  ChIP-­‐seq	  data	  and	  ChIP-­‐qPCR	  analysis	  show	  that	  cohesin	  binds	  just	  upstream	  and	  downstream	  of	  the	  Xist	  promoter	  and	  within	  the	  gene	   body	   in	   differentiated	   cells	   pointing	   to	   a	   role	   of	   cohesin	   in	   regulating	   its	  expression	  (see	  section	  3.5.2.).	  Using	  knockdown	  and	  genetic	  knockout	  strategies	  to	   deplete	   cohesin	   in	   female	   and	  male	   ES	   cells,	   we	  were	   able	   to	   study	  whether	  cohesin	  is	  involved	  in	  the	  regulation	  of	  the	  X-­‐inactivation	  players.	  	  	   Knockdown	  of	  Rad21	  in	  male	  ES	  cells	  does	  not	  change	  the	  expression	  of	  Xist	  and	  Tsix.	   This	   result	   has	   been	   confirmed	  with	   genetic	   studies	   using	  male	   Rad21	  conditional	  knockout	  ES	  cells.	  Cohesin	  is	  not	  fully	  depleted	  in	  the	  systems	  that	  we	  have	  used	   implying	   there	  will	  always	  be	  residual	  amounts	  of	  cohesin	   in	   the	  cells	  that	  might	  be	  sufficient	  to	  exert	  normal	  regulation	  of	  the	  targets	  we	  are	  currently	  investigating.	   Conversely,	   upon	   cohesin	   depletion	   in	   female	   cells	   using	   the	  conditional	   knockout	   system,	   Rnf12	   is	   upregulated	   two-­‐fold	   while	   Xist	   is	  upregulated	  almost	   two-­‐fold.	  On	   the	   contrary,	  Tsix	   expression	   is	  unmodified.	  We	  have	  shown	  that	  removal	  of	  cohesin	  results	  in	  cell	  stress	  and	  eventually	  death.	  Cell	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stress	  caused	  by	  doxorubicin	  results	  in	  decreased	  Nanog	  expression	  in	  blastocysts	  (T.	   Lin	   et	   al.	   2005).	   Partial	   suppression	   of	   Nanog	   expression	   will	   push	   cells	  towards	   differentiation.	   Although	   our	   time	  window	   of	   24h	  minimises	   cell	   stress	  and	   reduces	   cohesin	   by	   80%,	   it	   is	   possible	   that	   cells	   do	   stress	   and	   start	  differentiating,	   thus	   increasing	   the	   expression	   of	   Rnf12	   and	   Xist.	   In	   addition,	   if	  cohesin	   regulates	   the	   expression	   of	   the	   pluripotency-­‐associated	   factors	   such	   as	  Oct4,	  Nanog,	  etc,	  depletion	  of	  cohesin	  will	  push	  cells	  towards	  differentiation	  too.	  In	  our	  system,	  we	  do	  observe	  a	  down-­‐regulation	  of	  Nanog	  but	  not	  of	  Oct4	  and	  Rex1.	  Very	   recently,	   Navarro	   and	   colleagues	   have	   shown	   that	   Nanog,	   Oct4	   and	   Sox2	  negatively	  regulate	  Rnf12	  (Navarro	  et	  al.	  2011).	  In	  their	  system,	  only	  forced	  down-­‐regulation	  of	  Nanog	  to	  less	  than	  1%	  of	  normal	  levels	  shows	  a	  significant	  two-­‐fold	  upregulation	  of	  Rnf12.	  In	  our	  scenario,	  Nanog	  is	  reduced	  by	  a	  much	  lesser	  extent,	  i.e.	   by	  20%.	  This	  decrease	   in	  Nanog	  would	  not	  be	   sufficient	   to	  upregulate	  Rnf12	  two-­‐fold.	   Altogether,	   these	   results	   suggest	   that	   cohesin	   directly	   regulates	   Rnf12	  and	   that	   the	   upregulation	   of	   Rnf12	   that	  we	   are	   detecting	   is	   due	   to	   depletion	   of	  cohesin	  and	  not	  of	  the	  pluripotency	  associated	  factors.	  Indeed,	  cohesin	  binds	  10Kb	  upstream	  of	  the	  Rnf12	  promoter	  in	  male	  ES	  cells.	  A	  corollary	  of	  this	  result	  is	  that	  overexpression	   of	   cohesin,	   as	   with	   Nanog,	   in	   ES	   cells	   would	   produce	   a	   down-­‐regulation	  of	  Rnf12.	  Similarly,	  another	  system	  could	  be	  envisaged	  where	  cohesin	  is	  not	  allowed	  to	  unload	  from	  chromatin	  during	  interphase,	  such	  as	  Wapl-­‐/-­‐	  cells	  for	  instance.	  Of	  course,	  additional	  unknown	  factors	  involved	  in	  the	  regulation	  of	  Rnf12	  cannot	   be	   excluded.	   	   The	   fact	   that	   we	   see	   an	   upregulation	   of	   Xist	   does	   not	  necessarily	  mean	  the	  cells	  have	  started	  to	  inactivate	  the	  chromosome.	  It	  would	  be	  interesting	  to	  use	  RNA-­‐FISH	  and	  test	  whether	  this	  increase	  in	  Xist	  is	  due	  to	  a	  very	  small	  part	  of	  the	  population	  creating	  clouds	  on	  the	  inactive-­‐to-­‐be	  X	  chromosome	  or	  not.	  	   Strikingly,	   depletion	   of	   cohesin	   in	   24h-­‐differentiating	   ES	   cells	   does	   not	  result	   in	  an	   increase	   in	  Rnf12,	  whether	   the	   cells	   are	   female	  or	  male.	   In	  addition,	  Rex1	   expression	   is	   downregulated.	   On	   the	   contrary,	   expression	   of	   Xist	   is	  upregulated	   in	   both	   female	   and	   male	   cells.	   This	   effect	   on	   Xist	   is	   thus	   Rnf12-­‐independent	  and	  may	  be	  directly	  due	  to	  cohesin,	  or	  indirectly	  through	  the	  down-­‐regulation	   of	   pluripotency	   factors,	   such	   as	   Rex1.	   We	   know	   that	   cohesin	   is	  specifically	  recruited	  to	  Xist	  in	  male	  differentiated	  cells	  where	  Xist	  is	  not	  expressed	  
 181	  
(Figure	  3.12),	  suggesting	  a	  repressive	  role.	  Were	  cohesin	  recruited	  to	  CTCF	  sites	  at	  the	   Xist	   promoter	   on	   the	   Xa	   in	   24h-­‐differentiating	   ES	   cells,	   removal	   of	   cohesin	  would	  up-­‐regulate	  the	  Xa	  Xist	  in	  both	  female	  and	  male	  cells,	  in	  accordance	  with	  our	  result.	   This	   is	   not	   in	   accordance,	   though,	  with	  Xist	   expression	   being	   unmodified	  upon	  cohesin	  depletion	  after	  three	  days	  of	  differentiation,	  when	  the	  trigger	  of	  XCI	  has	  taken	  place.	  This	  excludes	  a	  role	  for	  cohesin	  in	  maintaining	  the	  expression	  of	  
Xist	  in	  differentiating	  female	  ES	  cells	  when	  XCI	  has	  been	  triggered.	  	   CTCF	  and	  cohesin	  have	  been	  postulated	  to	  act	  as	  chromatin	  boundaries.	  The	  Xi	  constitutes	  an	  ideal	  system	  to	  study	  the	  role	  of	  cohesin	  in	  chromatin	  boundary	  formation	  due	  to	  the	  presence	  of	  XCI	  escapees.	  Escapees	  are	  expressed	  from	  both	  X	  chromosomes	  and	  are	  embedded	  within	  large	  heterochromatic	  areas	  (F.	  Yang	  et	  al.	  2010).	  We	  hypothesised	  that	  removal	  of	  the	  chromatin	  boundary	  would	  result	   in	  extinguishment	  of	  the	  escapees’	  expression	  from	  the	  Xi.	  We	  have	  used	  thymocytes	  and	   ES-­‐differentiated	   neurons	   as	   two	   systems	  where	   XCI	   has	   been	   achieved	   but	  might	   still	   be	  plastic	   and	  mitotic-­‐related	   cohesin	  effects	   can	  be	  avoided	  by	  using	  cells	   arrested	   in	  G1.	  Removal	  of	   cohesin	   in	   female	   thymocytes	  does	  not	   result	   in	  decreased	   expression	   of	   several	   escapees,	  when	   analysed	   by	   qPCR	  with	   primers	  detecting	   stable	   spliced	   mRNA	   molecules,	   indicating	   that	   cohesin	   is	   not	  participating	  in	  boundary	  formation	  around	  these	  escapees.	  On	  the	  other	  hand,	  it	  is	  possible	  that	  the	  primary	  transcript	  is	  misregulated	  and	  we	  are	  not	  able	  to	  detect	  this	  change	  with	  the	  primers	  we	  have	  used.	  Analysis	  of	  primary	  transcripts	  would	  solve	   this	   issue.	   Moreover,	   were	   these	   genes	   truly	   escapees	   in	   thymocytes,	   we	  should	   have	   been	   able	   to	   detect	   increased	   RNA	   levels	   in	   females	   compared	   to	  males.	  This	  is	  not	  the	  case	  for	  Ddx3x	  in	  CD4+CD8+	  DP	  or	  CD4+CD8-­‐	  SP	  thymocytes,	  but	  is	  true	  for	  Eif2s3x	  in	  both	  systems	  and	  Kdm5c	  only	  in	  CD4+CD8-­‐	  SP	  thymocytes.	  It	   is	   thus	  possible	   that	  previously	  described	  escapees	   in	   fibroblasts	  are	   in	   reality	  not	  escaping	  in	  thymocytes	  (Yang	  et	  al.	  2010).	  This	  is	  sensible	  since	  escapism	  is	  a	  developmentally	   regulated	  phenomenon	  (Sheardown	  et	  al.	  1996).	  By	  using	  RNA-­‐FISH,	  we	  will	  be	  able	  to	  clarify	  the	  expression	  status	  of	  these	  genes.	  	   In	  neurons,	  cohesin	  removal	  results	  in	  down-­‐regulation	  of	  Kdm5c	  in	  female	  cells	   but	   not	   in	   male	   cells,	   suggesting	   a	   possible	   role	   of	   cohesin	   in	   chromatin	  boundary	  formation	  around	  it.	  We	  tried	  to	  confirm	  these	  results	  using	  RNA-­‐FISH.	  RNA-­‐FISH	   in	   neurons	   depleted	   of	   cohesin	   showed	   a	   very	   small	   decrease	   in	   the	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number	  of	  cells	  with	  biallelic	  signals	  for	  the	  escapees	  Kdm5c	  and	  Utx,	  which	  is	   in	  accordance	   with	   the	   qPCR	   results.	   Unexpectedly,	   the	   population	   of	   cells	   with	  monoallelic	   signals	   of	   the	   genes	   subject	   to	   XCI	   Huwe1	   and	   Lamp2	   decreased	  considerably.	   There	   was	   a	   strong	   increase	   in	   the	   number	   of	   cells	   with	   biallelic	  signals.	  Several	  reasons	  could	  be	  at	  the	  base	  of	  these	  changes.	  One	  is	  that	  cohesin	  is	  required	  to	  keep	  the	  X	  chromosome	  in	  an	  inactive	  state.	  The	  Xi	  condenses	  into	  the	  Barr	  body	  and	  RNA	  Pol	  II	  is	  excluded	  (Chaumeil	  et	  al.	  2006).	  If	  cohesin	  is	  required	  for	   the	   condensation	   of	   the	   chromatin	   into	   the	   Barr	   body,	   it	   is	   possible	   that	  removal	   “opens	   up”	   the	   chromatin	   and	   the	   RNA	   Pol	   II	   is	   allowed	   to	   enter.	  Unexpectedly,	  expression	  of	  Xist	  was	  reduced	  upon	  cohesin	  depletion.	  It	  would	  be	  interesting	  to	  know	  whether	  this	  translates	  into	  cells	  having	  less	  Xist	  clouds	  than	  in	   the	   control	   cells,	   or	   showing	   more	   of	   a	   “diffuse”	   pattern	   of	   clouds.	   Another	  reason	   for	   gene	   expression	   coming	   from	   the	   Xi	   might	   be	   due	   to	   cohesin	   being	  necessary	   for	   the	   process	   of	   inactivation	   of	   X-­‐linked	   genes.	   The	   status	   of	   the	   X	  chromosome	   at	   day	   9,	   when	   the	   cells	   are	   treated	   with	   4’OHT,	   is	   unknown.	  Potentially,	  if	  not	  all	  cells	  have	  fully	  inactivated	  the	  chromosome	  by	  then,	  cohesin	  might	  be	  necessary	  to	  the	  definitive	  extinguishment	  of	  gene	  expression	  from	  the	  Xi	  and	  thus	  removal	  of	  cohesin	  would	  block	  XCI.	  On	  the	  other	  hand,	  it	  is	  also	  possible	  that	  cohesin	  removal	   is	  more	  toxic	   to	  cells	   that	  are	  more	  differentiated	  and	  have	  fully	  inactivated	  one	  X	  chromosome	  than	  cells	  that	  are	  less	  differentiated	  and	  have	  not	  inactivated	  the	  X	  chromosome	  yet.	  By	  removing	  cohesin,	  we	  would	  be	  selecting	  a	   specific	   cell	   population	   that	   has	   not	   fully	   accomplished	   XCI,	   as	   per	   gene	  expression.	   IF	   for	   Nestin	   and	   TUJ-­‐1,	   markers	   of	   neural	   progenitors	   and	   fully	  differentiated	  neurons	  respectively,	  would	  answer	  this	  question.	  	   Excluding	   the	   selection	   process,	   these	   results	   suggest	   that	   depletion	   of	  cohesin	  affects	  gene	  expression	  on	  the	  Xi	  in	  a	  “chromosome-­‐wide”	  fashion.	  Huwe1	  and	   Lamp2	   are	   located	   112Mb	   apart	   (the	   mouse	   X	   chromosome	   is	   167Mb	  long)(Figure	   1.6).	   On	   the	   other	   hand,	   local	   mechanisms	   whereby	   euchromatic	  areas	  generated	  by	  escapees	  affect	  neighbouring	  genes	  cannot	  be	  discarded	  since	  
Huwe1	   is	  relatively	  close	  to	  kdm5c,	  300Kb.	  Nevertheless,	   ignoring	  unknown	  close	  escapees,	   Lamp2	   is	   located	   15Mb	   away	   from	   the	   closest	   known	   escapee,	  
67020401G13Rik,	   suggesting	   that	   the	  mechanism	   for	   increased	   biallelicity	  might	  not	  be	  local,	  but	  chromosome-­‐wide.	  
 183	  
	   Recently,	   it	   has	   been	   demonstrated	   that	   reactivation	   of	   the	   paternal	   X	  chromosome	   during	   ICM	   formation	   precedes	   loss	   of	   Xist	   coating	   and	   loss	   of	  H3K27me3	  mark,	  characteristic	  of	  the	  Xi,	  concluding	  that	  gene	  expression	  from	  the	  Xi	   is	  compatible	  with	  repressive	  histone	  modifications	  and	  Xist	   coating	  (Williams	  et	  al.	  2011).	  Although	  the	  reactivation	  mechanisms	  of	   the	   inactive	  Xp	  during	  ICM	  formation	  and	  the	  mechanisms	  of	  random	  XCI	  during	  ES	  cell	  differentiation	  might	  be	  different,	   it	   is	  possible	   that	  gene	  expression	  coming	   from	  the	  Xi	  upon	  cohesin	  removal	  is	  not	  H3K27me3	  dependent.	  Indeed,	  H3K27me3	  and	  H4K20me1,	  another	  mark	  characteristic	  of	  the	  repressed	  Xi,	  are	  not	  modified	  at	  the	  Huwe1	  and	  Lamp2	  promoters	  upon	  cohesin	  removal	  in	  neurons.	  In	  addition,	  H3K4me3,	  characteristic	  of	  active	  promoters,	  was	  not	  modified	  either.	  This	  excludes	  histone	  modifications	  as	  a	  mechanism	  to	  explain	  the	  increase	  in	  expression	  from	  the	  Xi.	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Chapter	   5:	   General	   discussion	   and	   future	  
perspectives.	  	  	  	   In	   order	   to	   understand	   the	   potential	   implications	   of	   cohesin	   in	   gene	  regulation,	  we	  have	  generated	  genome-­‐wide	  maps	  of	   cohesin	   in	  pluripotent	  cells	  and	   lineage-­‐committed	   cells	   using	   ChIP-­‐seq.	   We	   have	   confirmed	   that	   cohesin	  binding	  overlaps	  substantially	  with	  CTCF	  binding	  in	  different	  cell	  types.	  However,	  a	   subset	   of	   cohesin	   sites	   is	   CTCF-­‐independent,	   confirming	   previous	   reports	  (Schmidt	  et	  al.	  2010;	  Kagey	  et	  al.	  2010;	  Nitzsche	  et	  al.	  2011).	  We	  validated	  some	  of	  these	   peaks	   and	   discovered	   that	   CTCF	   is	   enriched	   at	   cohesin	   non-­‐CTCF	   sites.	  Nitzsche	  and	  colleagues	  report	  that	  the	  majority	  of	  cohesin	  non-­‐CTCF	  sites	  exhibit	  the	   CTCF	   binding	   motif	   and	   only	   a	   small	   minority	   have	   cell-­‐type-­‐specific	  transcription	   factor	   binding	   motifs	   (Nitzsche	   et	   al.	   2011).	   It	   is	   possible	   that	   we	  have	  selected	   for	  validation	  cohesin	  non-­‐CTCF	  peaks	   that	  have	   the	  CTCF	  binding	  motif.	  We	  will	  expand	  the	  validation	  and	  confirmation	  of	  this	  particular	  subset	  of	  cohesin	  sites	   to	  sites	   that	  do	  not	  exhibit	   the	  CTCF	  binding	  motif.	  Moreover,	  were	  the	  cell-­‐type-­‐specific	  transcription	  factors	  recruiting	  cohesin	  to	  those	  cohesin	  non-­‐CTCF	   sites	  with	  no	  CTCF	  binding	  motif,	   removal	   of	   these	   factors	  would	   result	   in	  loss	   of	   cohesin	   binding.	   Oct4	   depletion	   has	   no	   effect	   on	   cohesin	   recruitment	   to	  cohesin	   Oct4-­‐positive	   non-­‐CTCF	   sites.	   Usage	   of	   Nanog	   conditional	   knockout	   ES	  cells	   would	   help	   us	   clarify	   whether	   CTCF-­‐independent	   cohesin	   binding	   can	   be	  Nanog	  driven,	  since	  Nanog	  and	  Stag1	  interact	  (Nitzsche	  et	  al.	  2011).	  	  	   Upon	  comparison	  of	   the	  cohesin	  binding	  profile	   in	  different	   cell	   types,	  we	  have	  reported	  that	   the	  majority	  of	  cohesin	  binding	  events	   is	  shared	  between	  cell	  types	  but	  that	  it	  can	  also	  be	  developmentally	  regulated.	  Developmental	  regulation	  of	   cohesin	   binding	   is	   CTCF-­‐dependent	   and	   CTCF-­‐independent	   as	   well.	   Indeed,	  cohesin	  non-­‐CTCF	  sites	  tend	  to	  be	  cell-­‐type	  specific.	  Moreover,	  cohesin	  binding	  can	  be	  developmentally	  regulated	  at	  CTCF	  sites	  that	  are	  not.	  It	  has	  been	  reported	  that	  Oct4	  antagonises	  cohesin	  at	  some	  CTCF	  sites	  in	  ES	  cells.	  Nevertheless,	  this	  does	  not	  happen	  at	  our	  Xic	  sites.	  The	  CTCF	  paralogue,	  BORIS,	  does	  not	  antagonise	  cohesin	  at	  CTCF	  sites	   in	  ES	  cells	  either.	   Indeed,	   increased	  BORIS	  expression	   in	  ES	  cells	  does	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not	  change	  the	  binding	  of	  cohesin	  and	  CTCF	  at	  some	  sites.	  At	  other	  sites,	  mainly	  the	  DMRs	  of	  the	  H19	  and	  the	  Gtl2	  loci,	  BORIS	  even	  increases	  cohesin	  and	  CTCF	  binding,	  possibly	  due	   to	  decreased	   levels	   of	  DNA	  methylation.	  We	  will	   analyse	   additional	  imprinted	  loci,	  such	  as	  Peg3.	  The	  involvement	  of	  BORIS	  in	  DNA	  methylation	  could	  be	   studied	   by	   assessing	   potential	   BORIS	   interaction	   partners	   using	   mass	  spectrometry	   on	   FLAG-­‐BORIS	   pull-­‐downs.	   Eviction	   of	   CTCF	   and	   cohesin	   from	  unknown	  genomic	  positions	  upon	  BORIS	  expression	  and	  binding	  could	  be	   taking	  place.	   We	   will	   thus	   perform	   an	   analysis	   of	   Rad21	   ChIP-­‐seq	   in	   FLAG-­‐BORIS	  expressing	  ES	  cells	  to	  assess	  differences	  in	  cohesin	  binding	  at	  a	  genome-­‐wide	  level.	  In	  addition,	  the	  role	  of	  BORIS	  in	  ES	  cells	  is	  being	  further	  examined	  by	  performing	  functional	   insulation	   assays	   in	   the	   absence	   of	   CTCF.	   In	   collaboration	   with	   Gary	  Felsenfeld,	  although	  our	  data	  support	  that	  BORIS	  does	  not	  recruit	  cohesin	  in	  vivo,	  we	   are	   performing	   biochemical	   studies	   to	   elucidate	  whether	   cohesin	   and	   BORIS	  interact	  in	  vitro.	  We	  will	  expand	  our	  analysis	  of	  the	  genome-­‐wide	  binding	  profile	  of	  BORIS	  to	  assess	  whether	  BORIS	  binds	  to	  selected	  gene	  features,	  such	  as	  promoters,	  exons,	   introns,	   etc.	   Furthermore,	   we	   will	   also	   study	   whether	   BORIS	   binds	   to	   a	  selected	  set	  of	  genes	  in	  ES	  cells,	  e.g.	  expressed	  genes,	  cancer-­‐testis	  genes,	  etc.	  	   We	   have	   overlapped	   genome-­‐wide	   binding	   maps	   of	   cohesin	   with	   cell	  expression	   data	   from	   ES	   cells	   and	   pre-­‐B	   cells	   and	   have	   found	   a	   very	   strong	  correlation	  between	  genes	  that	  are	  differentially	  expressed	  and	  different	  types	  of	  cohesin	  binding	   events.	  Genes	  with	   shared	   cohesin	   and	  CTCF	  binding	   tend	   to	  be	  developmentally	   regulated	   indicating	   that	   shared	   cohesin	   binding	   events	   per	   se	  are	   independent	   of	   transcription.	  Nevertheless,	   as	   has	   been	   reported	  previously,	  differential	  gene	  expression	  might	  be	  dependent	  on	  the	  enrichment	  of	  cohesin	  at	  those	  sites.	  We	  could	  thus	  study	  the	  correlation	  of	  cohesin	  enrichment	  with	  gene	  expression	   and	   different	   epigenetic	   marks,	   such	   as	   H3K4me3,	   H3K27me3,	   etc.	  Rapid	  depletion	  of	  Rad21	  using	  a	  genetic	  approach	  deregulates	  hundreds	  of	  genes	  in	  ES	  cells.	  	  Comparison	  of	  this	  dataset	  with	  a	  published	  dataset	  of	  Smc1	  depletion	  by	  RNAi	   for	   an	  extended	  period	  of	   time	  has	   shown	   that	  our	  approach	   correlates	  better	   with	   genes	   that	   are	   bound	   by	   cohesin,	   Nipbl,	   mediator	   and	   RNA	   Pol	   II,	  proving	   that	   this	   method	   is	   a	   better	   strategy	   to	   study	   which	   genes	   are	   directly	  regulated	  by	  cohesin.	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   We	   have	   assessed	   the	   role	   of	   cohesin	   in	   gene	   regulation	   in	   two	   specific	  developmental	   systems.	   Cohesin	   is	   involved	   in	   the	   Tcrα	   locus	   transcriptional	  control	   through	   long-­‐range	   mediated	   interactions	   between	   regulatory	   regions.	  Cohesin	   depletion	   leads	   to	   impaired	   transcription,	   impaired	   Rag	   recombinases	  recruitment,	   reduced	   recombination	   and	   eventually	   impaired	   thymocyte	  differentiation.	   Involvement	   of	   cohesin	   in	   XCI	   is	   less	   clear.	   Cohesin	   directly	  represses	   Rnf12,	   and	   possibly	   not	   through	   the	   pluripotency-­‐associated	   factors,	  Oct4,	  Nanog	  and	  Sox2.	  An	  experiment	  could	  be	  envisaged	  where	  overexpression	  of	  cohesin	  in	  ES	  cells	  would	  result	  in	  Rnf12	  up-­‐regulation.	  Similarly,	  usage	  of	  Wapl-­‐/-­‐	  or	  Sororin-­‐overexpressing	  cells	  would	  result	  in	  an	  increase	  in	  the	  residence	  time	  of	  cohesin	   on	   chromatin	   and	   possibly	   decreased	   expression	   of	   Rnf12.	   The	  involvement	  of	  cohesin	  in	  the	  regulation	  of	  Xist	  in	  ES	  cells,	  at	  the	  onset	  of	  XCI	  and	  during	  XCI	   is	  not	   clear,	   although	  cohesin	   seems	   to	   repress	  Xist	   through	  Rnf12	   in	  female	  ES	  cells	  or	  directly	  in	  24h-­‐differentiating	  female	  and	  male	  ES	  cells.	  It	  would	  be	   interesting	   to	   know	   what	   the	   binding	   status	   of	   cohesin	   is	   around	   the	   Xist	  promoter	  after	  24h	  of	  differentiation.	  	   We	  have	  also	  shown	  that	  removal	  of	  cohesin	  does	  not	  have	  a	  clear	   impact	  on	   the	   expression	   of	   escapees	   in	   CD4+CD8+	   DP	   thymocytes	   and	   CD4+CD8-­‐	   SP	  thymocytes	   by	   qPCR.	   Possibly,	   the	   genes	   we	   consider	   to	   be	   escapees	   are	   not	  escapees	   in	   thymocytes.	  Consequently,	  we	  will	  perform	  RNA-­‐FISH	  to	  assess	   their	  expression	   status.	   Moreover,	   qPCR	   for	   mature	   mRNAs	   might	   not	   be	   sensitive	  enough	   to	   study	   transcript	   levels	   in	   this	   particular	   case	   since	   qPCR	   on	   ES-­‐differentiated	  neurons	  depleted	  of	  cohesin	  was	  not	  able	  to	  detect	  changes	  in	  mRNA	  levels	   of	   genes	   subject	   to	   XCI	   while	   RNA-­‐FISH	   showed	   a	   strong	   increase	   in	   the	  number	  of	  cells	  with	  biallelic	  signals.	  Primers	  detecting	  primary	  transcripts	  might	  be	  more	  sensitive.	  Indeed,	  cohesin	  depletion	  in	  neurons	  leads	  to	  an	  increased	  cell	  number	  with	  biallelic	  signals	  of	  genes	  subject	  to	  XCI.	  Whether	  cohesin	  is	  necessary	  for	   inactivation,	   for	   the	  process	   of	   inactivation	  or	  whether	   a	   selection	  process	   is	  occurring	  is	  currently	  unknown.	  To	  assess	  whether	  it	  is	  a	  reactivation	  or	  a	  block	  of	  XCI,	  we	  need	  to	  address	  the	  status	  of	  the	  X	  chromosome	  at	  day	  9.	  If	   it	   is	  not	  fully	  inactivated,	   we	   could	   shift	   the	   4’OHT	   treatment	   to	   later	   stages	   in	   the	  differentiation.	  Williams	  and	  colleagues	  suggest	  that	  reactivation	  of	  the	  Xi	  despite	  H3K27me3	   deposition	   and	   Xist	   coating	   might	   be	   due	   to	   inclusion	   of	   the	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transcriptional	  machinery	  within	  the	  X	  chromosome	  as	  a	  consequence	  of	  reduced	  expression	   from	   repeat	   elements	   (L.	  H.	  Williams	   et	   al.	   2011).	  Moreover,	   Splinter	  and	  colleagues	  have	  recently	  shown	  that	  upon	  depletion	  of	  Xist	   in	  female	  neuron	  stem	   cells,	   the	  Xi	   acquires	   a	   conformation	   reminiscent	   of	   the	  Xa,	   although	   genes	  remain	   inactive	   (Splinter	   et	   al.	   2011).	   The	   authors	   demonstrate	   that	   Xist	   is	  necessary	   to	  maintain	  a	  chromosome	  structure	  specific	   to	   the	  Xi.	  Disrupting	   that	  structure	  does	  not	  result	  in	  reactivation	  of	  the	  chromosomes,	  possibly	  due	  to	  DNA	  methylation.	  In	  our	  system,	  DNA	  methylation	  might	  not	  have	  been	  established	  yet	  and	   removal	   of	   cohesin	   might	   result	   in	   “opening”	   of	   the	   Xi	   and	   RNA	   Pol	   II	  recruitment.	  It	  will	  be	  interesting	  to	  study	  the	  binding	  profile	  of	  RNA	  Pol	  II	  at	  the	  promoters	  of	  genes	  subject	  to	  XCI	  upon	  cohesin	  removal	  in	  neurons	  using	  ChIP	  and	  assess	   whether	   it	   is	   increased,	   in	   correlation	   with	   the	   RNA-­‐FISH	   results.	   Using	  imaging	   techniques,	   we	   will	   study	   whether	   Xist	   clouds	   are	   more	   in	   an	   “open”	  conformation	  upon	  cohesin	  removal.	  In	  other	  words,	  we	  will	  study	  the	  compaction	  of	   Xist	   clouds	   upon	   cohesin	   depletion.	   We	   will	   also	   investigate	   what	   the	  transcriptional	   status	   of	   X-­‐linked	   repeat	   elements	   is	   and	   their	   exclusion	   or	   co-­‐localisation	  with	  Xist	  clouds.	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Appendix	  I	  	  	  
Table	  I.i	  Gene	  expression	  qPCR	  primers.	  	   Forward	   Reverse	  
β-­‐actin	   GATATCGCTGCGCTGGTCGT	   AGATCTTCTCCATGTCGTCC	  Ubc	   AGGAGGCTGATGAAGGAGCTTGA	   TGGTTTGAATGGATACTCTGCTGGA	  Ywhaz	   CGTTGTAGGAGCCCGTAGGTCAT	   	  TCTGGTTGCGGAAGCATTGGG	  Rad21	   AGGAAGAAGCTTTTGCGTTG	   CGCTAAGCTGGGCTCTAATG	  CTCF	   GTGGCCAAATTTCATTGTCC	   CGCTCATGAAACACAGCATC	  Boris	   CACCAGCGGCCAATCAGA	   TTGGAGGAAGTGAACGGG	  FlagBoris	  specific	   GACGACGATGACAAGGGAGGTGGT	   CCTCCTCTAGGTCTCCAGGCTTCAA	  Xist	   GCAAGGAAGACAAAGGCTCAAAGAAT	   GGAGAGAGAACCAAATAGAGCAGAAT	  Tsix	   TATACAATACGCATCACACAAAAG	   TACCACTGAGCCACATCCTTAC	  Xist	  RT	  primer	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	   GGCATGAGTAGGGTAGCAGT	  Tsix	  RT	  primer	   TATACAATACGCATCACACAAAAG	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  Rnf12	   CCCCAGGTGAAAGTACTGAGG	   CTCTCCAGCTCTATTTTCATCG	  Oct4	   CCCAAGGTGATCCTCTTCTGCTT	   GAGAAGGTGGAACCAACTCCCG	  Nanog	   GCATCTTCTGCTTCCTGGCAA	   GAACTATTCTTGCTTACAAGGGTCTGC	  Rex1	   GAGCTGAACTCCTAGCCGCCTAGATT	   TTTGGTCAGTGGTATTTGGGGACA	  Sox1	   TGAACGCCTTCATGGTGTGGTC	   GCGCGGCCGGTACTTGTAAT	  Bry	   GCTCTCTCTCCCCTCCACACA	   GCACTCCGAGGCTAGACCAGTT	  Gata4	   GAGGCTCAGCCGCAGTTGCAG	   CGGCTAAAGAAGCCTAGTCCTTGCTT	  Gata6	   GACTCCTACTTCCTCTTCTTCTAATTCAGA	   ACCTGAATACTTGAGGTCACTGTTCTC	  Nestin	   TGAGAACTCTCGCTTGCAGACAC	   GGTCCTCTGGTATCCCAAGGAAATG	  Huwe1	   CCACTCCCAGGATTCCATCTTTTC	   AACCAGAGCTGGAGCAGAAG	  Lamp2	   GTCTCTCGTGCTTTCGCTTC	   TAACCGGAGAGAGGCACATC	  Ddx3x	   ACCCCTATCCCAAACTGCAT	   TCATGACTGGAATGGCTTGT	  Kdm5c	   ACCTCACCCAAGACCTTCCT	   CAGCCCCATACTCCACAGTT	  Eif2s3x	   CTTTATCAGGGGCAGAGCAG	   AGCCTCAGACACCCAGTGTT	  Hprt	   TTGAAATTCCAGACAAGTTTGTTGTTGG	   CCTGCTAATTTTACTGGCAACATCAACA	  2610029G23Rik	   AACACCATCTTTGCACCC	   CTTCCTCTCCTTCTTTGTCCT	  Mdm2	   CTCTGGACTCGGAAGATTACAGCC	   CCTGTCTGATAGACTGTGACCCG	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Table	  I.ii	  ChIP-­qPCR	  primers.	  	   Forward	   Reverse	  17:16298	   AGGACATAGTCGCTTGAGTGATGG	   TTGGGCCAGGCTGGTACTTT	  IL4-­‐6	   TCCAGTCCAGTTCCAAAAGGAGC	   CAGGATGAGGATATGACTAGCTGTGG	  Igf2r-­‐2	   GGTCTCGCCAGCTTGCTATTTC	   TGGCTAGATGTCATTGTGGTGG	  Xist7Na	   TGGCTTGTACTTCCAGATCAT	   AATGTATAAGCAAGCTAGTACGCA	  Ifng1	   AGAAATCTGTCTGAACGGGTGGAG	   GGTCGGTCCTCTGTAAGACAAAACCTAC	  Peak5	   GAGAAGGAGGCACCCTACCCT	   GGTCCTCATACAGAAAGGTGTGCAG	  Peak10	   CCCTACCACTAGTAACTCTCAACCCC	   GAGGGTTTCAGAGCGCTAGACAG	  17:16548	   GGAATGGCTGTCTCCAGAGTTT	   GACCTGAGCAGCAGGACTGACT	  Igf2r-­‐3	   TACCCGGAGAGGACAAGCCA	   GTGCCCTGATCCTTTGAAATGC	  Xist1a	   CGAGGACCTCTGACAAGAAGC	   TGGGCTGTTAGCTCCGTTCT	  Esradsp1	   GTTCCTTCCTTCCCTCTA	   TTCCTCACACCTTCCTTT	  Esradsp2	   GGGGTGAGAAAAGGATGAA	   AAAGGATAGGTCTGTGGG	  Esradsp3	   GCGGAGAACAACAGAGAAG	   TTGGATGGCGGGAGTTAGA	  Esradsp4	   CGGGTTGGCTTTGATGGA	   TATTTGTGGTCGGCGTGG	  Esradsp5	   GAGAAGACCACAAGGAGA	   AGGGTGTGTTTACTGAGA	  Esradsp6	   TGAGTAAGACAGAGCTGGAA	   AGCACTAGTCTGGAAGGAA	  Esradsp7	   GGCTTTCAGTTGCTTTGT	   GTGGGAGAAGGTCTTATGT	  Esradsp8	   CACAGCACAGAAGGTAGA	   GGAGATTTGCATGAGAAAG	  Esradsp9	   GCACTGTCTTACCAACTT	   CCCACAGATAATAGCCAC	  Esradsp10	   CCGTAGTGCTGAAGTGGA	   GGCGATGCTGTAGGTGAGA	  Esradsp11	   GAAGGAATTTGACTGTGGA	   GCTAGACAGAAGTGAGGA	  Esradsp12	   TCACCAGTCTCCAAGCAA	   GCATCACAAAGGAGGTCAA	  Esradsp13	   GCGAATGAAGAACGGAGA	   TGTGGACCAGGCTGTAGA	  Esradsp14	   CCTTGCTCCTGTTTTTGT	   CCAGGTGTGCTTTGTTAT	  Esradsp15	   AGGAGCTGACCAGACTGA	   GGCTGCAAGAGTTGGGTT	  Esradsp16	   CCCTCCCGCTCTTTTATG	   TTTCCCTTGCGCTGTCTC	  preBsp1	   CAGTAGGTGGAGTGCTTT	   GCTTAATACTGAACAACCGT	  preBsp2	   GGTAGGGGGTTTTATGCTT	   TGATTGAGTGTGGATGCTT	  preBsp3	   CTGCCCTCTGCTGTAAAA	   CACATTACTATTCGCCACT	  preBsp4	   ATTATGTCTCCCTCTCCT	   CTCCTGCGAAATCCTTTA	  preBsp5	   GGACACCATCAATACCAAAAAG	   GAAGTGTGAGCAAGACCA	  preBsp6	   GCTTGTTCCTCCTTTTGT	   ACCTCCCCTGTAATCCTA	  preBsp7	   CAATTCCCCAACACCTTTAT	   TTACTACAGCTTCACCGGGTC	  Essp1	   CGAGTGGGTGTTGGAAAGTAT	   TCACGAAAACAAGACACAGGG	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Essp2	   GAGTGAAGGAGGGGAATGGG	   TGGTGAAGAACACGTTGGGG	  Essp3	   CCTGTTGTTTTTGGCCTG	   TGATTGGTCCTGATGCTG	  Essp4	   GTTCCTTCCTTCCCTCTA	   TTCCTCACACCTTCCTTT	  Essp5	   GGGGTGAGAAAAGGATGAA	   AAAGGATAGGTCTGTGGG	  Essp6	   CGGGTTGGCTTTGATGGA	   TATTTGTGGTCGGCGTGG	  Essp7	   GAGAAGACCACAAGGAGA	   AGGGTGTGTTTACTGAGA	  Essp8	   GGCTTTCAGTTGCTTTGT	   GTGGGAGAAGGTCTTATGT	  Essp9	   GCACTGTCTTACCAACTT	   CCCACAGATAATAGCCAC	  Xic	  -­‐16Kb	   TTGAGGCTCTGTCTGGGCAAT	  	   CATCCCTACTTGGAGGCTTT	  Xic	  -­‐7Kb	   CGAGGACCTCTGACAAGAAGC	  	   TGGGCTGTTAGCTCCGTTCT	  Xic	  -­‐5Kb	   GCTTTGTAGGAAGTTCCAAAATCAGC	   GCGGGCTGCTAAGTAGGTGTAGG	  Xic	  +12kb	   ACACAAGATGGCGTCTGT	   TGTGCATGAGTTTTGTCT	  Xic	  +18Kb	   AATTGCCAATGTGCTATGAG	  	   ATAAGGACTACTTAACGGGCTT	  Xic	  +24Kb	   GCAGGCAGAAGAGGTTCACTGG	   	   TGCCAGCTGATTTTACAAAGCCCTG	  Xic	  +30Kb	   AAACAGGACAGATCAAAGGTCTTC	  	   GCATTTGTGCCTGTTGTGTGCA	  Xic	  +34Kb	   TCATGTGACCTGCCCTCTAGT	   CACCCTACCATAATGCACCA	  Xic	  +36Kb	   CCCTACCTGAACCACCTCAATAGT	   AGTTCCCTTTAGGCGTCCCAT	  Xic	  +48Kb	   TGGCTTGTACTTCCAGATCAT	   AATGTATAAGCAAGCTAGTACGCA	  17:16219	   CCCCCAAGTGGTGAGACTCTGTAT	   GGGCTTGATTCCGACTGCAA	  17:16054	   TGAGGAGACTGTGCAGGAGGC	   GGTCTCTGTGAGGCAAGGCTT	  17:16551	   CCATTAGCCCTATGTATCCACTCC	   CCAAAGACCACTGAACCAACAGAG	  CD8-­‐85	   GGCTACTAGCTCCCCCCAAACACTA	   CCAGGCTGGTCTAAAACTTGTG	  CD4-­‐2	   AAACTCCCTGTCAGCAGCATCAG	   TGAGAGAAGGGAGCCCCTAGTG	  CD4-­‐11	   TAAAGCAAGCAACTCAGGACGC	   GTCTGCTGATTGGCCATCACTCT	  Ifng4	   ATCAAGCTGCCTCCCGTATGTGTT	   CCCCTTATGGTCCAGGCCTCT	  Nav5	   CCCTACCTGAACCACCTCAATAGT	   AGTTCCCTTTAGGCGTCCCAT	  Nav11	   TCATGTGACCTGCCCTCTAGT	   CACCCTACCATAATGCACCA	  CD4-­‐3	   GGATCCTGTCAGCTTTGCTCTCTC	   GAGGTAGCATGTCTCAGGGTTCAG	  IL4-­‐15	   GCATGCAGTCAATGCCCTCACAC	   GGGTTCTCTCCTCTCGATTCCTTCC	  17:16114	   CCTTCAAGGACAAACTGCCCTA	   GGGTGTCTGTCTGTGTGTTCCTATGT	  17:16137	   GTGGGAGTCAAAACCAACTGTCAG	   CCCAGAGCAGCCAAGACTATTACA	  CD8-­‐50	   GTGTGCTCCTGGGTGTTCAGAT	   TGAGTTCAACTCCCAGCCCAC	  CBS5	   CGACTGCTGCTCACACAAAT	   AATTCCAGGAGATGGCAGTG	  Xist4BCella	   AAACAGGACAGATCAAAGGTCTTC	   GCATTTGTGCCTGTTGTGTGCA	  H19ICRMS4a	   ATGCTATGCCTGAGTGAC	   GGTAAGACCGAAGTTGCC	  H19ICRMS1A	   GCTCTTTAGGTTTGGCGC	   CCATGCCCTATTCTTGGA	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Gtl2DMR2a	   CCCCCCAAGCCTGAAACCTGTT	   AAGACTCCAATAGCCCAACCACCT	  BAG1Borisd	   AATTGACACCAGAGCGAC	   CTTGGGTTTCGCTTTTCC	  Borisproma	   GAAAGGGGTGGAGCCAAGGAGA	   CCACTCCCAGGATTCCATCTTTTC	  esBoradsp1	   CTCTACCCACAACCTCAC	   GTTCTGCTTCCCACTCCA	  esBoradsp2	   CGCGCTTCTATACTTTGTT	   GCTGCTCTTTCCCTTTCC	  esBoradsp3	   TAGTAGCGTAGCCGGAGT	   GATCTTTCCTCACCCGGT	  esBoradsp4	   GGTGGGCTCTGTCTATTT	   TCTTTCCCCAGTTTGCTTT	  esBoradsp5	   GCGGCAAGAAGAAAGTGT	   TCGGCCACTCACCATCATA	  esBoradsp6	   GTTTCCGCTGGTGTCTAT	   TCCGTCCTCCAAAGAGTT	  esBoradsp7	   GTTCTTGTCCATGGTGCT	   TTGGCCACCCTCTGATGTA	  esBoradsp8	   TGCACTTGGAGCCAGAAA	   CACAAGTGGCGGACATAA	  Oct4	   GTGAGCCGTCTTTCCACCAGG	   GGGTGAGAAGGCGAAGTCTGAA	  Gapdh	   CCCCAGATCCAGAAAGGTCACAC	   GGCCAGGATGTAAAGGTCATTAAGAGG	  Huwe1	  Prom	   CCGCCTTTCTCCTTTTTAGG	   GCCGAGACCTTCGTAATTCA	  Huwe1	  Int1	   TCATAATTATTGCGCGCTTG	   CCACCTCGGATCAAGAAAAA	  Lamp2	  Prom	   TAACCGGAGAGAGGCACATC	   GTCTCTCGTGCTTTCGCTTC	  Lamp2	  Int1	   GCACATGCCTTTACTCAGCA	   CCCCAAACCAGGGTTATTCT	  Kdm5c	  Prom	   ACTGGCCTTTAAACGTGCAT	   CATTGGCGGAAGAACAAAAT	  Utx	  Prom	   CCTCCATTCTCTGCCTGTGT	   TCTGTCCGGAGTAGGGTTGT	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